date generated: 2022-06-06
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Here is the first few lines of the input profile.
## x
## -468.74375579
## A1BG -0.19116969
## A1CF 1.55834102
## A2M -0.29772738
## A3GALT2 1.30005608
## A4GALT 0.01967718
Here are some metrics about the input data profile:
| Profile metrics | |
|---|---|
| num_genesets | 2408 |
| num_genes_in_profile | 16477 |
| duplicated_genes_present | 0 |
| num_profile_genes_in_sets | 8847 |
| num_profile_genes_not_in_sets | 7630 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
| Gene sets metrics | |
|---|---|
| num_genesets | 2408 |
| num_genesets_excluded | 1004 |
| num_genesets_included | 1404 |
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Significance is calculated by -log10(p-value). Top N sets shown irrespective of FDR.
| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| Major pathway of rRNA processing in the nucleolus and cytosol | 148 | 7.55e-15 | -0.3700 | 1.06e-11 |
| SRP-dependent cotranslational protein targeting to membrane | 83 | 2.52e-14 | -0.4840 | 1.24e-11 |
| rRNA processing in the nucleus and cytosol | 155 | 2.66e-14 | -0.3540 | 1.24e-11 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | 72 | 1.15e-12 | -0.4850 | 3.56e-10 |
| Peptide chain elongation | 60 | 1.66e-12 | -0.5270 | 3.56e-10 |
| Eukaryotic Translation Termination | 63 | 1.73e-12 | -0.5140 | 3.56e-10 |
| Viral mRNA Translation | 60 | 1.88e-12 | -0.5260 | 3.56e-10 |
| Selenocysteine synthesis | 63 | 2.03e-12 | -0.5120 | 3.56e-10 |
| Metabolism | 1845 | 2.70e-12 | 0.0997 | 3.92e-10 |
| Eukaryotic Translation Elongation | 63 | 2.79e-12 | -0.5090 | 3.92e-10 |
| Cap-dependent Translation Initiation | 87 | 9.53e-12 | -0.4230 | 1.12e-09 |
| Eukaryotic Translation Initiation | 87 | 9.53e-12 | -0.4230 | 1.12e-09 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | 65 | 1.98e-11 | -0.4810 | 2.01e-09 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | 81 | 2.00e-11 | -0.4310 | 2.01e-09 |
| Formation of a pool of free 40S subunits | 71 | 2.96e-11 | -0.4560 | 2.77e-09 |
| L13a-mediated translational silencing of Ceruloplasmin expression | 79 | 3.62e-11 | -0.4310 | 3.18e-09 |
| The citric acid (TCA) cycle and respiratory electron transport | 150 | 6.21e-11 | 0.3090 | 5.13e-09 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 83 | 1.19e-10 | -0.4090 | 8.76e-09 |
| Nonsense-Mediated Decay (NMD) | 83 | 1.19e-10 | -0.4090 | 8.76e-09 |
| rRNA processing | 176 | 1.45e-09 | -0.2650 | 1.01e-07 |
| Metabolism of lipids | 669 | 2.49e-09 | 0.1360 | 1.67e-07 |
| Regulation of expression of SLITs and ROBOs | 133 | 2.86e-09 | -0.2980 | 1.82e-07 |
| Metabolism of RNA | 604 | 2.49e-08 | -0.1330 | 1.52e-06 |
| Influenza Viral RNA Transcription and Replication | 103 | 4.97e-08 | -0.3110 | 2.91e-06 |
| Formation of the ternary complex, and subsequently, the 43S complex | 42 | 4.75e-07 | -0.4490 | 2.67e-05 |
| Influenza Infection | 120 | 6.95e-07 | -0.2620 | 3.75e-05 |
| Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. | 102 | 7.85e-07 | 0.2830 | 4.08e-05 |
| Mitochondrial Fatty Acid Beta-Oxidation | 34 | 9.41e-07 | 0.4860 | 4.72e-05 |
| Selenoamino acid metabolism | 84 | 1.09e-06 | -0.3080 | 5.17e-05 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | 106 | 1.11e-06 | -0.2740 | 5.17e-05 |
| Fatty acid metabolism | 160 | 1.41e-06 | 0.2210 | 6.40e-05 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | 48 | 2.23e-06 | -0.3950 | 9.77e-05 |
| Citric acid cycle (TCA cycle) | 22 | 2.43e-06 | 0.5800 | 1.03e-04 |
| Respiratory electron transport | 83 | 2.51e-06 | 0.2990 | 1.04e-04 |
| Signaling by ROBO receptors | 178 | 2.76e-06 | -0.2040 | 1.10e-04 |
| Ribosomal scanning and start codon recognition | 48 | 2.82e-06 | -0.3910 | 1.10e-04 |
| Pyruvate metabolism and Citric Acid (TCA) cycle | 52 | 4.40e-06 | 0.3680 | 1.67e-04 |
| Translation initiation complex formation | 47 | 4.56e-06 | -0.3870 | 1.68e-04 |
| Bile acid and bile salt metabolism | 37 | 1.16e-05 | 0.4170 | 4.19e-04 |
| Adaptive Immune System | 643 | 2.24e-05 | -0.0985 | 7.85e-04 |
| Transport of small molecules | 656 | 3.34e-05 | 0.0954 | 1.14e-03 |
| Peroxisomal lipid metabolism | 27 | 3.54e-05 | 0.4600 | 1.18e-03 |
| Synthesis of bile acids and bile salts | 29 | 6.39e-05 | 0.4290 | 2.09e-03 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | 19 | 8.00e-05 | 0.5230 | 2.55e-03 |
| Separation of Sister Chromatids | 157 | 1.67e-04 | -0.1740 | 5.20e-03 |
| Generation of second messenger molecules | 24 | 2.00e-04 | -0.4380 | 6.12e-03 |
| TCR signaling | 96 | 2.89e-04 | -0.2140 | 8.63e-03 |
| Complex I biogenesis | 46 | 3.44e-04 | 0.3050 | 1.01e-02 |
| PD-1 signaling | 15 | 5.93e-04 | -0.5120 | 1.70e-02 |
| Protein localization | 144 | 6.18e-04 | 0.1650 | 1.73e-02 |
| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| Major pathway of rRNA processing in the nucleolus and cytosol | 148 | 7.55e-15 | -3.70e-01 | 1.06e-11 |
| SRP-dependent cotranslational protein targeting to membrane | 83 | 2.52e-14 | -4.84e-01 | 1.24e-11 |
| rRNA processing in the nucleus and cytosol | 155 | 2.66e-14 | -3.54e-01 | 1.24e-11 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | 72 | 1.15e-12 | -4.85e-01 | 3.56e-10 |
| Peptide chain elongation | 60 | 1.66e-12 | -5.27e-01 | 3.56e-10 |
| Eukaryotic Translation Termination | 63 | 1.73e-12 | -5.14e-01 | 3.56e-10 |
| Viral mRNA Translation | 60 | 1.88e-12 | -5.26e-01 | 3.56e-10 |
| Selenocysteine synthesis | 63 | 2.03e-12 | -5.12e-01 | 3.56e-10 |
| Metabolism | 1845 | 2.70e-12 | 9.97e-02 | 3.92e-10 |
| Eukaryotic Translation Elongation | 63 | 2.79e-12 | -5.09e-01 | 3.92e-10 |
| Cap-dependent Translation Initiation | 87 | 9.53e-12 | -4.23e-01 | 1.12e-09 |
| Eukaryotic Translation Initiation | 87 | 9.53e-12 | -4.23e-01 | 1.12e-09 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | 65 | 1.98e-11 | -4.81e-01 | 2.01e-09 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | 81 | 2.00e-11 | -4.31e-01 | 2.01e-09 |
| Formation of a pool of free 40S subunits | 71 | 2.96e-11 | -4.56e-01 | 2.77e-09 |
| L13a-mediated translational silencing of Ceruloplasmin expression | 79 | 3.62e-11 | -4.31e-01 | 3.18e-09 |
| The citric acid (TCA) cycle and respiratory electron transport | 150 | 6.21e-11 | 3.09e-01 | 5.13e-09 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 83 | 1.19e-10 | -4.09e-01 | 8.76e-09 |
| Nonsense-Mediated Decay (NMD) | 83 | 1.19e-10 | -4.09e-01 | 8.76e-09 |
| rRNA processing | 176 | 1.45e-09 | -2.65e-01 | 1.01e-07 |
| Metabolism of lipids | 669 | 2.49e-09 | 1.36e-01 | 1.67e-07 |
| Regulation of expression of SLITs and ROBOs | 133 | 2.86e-09 | -2.98e-01 | 1.82e-07 |
| Metabolism of RNA | 604 | 2.49e-08 | -1.33e-01 | 1.52e-06 |
| Influenza Viral RNA Transcription and Replication | 103 | 4.97e-08 | -3.11e-01 | 2.91e-06 |
| Formation of the ternary complex, and subsequently, the 43S complex | 42 | 4.75e-07 | -4.49e-01 | 2.67e-05 |
| Influenza Infection | 120 | 6.95e-07 | -2.62e-01 | 3.75e-05 |
| Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. | 102 | 7.85e-07 | 2.83e-01 | 4.08e-05 |
| Mitochondrial Fatty Acid Beta-Oxidation | 34 | 9.41e-07 | 4.86e-01 | 4.72e-05 |
| Selenoamino acid metabolism | 84 | 1.09e-06 | -3.08e-01 | 5.17e-05 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | 106 | 1.11e-06 | -2.74e-01 | 5.17e-05 |
| Fatty acid metabolism | 160 | 1.41e-06 | 2.21e-01 | 6.40e-05 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | 48 | 2.23e-06 | -3.95e-01 | 9.77e-05 |
| Citric acid cycle (TCA cycle) | 22 | 2.43e-06 | 5.80e-01 | 1.03e-04 |
| Respiratory electron transport | 83 | 2.51e-06 | 2.99e-01 | 1.04e-04 |
| Signaling by ROBO receptors | 178 | 2.76e-06 | -2.04e-01 | 1.10e-04 |
| Ribosomal scanning and start codon recognition | 48 | 2.82e-06 | -3.91e-01 | 1.10e-04 |
| Pyruvate metabolism and Citric Acid (TCA) cycle | 52 | 4.40e-06 | 3.68e-01 | 1.67e-04 |
| Translation initiation complex formation | 47 | 4.56e-06 | -3.87e-01 | 1.68e-04 |
| Bile acid and bile salt metabolism | 37 | 1.16e-05 | 4.17e-01 | 4.19e-04 |
| Adaptive Immune System | 643 | 2.24e-05 | -9.85e-02 | 7.85e-04 |
| Transport of small molecules | 656 | 3.34e-05 | 9.54e-02 | 1.14e-03 |
| Peroxisomal lipid metabolism | 27 | 3.54e-05 | 4.60e-01 | 1.18e-03 |
| Synthesis of bile acids and bile salts | 29 | 6.39e-05 | 4.29e-01 | 2.09e-03 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | 19 | 8.00e-05 | 5.23e-01 | 2.55e-03 |
| Separation of Sister Chromatids | 157 | 1.67e-04 | -1.74e-01 | 5.20e-03 |
| Generation of second messenger molecules | 24 | 2.00e-04 | -4.38e-01 | 6.12e-03 |
| TCR signaling | 96 | 2.89e-04 | -2.14e-01 | 8.63e-03 |
| Complex I biogenesis | 46 | 3.44e-04 | 3.05e-01 | 1.01e-02 |
| PD-1 signaling | 15 | 5.93e-04 | -5.12e-01 | 1.70e-02 |
| Protein localization | 144 | 6.18e-04 | 1.65e-01 | 1.73e-02 |
| TNFR2 non-canonical NF-kB pathway | 86 | 6.31e-04 | -2.13e-01 | 1.74e-02 |
| Fc epsilon receptor (FCERI) signaling | 129 | 7.14e-04 | -1.73e-01 | 1.93e-02 |
| Intrinsic Pathway of Fibrin Clot Formation | 22 | 7.80e-04 | 4.14e-01 | 2.07e-02 |
| Cellular responses to stress | 442 | 8.29e-04 | -9.30e-02 | 2.16e-02 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | 67 | 9.08e-04 | -2.34e-01 | 2.32e-02 |
| Cellular responses to external stimuli | 449 | 1.01e-03 | -9.08e-02 | 2.52e-02 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | 66 | 1.03e-03 | -2.34e-01 | 2.52e-02 |
| Recycling of bile acids and salts | 15 | 1.05e-03 | 4.89e-01 | 2.52e-02 |
| rRNA modification in the nucleus and cytosol | 54 | 1.06e-03 | -2.58e-01 | 2.52e-02 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | 12 | 1.14e-03 | 5.42e-01 | 2.63e-02 |
| alpha-linolenic acid (ALA) metabolism | 12 | 1.14e-03 | 5.42e-01 | 2.63e-02 |
| SLC-mediated transmembrane transport | 233 | 1.19e-03 | 1.23e-01 | 2.69e-02 |
| tRNA processing in the mitochondrion | 18 | 1.34e-03 | 4.37e-01 | 2.99e-02 |
| TNFs bind their physiological receptors | 25 | 1.43e-03 | -3.69e-01 | 3.13e-02 |
| Metabolism of porphyrins | 23 | 1.52e-03 | 3.82e-01 | 3.29e-02 |
| rRNA processing in the mitochondrion | 21 | 1.58e-03 | 3.98e-01 | 3.36e-02 |
| Downstream TCR signaling | 76 | 1.63e-03 | -2.09e-01 | 3.37e-02 |
| Collagen chain trimerization | 35 | 1.63e-03 | -3.08e-01 | 3.37e-02 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | 64 | 1.76e-03 | -2.26e-01 | 3.49e-02 |
| Regulation of APC/C activators between G1/S and early anaphase | 71 | 1.76e-03 | -2.15e-01 | 3.49e-02 |
| Transcriptional activation of mitochondrial biogenesis | 51 | 1.76e-03 | 2.53e-01 | 3.49e-02 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | 63 | 1.84e-03 | -2.27e-01 | 3.58e-02 |
| C-type lectin receptors (CLRs) | 114 | 1.89e-03 | -1.69e-01 | 3.63e-02 |
| Sphingolipid metabolism | 79 | 2.05e-03 | 2.01e-01 | 3.89e-02 |
| Downstream signaling events of B Cell Receptor (BCR) | 69 | 2.14e-03 | -2.14e-01 | 4.01e-02 |
| Mitochondrial biogenesis | 82 | 2.53e-03 | 1.93e-01 | 4.60e-02 |
| Regulation of insulin secretion | 72 | 2.55e-03 | 2.06e-01 | 4.60e-02 |
| Prolactin receptor signaling | 15 | 2.56e-03 | -4.50e-01 | 4.60e-02 |
| Unblocking of NMDA receptors, glutamate binding and activation | 20 | 2.66e-03 | -3.88e-01 | 4.73e-02 |
| L1CAM interactions | 96 | 2.89e-03 | 1.76e-01 | 5.04e-02 |
| APC/C-mediated degradation of cell cycle proteins | 78 | 2.94e-03 | -1.95e-01 | 5.04e-02 |
| Regulation of mitotic cell cycle | 78 | 2.94e-03 | -1.95e-01 | 5.04e-02 |
| Assembly of collagen fibrils and other multimeric structures | 49 | 2.98e-03 | -2.45e-01 | 5.04e-02 |
| Mitochondrial calcium ion transport | 20 | 3.12e-03 | 3.82e-01 | 5.22e-02 |
| RNA Polymerase II Transcription | 1008 | 3.27e-03 | -5.52e-02 | 5.41e-02 |
| Sema4D in semaphorin signaling | 23 | 3.60e-03 | 3.51e-01 | 5.82e-02 |
| Long-term potentiation | 22 | 3.61e-03 | -3.58e-01 | 5.82e-02 |
| Heme degradation | 12 | 3.87e-03 | 4.82e-01 | 6.11e-02 |
| Phospholipid metabolism | 196 | 3.89e-03 | 1.20e-01 | 6.11e-02 |
| Transport of inorganic cations/anions and amino acids/oligopeptides | 103 | 3.92e-03 | 1.65e-01 | 6.11e-02 |
| Translocation of ZAP-70 to Immunological synapse | 10 | 4.33e-03 | -5.21e-01 | 6.68e-02 |
| APC/C:Cdc20 mediated degradation of Securin | 58 | 4.42e-03 | -2.16e-01 | 6.75e-02 |
| Glyoxylate metabolism and glycine degradation | 29 | 4.62e-03 | 3.04e-01 | 6.97e-02 |
| tRNA Aminoacylation | 38 | 4.81e-03 | 2.64e-01 | 7.18e-02 |
| Collagen formation | 78 | 5.16e-03 | -1.83e-01 | 7.60e-02 |
| Stabilization of p53 | 46 | 5.20e-03 | -2.38e-01 | 7.60e-02 |
| Cell Cycle Checkpoints | 235 | 5.62e-03 | -1.05e-01 | 8.13e-02 |
| LDL clearance | 18 | 5.75e-03 | 3.76e-01 | 8.24e-02 |
| Gene expression (Transcription) | 1138 | 5.84e-03 | -4.89e-02 | 8.28e-02 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | 37 | 5.95e-03 | 2.61e-01 | 8.29e-02 |
| Apoptotic cleavage of cell adhesion proteins | 11 | 6.07e-03 | 4.78e-01 | 8.29e-02 |
| Mitotic Spindle Checkpoint | 104 | 6.11e-03 | -1.56e-01 | 8.29e-02 |
| Branched-chain amino acid catabolism | 20 | 6.11e-03 | 3.54e-01 | 8.29e-02 |
| Mitochondrial protein import | 54 | 6.14e-03 | 2.16e-01 | 8.29e-02 |
| Processing of SMDT1 | 13 | 6.61e-03 | 4.35e-01 | 8.84e-02 |
| Resolution of Sister Chromatid Cohesion | 101 | 6.70e-03 | -1.56e-01 | 8.87e-02 |
| Immune System | 1805 | 6.78e-03 | -3.90e-02 | 8.87e-02 |
| Collagen biosynthesis and modifying enzymes | 57 | 6.83e-03 | -2.07e-01 | 8.87e-02 |
| Mitotic Metaphase and Anaphase | 208 | 7.12e-03 | -1.08e-01 | 9.17e-02 |
| Dectin-2 family | 15 | 7.42e-03 | -3.99e-01 | 9.47e-02 |
| Mitochondrial tRNA aminoacylation | 18 | 7.57e-03 | 3.64e-01 | 9.57e-02 |
| Cross-presentation of soluble exogenous antigens (endosomes) | 43 | 7.80e-03 | -2.35e-01 | 9.78e-02 |
| Metabolism of vitamins and cofactors | 168 | 8.17e-03 | 1.18e-01 | 9.91e-02 |
| Antigen processing-Cross presentation | 86 | 8.18e-03 | -1.65e-01 | 9.91e-02 |
| Phosphorylation of CD3 and TCR zeta chains | 14 | 8.19e-03 | -4.08e-01 | 9.91e-02 |
| FCGR activation | 25 | 8.19e-03 | -3.06e-01 | 9.91e-02 |
| Hemostasis | 536 | 8.47e-03 | 6.67e-02 | 1.01e-01 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | 49 | 8.48e-03 | -2.17e-01 | 1.01e-01 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | 66 | 8.72e-03 | -1.87e-01 | 1.03e-01 |
| Mitotic Anaphase | 207 | 8.78e-03 | -1.06e-01 | 1.03e-01 |
| Mitochondrial translation | 88 | 8.85e-03 | 1.62e-01 | 1.03e-01 |
| Transport of vitamins, nucleosides, and related molecules | 39 | 8.96e-03 | 2.42e-01 | 1.03e-01 |
| Miscellaneous transport and binding events | 21 | 9.02e-03 | 3.29e-01 | 1.03e-01 |
| Adrenaline,noradrenaline inhibits insulin secretion | 24 | 9.08e-03 | 3.08e-01 | 1.03e-01 |
| Nucleobase catabolism | 32 | 9.29e-03 | 2.66e-01 | 1.04e-01 |
| Generic Transcription Pathway | 894 | 9.33e-03 | -5.16e-02 | 1.04e-01 |
| Sphingolipid de novo biosynthesis | 39 | 1.01e-02 | 2.38e-01 | 1.12e-01 |
| Neuronal System | 353 | 1.07e-02 | 7.93e-02 | 1.17e-01 |
| Organelle biogenesis and maintenance | 257 | 1.08e-02 | 9.25e-02 | 1.18e-01 |
| Interaction between L1 and Ankyrins | 28 | 1.16e-02 | 2.76e-01 | 1.25e-01 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | 13 | 1.17e-02 | -4.04e-01 | 1.25e-01 |
| Cristae formation | 24 | 1.20e-02 | 2.96e-01 | 1.27e-01 |
| Beta-oxidation of very long chain fatty acids | 10 | 1.24e-02 | 4.57e-01 | 1.31e-01 |
| cGMP effects | 15 | 1.25e-02 | 3.72e-01 | 1.31e-01 |
| M Phase | 323 | 1.30e-02 | -8.06e-02 | 1.35e-01 |
| Vif-mediated degradation of APOBEC3G | 44 | 1.34e-02 | -2.15e-01 | 1.38e-01 |
| Assembly and cell surface presentation of NMDA receptors | 22 | 1.35e-02 | -3.04e-01 | 1.38e-01 |
| MAPK6/MAPK4 signaling | 78 | 1.36e-02 | -1.62e-01 | 1.39e-01 |
| Deposition of new CENPA-containing nucleosomes at the centromere | 29 | 1.40e-02 | -2.64e-01 | 1.40e-01 |
| Nucleosome assembly | 29 | 1.40e-02 | -2.64e-01 | 1.40e-01 |
| Autodegradation of Cdh1 by Cdh1:APC/C | 55 | 1.43e-02 | -1.91e-01 | 1.42e-01 |
| Regulation of RUNX3 expression and activity | 47 | 1.46e-02 | -2.06e-01 | 1.44e-01 |
| ER to Golgi Anterograde Transport | 124 | 1.47e-02 | -1.27e-01 | 1.44e-01 |
| GABA synthesis, release, reuptake and degradation | 17 | 1.52e-02 | 3.40e-01 | 1.48e-01 |
| Regulation of TP53 Expression and Degradation | 32 | 1.54e-02 | -2.47e-01 | 1.49e-01 |
| FCERI mediated NF-kB activation | 79 | 1.55e-02 | -1.58e-01 | 1.49e-01 |
| Assembly Of The HIV Virion | 14 | 1.59e-02 | -3.72e-01 | 1.52e-01 |
| Recycling pathway of L1 | 27 | 1.64e-02 | 2.67e-01 | 1.56e-01 |
| APC/C:Cdc20 mediated degradation of Cyclin B | 20 | 1.67e-02 | -3.09e-01 | 1.56e-01 |
| Triglyceride metabolism | 34 | 1.69e-02 | 2.37e-01 | 1.56e-01 |
| Costimulation by the CD28 family | 60 | 1.69e-02 | -1.78e-01 | 1.56e-01 |
| Pyrimidine catabolism | 10 | 1.72e-02 | 4.35e-01 | 1.56e-01 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | 27 | 1.72e-02 | -2.65e-01 | 1.56e-01 |
| Trafficking of AMPA receptors | 27 | 1.72e-02 | -2.65e-01 | 1.56e-01 |
| Formation of Fibrin Clot (Clotting Cascade) | 36 | 1.73e-02 | 2.29e-01 | 1.56e-01 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | 10 | 1.74e-02 | 4.34e-01 | 1.56e-01 |
| Phase I - Functionalization of compounds | 88 | 1.81e-02 | 1.46e-01 | 1.62e-01 |
| Sema4D induced cell migration and growth-cone collapse | 19 | 1.82e-02 | 3.13e-01 | 1.62e-01 |
| Regulation of TP53 Degradation | 31 | 1.87e-02 | -2.44e-01 | 1.65e-01 |
| Mitochondrial translation elongation | 83 | 1.92e-02 | 1.49e-01 | 1.66e-01 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | 64 | 1.92e-02 | -1.69e-01 | 1.66e-01 |
| Transcriptional regulation by RUNX2 | 107 | 1.92e-02 | -1.31e-01 | 1.66e-01 |
| Extracellular matrix organization | 265 | 1.97e-02 | -8.34e-02 | 1.68e-01 |
| p53-Dependent G1 DNA Damage Response | 55 | 1.98e-02 | -1.82e-01 | 1.68e-01 |
| p53-Dependent G1/S DNA damage checkpoint | 55 | 1.98e-02 | -1.82e-01 | 1.68e-01 |
| SCF-beta-TrCP mediated degradation of Emi1 | 47 | 2.01e-02 | -1.96e-01 | 1.68e-01 |
| Biotin transport and metabolism | 10 | 2.03e-02 | 4.24e-01 | 1.68e-01 |
| Glycerophospholipid biosynthesis | 120 | 2.03e-02 | 1.23e-01 | 1.68e-01 |
| Removal of aminoterminal propeptides from gamma-carboxylated proteins | 10 | 2.05e-02 | 4.23e-01 | 1.68e-01 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | 89 | 2.05e-02 | -1.42e-01 | 1.68e-01 |
| Amplification of signal from the kinetochores | 89 | 2.05e-02 | -1.42e-01 | 1.68e-01 |
| Potassium Channels | 90 | 2.06e-02 | 1.41e-01 | 1.68e-01 |
| Infectious disease | 698 | 2.13e-02 | -5.14e-02 | 1.73e-01 |
| Signaling by the B Cell Receptor (BCR) | 112 | 2.14e-02 | -1.26e-01 | 1.73e-01 |
| Phospholipase C-mediated cascade; FGFR3 | 12 | 2.16e-02 | 3.83e-01 | 1.73e-01 |
| Aflatoxin activation and detoxification | 17 | 2.17e-02 | 3.22e-01 | 1.73e-01 |
| Metabolism of steroids | 130 | 2.23e-02 | 1.16e-01 | 1.77e-01 |
| ER-Phagosome pathway | 74 | 2.30e-02 | -1.53e-01 | 1.80e-01 |
| Scavenging by Class A Receptors | 17 | 2.31e-02 | -3.18e-01 | 1.80e-01 |
| Interleukin-10 signaling | 37 | 2.31e-02 | -2.16e-01 | 1.80e-01 |
| Autodegradation of the E3 ubiquitin ligase COP1 | 42 | 2.32e-02 | -2.02e-01 | 1.80e-01 |
| EML4 and NUDC in mitotic spindle formation | 93 | 2.40e-02 | -1.36e-01 | 1.85e-01 |
| Cytosolic sulfonation of small molecules | 22 | 2.41e-02 | 2.78e-01 | 1.85e-01 |
| Regulation of RAS by GAPs | 58 | 2.46e-02 | -1.71e-01 | 1.87e-01 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | 42 | 2.47e-02 | -2.00e-01 | 1.87e-01 |
| Defective B3GALTL causes Peters-plus syndrome (PpS) | 36 | 2.48e-02 | -2.16e-01 | 1.87e-01 |
| Hedgehog ‘on’ state | 74 | 2.50e-02 | -1.51e-01 | 1.87e-01 |
| Triglyceride biosynthesis | 13 | 2.51e-02 | 3.59e-01 | 1.87e-01 |
| Translation | 248 | 2.53e-02 | -8.26e-02 | 1.88e-01 |
| Interconversion of nucleotide di- and triphosphates | 27 | 2.57e-02 | -2.48e-01 | 1.90e-01 |
| Transcriptional regulation by RUNX3 | 82 | 2.60e-02 | -1.42e-01 | 1.91e-01 |
| Nitric oxide stimulates guanylate cyclase | 19 | 2.63e-02 | 2.94e-01 | 1.92e-01 |
| Mismatch Repair | 13 | 2.70e-02 | 3.54e-01 | 1.95e-01 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | 13 | 2.70e-02 | 3.54e-01 | 1.95e-01 |
| Classical antibody-mediated complement activation | 18 | 2.70e-02 | -3.01e-01 | 1.95e-01 |
| Activation of NF-kappaB in B cells | 57 | 2.75e-02 | -1.69e-01 | 1.97e-01 |
| Peroxisomal protein import | 58 | 2.79e-02 | 1.67e-01 | 1.99e-01 |
| STING mediated induction of host immune responses | 15 | 2.80e-02 | -3.28e-01 | 1.99e-01 |
| G alpha (12/13) signalling events | 71 | 2.83e-02 | 1.51e-01 | 1.99e-01 |
| Mitochondrial translation termination | 83 | 2.84e-02 | 1.39e-01 | 1.99e-01 |
| FGFR3 mutant receptor activation | 11 | 2.86e-02 | 3.81e-01 | 1.99e-01 |
| Signaling by activated point mutants of FGFR3 | 11 | 2.86e-02 | 3.81e-01 | 1.99e-01 |
| Post-translational protein phosphorylation | 100 | 2.91e-02 | 1.26e-01 | 2.01e-01 |
| O-glycosylation of TSR domain-containing proteins | 37 | 2.94e-02 | -2.07e-01 | 2.02e-01 |
| CDK-mediated phosphorylation and removal of Cdc6 | 63 | 2.96e-02 | -1.59e-01 | 2.02e-01 |
| Negative regulation of NOTCH4 signaling | 47 | 2.96e-02 | -1.83e-01 | 2.02e-01 |
| Cytochrome P450 - arranged by substrate type | 58 | 3.00e-02 | 1.65e-01 | 2.02e-01 |
| Degradation of the extracellular matrix | 99 | 3.00e-02 | -1.26e-01 | 2.02e-01 |
| SCF(Skp2)-mediated degradation of p27/p21 | 53 | 3.04e-02 | -1.72e-01 | 2.04e-01 |
| G1/S DNA Damage Checkpoints | 56 | 3.09e-02 | -1.67e-01 | 2.07e-01 |
| Cell-extracellular matrix interactions | 16 | 3.14e-02 | 3.11e-01 | 2.08e-01 |
| Creation of C4 and C2 activators | 24 | 3.15e-02 | -2.54e-01 | 2.08e-01 |
| Regulation of pyruvate dehydrogenase (PDH) complex | 15 | 3.18e-02 | 3.20e-01 | 2.10e-01 |
| IRF3-mediated induction of type I IFN | 12 | 3.21e-02 | -3.57e-01 | 2.11e-01 |
| NIK–>noncanonical NF-kB signaling | 51 | 3.25e-02 | -1.73e-01 | 2.12e-01 |
| Integration of energy metabolism | 100 | 3.29e-02 | 1.24e-01 | 2.14e-01 |
| Membrane binding and targetting of GAG proteins | 12 | 3.33e-02 | -3.55e-01 | 2.15e-01 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | 12 | 3.33e-02 | -3.55e-01 | 2.15e-01 |
| APC-Cdc20 mediated degradation of Nek2A | 22 | 3.36e-02 | -2.62e-01 | 2.15e-01 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | 15 | 3.38e-02 | 3.17e-01 | 2.15e-01 |
| Diseases of hemostasis | 15 | 3.38e-02 | 3.17e-01 | 2.15e-01 |
| DAP12 interactions | 35 | 3.46e-02 | -2.06e-01 | 2.19e-01 |
| Apoptotic execution phase | 50 | 3.51e-02 | 1.72e-01 | 2.21e-01 |
| Class I MHC mediated antigen processing & presentation | 331 | 3.53e-02 | -6.75e-02 | 2.21e-01 |
| Signal regulatory protein family interactions | 12 | 3.60e-02 | -3.50e-01 | 2.25e-01 |
| Mitochondrial translation initiation | 82 | 3.65e-02 | 1.34e-01 | 2.26e-01 |
| Signaling by Interleukins | 387 | 3.67e-02 | -6.20e-02 | 2.26e-01 |
| Metabolism of fat-soluble vitamins | 41 | 3.70e-02 | 1.88e-01 | 2.26e-01 |
| Bicarbonate transporters | 10 | 3.70e-02 | 3.81e-01 | 2.26e-01 |
| Regulation of ornithine decarboxylase (ODC) | 45 | 3.72e-02 | -1.80e-01 | 2.26e-01 |
| PI-3K cascade:FGFR3 | 17 | 3.73e-02 | 2.92e-01 | 2.26e-01 |
| CD28 dependent Vav1 pathway | 12 | 3.80e-02 | -3.46e-01 | 2.29e-01 |
| Ovarian tumor domain proteases | 33 | 3.82e-02 | 2.09e-01 | 2.29e-01 |
| Initiation of Nuclear Envelope (NE) Reformation | 16 | 3.83e-02 | 2.99e-01 | 2.29e-01 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | 114 | 3.83e-02 | 1.12e-01 | 2.29e-01 |
| Formation of TC-NER Pre-Incision Complex | 49 | 3.90e-02 | -1.71e-01 | 2.31e-01 |
| RHO GTPases activate IQGAPs | 11 | 3.90e-02 | 3.59e-01 | 2.31e-01 |
| GLI3 is processed to GLI3R by the proteasome | 50 | 3.99e-02 | -1.68e-01 | 2.35e-01 |
| CLEC7A (Dectin-1) signaling | 88 | 4.04e-02 | -1.26e-01 | 2.37e-01 |
| Phosphorylation of the APC/C | 18 | 4.07e-02 | -2.79e-01 | 2.38e-01 |
| Miscellaneous substrates | 12 | 4.13e-02 | 3.40e-01 | 2.38e-01 |
| VEGFR2 mediated vascular permeability | 25 | 4.13e-02 | 2.36e-01 | 2.38e-01 |
| Signaling by FGFR3 in disease | 20 | 4.19e-02 | 2.63e-01 | 2.38e-01 |
| Signaling by FGFR3 point mutants in cancer | 20 | 4.19e-02 | 2.63e-01 | 2.38e-01 |
| Vpu mediated degradation of CD4 | 43 | 4.20e-02 | -1.79e-01 | 2.38e-01 |
| Dectin-1 mediated noncanonical NF-kB signaling | 54 | 4.20e-02 | -1.60e-01 | 2.38e-01 |
| Neddylation | 213 | 4.21e-02 | -8.09e-02 | 2.38e-01 |
| Retinoid metabolism and transport | 38 | 4.21e-02 | 1.91e-01 | 2.38e-01 |
| COPI-mediated anterograde transport | 75 | 4.36e-02 | -1.35e-01 | 2.46e-01 |
| Hedgehog ‘off’ state | 89 | 4.44e-02 | -1.23e-01 | 2.49e-01 |
| Metabolism of polyamines | 53 | 4.49e-02 | -1.59e-01 | 2.50e-01 |
| Cell junction organization | 80 | 4.49e-02 | 1.30e-01 | 2.50e-01 |
| Regulation of Apoptosis | 45 | 4.56e-02 | -1.72e-01 | 2.51e-01 |
| Ubiquitin Mediated Degradation of Phosphorylated Cdc25A | 43 | 4.59e-02 | -1.76e-01 | 2.51e-01 |
| p53-Independent DNA Damage Response | 43 | 4.59e-02 | -1.76e-01 | 2.51e-01 |
| p53-Independent G1/S DNA damage checkpoint | 43 | 4.59e-02 | -1.76e-01 | 2.51e-01 |
| Erythrocytes take up carbon dioxide and release oxygen | 11 | 4.81e-02 | 3.44e-01 | 2.62e-01 |
| O2/CO2 exchange in erythrocytes | 11 | 4.81e-02 | 3.44e-01 | 2.62e-01 |
| Apoptotic cleavage of cellular proteins | 38 | 4.83e-02 | 1.85e-01 | 2.62e-01 |
| Initial triggering of complement | 28 | 4.86e-02 | -2.15e-01 | 2.62e-01 |
| Glycogen breakdown (glycogenolysis) | 14 | 4.90e-02 | -3.04e-01 | 2.63e-01 |
| Transport to the Golgi and subsequent modification | 149 | 4.91e-02 | -9.35e-02 | 2.63e-01 |
| Signaling by Hedgehog | 123 | 5.01e-02 | -1.02e-01 | 2.65e-01 |
| Keratan sulfate degradation | 12 | 5.02e-02 | -3.26e-01 | 2.65e-01 |
| COPII-mediated vesicle transport | 61 | 5.05e-02 | -1.45e-01 | 2.65e-01 |
| FGFR3 ligand binding and activation | 12 | 5.06e-02 | 3.26e-01 | 2.65e-01 |
| FGFR3c ligand binding and activation | 12 | 5.06e-02 | 3.26e-01 | 2.65e-01 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | 47 | 5.09e-02 | -1.65e-01 | 2.65e-01 |
| Response of EIF2AK1 (HRI) to heme deficiency | 14 | 5.09e-02 | -3.01e-01 | 2.65e-01 |
| Glycogen metabolism | 24 | 5.10e-02 | -2.30e-01 | 2.65e-01 |
| Degradation of DVL | 49 | 5.30e-02 | -1.60e-01 | 2.75e-01 |
| Nuclear Receptor transcription pathway | 52 | 5.52e-02 | 1.54e-01 | 2.85e-01 |
| Cytosolic tRNA aminoacylation | 22 | 5.54e-02 | 2.36e-01 | 2.85e-01 |
| Nephrin family interactions | 20 | 5.60e-02 | 2.47e-01 | 2.87e-01 |
| CDT1 association with the CDC6:ORC:origin complex | 51 | 5.66e-02 | -1.54e-01 | 2.87e-01 |
| HS-GAG degradation | 18 | 5.66e-02 | 2.60e-01 | 2.87e-01 |
| Laminin interactions | 23 | 5.67e-02 | 2.30e-01 | 2.87e-01 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | 19 | 5.70e-02 | -2.52e-01 | 2.87e-01 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | 19 | 5.70e-02 | -2.52e-01 | 2.87e-01 |
| Regulation of TP53 Activity through Methylation | 15 | 5.72e-02 | -2.84e-01 | 2.87e-01 |
| ABC transporters in lipid homeostasis | 17 | 5.74e-02 | 2.66e-01 | 2.87e-01 |
| HATs acetylate histones | 74 | 5.77e-02 | -1.28e-01 | 2.88e-01 |
| Metabolism of cofactors | 17 | 5.86e-02 | 2.65e-01 | 2.91e-01 |
| Signaling by Leptin | 10 | 6.07e-02 | -3.43e-01 | 3.00e-01 |
| Condensation of Prophase Chromosomes | 16 | 6.14e-02 | -2.70e-01 | 3.02e-01 |
| Pre-NOTCH Processing in Golgi | 18 | 6.25e-02 | 2.54e-01 | 3.07e-01 |
| RHO GTPases Activate ROCKs | 18 | 6.33e-02 | 2.53e-01 | 3.07e-01 |
| Cytosolic iron-sulfur cluster assembly | 12 | 6.34e-02 | 3.10e-01 | 3.07e-01 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | 11 | 6.36e-02 | 3.23e-01 | 3.07e-01 |
| RUNX2 regulates osteoblast differentiation | 22 | 6.36e-02 | -2.29e-01 | 3.07e-01 |
| Degradation of AXIN | 46 | 6.37e-02 | -1.58e-01 | 3.07e-01 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | 56 | 6.43e-02 | -1.43e-01 | 3.09e-01 |
| Ras activation upon Ca2+ influx through NMDA receptor | 18 | 6.46e-02 | -2.52e-01 | 3.09e-01 |
| Intrinsic Pathway for Apoptosis | 44 | 6.47e-02 | 1.61e-01 | 3.09e-01 |
| Signaling by SCF-KIT | 41 | 6.57e-02 | -1.66e-01 | 3.12e-01 |
| Degradation of GLI2 by the proteasome | 49 | 6.57e-02 | -1.52e-01 | 3.12e-01 |
| Pentose phosphate pathway | 13 | 6.64e-02 | -2.94e-01 | 3.14e-01 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | 19 | 6.68e-02 | 2.43e-01 | 3.15e-01 |
| DNA Damage Recognition in GG-NER | 36 | 6.74e-02 | -1.76e-01 | 3.16e-01 |
| A tetrasaccharide linker sequence is required for GAG synthesis | 24 | 6.77e-02 | 2.15e-01 | 3.16e-01 |
| Pyruvate metabolism | 28 | 6.78e-02 | 1.99e-01 | 3.16e-01 |
| Cell Cycle | 579 | 6.83e-02 | -4.45e-02 | 3.18e-01 |
| Degradation of GLI1 by the proteasome | 51 | 6.95e-02 | -1.47e-01 | 3.22e-01 |
| FCERI mediated MAPK activation | 40 | 6.98e-02 | -1.66e-01 | 3.22e-01 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | 12 | 7.07e-02 | 3.01e-01 | 3.26e-01 |
| Establishment of Sister Chromatid Cohesion | 11 | 7.12e-02 | -3.14e-01 | 3.27e-01 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | 13 | 7.17e-02 | 2.89e-01 | 3.28e-01 |
| Glycosphingolipid metabolism | 40 | 7.37e-02 | 1.63e-01 | 3.34e-01 |
| Crosslinking of collagen fibrils | 10 | 7.37e-02 | -3.27e-01 | 3.34e-01 |
| Activation of BAD and translocation to mitochondria | 14 | 7.39e-02 | 2.76e-01 | 3.34e-01 |
| Cellular response to hypoxia | 65 | 7.42e-02 | -1.28e-01 | 3.34e-01 |
| Cytokine Signaling in Immune system | 750 | 7.43e-02 | -3.85e-02 | 3.34e-01 |
| DARPP-32 events | 23 | 7.47e-02 | -2.15e-01 | 3.35e-01 |
| Gamma-carboxylation of protein precursors | 10 | 7.57e-02 | 3.24e-01 | 3.37e-01 |
| Defective B4GALT7 causes EDS, progeroid type | 19 | 7.57e-02 | 2.35e-01 | 3.37e-01 |
| Chromosome Maintenance | 90 | 7.60e-02 | -1.08e-01 | 3.38e-01 |
| Biological oxidations | 169 | 7.70e-02 | 7.90e-02 | 3.41e-01 |
| ADP signalling through P2Y purinoceptor 12 | 18 | 7.75e-02 | 2.40e-01 | 3.42e-01 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | 72 | 7.83e-02 | -1.20e-01 | 3.44e-01 |
| Synaptic adhesion-like molecules | 21 | 7.85e-02 | -2.22e-01 | 3.44e-01 |
| IKK complex recruitment mediated by RIP1 | 16 | 7.89e-02 | -2.54e-01 | 3.45e-01 |
| Switching of origins to a post-replicative state | 81 | 8.02e-02 | -1.13e-01 | 3.48e-01 |
| Lysine catabolism | 12 | 8.02e-02 | 2.92e-01 | 3.48e-01 |
| Cell Cycle, Mitotic | 460 | 8.03e-02 | -4.77e-02 | 3.48e-01 |
| RHO GTPases Activate Formins | 116 | 8.05e-02 | -9.40e-02 | 3.48e-01 |
| FGFR1c ligand binding and activation | 10 | 8.20e-02 | 3.18e-01 | 3.52e-01 |
| Signaling by activated point mutants of FGFR1 | 10 | 8.20e-02 | 3.18e-01 | 3.52e-01 |
| SIRT1 negatively regulates rRNA expression | 12 | 8.24e-02 | -2.90e-01 | 3.53e-01 |
| Heme biosynthesis | 12 | 8.29e-02 | 2.89e-01 | 3.53e-01 |
| G-protein activation | 24 | 8.33e-02 | 2.04e-01 | 3.53e-01 |
| XBP1(S) activates chaperone genes | 47 | 8.33e-02 | 1.46e-01 | 3.53e-01 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | 14 | 8.37e-02 | -2.67e-01 | 3.54e-01 |
| FGFR2 alternative splicing | 22 | 8.39e-02 | -2.13e-01 | 3.54e-01 |
| PECAM1 interactions | 11 | 8.46e-02 | -3.00e-01 | 3.55e-01 |
| Translesion synthesis by POLK | 15 | 8.48e-02 | -2.57e-01 | 3.56e-01 |
| Signaling by VEGF | 97 | 8.58e-02 | 1.01e-01 | 3.59e-01 |
| HIV Infection | 207 | 8.64e-02 | -6.92e-02 | 3.60e-01 |
| Mitotic Telophase/Cytokinesis | 13 | 8.66e-02 | -2.75e-01 | 3.60e-01 |
| Nucleotide Excision Repair | 103 | 8.73e-02 | -9.76e-02 | 3.60e-01 |
| Acetylcholine binding and downstream events | 11 | 8.76e-02 | 2.97e-01 | 3.60e-01 |
| Postsynaptic nicotinic acetylcholine receptors | 11 | 8.76e-02 | 2.97e-01 | 3.60e-01 |
| Synthesis, secretion, and deacylation of Ghrelin | 19 | 8.79e-02 | -2.26e-01 | 3.60e-01 |
| Innate Immune System | 882 | 8.80e-02 | -3.41e-02 | 3.60e-01 |
| Synthesis of DNA | 109 | 8.86e-02 | -9.45e-02 | 3.61e-01 |
| Gamma-carboxylation, transport, and amino-terminal cleavage of proteins | 11 | 8.89e-02 | 2.96e-01 | 3.62e-01 |
| Ubiquitin-dependent degradation of Cyclin D | 44 | 8.99e-02 | -1.48e-01 | 3.65e-01 |
| SARS-CoV Infections | 131 | 9.17e-02 | 8.54e-02 | 3.70e-01 |
| tRNA modification in the nucleus and cytosol | 41 | 9.18e-02 | -1.52e-01 | 3.70e-01 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | 13 | 9.49e-02 | 2.68e-01 | 3.80e-01 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | 13 | 9.49e-02 | 2.68e-01 | 3.80e-01 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | 46 | 9.53e-02 | -1.42e-01 | 3.80e-01 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | 78 | 9.59e-02 | -1.09e-01 | 3.80e-01 |
| Cell-Cell communication | 111 | 9.60e-02 | 9.15e-02 | 3.80e-01 |
| Mitotic Prometaphase | 175 | 9.61e-02 | -7.30e-02 | 3.80e-01 |
| Extra-nuclear estrogen signaling | 65 | 9.61e-02 | 1.19e-01 | 3.80e-01 |
| Regulation of KIT signaling | 16 | 9.64e-02 | -2.40e-01 | 3.80e-01 |
| GPVI-mediated activation cascade | 31 | 9.66e-02 | -1.72e-01 | 3.80e-01 |
| NGF-stimulated transcription | 37 | 9.83e-02 | -1.57e-01 | 3.85e-01 |
| Defective CFTR causes cystic fibrosis | 53 | 9.85e-02 | -1.31e-01 | 3.85e-01 |
| DNA Replication | 116 | 9.89e-02 | -8.88e-02 | 3.85e-01 |
| Platelet homeostasis | 77 | 9.91e-02 | 1.09e-01 | 3.85e-01 |
| Defensins | 20 | 9.95e-02 | 2.13e-01 | 3.86e-01 |
| Budding and maturation of HIV virion | 24 | 1.00e-01 | -1.94e-01 | 3.86e-01 |
| Smooth Muscle Contraction | 32 | 1.00e-01 | 1.68e-01 | 3.86e-01 |
| Incretin synthesis, secretion, and inactivation | 22 | 1.00e-01 | -2.02e-01 | 3.86e-01 |
| Trafficking and processing of endosomal TLR | 12 | 1.02e-01 | -2.73e-01 | 3.90e-01 |
| Prolonged ERK activation events | 13 | 1.04e-01 | 2.61e-01 | 3.96e-01 |
| Reduction of cytosolic Ca++ levels | 12 | 1.05e-01 | 2.71e-01 | 3.99e-01 |
| SHC-mediated cascade:FGFR3 | 16 | 1.06e-01 | 2.34e-01 | 4.03e-01 |
| Signaling by Retinoic Acid | 35 | 1.06e-01 | 1.58e-01 | 4.04e-01 |
| Aspartate and asparagine metabolism | 10 | 1.07e-01 | 2.94e-01 | 4.04e-01 |
| Lysosphingolipid and LPA receptors | 13 | 1.07e-01 | 2.58e-01 | 4.05e-01 |
| IRE1alpha activates chaperones | 49 | 1.08e-01 | 1.33e-01 | 4.05e-01 |
| Visual phototransduction | 85 | 1.08e-01 | 1.01e-01 | 4.06e-01 |
| MTOR signalling | 37 | 1.10e-01 | -1.52e-01 | 4.12e-01 |
| ER Quality Control Compartment (ERQC) | 18 | 1.12e-01 | 2.16e-01 | 4.18e-01 |
| Heparan sulfate/heparin (HS-GAG) metabolism | 46 | 1.13e-01 | 1.35e-01 | 4.19e-01 |
| Cell surface interactions at the vascular wall | 132 | 1.13e-01 | 8.00e-02 | 4.19e-01 |
| S Phase | 151 | 1.14e-01 | -7.47e-02 | 4.20e-01 |
| Early Phase of HIV Life Cycle | 12 | 1.14e-01 | -2.63e-01 | 4.22e-01 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | 18 | 1.15e-01 | -2.15e-01 | 4.22e-01 |
| RHO GTPases activate PKNs | 35 | 1.15e-01 | 1.54e-01 | 4.22e-01 |
| Common Pathway of Fibrin Clot Formation | 20 | 1.16e-01 | 2.03e-01 | 4.24e-01 |
| VEGFA-VEGFR2 Pathway | 88 | 1.18e-01 | 9.65e-02 | 4.30e-01 |
| Defective B3GAT3 causes JDSSDHD | 18 | 1.19e-01 | 2.12e-01 | 4.30e-01 |
| Caspase activation via extrinsic apoptotic signalling pathway | 20 | 1.19e-01 | -2.01e-01 | 4.30e-01 |
| Adenylate cyclase inhibitory pathway | 14 | 1.19e-01 | 2.41e-01 | 4.30e-01 |
| Regulation of RUNX2 expression and activity | 63 | 1.20e-01 | -1.13e-01 | 4.30e-01 |
| SLC transporter disorders | 92 | 1.20e-01 | 9.39e-02 | 4.30e-01 |
| Leading Strand Synthesis | 13 | 1.20e-01 | -2.49e-01 | 4.30e-01 |
| Polymerase switching | 13 | 1.20e-01 | -2.49e-01 | 4.30e-01 |
| Formation of ATP by chemiosmotic coupling | 13 | 1.21e-01 | 2.48e-01 | 4.35e-01 |
| Ion homeostasis | 45 | 1.22e-01 | 1.33e-01 | 4.37e-01 |
| Carboxyterminal post-translational modifications of tubulin | 30 | 1.23e-01 | -1.63e-01 | 4.37e-01 |
| Signaling by NOTCH4 | 72 | 1.23e-01 | -1.05e-01 | 4.38e-01 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | 20 | 1.24e-01 | -1.99e-01 | 4.40e-01 |
| Translesion synthesis by REV1 | 14 | 1.25e-01 | -2.37e-01 | 4.44e-01 |
| Platelet calcium homeostasis | 27 | 1.26e-01 | 1.70e-01 | 4.44e-01 |
| Global Genome Nucleotide Excision Repair (GG-NER) | 79 | 1.27e-01 | -9.93e-02 | 4.48e-01 |
| PI Metabolism | 77 | 1.31e-01 | 9.97e-02 | 4.59e-01 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | 40 | 1.32e-01 | -1.38e-01 | 4.61e-01 |
| Processing of Capped Intron-Containing Pre-mRNA | 223 | 1.33e-01 | -5.85e-02 | 4.61e-01 |
| Post NMDA receptor activation events | 57 | 1.33e-01 | -1.15e-01 | 4.61e-01 |
| Activation of NMDA receptors and postsynaptic events | 68 | 1.34e-01 | -1.05e-01 | 4.61e-01 |
| Acyl chain remodelling of PS | 20 | 1.34e-01 | -1.94e-01 | 4.61e-01 |
| CTLA4 inhibitory signaling | 21 | 1.34e-01 | -1.89e-01 | 4.61e-01 |
| VLDLR internalisation and degradation | 12 | 1.34e-01 | 2.50e-01 | 4.61e-01 |
| Signaling by Insulin receptor | 67 | 1.34e-01 | 1.06e-01 | 4.61e-01 |
| Retrograde neurotrophin signalling | 14 | 1.35e-01 | 2.31e-01 | 4.62e-01 |
| RHO GTPases activate KTN1 | 10 | 1.35e-01 | 2.73e-01 | 4.62e-01 |
| Signaling by ERBB2 in Cancer | 22 | 1.35e-01 | 1.84e-01 | 4.62e-01 |
| DAP12 signaling | 27 | 1.36e-01 | -1.66e-01 | 4.63e-01 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | 24 | 1.37e-01 | 1.75e-01 | 4.63e-01 |
| CD22 mediated BCR regulation | 19 | 1.37e-01 | -1.97e-01 | 4.63e-01 |
| IRS-related events triggered by IGF1R | 45 | 1.37e-01 | 1.28e-01 | 4.63e-01 |
| Nuclear Envelope (NE) Reassembly | 62 | 1.37e-01 | 1.09e-01 | 4.63e-01 |
| Muscle contraction | 166 | 1.37e-01 | 6.69e-02 | 4.63e-01 |
| Activation of Matrix Metalloproteinases | 26 | 1.38e-01 | -1.68e-01 | 4.63e-01 |
| SUMOylation of DNA methylation proteins | 15 | 1.39e-01 | 2.21e-01 | 4.63e-01 |
| Phospholipase C-mediated cascade: FGFR1 | 14 | 1.39e-01 | 2.28e-01 | 4.63e-01 |
| Negative regulation of FGFR3 signaling | 24 | 1.39e-01 | 1.74e-01 | 4.63e-01 |
| DNA Repair | 265 | 1.40e-01 | -5.28e-02 | 4.63e-01 |
| TGF-beta receptor signaling activates SMADs | 27 | 1.40e-01 | 1.64e-01 | 4.63e-01 |
| Asparagine N-linked glycosylation | 259 | 1.40e-01 | -5.33e-02 | 4.63e-01 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | 11 | 1.40e-01 | 2.57e-01 | 4.63e-01 |
| PKMTs methylate histone lysines | 40 | 1.41e-01 | 1.34e-01 | 4.63e-01 |
| E2F mediated regulation of DNA replication | 21 | 1.42e-01 | -1.85e-01 | 4.63e-01 |
| Synthesis of PIPs at the plasma membrane | 49 | 1.42e-01 | 1.21e-01 | 4.63e-01 |
| Signaling by Nuclear Receptors | 219 | 1.42e-01 | 5.77e-02 | 4.63e-01 |
| Frs2-mediated activation | 11 | 1.42e-01 | 2.55e-01 | 4.63e-01 |
| Metabolism of non-coding RNA | 51 | 1.43e-01 | -1.19e-01 | 4.63e-01 |
| snRNP Assembly | 51 | 1.43e-01 | -1.19e-01 | 4.63e-01 |
| RHO GTPases activate PAKs | 20 | 1.43e-01 | 1.89e-01 | 4.63e-01 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | 28 | 1.43e-01 | -1.60e-01 | 4.63e-01 |
| HIV Life Cycle | 134 | 1.44e-01 | -7.32e-02 | 4.63e-01 |
| RHO GTPases activate CIT | 18 | 1.44e-01 | 1.99e-01 | 4.63e-01 |
| Potential therapeutics for SARS | 72 | 1.44e-01 | 9.96e-02 | 4.63e-01 |
| Metabolism of steroid hormones | 27 | 1.45e-01 | 1.62e-01 | 4.63e-01 |
| Signaling by RAF1 mutants | 36 | 1.45e-01 | -1.40e-01 | 4.64e-01 |
| Eicosanoids | 12 | 1.46e-01 | 2.43e-01 | 4.65e-01 |
| Presynaptic depolarization and calcium channel opening | 11 | 1.46e-01 | -2.53e-01 | 4.66e-01 |
| The canonical retinoid cycle in rods (twilight vision) | 21 | 1.47e-01 | 1.83e-01 | 4.68e-01 |
| Calnexin/calreticulin cycle | 23 | 1.49e-01 | 1.74e-01 | 4.70e-01 |
| Rap1 signalling | 14 | 1.49e-01 | 2.23e-01 | 4.70e-01 |
| Transcriptional regulation of granulopoiesis | 34 | 1.50e-01 | -1.43e-01 | 4.74e-01 |
| Energy dependent regulation of mTOR by LKB1-AMPK | 27 | 1.51e-01 | -1.60e-01 | 4.75e-01 |
| Downstream signaling of activated FGFR3 | 23 | 1.52e-01 | 1.73e-01 | 4.75e-01 |
| Transport of organic anions | 12 | 1.52e-01 | 2.39e-01 | 4.75e-01 |
| G alpha (q) signalling events | 180 | 1.53e-01 | 6.19e-02 | 4.75e-01 |
| Sialic acid metabolism | 30 | 1.53e-01 | 1.51e-01 | 4.75e-01 |
| p130Cas linkage to MAPK signaling for integrins | 15 | 1.54e-01 | -2.13e-01 | 4.75e-01 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | 15 | 1.54e-01 | -2.12e-01 | 4.75e-01 |
| Signaling by Non-Receptor Tyrosine Kinases | 49 | 1.55e-01 | 1.18e-01 | 4.75e-01 |
| Signaling by PTK6 | 49 | 1.55e-01 | 1.18e-01 | 4.75e-01 |
| Activation of GABAB receptors | 36 | 1.56e-01 | 1.37e-01 | 4.75e-01 |
| GABA B receptor activation | 36 | 1.56e-01 | 1.37e-01 | 4.75e-01 |
| Plasma lipoprotein assembly, remodeling, and clearance | 66 | 1.56e-01 | 1.01e-01 | 4.75e-01 |
| Gene Silencing by RNA | 77 | 1.56e-01 | -9.36e-02 | 4.75e-01 |
| Anchoring of the basal body to the plasma membrane | 91 | 1.56e-01 | 8.60e-02 | 4.75e-01 |
| Ub-specific processing proteases | 146 | 1.57e-01 | -6.80e-02 | 4.75e-01 |
| Regulation of HSF1-mediated heat shock response | 74 | 1.57e-01 | 9.53e-02 | 4.75e-01 |
| mRNA Splicing - Minor Pathway | 47 | 1.57e-01 | -1.19e-01 | 4.75e-01 |
| PI-3K cascade:FGFR1 | 19 | 1.57e-01 | 1.87e-01 | 4.75e-01 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | 27 | 1.57e-01 | -1.57e-01 | 4.75e-01 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | 19 | 1.57e-01 | 1.87e-01 | 4.75e-01 |
| Hh mutants that don’t undergo autocatalytic processing are degraded by ERAD | 48 | 1.58e-01 | -1.18e-01 | 4.75e-01 |
| UCH proteinases | 77 | 1.59e-01 | -9.29e-02 | 4.77e-01 |
| Adherens junctions interactions | 31 | 1.60e-01 | 1.46e-01 | 4.79e-01 |
| Cyclin E associated events during G1/S transition | 76 | 1.61e-01 | -9.30e-02 | 4.83e-01 |
| LGI-ADAM interactions | 10 | 1.62e-01 | -2.55e-01 | 4.83e-01 |
| IGF1R signaling cascade | 46 | 1.62e-01 | 1.19e-01 | 4.83e-01 |
| Orc1 removal from chromatin | 63 | 1.63e-01 | -1.02e-01 | 4.84e-01 |
| Gamma carboxylation, hypusine formation and arylsulfatase activation | 37 | 1.67e-01 | 1.31e-01 | 4.95e-01 |
| Regulation of beta-cell development | 36 | 1.68e-01 | 1.33e-01 | 4.95e-01 |
| Metabolism of amino acids and derivatives | 317 | 1.68e-01 | -4.52e-02 | 4.95e-01 |
| Signaling by FGFR1 | 41 | 1.68e-01 | 1.24e-01 | 4.95e-01 |
| Signal Transduction | 2155 | 1.68e-01 | 1.84e-02 | 4.95e-01 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | 28 | 1.69e-01 | 1.50e-01 | 4.95e-01 |
| Metabolism of proteins | 1732 | 1.70e-01 | -2.01e-02 | 4.95e-01 |
| Eicosanoid ligand-binding receptors | 11 | 1.70e-01 | -2.39e-01 | 4.95e-01 |
| Activation of HOX genes during differentiation | 59 | 1.70e-01 | -1.03e-01 | 4.95e-01 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | 59 | 1.70e-01 | -1.03e-01 | 4.95e-01 |
| Degradation of beta-catenin by the destruction complex | 75 | 1.71e-01 | -9.15e-02 | 4.95e-01 |
| mTORC1-mediated signalling | 21 | 1.71e-01 | -1.73e-01 | 4.95e-01 |
| Transferrin endocytosis and recycling | 26 | 1.71e-01 | 1.55e-01 | 4.95e-01 |
| Phospholipase C-mediated cascade; FGFR4 | 13 | 1.71e-01 | 2.19e-01 | 4.95e-01 |
| Late endosomal microautophagy | 26 | 1.72e-01 | -1.55e-01 | 4.95e-01 |
| Inhibition of DNA recombination at telomere | 22 | 1.72e-01 | -1.68e-01 | 4.95e-01 |
| Biosynthesis of specialized proresolving mediators (SPMs) | 17 | 1.74e-01 | -1.91e-01 | 4.98e-01 |
| Caspase activation via Death Receptors in the presence of ligand | 10 | 1.74e-01 | -2.48e-01 | 4.99e-01 |
| Condensation of Prometaphase Chromosomes | 10 | 1.76e-01 | -2.47e-01 | 5.02e-01 |
| Xenobiotics | 20 | 1.77e-01 | 1.74e-01 | 5.06e-01 |
| Glutathione conjugation | 28 | 1.78e-01 | -1.47e-01 | 5.06e-01 |
| PI3K Cascade | 39 | 1.79e-01 | 1.24e-01 | 5.08e-01 |
| Platelet sensitization by LDL | 16 | 1.79e-01 | -1.94e-01 | 5.08e-01 |
| FGFR1 ligand binding and activation | 13 | 1.80e-01 | 2.15e-01 | 5.08e-01 |
| Purine catabolism | 15 | 1.80e-01 | 2.00e-01 | 5.08e-01 |
| Antigen processing: Ubiquitination & Proteasome degradation | 277 | 1.80e-01 | -4.69e-02 | 5.08e-01 |
| Mitochondrial iron-sulfur cluster biogenesis | 11 | 1.81e-01 | 2.33e-01 | 5.09e-01 |
| RIP-mediated NFkB activation via ZBP1 | 15 | 1.82e-01 | 1.99e-01 | 5.09e-01 |
| RUNX2 regulates bone development | 28 | 1.82e-01 | -1.46e-01 | 5.09e-01 |
| p75 NTR receptor-mediated signalling | 89 | 1.82e-01 | 8.19e-02 | 5.09e-01 |
| FGFR2 ligand binding and activation | 17 | 1.82e-01 | 1.87e-01 | 5.09e-01 |
| Processing of DNA double-strand break ends | 56 | 1.83e-01 | -1.03e-01 | 5.09e-01 |
| RET signaling | 38 | 1.83e-01 | 1.25e-01 | 5.09e-01 |
| Rab regulation of trafficking | 115 | 1.83e-01 | 7.19e-02 | 5.09e-01 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | 24 | 1.84e-01 | -1.57e-01 | 5.10e-01 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | 25 | 1.85e-01 | -1.53e-01 | 5.10e-01 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | 19 | 1.85e-01 | -1.76e-01 | 5.10e-01 |
| Regulation of localization of FOXO transcription factors | 11 | 1.85e-01 | 2.31e-01 | 5.10e-01 |
| Downregulation of TGF-beta receptor signaling | 22 | 1.86e-01 | 1.63e-01 | 5.10e-01 |
| RNA Polymerase I Promoter Escape | 32 | 1.86e-01 | -1.35e-01 | 5.10e-01 |
| DNA Double-Strand Break Repair | 119 | 1.87e-01 | -7.02e-02 | 5.10e-01 |
| Phospholipase C-mediated cascade; FGFR2 | 16 | 1.87e-01 | 1.91e-01 | 5.10e-01 |
| RNA Polymerase II Pre-transcription Events | 74 | 1.88e-01 | -8.85e-02 | 5.11e-01 |
| Interleukin-4 and Interleukin-13 signaling | 95 | 1.89e-01 | -7.81e-02 | 5.11e-01 |
| RMTs methylate histone arginines | 33 | 1.89e-01 | -1.32e-01 | 5.11e-01 |
| Metalloprotease DUBs | 15 | 1.89e-01 | -1.96e-01 | 5.11e-01 |
| Fatty acids | 14 | 1.90e-01 | 2.03e-01 | 5.11e-01 |
| Insulin receptor recycling | 22 | 1.90e-01 | 1.62e-01 | 5.11e-01 |
| PI-3K cascade:FGFR4 | 18 | 1.90e-01 | 1.79e-01 | 5.11e-01 |
| ATF6 (ATF6-alpha) activates chaperones | 12 | 1.90e-01 | -2.18e-01 | 5.12e-01 |
| Ca-dependent events | 34 | 1.91e-01 | -1.30e-01 | 5.13e-01 |
| Neurexins and neuroligins | 53 | 1.92e-01 | 1.04e-01 | 5.13e-01 |
| Regulation of TP53 Activity through Phosphorylation | 81 | 1.92e-01 | -8.39e-02 | 5.14e-01 |
| Receptor-type tyrosine-protein phosphatases | 19 | 1.93e-01 | 1.73e-01 | 5.14e-01 |
| AKT phosphorylates targets in the cytosol | 14 | 1.93e-01 | 2.01e-01 | 5.14e-01 |
| mRNA Splicing | 172 | 1.94e-01 | -5.75e-02 | 5.16e-01 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | 47 | 1.95e-01 | 1.09e-01 | 5.17e-01 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | 23 | 1.97e-01 | -1.55e-01 | 5.20e-01 |
| Regulation of gene expression in beta cells | 20 | 1.97e-01 | 1.67e-01 | 5.20e-01 |
| PI-3K cascade:FGFR2 | 21 | 1.97e-01 | 1.63e-01 | 5.20e-01 |
| Plasma lipoprotein remodeling | 29 | 1.99e-01 | 1.38e-01 | 5.23e-01 |
| FGFR1 mutant receptor activation | 29 | 2.00e-01 | 1.38e-01 | 5.25e-01 |
| FCERI mediated Ca+2 mobilization | 41 | 2.00e-01 | -1.16e-01 | 5.25e-01 |
| Receptor Mediated Mitophagy | 11 | 2.01e-01 | -2.23e-01 | 5.25e-01 |
| CaM pathway | 32 | 2.01e-01 | -1.31e-01 | 5.25e-01 |
| Calmodulin induced events | 32 | 2.01e-01 | -1.31e-01 | 5.25e-01 |
| Regulation of FZD by ubiquitination | 16 | 2.02e-01 | 1.84e-01 | 5.25e-01 |
| Metabolism of water-soluble vitamins and cofactors | 111 | 2.02e-01 | 7.01e-02 | 5.25e-01 |
| Triglyceride catabolism | 21 | 2.02e-01 | 1.61e-01 | 5.25e-01 |
| Cohesin Loading onto Chromatin | 10 | 2.05e-01 | -2.31e-01 | 5.31e-01 |
| COPI-independent Golgi-to-ER retrograde traffic | 32 | 2.05e-01 | -1.29e-01 | 5.31e-01 |
| Assembly of active LPL and LIPC lipase complexes | 18 | 2.06e-01 | 1.72e-01 | 5.31e-01 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | 32 | 2.07e-01 | 1.29e-01 | 5.31e-01 |
| Synthesis of PIPs at the early endosome membrane | 16 | 2.07e-01 | 1.82e-01 | 5.31e-01 |
| Regulated proteolysis of p75NTR | 11 | 2.07e-01 | 2.20e-01 | 5.31e-01 |
| Regulation of TP53 Activity through Association with Co-factors | 12 | 2.08e-01 | 2.10e-01 | 5.32e-01 |
| Biosynthesis of DHA-derived SPMs | 15 | 2.09e-01 | -1.87e-01 | 5.35e-01 |
| RHO GTPases Activate NADPH Oxidases | 22 | 2.10e-01 | -1.54e-01 | 5.37e-01 |
| MHC class II antigen presentation | 90 | 2.11e-01 | -7.63e-02 | 5.37e-01 |
| Caspase-mediated cleavage of cytoskeletal proteins | 12 | 2.12e-01 | 2.08e-01 | 5.37e-01 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | 13 | 2.13e-01 | 2.00e-01 | 5.37e-01 |
| Class I peroxisomal membrane protein import | 18 | 2.14e-01 | 1.69e-01 | 5.37e-01 |
| ROS and RNS production in phagocytes | 31 | 2.14e-01 | 1.29e-01 | 5.37e-01 |
| Disorders of Developmental Biology | 13 | 2.14e-01 | 1.99e-01 | 5.37e-01 |
| Disorders of Nervous System Development | 13 | 2.14e-01 | 1.99e-01 | 5.37e-01 |
| Loss of function of MECP2 in Rett syndrome | 13 | 2.14e-01 | 1.99e-01 | 5.37e-01 |
| Pervasive developmental disorders | 13 | 2.14e-01 | 1.99e-01 | 5.37e-01 |
| Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon | 12 | 2.14e-01 | -2.07e-01 | 5.37e-01 |
| Cardiac conduction | 109 | 2.15e-01 | 6.87e-02 | 5.39e-01 |
| Meiotic recombination | 29 | 2.16e-01 | -1.33e-01 | 5.40e-01 |
| Reversible hydration of carbon dioxide | 12 | 2.18e-01 | 2.06e-01 | 5.43e-01 |
| Binding and Uptake of Ligands by Scavenger Receptors | 49 | 2.19e-01 | -1.02e-01 | 5.45e-01 |
| Inositol phosphate metabolism | 45 | 2.20e-01 | 1.06e-01 | 5.46e-01 |
| Signaling by WNT in cancer | 29 | 2.20e-01 | 1.31e-01 | 5.47e-01 |
| FGFR4 ligand binding and activation | 12 | 2.22e-01 | 2.04e-01 | 5.49e-01 |
| RAS processing | 18 | 2.23e-01 | 1.66e-01 | 5.51e-01 |
| The NLRP3 inflammasome | 15 | 2.23e-01 | -1.82e-01 | 5.51e-01 |
| Dissolution of Fibrin Clot | 11 | 2.24e-01 | -2.12e-01 | 5.51e-01 |
| NOD1/2 Signaling Pathway | 30 | 2.24e-01 | -1.28e-01 | 5.51e-01 |
| Signaling by FGFR3 | 34 | 2.25e-01 | 1.20e-01 | 5.51e-01 |
| Protein folding | 88 | 2.25e-01 | 7.48e-02 | 5.51e-01 |
| FGFRL1 modulation of FGFR1 signaling | 10 | 2.25e-01 | 2.21e-01 | 5.51e-01 |
| Apoptotic factor-mediated response | 13 | 2.26e-01 | 1.94e-01 | 5.51e-01 |
| G beta:gamma signalling through PLC beta | 16 | 2.27e-01 | 1.75e-01 | 5.51e-01 |
| EGFR downregulation | 29 | 2.27e-01 | 1.30e-01 | 5.51e-01 |
| Other semaphorin interactions | 19 | 2.27e-01 | -1.60e-01 | 5.51e-01 |
| Unwinding of DNA | 12 | 2.28e-01 | 2.01e-01 | 5.51e-01 |
| PI3K events in ERBB2 signaling | 15 | 2.28e-01 | 1.80e-01 | 5.51e-01 |
| Cyclin A:Cdk2-associated events at S phase entry | 78 | 2.28e-01 | -7.90e-02 | 5.51e-01 |
| Transcriptional regulation by small RNAs | 47 | 2.29e-01 | -1.01e-01 | 5.53e-01 |
| Signal transduction by L1 | 20 | 2.31e-01 | 1.55e-01 | 5.55e-01 |
| Cellular hexose transport | 19 | 2.32e-01 | 1.58e-01 | 5.57e-01 |
| Tryptophan catabolism | 14 | 2.32e-01 | 1.84e-01 | 5.57e-01 |
| Signaling by ERBB2 KD Mutants | 21 | 2.33e-01 | 1.50e-01 | 5.57e-01 |
| Chaperone Mediated Autophagy | 14 | 2.34e-01 | -1.84e-01 | 5.57e-01 |
| Signaling by FGFR1 in disease | 35 | 2.34e-01 | 1.16e-01 | 5.57e-01 |
| Oncogenic MAPK signaling | 74 | 2.34e-01 | 8.00e-02 | 5.57e-01 |
| Removal of the Flap Intermediate from the C-strand | 16 | 2.34e-01 | 1.72e-01 | 5.57e-01 |
| Glutamate Neurotransmitter Release Cycle | 23 | 2.34e-01 | 1.43e-01 | 5.57e-01 |
| Synthesis of PA | 36 | 2.35e-01 | 1.14e-01 | 5.57e-01 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | 11 | 2.36e-01 | 2.06e-01 | 5.58e-01 |
| p38MAPK events | 12 | 2.37e-01 | -1.97e-01 | 5.58e-01 |
| Activated point mutants of FGFR2 | 15 | 2.37e-01 | 1.77e-01 | 5.58e-01 |
| Late Phase of HIV Life Cycle | 123 | 2.37e-01 | -6.18e-02 | 5.58e-01 |
| Golgi-to-ER retrograde transport | 109 | 2.38e-01 | -6.55e-02 | 5.59e-01 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | 25 | 2.40e-01 | -1.36e-01 | 5.64e-01 |
| Polymerase switching on the C-strand of the telomere | 25 | 2.41e-01 | -1.36e-01 | 5.64e-01 |
| Prefoldin mediated transfer of substrate to CCT/TriC | 22 | 2.41e-01 | -1.44e-01 | 5.64e-01 |
| RNA Polymerase I Promoter Clearance | 49 | 2.42e-01 | -9.66e-02 | 5.64e-01 |
| RNA Polymerase I Transcription | 49 | 2.42e-01 | -9.66e-02 | 5.64e-01 |
| Thrombin signalling through proteinase activated receptors (PARs) | 24 | 2.42e-01 | 1.38e-01 | 5.64e-01 |
| Na+/Cl- dependent neurotransmitter transporters | 17 | 2.45e-01 | 1.63e-01 | 5.68e-01 |
| Nonhomologous End-Joining (NHEJ) | 33 | 2.46e-01 | -1.17e-01 | 5.68e-01 |
| Deactivation of the beta-catenin transactivating complex | 35 | 2.46e-01 | 1.13e-01 | 5.68e-01 |
| Protein-protein interactions at synapses | 83 | 2.46e-01 | 7.37e-02 | 5.68e-01 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer’s disease models | 17 | 2.46e-01 | 1.62e-01 | 5.68e-01 |
| Neurodegenerative Diseases | 17 | 2.46e-01 | 1.62e-01 | 5.68e-01 |
| Aquaporin-mediated transport | 43 | 2.47e-01 | 1.02e-01 | 5.68e-01 |
| Translesion Synthesis by POLH | 15 | 2.47e-01 | -1.72e-01 | 5.68e-01 |
| B-WICH complex positively regulates rRNA expression | 32 | 2.48e-01 | -1.18e-01 | 5.68e-01 |
| Non-integrin membrane-ECM interactions | 41 | 2.48e-01 | 1.04e-01 | 5.68e-01 |
| Chaperonin-mediated protein folding | 82 | 2.50e-01 | 7.36e-02 | 5.71e-01 |
| Golgi Cisternae Pericentriolar Stack Reorganization | 11 | 2.52e-01 | -1.99e-01 | 5.75e-01 |
| IRS-mediated signalling | 42 | 2.52e-01 | 1.02e-01 | 5.75e-01 |
| Cytosolic sensors of pathogen-associated DNA | 53 | 2.53e-01 | -9.08e-02 | 5.75e-01 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | 37 | 2.53e-01 | 1.09e-01 | 5.75e-01 |
| Golgi Associated Vesicle Biogenesis | 54 | 2.54e-01 | -8.98e-02 | 5.75e-01 |
| Translesion synthesis by POLI | 15 | 2.58e-01 | -1.69e-01 | 5.84e-01 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | 10 | 2.59e-01 | -2.06e-01 | 5.84e-01 |
| Processive synthesis on the C-strand of the telomere | 18 | 2.59e-01 | 1.54e-01 | 5.84e-01 |
| Endogenous sterols | 24 | 2.60e-01 | 1.33e-01 | 5.84e-01 |
| Other interleukin signaling | 21 | 2.60e-01 | -1.42e-01 | 5.84e-01 |
| Plasma lipoprotein clearance | 32 | 2.61e-01 | 1.15e-01 | 5.87e-01 |
| Toll-like Receptor Cascades | 134 | 2.62e-01 | -5.62e-02 | 5.87e-01 |
| Signaling by ERBB2 ECD mutants | 13 | 2.62e-01 | 1.80e-01 | 5.87e-01 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | 48 | 2.62e-01 | -9.35e-02 | 5.87e-01 |
| Diseases of programmed cell death | 23 | 2.63e-01 | 1.35e-01 | 5.87e-01 |
| NOTCH1 Intracellular Domain Regulates Transcription | 41 | 2.64e-01 | -1.01e-01 | 5.88e-01 |
| Growth hormone receptor signaling | 22 | 2.65e-01 | -1.37e-01 | 5.89e-01 |
| Signaling by GPCR | 734 | 2.66e-01 | 2.42e-02 | 5.91e-01 |
| Uptake and actions of bacterial toxins | 25 | 2.68e-01 | 1.28e-01 | 5.93e-01 |
| Senescence-Associated Secretory Phenotype (SASP) | 47 | 2.71e-01 | -9.29e-02 | 5.98e-01 |
| Negative regulation of MAPK pathway | 38 | 2.71e-01 | 1.03e-01 | 5.98e-01 |
| Formation of the beta-catenin:TCF transactivating complex | 33 | 2.71e-01 | -1.11e-01 | 5.98e-01 |
| NRAGE signals death through JNK | 54 | 2.71e-01 | 8.66e-02 | 5.98e-01 |
| Downregulation of ERBB2 signaling | 24 | 2.73e-01 | 1.29e-01 | 5.98e-01 |
| Signaling by NOTCH3 | 42 | 2.73e-01 | 9.78e-02 | 5.98e-01 |
| Post-translational protein modification | 1214 | 2.75e-01 | -1.88e-02 | 5.98e-01 |
| Insulin receptor signalling cascade | 47 | 2.75e-01 | 9.21e-02 | 5.98e-01 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | 39 | 2.76e-01 | 1.01e-01 | 5.98e-01 |
| ESR-mediated signaling | 153 | 2.76e-01 | 5.11e-02 | 5.98e-01 |
| Thromboxane signalling through TP receptor | 18 | 2.76e-01 | 1.48e-01 | 5.98e-01 |
| N-glycan antennae elongation in the medial/trans-Golgi | 21 | 2.76e-01 | 1.37e-01 | 5.98e-01 |
| FRS-mediated FGFR3 signaling | 18 | 2.77e-01 | 1.48e-01 | 5.98e-01 |
| HCMV Infection | 80 | 2.77e-01 | -7.03e-02 | 5.98e-01 |
| Diseases associated with O-glycosylation of proteins | 56 | 2.78e-01 | -8.39e-02 | 5.98e-01 |
| HS-GAG biosynthesis | 26 | 2.78e-01 | 1.23e-01 | 5.98e-01 |
| Pre-NOTCH Transcription and Translation | 39 | 2.79e-01 | -1.00e-01 | 5.98e-01 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | 10 | 2.79e-01 | 1.98e-01 | 5.98e-01 |
| FGFR2c ligand binding and activation | 12 | 2.79e-01 | 1.80e-01 | 5.98e-01 |
| G2/M Checkpoints | 120 | 2.80e-01 | -5.72e-02 | 5.98e-01 |
| CRMPs in Sema3A signaling | 15 | 2.80e-01 | -1.61e-01 | 5.98e-01 |
| Meiosis | 58 | 2.81e-01 | -8.19e-02 | 5.98e-01 |
| HIV Transcription Initiation | 42 | 2.82e-01 | -9.60e-02 | 5.98e-01 |
| RNA Polymerase II HIV Promoter Escape | 42 | 2.82e-01 | -9.60e-02 | 5.98e-01 |
| RNA Polymerase II Promoter Escape | 42 | 2.82e-01 | -9.60e-02 | 5.98e-01 |
| RNA Polymerase II Transcription Initiation | 42 | 2.82e-01 | -9.60e-02 | 5.98e-01 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | 42 | 2.82e-01 | -9.60e-02 | 5.98e-01 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | 42 | 2.82e-01 | -9.60e-02 | 5.98e-01 |
| SARS-CoV-1 Infection | 44 | 2.84e-01 | 9.34e-02 | 6.03e-01 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | 22 | 2.86e-01 | 1.32e-01 | 6.04e-01 |
| Developmental Biology | 826 | 2.86e-01 | -2.20e-02 | 6.04e-01 |
| RA biosynthesis pathway | 16 | 2.87e-01 | -1.54e-01 | 6.06e-01 |
| Diseases of carbohydrate metabolism | 26 | 2.88e-01 | 1.20e-01 | 6.07e-01 |
| Nucleobase biosynthesis | 12 | 2.90e-01 | 1.76e-01 | 6.11e-01 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | 170 | 2.91e-01 | -4.70e-02 | 6.12e-01 |
| Host Interactions of HIV factors | 115 | 2.92e-01 | -5.69e-02 | 6.12e-01 |
| Nuclear Events (kinase and transcription factor activation) | 57 | 2.94e-01 | -8.04e-02 | 6.12e-01 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | 39 | 2.94e-01 | -9.71e-02 | 6.12e-01 |
| Signaling by RAS mutants | 39 | 2.94e-01 | -9.71e-02 | 6.12e-01 |
| Signaling by moderate kinase activity BRAF mutants | 39 | 2.94e-01 | -9.71e-02 | 6.12e-01 |
| Signaling downstream of RAS mutants | 39 | 2.94e-01 | -9.71e-02 | 6.12e-01 |
| Transcriptional regulation by RUNX1 | 164 | 2.94e-01 | -4.75e-02 | 6.12e-01 |
| PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases | 13 | 2.95e-01 | 1.68e-01 | 6.12e-01 |
| Metabolism of Angiotensinogen to Angiotensins | 17 | 2.96e-01 | 1.47e-01 | 6.12e-01 |
| RAB GEFs exchange GTP for GDP on RABs | 84 | 2.96e-01 | 6.60e-02 | 6.12e-01 |
| ERKs are inactivated | 11 | 2.96e-01 | 1.82e-01 | 6.12e-01 |
| Signaling by KIT in disease | 19 | 2.97e-01 | -1.38e-01 | 6.12e-01 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | 19 | 2.97e-01 | -1.38e-01 | 6.12e-01 |
| N-Glycan antennae elongation | 13 | 2.98e-01 | 1.67e-01 | 6.13e-01 |
| Signaling by FGFR in disease | 57 | 2.98e-01 | 7.96e-02 | 6.14e-01 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | 11 | 2.99e-01 | 1.81e-01 | 6.14e-01 |
| RIPK1-mediated regulated necrosis | 22 | 3.00e-01 | -1.28e-01 | 6.14e-01 |
| Regulated Necrosis | 22 | 3.00e-01 | -1.28e-01 | 6.14e-01 |
| Regulation of necroptotic cell death | 22 | 3.00e-01 | -1.28e-01 | 6.14e-01 |
| Sema3A PAK dependent Axon repulsion | 15 | 3.01e-01 | -1.54e-01 | 6.14e-01 |
| G alpha (z) signalling events | 44 | 3.02e-01 | 8.99e-02 | 6.16e-01 |
| Hh mutants abrogate ligand secretion | 51 | 3.03e-01 | -8.34e-02 | 6.16e-01 |
| Signaling by NODAL | 18 | 3.04e-01 | -1.40e-01 | 6.18e-01 |
| CD209 (DC-SIGN) signaling | 18 | 3.06e-01 | -1.39e-01 | 6.21e-01 |
| Regulation of TP53 Activity | 144 | 3.07e-01 | -4.94e-02 | 6.22e-01 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | 21 | 3.08e-01 | 1.28e-01 | 6.24e-01 |
| Signal amplification | 27 | 3.10e-01 | 1.13e-01 | 6.25e-01 |
| Transcription of the HIV genome | 63 | 3.13e-01 | -7.35e-02 | 6.29e-01 |
| Cilium Assembly | 175 | 3.14e-01 | 4.42e-02 | 6.29e-01 |
| Downstream signaling of activated FGFR1 | 28 | 3.14e-01 | 1.10e-01 | 6.29e-01 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | 25 | 3.15e-01 | -1.16e-01 | 6.29e-01 |
| TP53 Regulates Metabolic Genes | 78 | 3.15e-01 | 6.59e-02 | 6.29e-01 |
| PERK regulates gene expression | 30 | 3.15e-01 | -1.06e-01 | 6.29e-01 |
| Formation of RNA Pol II elongation complex | 54 | 3.16e-01 | -7.90e-02 | 6.29e-01 |
| RNA Polymerase II Transcription Elongation | 54 | 3.16e-01 | -7.90e-02 | 6.29e-01 |
| G beta:gamma signalling through PI3Kgamma | 21 | 3.16e-01 | 1.26e-01 | 6.29e-01 |
| TICAM1, RIP1-mediated IKK complex recruitment | 14 | 3.16e-01 | -1.55e-01 | 6.29e-01 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | 12 | 3.16e-01 | 1.67e-01 | 6.29e-01 |
| Suppression of phagosomal maturation | 11 | 3.18e-01 | -1.74e-01 | 6.31e-01 |
| Telomere Maintenance | 65 | 3.18e-01 | -7.16e-02 | 6.31e-01 |
| Assembly of the pre-replicative complex | 60 | 3.19e-01 | -7.45e-02 | 6.31e-01 |
| Cellular response to heat stress | 90 | 3.20e-01 | 6.07e-02 | 6.32e-01 |
| Cargo concentration in the ER | 29 | 3.20e-01 | -1.07e-01 | 6.32e-01 |
| ISG15 antiviral mechanism | 66 | 3.21e-01 | -7.07e-02 | 6.32e-01 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | 16 | 3.22e-01 | -1.43e-01 | 6.34e-01 |
| Transcriptional regulation of white adipocyte differentiation | 79 | 3.23e-01 | -6.43e-02 | 6.36e-01 |
| MASTL Facilitates Mitotic Progression | 10 | 3.25e-01 | -1.80e-01 | 6.39e-01 |
| RNA Polymerase III Transcription Initiation | 32 | 3.26e-01 | -1.00e-01 | 6.39e-01 |
| Synthesis of PE | 13 | 3.27e-01 | 1.57e-01 | 6.39e-01 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | 18 | 3.28e-01 | -1.33e-01 | 6.39e-01 |
| TBC/RABGAPs | 43 | 3.28e-01 | 8.63e-02 | 6.39e-01 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | 86 | 3.28e-01 | -6.11e-02 | 6.39e-01 |
| NCAM signaling for neurite out-growth | 50 | 3.28e-01 | 7.99e-02 | 6.40e-01 |
| Neurotransmitter release cycle | 47 | 3.30e-01 | 8.22e-02 | 6.41e-01 |
| Sulfur amino acid metabolism | 24 | 3.30e-01 | 1.15e-01 | 6.41e-01 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | 17 | 3.31e-01 | -1.36e-01 | 6.42e-01 |
| Cell-cell junction organization | 56 | 3.33e-01 | 7.48e-02 | 6.45e-01 |
| Vesicle-mediated transport | 608 | 3.34e-01 | -2.31e-02 | 6.45e-01 |
| Platelet degranulation | 120 | 3.34e-01 | 5.11e-02 | 6.45e-01 |
| E3 ubiquitin ligases ubiquitinate target proteins | 40 | 3.36e-01 | -8.80e-02 | 6.47e-01 |
| G alpha (i) signalling events | 331 | 3.38e-01 | 3.07e-02 | 6.51e-01 |
| Regulation of PTEN stability and activity | 61 | 3.38e-01 | -7.09e-02 | 6.51e-01 |
| Metabolism of amine-derived hormones | 15 | 3.39e-01 | -1.43e-01 | 6.51e-01 |
| SHC-mediated cascade:FGFR1 | 18 | 3.40e-01 | 1.30e-01 | 6.51e-01 |
| Zinc transporters | 15 | 3.41e-01 | -1.42e-01 | 6.51e-01 |
| ADP signalling through P2Y purinoceptor 1 | 20 | 3.41e-01 | 1.23e-01 | 6.51e-01 |
| RNA polymerase II transcribes snRNA genes | 68 | 3.41e-01 | -6.68e-02 | 6.51e-01 |
| Synthesis of IP2, IP, and Ins in the cytosol | 13 | 3.42e-01 | 1.52e-01 | 6.51e-01 |
| Glucose metabolism | 86 | 3.42e-01 | 5.93e-02 | 6.51e-01 |
| Negative regulation of FGFR1 signaling | 26 | 3.45e-01 | 1.07e-01 | 6.56e-01 |
| Regulation of IFNG signaling | 13 | 3.45e-01 | -1.51e-01 | 6.56e-01 |
| SARS-CoV-2 Infection | 61 | 3.46e-01 | 6.98e-02 | 6.56e-01 |
| Negative regulation of the PI3K/AKT network | 104 | 3.47e-01 | 5.34e-02 | 6.56e-01 |
| mRNA Splicing - Major Pathway | 164 | 3.47e-01 | -4.26e-02 | 6.56e-01 |
| Dermatan sulfate biosynthesis | 11 | 3.48e-01 | -1.64e-01 | 6.56e-01 |
| Death Receptor Signalling | 125 | 3.48e-01 | 4.87e-02 | 6.56e-01 |
| trans-Golgi Network Vesicle Budding | 69 | 3.48e-01 | -6.53e-02 | 6.56e-01 |
| Formation of tubulin folding intermediates by CCT/TriC | 20 | 3.49e-01 | -1.21e-01 | 6.57e-01 |
| GPCR ligand binding | 362 | 3.50e-01 | 2.87e-02 | 6.58e-01 |
| RNA Polymerase II Transcription Termination | 61 | 3.51e-01 | -6.91e-02 | 6.58e-01 |
| Presynaptic function of Kainate receptors | 17 | 3.51e-01 | 1.31e-01 | 6.58e-01 |
| mRNA decay by 3’ to 5’ exoribonuclease | 15 | 3.51e-01 | -1.39e-01 | 6.58e-01 |
| Postmitotic nuclear pore complex (NPC) reformation | 25 | 3.55e-01 | 1.07e-01 | 6.62e-01 |
| Antimicrobial peptides | 48 | 3.55e-01 | 7.72e-02 | 6.62e-01 |
| VEGFR2 mediated cell proliferation | 18 | 3.57e-01 | 1.25e-01 | 6.66e-01 |
| Dual incision in TC-NER | 59 | 3.58e-01 | -6.92e-02 | 6.66e-01 |
| FCGR3A-mediated IL10 synthesis | 50 | 3.59e-01 | -7.50e-02 | 6.66e-01 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | 11 | 3.59e-01 | -1.60e-01 | 6.66e-01 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | 13 | 3.59e-01 | 1.47e-01 | 6.66e-01 |
| Defective EXT2 causes exostoses 2 | 13 | 3.59e-01 | 1.47e-01 | 6.66e-01 |
| Cell death signalling via NRAGE, NRIF and NADE | 69 | 3.65e-01 | 6.31e-02 | 6.74e-01 |
| Arachidonic acid metabolism | 51 | 3.65e-01 | 7.34e-02 | 6.74e-01 |
| Negative regulation of MET activity | 19 | 3.66e-01 | -1.20e-01 | 6.76e-01 |
| ATF6 (ATF6-alpha) activates chaperone genes | 10 | 3.67e-01 | -1.65e-01 | 6.77e-01 |
| GPCR downstream signalling | 670 | 3.69e-01 | 2.05e-02 | 6.79e-01 |
| Interleukin-1 family signaling | 124 | 3.72e-01 | -4.65e-02 | 6.82e-01 |
| Molecules associated with elastic fibres | 27 | 3.73e-01 | 9.91e-02 | 6.82e-01 |
| Selective autophagy | 52 | 3.73e-01 | -7.14e-02 | 6.82e-01 |
| HDACs deacetylate histones | 30 | 3.73e-01 | 9.39e-02 | 6.82e-01 |
| Defects in vitamin and cofactor metabolism | 21 | 3.73e-01 | 1.12e-01 | 6.82e-01 |
| Synthesis of PIPs at the late endosome membrane | 11 | 3.73e-01 | 1.55e-01 | 6.82e-01 |
| Acetylcholine Neurotransmitter Release Cycle | 15 | 3.74e-01 | 1.33e-01 | 6.82e-01 |
| Regulation of lipid metabolism by PPARalpha | 115 | 3.74e-01 | 4.80e-02 | 6.82e-01 |
| HCMV Late Events | 52 | 3.78e-01 | -7.08e-02 | 6.87e-01 |
| Folding of actin by CCT/TriC | 10 | 3.79e-01 | -1.61e-01 | 6.88e-01 |
| Nicotinamide salvaging | 18 | 3.80e-01 | 1.20e-01 | 6.88e-01 |
| Lysosome Vesicle Biogenesis | 33 | 3.81e-01 | 8.81e-02 | 6.91e-01 |
| Axon guidance | 470 | 3.82e-01 | -2.36e-02 | 6.91e-01 |
| TRP channels | 24 | 3.83e-01 | -1.03e-01 | 6.91e-01 |
| Fanconi Anemia Pathway | 32 | 3.83e-01 | -8.92e-02 | 6.91e-01 |
| DNA Replication Pre-Initiation | 76 | 3.84e-01 | -5.78e-02 | 6.91e-01 |
| Activation of the pre-replicative complex | 32 | 3.84e-01 | 8.89e-02 | 6.91e-01 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | 40 | 3.84e-01 | -7.95e-02 | 6.91e-01 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | 72 | 3.86e-01 | -5.92e-02 | 6.93e-01 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | 10 | 3.87e-01 | 1.58e-01 | 6.93e-01 |
| Apoptosis | 152 | 3.88e-01 | 4.06e-02 | 6.94e-01 |
| Negative regulation of FGFR2 signaling | 28 | 3.88e-01 | 9.42e-02 | 6.94e-01 |
| Protein ubiquitination | 59 | 3.89e-01 | -6.49e-02 | 6.94e-01 |
| Homology Directed Repair | 92 | 3.90e-01 | -5.19e-02 | 6.94e-01 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | 18 | 3.90e-01 | -1.17e-01 | 6.94e-01 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | 11 | 3.90e-01 | 1.50e-01 | 6.94e-01 |
| Asymmetric localization of PCP proteins | 53 | 3.91e-01 | -6.82e-02 | 6.94e-01 |
| HDMs demethylate histones | 20 | 3.91e-01 | 1.11e-01 | 6.94e-01 |
| eNOS activation | 10 | 3.91e-01 | 1.57e-01 | 6.94e-01 |
| ABC transporter disorders | 69 | 3.93e-01 | -5.95e-02 | 6.95e-01 |
| Glycogen synthesis | 13 | 3.93e-01 | -1.37e-01 | 6.96e-01 |
| Passive transport by Aquaporins | 10 | 3.94e-01 | 1.56e-01 | 6.96e-01 |
| SHC-mediated cascade:FGFR2 | 20 | 3.96e-01 | 1.10e-01 | 6.98e-01 |
| Translation of structural proteins | 24 | 3.96e-01 | 1.00e-01 | 6.98e-01 |
| Trafficking of GluR2-containing AMPA receptors | 17 | 3.98e-01 | -1.19e-01 | 6.98e-01 |
| Oxidative Stress Induced Senescence | 59 | 3.98e-01 | -6.37e-02 | 6.98e-01 |
| Caspase activation via Dependence Receptors in the absence of ligand | 10 | 3.98e-01 | -1.54e-01 | 6.98e-01 |
| Negative regulation of FGFR4 signaling | 25 | 3.99e-01 | 9.74e-02 | 6.98e-01 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | 39 | 4.00e-01 | -7.79e-02 | 6.98e-01 |
| HIV Transcription Elongation | 39 | 4.00e-01 | -7.79e-02 | 6.98e-01 |
| Tat-mediated elongation of the HIV-1 transcript | 39 | 4.00e-01 | -7.79e-02 | 6.98e-01 |
| Clathrin-mediated endocytosis | 132 | 4.01e-01 | 4.24e-02 | 7.00e-01 |
| G beta:gamma signalling through BTK | 14 | 4.03e-01 | 1.29e-01 | 7.02e-01 |
| SHC-mediated cascade:FGFR4 | 17 | 4.03e-01 | 1.17e-01 | 7.02e-01 |
| Activation of RAC1 | 13 | 4.06e-01 | -1.33e-01 | 7.06e-01 |
| Acyl chain remodelling of PC | 24 | 4.09e-01 | 9.73e-02 | 7.10e-01 |
| activated TAK1 mediates p38 MAPK activation | 17 | 4.10e-01 | 1.15e-01 | 7.11e-01 |
| Processive synthesis on the lagging strand | 14 | 4.11e-01 | 1.27e-01 | 7.12e-01 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | 13 | 4.14e-01 | -1.31e-01 | 7.15e-01 |
| Deubiquitination | 217 | 4.14e-01 | -3.22e-02 | 7.15e-01 |
| Formation of HIV elongation complex in the absence of HIV Tat | 41 | 4.15e-01 | -7.37e-02 | 7.15e-01 |
| Regulation of PTEN gene transcription | 54 | 4.15e-01 | 6.41e-02 | 7.16e-01 |
| Reproduction | 77 | 4.18e-01 | -5.34e-02 | 7.17e-01 |
| Activation of BH3-only proteins | 26 | 4.18e-01 | 9.17e-02 | 7.17e-01 |
| Recruitment of NuMA to mitotic centrosomes | 73 | 4.19e-01 | 5.47e-02 | 7.17e-01 |
| Signaling by ERBB2 TMD/JMD mutants | 18 | 4.20e-01 | 1.10e-01 | 7.17e-01 |
| Downstream signaling of activated FGFR2 | 27 | 4.20e-01 | 8.97e-02 | 7.17e-01 |
| Regulation of TLR by endogenous ligand | 15 | 4.20e-01 | -1.20e-01 | 7.17e-01 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | 16 | 4.20e-01 | 1.16e-01 | 7.17e-01 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | 16 | 4.20e-01 | 1.16e-01 | 7.17e-01 |
| Hedgehog ligand biogenesis | 56 | 4.21e-01 | -6.21e-02 | 7.18e-01 |
| Acyl chain remodelling of PI | 15 | 4.24e-01 | 1.19e-01 | 7.20e-01 |
| Activation of SMO | 16 | 4.24e-01 | -1.15e-01 | 7.20e-01 |
| Iron uptake and transport | 50 | 4.24e-01 | 6.53e-02 | 7.20e-01 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | 10 | 4.25e-01 | -1.46e-01 | 7.20e-01 |
| FOXO-mediated transcription of cell cycle genes | 16 | 4.25e-01 | -1.15e-01 | 7.20e-01 |
| Chondroitin sulfate/dermatan sulfate metabolism | 46 | 4.27e-01 | 6.77e-02 | 7.23e-01 |
| Voltage gated Potassium channels | 39 | 4.28e-01 | 7.34e-02 | 7.23e-01 |
| NCAM1 interactions | 31 | 4.28e-01 | 8.22e-02 | 7.23e-01 |
| Constitutive Signaling by EGFRvIII | 13 | 4.31e-01 | 1.26e-01 | 7.25e-01 |
| Signaling by EGFRvIII in Cancer | 13 | 4.31e-01 | 1.26e-01 | 7.25e-01 |
| Downstream signaling of activated FGFR4 | 24 | 4.33e-01 | 9.26e-02 | 7.25e-01 |
| GABA receptor activation | 52 | 4.33e-01 | 6.29e-02 | 7.25e-01 |
| Glucagon signaling in metabolic regulation | 29 | 4.33e-01 | 8.41e-02 | 7.25e-01 |
| Programmed Cell Death | 162 | 4.33e-01 | 3.57e-02 | 7.25e-01 |
| G1/S Transition | 122 | 4.33e-01 | -4.11e-02 | 7.25e-01 |
| CS/DS degradation | 12 | 4.35e-01 | 1.30e-01 | 7.27e-01 |
| Signaling by FGFR4 | 34 | 4.36e-01 | 7.72e-02 | 7.27e-01 |
| TP53 Regulates Transcription of DNA Repair Genes | 55 | 4.36e-01 | -6.07e-02 | 7.27e-01 |
| Telomere C-strand synthesis initiation | 13 | 4.39e-01 | -1.24e-01 | 7.31e-01 |
| Vasopressin regulates renal water homeostasis via Aquaporins | 37 | 4.40e-01 | 7.34e-02 | 7.31e-01 |
| Signaling by FGFR2 in disease | 38 | 4.40e-01 | 7.23e-02 | 7.32e-01 |
| TRAF6 mediated NF-kB activation | 19 | 4.41e-01 | 1.02e-01 | 7.32e-01 |
| Signalling to RAS | 18 | 4.44e-01 | -1.04e-01 | 7.35e-01 |
| CD28 dependent PI3K/Akt signaling | 21 | 4.44e-01 | 9.65e-02 | 7.35e-01 |
| Mitotic Prophase | 80 | 4.45e-01 | -4.94e-02 | 7.35e-01 |
| CD28 co-stimulation | 32 | 4.45e-01 | -7.80e-02 | 7.35e-01 |
| Gap junction trafficking | 24 | 4.46e-01 | 9.00e-02 | 7.35e-01 |
| Gap junction trafficking and regulation | 26 | 4.47e-01 | 8.61e-02 | 7.35e-01 |
| Formation of the Early Elongation Complex | 31 | 4.47e-01 | -7.89e-02 | 7.35e-01 |
| Formation of the HIV-1 Early Elongation Complex | 31 | 4.47e-01 | -7.89e-02 | 7.35e-01 |
| Acyl chain remodelling of PG | 16 | 4.48e-01 | 1.10e-01 | 7.35e-01 |
| Cell recruitment (pro-inflammatory response) | 23 | 4.49e-01 | -9.12e-02 | 7.36e-01 |
| Purinergic signaling in leishmaniasis infection | 23 | 4.49e-01 | -9.12e-02 | 7.36e-01 |
| Regulation of IFNA signaling | 11 | 4.51e-01 | 1.31e-01 | 7.39e-01 |
| Autophagy | 116 | 4.52e-01 | -4.04e-02 | 7.39e-01 |
| RHO GTPases Activate WASPs and WAVEs | 34 | 4.53e-01 | 7.43e-02 | 7.39e-01 |
| ERBB2 Regulates Cell Motility | 14 | 4.54e-01 | 1.16e-01 | 7.39e-01 |
| SUMOylation of transcription cofactors | 41 | 4.55e-01 | 6.75e-02 | 7.39e-01 |
| RNA Polymerase III Chain Elongation | 14 | 4.56e-01 | -1.15e-01 | 7.39e-01 |
| Integrin cell surface interactions | 60 | 4.56e-01 | 5.57e-02 | 7.39e-01 |
| IRAK4 deficiency (TLR2/4) | 10 | 4.56e-01 | -1.36e-01 | 7.39e-01 |
| Signaling by FGFR4 in disease | 10 | 4.56e-01 | 1.36e-01 | 7.39e-01 |
| EPH-Ephrin signaling | 88 | 4.57e-01 | 4.59e-02 | 7.40e-01 |
| Activated NTRK2 signals through FRS2 and FRS3 | 10 | 4.58e-01 | -1.36e-01 | 7.40e-01 |
| Metabolism of nitric oxide: NOS3 activation and regulation | 14 | 4.60e-01 | 1.14e-01 | 7.43e-01 |
| Aggrephagy | 18 | 4.62e-01 | -1.00e-01 | 7.46e-01 |
| Transport of Mature Transcript to Cytoplasm | 80 | 4.63e-01 | -4.75e-02 | 7.46e-01 |
| Norepinephrine Neurotransmitter Release Cycle | 17 | 4.65e-01 | 1.02e-01 | 7.49e-01 |
| Signaling by WNT | 243 | 4.67e-01 | 2.71e-02 | 7.50e-01 |
| Mitotic G1 phase and G1/S transition | 137 | 4.68e-01 | -3.60e-02 | 7.50e-01 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | 12 | 4.69e-01 | 1.21e-01 | 7.50e-01 |
| Membrane Trafficking | 561 | 4.70e-01 | -1.79e-02 | 7.50e-01 |
| Regulation of RUNX1 Expression and Activity | 18 | 4.71e-01 | -9.82e-02 | 7.50e-01 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | 71 | 4.71e-01 | -4.95e-02 | 7.50e-01 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | 59 | 4.71e-01 | -5.43e-02 | 7.50e-01 |
| G beta:gamma signalling through CDC42 | 16 | 4.72e-01 | 1.04e-01 | 7.50e-01 |
| Blood group systems biosynthesis | 17 | 4.72e-01 | 1.01e-01 | 7.50e-01 |
| Nucleotide-like (purinergic) receptors | 13 | 4.73e-01 | 1.15e-01 | 7.50e-01 |
| Activated NOTCH1 Transmits Signal to the Nucleus | 29 | 4.73e-01 | 7.70e-02 | 7.50e-01 |
| Peptide ligand-binding receptors | 150 | 4.74e-01 | 3.39e-02 | 7.50e-01 |
| NOTCH3 Intracellular Domain Regulates Transcription | 21 | 4.75e-01 | 9.01e-02 | 7.50e-01 |
| Centrosome maturation | 74 | 4.75e-01 | 4.81e-02 | 7.50e-01 |
| Recruitment of mitotic centrosome proteins and complexes | 74 | 4.75e-01 | 4.81e-02 | 7.50e-01 |
| Loss of Nlp from mitotic centrosomes | 65 | 4.75e-01 | 5.12e-02 | 7.50e-01 |
| Loss of proteins required for interphase microtubule organization from the centrosome | 65 | 4.75e-01 | 5.12e-02 | 7.50e-01 |
| Interactions of Rev with host cellular proteins | 35 | 4.77e-01 | 6.94e-02 | 7.52e-01 |
| Interferon alpha/beta signaling | 49 | 4.79e-01 | 5.85e-02 | 7.52e-01 |
| MyD88 cascade initiated on plasma membrane | 73 | 4.79e-01 | 4.79e-02 | 7.52e-01 |
| Toll Like Receptor 10 (TLR10) Cascade | 73 | 4.79e-01 | 4.79e-02 | 7.52e-01 |
| Toll Like Receptor 5 (TLR5) Cascade | 73 | 4.79e-01 | 4.79e-02 | 7.52e-01 |
| DCC mediated attractive signaling | 14 | 4.80e-01 | 1.09e-01 | 7.52e-01 |
| MECP2 regulates neuronal receptors and channels | 16 | 4.80e-01 | 1.02e-01 | 7.52e-01 |
| Semaphorin interactions | 61 | 4.80e-01 | 5.23e-02 | 7.52e-01 |
| MET activates RAS signaling | 10 | 4.82e-01 | -1.28e-01 | 7.53e-01 |
| Deadenylation of mRNA | 20 | 4.82e-01 | 9.07e-02 | 7.53e-01 |
| AURKA Activation by TPX2 | 68 | 4.85e-01 | 4.90e-02 | 7.57e-01 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | 19 | 4.86e-01 | 9.24e-02 | 7.57e-01 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) | 34 | 4.87e-01 | -6.89e-02 | 7.58e-01 |
| Meiotic synapsis | 33 | 4.89e-01 | -6.96e-02 | 7.60e-01 |
| MAP2K and MAPK activation | 36 | 4.91e-01 | -6.64e-02 | 7.62e-01 |
| Synthesis of very long-chain fatty acyl-CoAs | 24 | 4.92e-01 | 8.10e-02 | 7.64e-01 |
| Role of LAT2/NTAL/LAB on calcium mobilization | 25 | 4.94e-01 | -7.90e-02 | 7.65e-01 |
| Complement cascade | 57 | 4.95e-01 | -5.23e-02 | 7.66e-01 |
| Phase 4 - resting membrane potential | 16 | 4.95e-01 | -9.85e-02 | 7.66e-01 |
| Apoptosis induced DNA fragmentation | 11 | 4.98e-01 | 1.18e-01 | 7.69e-01 |
| Positive epigenetic regulation of rRNA expression | 45 | 5.00e-01 | -5.81e-02 | 7.70e-01 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | 11 | 5.00e-01 | -1.17e-01 | 7.70e-01 |
| Resolution of Abasic Sites (AP sites) | 37 | 5.03e-01 | 6.37e-02 | 7.72e-01 |
| NF-kB is activated and signals survival | 10 | 5.03e-01 | 1.22e-01 | 7.72e-01 |
| tRNA processing in the nucleus | 53 | 5.03e-01 | -5.32e-02 | 7.72e-01 |
| Vitamin D (calciferol) metabolism | 10 | 5.04e-01 | -1.22e-01 | 7.72e-01 |
| Cyclin D associated events in G1 | 41 | 5.05e-01 | -6.03e-02 | 7.72e-01 |
| G1 Phase | 41 | 5.05e-01 | -6.03e-02 | 7.72e-01 |
| PIWI-interacting RNA (piRNA) biogenesis | 26 | 5.05e-01 | -7.56e-02 | 7.72e-01 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | 16 | 5.06e-01 | -9.61e-02 | 7.73e-01 |
| Nuclear Pore Complex (NPC) Disassembly | 34 | 5.07e-01 | -6.57e-02 | 7.74e-01 |
| Creatine metabolism | 10 | 5.09e-01 | -1.21e-01 | 7.76e-01 |
| Serotonin Neurotransmitter Release Cycle | 17 | 5.11e-01 | 9.21e-02 | 7.78e-01 |
| Signaling by ERBB4 | 52 | 5.12e-01 | -5.25e-02 | 7.78e-01 |
| Keratan sulfate biosynthesis | 25 | 5.13e-01 | -7.57e-02 | 7.78e-01 |
| HDR through Homologous Recombination (HRR) | 60 | 5.13e-01 | -4.88e-02 | 7.78e-01 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | 12 | 5.13e-01 | -1.09e-01 | 7.78e-01 |
| PPARA activates gene expression | 113 | 5.14e-01 | 3.56e-02 | 7.79e-01 |
| Signaling by Receptor Tyrosine Kinases | 449 | 5.15e-01 | 1.80e-02 | 7.79e-01 |
| Dual Incision in GG-NER | 37 | 5.16e-01 | -6.17e-02 | 7.80e-01 |
| RNA Polymerase I Transcription Initiation | 44 | 5.17e-01 | -5.65e-02 | 7.80e-01 |
| Class A/1 (Rhodopsin-like receptors) | 255 | 5.17e-01 | 2.36e-02 | 7.80e-01 |
| Amine ligand-binding receptors | 35 | 5.18e-01 | 6.32e-02 | 7.80e-01 |
| Interferon Signaling | 159 | 5.19e-01 | -2.97e-02 | 7.80e-01 |
| Striated Muscle Contraction | 31 | 5.19e-01 | -6.69e-02 | 7.80e-01 |
| Diseases of signal transduction by growth factor receptors and second messengers | 347 | 5.19e-01 | 2.02e-02 | 7.80e-01 |
| Role of phospholipids in phagocytosis | 36 | 5.20e-01 | -6.20e-02 | 7.80e-01 |
| Metabolism of nucleotides | 89 | 5.21e-01 | 3.94e-02 | 7.81e-01 |
| Post-translational modification: synthesis of GPI-anchored proteins | 75 | 5.22e-01 | 4.27e-02 | 7.81e-01 |
| Glycogen storage diseases | 12 | 5.23e-01 | 1.07e-01 | 7.81e-01 |
| Glycosaminoglycan metabolism | 108 | 5.23e-01 | 3.56e-02 | 7.81e-01 |
| Signaling by BMP | 25 | 5.24e-01 | 7.36e-02 | 7.82e-01 |
| mRNA 3’-end processing | 54 | 5.25e-01 | -5.00e-02 | 7.82e-01 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | 24 | 5.25e-01 | -7.49e-02 | 7.82e-01 |
| Transmission across Chemical Synapses | 221 | 5.27e-01 | 2.47e-02 | 7.84e-01 |
| Vitamin B5 (pantothenate) metabolism | 14 | 5.28e-01 | 9.74e-02 | 7.85e-01 |
| Interleukin-15 signaling | 13 | 5.31e-01 | 1.00e-01 | 7.88e-01 |
| EPHB-mediated forward signaling | 33 | 5.32e-01 | -6.28e-02 | 7.89e-01 |
| Regulation of innate immune responses to cytosolic DNA | 12 | 5.35e-01 | -1.03e-01 | 7.91e-01 |
| Signaling by NOTCH | 169 | 5.36e-01 | -2.76e-02 | 7.91e-01 |
| Platelet activation, signaling and aggregation | 240 | 5.36e-01 | 2.32e-02 | 7.91e-01 |
| Stimuli-sensing channels | 94 | 5.37e-01 | -3.69e-02 | 7.91e-01 |
| Disorders of transmembrane transporters | 161 | 5.37e-01 | 2.82e-02 | 7.91e-01 |
| Formation of the cornified envelope | 33 | 5.37e-01 | 6.21e-02 | 7.91e-01 |
| Effects of PIP2 hydrolysis | 26 | 5.38e-01 | 6.97e-02 | 7.92e-01 |
| Association of TriC/CCT with target proteins during biosynthesis | 38 | 5.39e-01 | 5.76e-02 | 7.92e-01 |
| Elastic fibre formation | 37 | 5.41e-01 | -5.81e-02 | 7.92e-01 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | 29 | 5.41e-01 | 6.56e-02 | 7.92e-01 |
| ZBP1(DAI) mediated induction of type I IFNs | 19 | 5.41e-01 | 8.10e-02 | 7.92e-01 |
| Activation of Ca-permeable Kainate Receptor | 10 | 5.41e-01 | -1.12e-01 | 7.92e-01 |
| Ionotropic activity of kainate receptors | 10 | 5.41e-01 | -1.12e-01 | 7.92e-01 |
| Fatty acyl-CoA biosynthesis | 35 | 5.42e-01 | 5.95e-02 | 7.92e-01 |
| Glutamate and glutamine metabolism | 12 | 5.46e-01 | 1.01e-01 | 7.96e-01 |
| p75NTR recruits signalling complexes | 11 | 5.47e-01 | -1.05e-01 | 7.98e-01 |
| Elevation of cytosolic Ca2+ levels | 15 | 5.48e-01 | 8.96e-02 | 7.98e-01 |
| Rho GTPase cycle | 129 | 5.49e-01 | 3.06e-02 | 7.99e-01 |
| Factors involved in megakaryocyte development and platelet production | 110 | 5.49e-01 | 3.31e-02 | 7.99e-01 |
| Telomere Extension By Telomerase | 22 | 5.51e-01 | 7.35e-02 | 8.00e-01 |
| Interleukin-6 signaling | 10 | 5.56e-01 | 1.08e-01 | 8.06e-01 |
| COPI-dependent Golgi-to-ER retrograde traffic | 77 | 5.57e-01 | -3.87e-02 | 8.07e-01 |
| Carnitine metabolism | 11 | 5.58e-01 | 1.02e-01 | 8.07e-01 |
| Killing mechanisms | 12 | 5.59e-01 | 9.74e-02 | 8.07e-01 |
| WNT5:FZD7-mediated leishmania damping | 12 | 5.59e-01 | 9.74e-02 | 8.07e-01 |
| Processing of Capped Intronless Pre-mRNA | 24 | 5.59e-01 | -6.89e-02 | 8.07e-01 |
| CLEC7A (Dectin-1) induces NFAT activation | 11 | 5.60e-01 | 1.01e-01 | 8.07e-01 |
| Nicotinate metabolism | 30 | 5.61e-01 | 6.14e-02 | 8.07e-01 |
| Ion transport by P-type ATPases | 49 | 5.66e-01 | 4.75e-02 | 8.09e-01 |
| EPH-ephrin mediated repulsion of cells | 47 | 5.66e-01 | 4.84e-02 | 8.09e-01 |
| Pausing and recovery of Tat-mediated HIV elongation | 27 | 5.66e-01 | -6.39e-02 | 8.09e-01 |
| Tat-mediated HIV elongation arrest and recovery | 27 | 5.66e-01 | -6.39e-02 | 8.09e-01 |
| Regulation of TP53 Activity through Acetylation | 28 | 5.67e-01 | 6.25e-02 | 8.09e-01 |
| Activation of G protein gated Potassium channels | 22 | 5.67e-01 | 7.05e-02 | 8.09e-01 |
| G protein gated Potassium channels | 22 | 5.67e-01 | 7.05e-02 | 8.09e-01 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | 22 | 5.67e-01 | 7.05e-02 | 8.09e-01 |
| Activation of kainate receptors upon glutamate binding | 26 | 5.69e-01 | 6.46e-02 | 8.09e-01 |
| Integrin signaling | 27 | 5.69e-01 | -6.33e-02 | 8.09e-01 |
| Regulation of gene expression by Hypoxia-inducible Factor | 11 | 5.69e-01 | 9.91e-02 | 8.09e-01 |
| Nervous system development | 491 | 5.71e-01 | -1.50e-02 | 8.09e-01 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | 21 | 5.71e-01 | -7.15e-02 | 8.09e-01 |
| Signaling by NOTCH2 | 28 | 5.72e-01 | 6.18e-02 | 8.09e-01 |
| Anti-inflammatory response favouring Leishmania parasite infection | 151 | 5.72e-01 | -2.66e-02 | 8.09e-01 |
| Leishmania parasite growth and survival | 151 | 5.72e-01 | -2.66e-02 | 8.09e-01 |
| Lewis blood group biosynthesis | 13 | 5.73e-01 | 9.04e-02 | 8.09e-01 |
| Toll Like Receptor 9 (TLR9) Cascade | 81 | 5.73e-01 | 3.63e-02 | 8.09e-01 |
| Gastrin-CREB signalling pathway via PKC and MAPK | 15 | 5.73e-01 | -8.41e-02 | 8.09e-01 |
| TAK1 activates NFkB by phosphorylation and activation of IKKs complex | 23 | 5.73e-01 | 6.79e-02 | 8.09e-01 |
| Regulation of PLK1 Activity at G2/M Transition | 80 | 5.79e-01 | 3.59e-02 | 8.16e-01 |
| WNT5A-dependent internalization of FZD4 | 14 | 5.79e-01 | 8.56e-02 | 8.16e-01 |
| Nuclear signaling by ERBB4 | 29 | 5.81e-01 | 5.92e-02 | 8.17e-01 |
| Removal of the Flap Intermediate | 13 | 5.84e-01 | 8.77e-02 | 8.18e-01 |
| HIV elongation arrest and recovery | 29 | 5.84e-01 | -5.88e-02 | 8.18e-01 |
| Pausing and recovery of HIV elongation | 29 | 5.84e-01 | -5.88e-02 | 8.18e-01 |
| Misspliced GSK3beta mutants stabilize beta-catenin | 13 | 5.86e-01 | 8.72e-02 | 8.18e-01 |
| S33 mutants of beta-catenin aren’t phosphorylated | 13 | 5.86e-01 | 8.72e-02 | 8.18e-01 |
| S37 mutants of beta-catenin aren’t phosphorylated | 13 | 5.86e-01 | 8.72e-02 | 8.18e-01 |
| S45 mutants of beta-catenin aren’t phosphorylated | 13 | 5.86e-01 | 8.72e-02 | 8.18e-01 |
| T41 mutants of beta-catenin aren’t phosphorylated | 13 | 5.86e-01 | 8.72e-02 | 8.18e-01 |
| phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex | 13 | 5.86e-01 | 8.72e-02 | 8.18e-01 |
| FGFR2 mutant receptor activation | 29 | 5.88e-01 | 5.81e-02 | 8.18e-01 |
| Negative epigenetic regulation of rRNA expression | 51 | 5.88e-01 | 4.38e-02 | 8.18e-01 |
| Phase 2 - plateau phase | 12 | 5.88e-01 | 9.03e-02 | 8.18e-01 |
| Base-Excision Repair, AP Site Formation | 20 | 5.89e-01 | 6.97e-02 | 8.18e-01 |
| MyD88 dependent cascade initiated on endosome | 77 | 5.91e-01 | 3.54e-02 | 8.20e-01 |
| Transcriptional regulation of pluripotent stem cells | 27 | 5.92e-01 | -5.97e-02 | 8.20e-01 |
| Metabolism of folate and pterines | 17 | 5.92e-01 | -7.51e-02 | 8.20e-01 |
| Diseases of glycosylation | 126 | 5.93e-01 | -2.76e-02 | 8.20e-01 |
| Inflammasomes | 19 | 5.96e-01 | -7.02e-02 | 8.24e-01 |
| Prostacyclin signalling through prostacyclin receptor | 15 | 5.97e-01 | 7.89e-02 | 8.24e-01 |
| Rev-mediated nuclear export of HIV RNA | 33 | 5.97e-01 | 5.32e-02 | 8.24e-01 |
| NR1H2 and NR1H3-mediated signaling | 48 | 5.98e-01 | 4.40e-02 | 8.24e-01 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | 21 | 6.00e-01 | -6.62e-02 | 8.25e-01 |
| Cholesterol biosynthesis | 21 | 6.00e-01 | 6.61e-02 | 8.25e-01 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | 12 | 6.02e-01 | -8.70e-02 | 8.26e-01 |
| Telomere C-strand (Lagging Strand) Synthesis | 33 | 6.02e-01 | -5.24e-02 | 8.26e-01 |
| Adenylate cyclase activating pathway | 10 | 6.04e-01 | 9.47e-02 | 8.28e-01 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | 97 | 6.05e-01 | 3.04e-02 | 8.28e-01 |
| O-linked glycosylation | 90 | 6.06e-01 | -3.15e-02 | 8.29e-01 |
| TP53 Regulates Transcription of Cell Death Genes | 34 | 6.06e-01 | -5.11e-02 | 8.29e-01 |
| Activation of gene expression by SREBF (SREBP) | 40 | 6.07e-01 | 4.70e-02 | 8.29e-01 |
| RAF activation | 31 | 6.11e-01 | -5.28e-02 | 8.33e-01 |
| Signaling by FGFR2 IIIa TM | 17 | 6.11e-01 | -7.12e-02 | 8.33e-01 |
| HSF1 activation | 24 | 6.13e-01 | 5.97e-02 | 8.34e-01 |
| Regulation of PTEN mRNA translation | 19 | 6.14e-01 | -6.69e-02 | 8.35e-01 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | 83 | 6.17e-01 | 3.17e-02 | 8.35e-01 |
| Toll Like Receptor 2 (TLR2) Cascade | 83 | 6.17e-01 | 3.17e-02 | 8.35e-01 |
| Toll Like Receptor TLR1:TLR2 Cascade | 83 | 6.17e-01 | 3.17e-02 | 8.35e-01 |
| Toll Like Receptor TLR6:TLR2 Cascade | 83 | 6.17e-01 | 3.17e-02 | 8.35e-01 |
| Signaling by PDGFRA extracellular domain mutants | 10 | 6.18e-01 | 9.12e-02 | 8.35e-01 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | 10 | 6.18e-01 | 9.12e-02 | 8.35e-01 |
| HDR through Single Strand Annealing (SSA) | 35 | 6.19e-01 | -4.86e-02 | 8.36e-01 |
| Repression of WNT target genes | 14 | 6.21e-01 | 7.63e-02 | 8.38e-01 |
| Chemokine receptors bind chemokines | 41 | 6.21e-01 | 4.46e-02 | 8.38e-01 |
| Termination of translesion DNA synthesis | 27 | 6.22e-01 | 5.48e-02 | 8.39e-01 |
| FRS-mediated FGFR1 signaling | 20 | 6.24e-01 | 6.34e-02 | 8.40e-01 |
| NoRC negatively regulates rRNA expression | 48 | 6.25e-01 | 4.08e-02 | 8.40e-01 |
| Epigenetic regulation of gene expression | 87 | 6.29e-01 | 3.00e-02 | 8.43e-01 |
| Peptide hormone metabolism | 81 | 6.29e-01 | -3.11e-02 | 8.43e-01 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | 53 | 6.29e-01 | 3.83e-02 | 8.43e-01 |
| G alpha (s) signalling events | 195 | 6.32e-01 | -1.99e-02 | 8.43e-01 |
| Infection with Mycobacterium tuberculosis | 24 | 6.32e-01 | -5.65e-02 | 8.43e-01 |
| Acyl chain remodelling of PE | 25 | 6.32e-01 | 5.53e-02 | 8.43e-01 |
| NRIF signals cell death from the nucleus | 14 | 6.32e-01 | -7.39e-02 | 8.43e-01 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | 39 | 6.33e-01 | -4.42e-02 | 8.43e-01 |
| Interleukin-20 family signaling | 16 | 6.34e-01 | -6.88e-02 | 8.43e-01 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | 76 | 6.34e-01 | 3.16e-02 | 8.43e-01 |
| Transcriptional Regulation by TP53 | 325 | 6.34e-01 | -1.54e-02 | 8.43e-01 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | 16 | 6.36e-01 | -6.84e-02 | 8.45e-01 |
| MET activates RAP1 and RAC1 | 11 | 6.36e-01 | 8.23e-02 | 8.45e-01 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | 78 | 6.38e-01 | 3.09e-02 | 8.46e-01 |
| Syndecan interactions | 19 | 6.38e-01 | 6.23e-02 | 8.46e-01 |
| Regulation of signaling by CBL | 17 | 6.40e-01 | -6.55e-02 | 8.48e-01 |
| Signaling by EGFR in Cancer | 21 | 6.44e-01 | 5.83e-02 | 8.52e-01 |
| BBSome-mediated cargo-targeting to cilium | 21 | 6.46e-01 | -5.79e-02 | 8.54e-01 |
| Class B/2 (Secretin family receptors) | 78 | 6.48e-01 | 3.00e-02 | 8.55e-01 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | 19 | 6.49e-01 | 6.04e-02 | 8.56e-01 |
| The role of Nef in HIV-1 replication and disease pathogenesis | 26 | 6.51e-01 | 5.13e-02 | 8.57e-01 |
| Listeria monocytogenes entry into host cells | 18 | 6.51e-01 | 6.15e-02 | 8.57e-01 |
| DNA strand elongation | 31 | 6.52e-01 | 4.68e-02 | 8.57e-01 |
| Regulation of Complement cascade | 49 | 6.52e-01 | -3.73e-02 | 8.57e-01 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | 30 | 6.52e-01 | 4.76e-02 | 8.57e-01 |
| Organic cation/anion/zwitterion transport | 12 | 6.53e-01 | 7.49e-02 | 8.57e-01 |
| Signaling by Hippo | 20 | 6.54e-01 | 5.79e-02 | 8.57e-01 |
| Inwardly rectifying K+ channels | 28 | 6.55e-01 | 4.88e-02 | 8.57e-01 |
| G2/M Transition | 165 | 6.56e-01 | -2.01e-02 | 8.57e-01 |
| Synthesis of PC | 28 | 6.56e-01 | 4.87e-02 | 8.57e-01 |
| Transport of the SLBP Dependant Mature mRNA | 35 | 6.57e-01 | -4.34e-02 | 8.58e-01 |
| Mitotic G2-G2/M phases | 167 | 6.58e-01 | -1.99e-02 | 8.58e-01 |
| TP53 Regulates Transcription of Cell Cycle Genes | 47 | 6.62e-01 | 3.68e-02 | 8.63e-01 |
| ERK/MAPK targets | 20 | 6.64e-01 | 5.61e-02 | 8.65e-01 |
| Unfolded Protein Response (UPR) | 89 | 6.65e-01 | 2.66e-02 | 8.65e-01 |
| Interleukin-2 family signaling | 38 | 6.65e-01 | -4.06e-02 | 8.65e-01 |
| MET promotes cell motility | 28 | 6.68e-01 | 4.69e-02 | 8.67e-01 |
| Ca2+ pathway | 54 | 6.71e-01 | 3.35e-02 | 8.70e-01 |
| Amyloid fiber formation | 48 | 6.72e-01 | 3.54e-02 | 8.71e-01 |
| Diseases associated with glycosylation precursor biosynthesis | 17 | 6.74e-01 | 5.89e-02 | 8.73e-01 |
| Interleukin-6 family signaling | 23 | 6.75e-01 | 5.05e-02 | 8.73e-01 |
| Physiological factors | 12 | 6.76e-01 | 6.98e-02 | 8.73e-01 |
| Glutathione synthesis and recycling | 11 | 6.76e-01 | 7.27e-02 | 8.73e-01 |
| Antiviral mechanism by IFN-stimulated genes | 74 | 6.78e-01 | -2.80e-02 | 8.74e-01 |
| Interleukin-35 Signalling | 11 | 6.78e-01 | 7.23e-02 | 8.74e-01 |
| Beta-catenin phosphorylation cascade | 15 | 6.79e-01 | 6.18e-02 | 8.74e-01 |
| FRS-mediated FGFR2 signaling | 22 | 6.79e-01 | 5.10e-02 | 8.74e-01 |
| Termination of O-glycan biosynthesis | 14 | 6.80e-01 | 6.37e-02 | 8.74e-01 |
| MicroRNA (miRNA) biogenesis | 22 | 6.85e-01 | -5.00e-02 | 8.80e-01 |
| PCP/CE pathway | 80 | 6.85e-01 | -2.62e-02 | 8.80e-01 |
| Recognition of DNA damage by PCNA-containing replication complex | 27 | 6.87e-01 | -4.48e-02 | 8.80e-01 |
| Signaling by BRAF and RAF fusions | 59 | 6.88e-01 | 3.02e-02 | 8.80e-01 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | 22 | 6.88e-01 | -4.95e-02 | 8.80e-01 |
| Downregulation of ERBB2:ERBB3 signaling | 11 | 6.88e-01 | 6.98e-02 | 8.80e-01 |
| Erythropoietin activates RAS | 13 | 6.91e-01 | 6.37e-02 | 8.81e-01 |
| Response to elevated platelet cytosolic Ca2+ | 125 | 6.91e-01 | 2.06e-02 | 8.81e-01 |
| Interleukin-1 signaling | 89 | 6.92e-01 | -2.43e-02 | 8.81e-01 |
| Detoxification of Reactive Oxygen Species | 32 | 6.92e-01 | 4.05e-02 | 8.81e-01 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | 17 | 6.92e-01 | -5.54e-02 | 8.81e-01 |
| Signaling by NOTCH1 | 67 | 6.93e-01 | -2.79e-02 | 8.82e-01 |
| Insulin processing | 25 | 6.94e-01 | -4.55e-02 | 8.82e-01 |
| NS1 Mediated Effects on Host Pathways | 39 | 6.95e-01 | -3.63e-02 | 8.82e-01 |
| ERBB2 Activates PTK6 Signaling | 12 | 6.95e-01 | 6.53e-02 | 8.82e-01 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | 31 | 6.97e-01 | 4.04e-02 | 8.83e-01 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | 31 | 6.97e-01 | 4.04e-02 | 8.83e-01 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | 28 | 6.99e-01 | -4.22e-02 | 8.84e-01 |
| Signaling by NTRK3 (TRKC) | 16 | 7.01e-01 | 5.55e-02 | 8.86e-01 |
| Lagging Strand Synthesis | 19 | 7.02e-01 | -5.07e-02 | 8.86e-01 |
| Platelet Adhesion to exposed collagen | 12 | 7.04e-01 | 6.35e-02 | 8.87e-01 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | 15 | 7.04e-01 | 5.66e-02 | 8.87e-01 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | 15 | 7.04e-01 | 5.66e-02 | 8.87e-01 |
| DSCAM interactions | 11 | 7.06e-01 | -6.57e-02 | 8.88e-01 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | 21 | 7.06e-01 | 4.75e-02 | 8.88e-01 |
| Digestion and absorption | 20 | 7.07e-01 | -4.85e-02 | 8.88e-01 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | 51 | 7.07e-01 | -3.04e-02 | 8.88e-01 |
| Interleukin-27 signaling | 11 | 7.08e-01 | 6.52e-02 | 8.88e-01 |
| Oncogene Induced Senescence | 28 | 7.09e-01 | -4.07e-02 | 8.88e-01 |
| Synthesis of substrates in N-glycan biosythesis | 57 | 7.10e-01 | -2.85e-02 | 8.89e-01 |
| Signaling by MET | 62 | 7.12e-01 | -2.72e-02 | 8.90e-01 |
| Plasma lipoprotein assembly | 18 | 7.14e-01 | -4.99e-02 | 8.91e-01 |
| Transcriptional Regulation by VENTX | 35 | 7.15e-01 | -3.57e-02 | 8.91e-01 |
| FRS-mediated FGFR4 signaling | 19 | 7.15e-01 | 4.84e-02 | 8.91e-01 |
| Signaling by Rho GTPases | 356 | 7.15e-01 | 1.13e-02 | 8.91e-01 |
| GRB2 events in ERBB2 signaling | 14 | 7.17e-01 | 5.61e-02 | 8.92e-01 |
| Vpr-mediated nuclear import of PICs | 32 | 7.19e-01 | -3.67e-02 | 8.93e-01 |
| Protein methylation | 14 | 7.20e-01 | -5.53e-02 | 8.93e-01 |
| RNA Polymerase III Abortive And Retractive Initiation | 37 | 7.20e-01 | -3.40e-02 | 8.93e-01 |
| RNA Polymerase III Transcription | 37 | 7.20e-01 | -3.40e-02 | 8.93e-01 |
| Presynaptic phase of homologous DNA pairing and strand exchange | 36 | 7.20e-01 | -3.45e-02 | 8.93e-01 |
| MAPK family signaling cascades | 292 | 7.21e-01 | -1.22e-02 | 8.93e-01 |
| HCMV Early Events | 59 | 7.22e-01 | -2.67e-02 | 8.94e-01 |
| RNA Polymerase I Transcription Termination | 28 | 7.23e-01 | -3.87e-02 | 8.94e-01 |
| DNA Damage/Telomere Stress Induced Senescence | 33 | 7.24e-01 | -3.55e-02 | 8.94e-01 |
| Gap junction assembly | 16 | 7.25e-01 | 5.08e-02 | 8.94e-01 |
| Free fatty acids regulate insulin secretion | 10 | 7.26e-01 | 6.39e-02 | 8.95e-01 |
| Formation of Incision Complex in GG-NER | 39 | 7.27e-01 | -3.23e-02 | 8.95e-01 |
| Myogenesis | 29 | 7.27e-01 | -3.74e-02 | 8.95e-01 |
| Diseases associated with the TLR signaling cascade | 20 | 7.29e-01 | -4.48e-02 | 8.95e-01 |
| Diseases of Immune System | 20 | 7.29e-01 | -4.48e-02 | 8.95e-01 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | 24 | 7.35e-01 | -3.99e-02 | 9.01e-01 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | 12 | 7.36e-01 | 5.62e-02 | 9.01e-01 |
| MyD88-independent TLR4 cascade | 83 | 7.36e-01 | -2.14e-02 | 9.01e-01 |
| TRIF(TICAM1)-mediated TLR4 signaling | 83 | 7.36e-01 | -2.14e-02 | 9.01e-01 |
| Signaling by FGFR | 72 | 7.38e-01 | 2.28e-02 | 9.02e-01 |
| Basigin interactions | 25 | 7.40e-01 | 3.84e-02 | 9.04e-01 |
| Nuclear import of Rev protein | 32 | 7.40e-01 | 3.39e-02 | 9.04e-01 |
| Activation of the TFAP2 (AP-2) family of transcription factors | 11 | 7.43e-01 | 5.72e-02 | 9.06e-01 |
| PLC beta mediated events | 50 | 7.43e-01 | 2.68e-02 | 9.06e-01 |
| MAP kinase activation | 57 | 7.45e-01 | 2.49e-02 | 9.06e-01 |
| DNA Damage Bypass | 41 | 7.45e-01 | 2.93e-02 | 9.06e-01 |
| DAG and IP3 signaling | 38 | 7.45e-01 | -3.05e-02 | 9.06e-01 |
| Digestion | 15 | 7.47e-01 | -4.81e-02 | 9.07e-01 |
| Intra-Golgi traffic | 40 | 7.48e-01 | -2.94e-02 | 9.07e-01 |
| Interleukin-7 signaling | 21 | 7.49e-01 | -4.03e-02 | 9.07e-01 |
| Signaling by high-kinase activity BRAF mutants | 32 | 7.49e-01 | -3.26e-02 | 9.07e-01 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | 14 | 7.49e-01 | -4.93e-02 | 9.07e-01 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | 23 | 7.54e-01 | 3.77e-02 | 9.12e-01 |
| Degradation of cysteine and homocysteine | 10 | 7.56e-01 | 5.69e-02 | 9.13e-01 |
| Chromatin modifying enzymes | 195 | 7.58e-01 | -1.28e-02 | 9.14e-01 |
| Chromatin organization | 195 | 7.58e-01 | -1.28e-02 | 9.14e-01 |
| Cargo recognition for clathrin-mediated endocytosis | 96 | 7.59e-01 | -1.81e-02 | 9.15e-01 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | 12 | 7.61e-01 | -5.07e-02 | 9.16e-01 |
| SHC1 events in EGFR signaling | 13 | 7.61e-01 | -4.87e-02 | 9.16e-01 |
| Regulation of actin dynamics for phagocytic cup formation | 70 | 7.65e-01 | 2.07e-02 | 9.19e-01 |
| Retrograde transport at the Trans-Golgi-Network | 44 | 7.66e-01 | -2.60e-02 | 9.19e-01 |
| Amino acid transport across the plasma membrane | 31 | 7.66e-01 | 3.09e-02 | 9.19e-01 |
| Signaling by FGFR2 | 61 | 7.68e-01 | -2.19e-02 | 9.20e-01 |
| Sodium/Calcium exchangers | 11 | 7.69e-01 | 5.12e-02 | 9.21e-01 |
| TRAF3-dependent IRF activation pathway | 12 | 7.70e-01 | 4.87e-02 | 9.21e-01 |
| Tie2 Signaling | 16 | 7.70e-01 | -4.21e-02 | 9.21e-01 |
| Diseases associated with glycosaminoglycan metabolism | 38 | 7.70e-01 | 2.74e-02 | 9.21e-01 |
| G2/M DNA damage checkpoint | 56 | 7.72e-01 | -2.24e-02 | 9.21e-01 |
| Nucleotide salvage | 21 | 7.72e-01 | 3.66e-02 | 9.21e-01 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | 31 | 7.73e-01 | -2.99e-02 | 9.22e-01 |
| PRC2 methylates histones and DNA | 17 | 7.74e-01 | 4.01e-02 | 9.22e-01 |
| SUMOylation of intracellular receptors | 29 | 7.76e-01 | -3.06e-02 | 9.23e-01 |
| Pregnenolone biosynthesis | 11 | 7.77e-01 | 4.92e-02 | 9.24e-01 |
| Signaling by TGFB family members | 91 | 7.78e-01 | 1.71e-02 | 9.24e-01 |
| Platelet Aggregation (Plug Formation) | 36 | 7.78e-01 | -2.71e-02 | 9.24e-01 |
| FOXO-mediated transcription | 63 | 7.82e-01 | 2.02e-02 | 9.27e-01 |
| Cytochrome c-mediated apoptotic response | 10 | 7.83e-01 | 5.03e-02 | 9.28e-01 |
| Signaling by PDGF | 48 | 7.87e-01 | -2.26e-02 | 9.31e-01 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | 32 | 7.89e-01 | 2.74e-02 | 9.32e-01 |
| ATF4 activates genes in response to endoplasmic reticulum stress | 25 | 7.89e-01 | -3.09e-02 | 9.32e-01 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | 24 | 7.90e-01 | 3.14e-02 | 9.33e-01 |
| EPHA-mediated growth cone collapse | 14 | 7.92e-01 | -4.07e-02 | 9.33e-01 |
| Regulation of TNFR1 signaling | 30 | 7.93e-01 | -2.77e-02 | 9.33e-01 |
| Response of Mtb to phagocytosis | 20 | 7.94e-01 | -3.37e-02 | 9.33e-01 |
| PTEN Regulation | 134 | 7.94e-01 | -1.31e-02 | 9.33e-01 |
| Signaling by EGFR | 47 | 7.94e-01 | 2.20e-02 | 9.33e-01 |
| Interleukin-17 signaling | 64 | 7.94e-01 | 1.88e-02 | 9.33e-01 |
| TNFR1-induced NFkappaB signaling pathway | 23 | 7.95e-01 | 3.14e-02 | 9.33e-01 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | 14 | 7.97e-01 | 3.96e-02 | 9.35e-01 |
| ECM proteoglycans | 52 | 7.98e-01 | 2.05e-02 | 9.35e-01 |
| ABC-family proteins mediated transport | 92 | 7.99e-01 | -1.53e-02 | 9.35e-01 |
| Fertilization | 19 | 8.00e-01 | 3.36e-02 | 9.35e-01 |
| Signaling by NTRK1 (TRKA) | 107 | 8.01e-01 | 1.41e-02 | 9.35e-01 |
| Viral Messenger RNA Synthesis | 41 | 8.02e-01 | -2.27e-02 | 9.35e-01 |
| Surfactant metabolism | 24 | 8.02e-01 | 2.96e-02 | 9.35e-01 |
| Ion channel transport | 161 | 8.03e-01 | 1.14e-02 | 9.35e-01 |
| Signalling to ERKs | 30 | 8.03e-01 | 2.63e-02 | 9.35e-01 |
| Transport of bile salts and organic acids, metal ions and amine compounds | 77 | 8.04e-01 | 1.64e-02 | 9.35e-01 |
| Beta-catenin independent WNT signaling | 127 | 8.04e-01 | -1.28e-02 | 9.35e-01 |
| Metal ion SLC transporters | 24 | 8.05e-01 | -2.92e-02 | 9.35e-01 |
| Depolymerisation of the Nuclear Lamina | 15 | 8.05e-01 | 3.68e-02 | 9.35e-01 |
| Tandem pore domain potassium channels | 10 | 8.12e-01 | 4.34e-02 | 9.42e-01 |
| RAF-independent MAPK1/3 activation | 21 | 8.13e-01 | 2.98e-02 | 9.42e-01 |
| SUMOylation of SUMOylation proteins | 33 | 8.14e-01 | -2.37e-02 | 9.42e-01 |
| Metabolic disorders of biological oxidation enzymes | 32 | 8.15e-01 | 2.39e-02 | 9.43e-01 |
| Chondroitin sulfate biosynthesis | 20 | 8.18e-01 | -2.97e-02 | 9.46e-01 |
| RAF/MAP kinase cascade | 250 | 8.19e-01 | 8.42e-03 | 9.46e-01 |
| mRNA Capping | 27 | 8.20e-01 | -2.54e-02 | 9.46e-01 |
| G-protein beta:gamma signalling | 28 | 8.26e-01 | 2.40e-02 | 9.48e-01 |
| AMER1 mutants destabilize the destruction complex | 12 | 8.26e-01 | 3.66e-02 | 9.48e-01 |
| APC truncation mutants have impaired AXIN binding | 12 | 8.26e-01 | 3.66e-02 | 9.48e-01 |
| AXIN missense mutants destabilize the destruction complex | 12 | 8.26e-01 | 3.66e-02 | 9.48e-01 |
| AXIN mutants destabilize the destruction complex, activating WNT signaling | 12 | 8.26e-01 | 3.66e-02 | 9.48e-01 |
| Truncations of AMER1 destabilize the destruction complex | 12 | 8.26e-01 | 3.66e-02 | 9.48e-01 |
| truncated APC mutants destabilize the destruction complex | 12 | 8.26e-01 | 3.66e-02 | 9.48e-01 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | 22 | 8.27e-01 | 2.69e-02 | 9.48e-01 |
| CDC6 association with the ORC:origin complex | 11 | 8.28e-01 | -3.79e-02 | 9.48e-01 |
| Netrin-1 signaling | 47 | 8.29e-01 | 1.82e-02 | 9.48e-01 |
| PI3K/AKT Signaling in Cancer | 95 | 8.31e-01 | 1.27e-02 | 9.48e-01 |
| Neurotransmitter receptors and postsynaptic signal transmission | 160 | 8.31e-01 | 9.80e-03 | 9.48e-01 |
| Base Excision Repair | 47 | 8.31e-01 | 1.80e-02 | 9.48e-01 |
| Keratinization | 84 | 8.31e-01 | -1.34e-02 | 9.48e-01 |
| RUNX3 regulates NOTCH signaling | 12 | 8.31e-01 | -3.55e-02 | 9.48e-01 |
| Transport of the SLBP independent Mature mRNA | 34 | 8.32e-01 | -2.11e-02 | 9.48e-01 |
| Ephrin signaling | 18 | 8.34e-01 | 2.86e-02 | 9.49e-01 |
| SUMO E3 ligases SUMOylate target proteins | 155 | 8.36e-01 | 9.66e-03 | 9.49e-01 |
| Cleavage of the damaged pyrimidine | 18 | 8.37e-01 | 2.80e-02 | 9.49e-01 |
| Depyrimidination | 18 | 8.37e-01 | 2.80e-02 | 9.49e-01 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | 18 | 8.37e-01 | 2.80e-02 | 9.49e-01 |
| SUMOylation of immune response proteins | 10 | 8.37e-01 | -3.75e-02 | 9.49e-01 |
| Interleukin-12 family signaling | 49 | 8.38e-01 | 1.69e-02 | 9.49e-01 |
| Mitophagy | 24 | 8.39e-01 | -2.40e-02 | 9.49e-01 |
| InlB-mediated entry of Listeria monocytogenes into host cell | 13 | 8.39e-01 | -3.25e-02 | 9.49e-01 |
| Purine salvage | 13 | 8.40e-01 | 3.24e-02 | 9.49e-01 |
| SUMOylation of DNA replication proteins | 43 | 8.40e-01 | 1.77e-02 | 9.49e-01 |
| Leishmania infection | 230 | 8.42e-01 | -7.66e-03 | 9.49e-01 |
| Chylomicron assembly | 10 | 8.42e-01 | -3.64e-02 | 9.49e-01 |
| SHC1 events in ERBB2 signaling | 20 | 8.43e-01 | -2.56e-02 | 9.49e-01 |
| FCGR3A-mediated phagocytosis | 69 | 8.44e-01 | -1.37e-02 | 9.49e-01 |
| Leishmania phagocytosis | 69 | 8.44e-01 | -1.37e-02 | 9.49e-01 |
| Parasite infection | 69 | 8.44e-01 | -1.37e-02 | 9.49e-01 |
| WNT ligand biogenesis and trafficking | 25 | 8.46e-01 | 2.25e-02 | 9.49e-01 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | 16 | 8.46e-01 | 2.80e-02 | 9.49e-01 |
| Toll Like Receptor 4 (TLR4) Cascade | 110 | 8.47e-01 | -1.07e-02 | 9.49e-01 |
| Transcription of E2F targets under negative control by DREAM complex | 19 | 8.48e-01 | 2.54e-02 | 9.49e-01 |
| Signaling by cytosolic FGFR1 fusion mutants | 17 | 8.48e-01 | -2.68e-02 | 9.49e-01 |
| RAB geranylgeranylation | 58 | 8.49e-01 | 1.45e-02 | 9.49e-01 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | 37 | 8.50e-01 | 1.80e-02 | 9.49e-01 |
| Phase II - Conjugation of compounds | 76 | 8.51e-01 | -1.25e-02 | 9.49e-01 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | 13 | 8.51e-01 | -3.00e-02 | 9.49e-01 |
| Regulation of signaling by NODAL | 11 | 8.51e-01 | -3.26e-02 | 9.49e-01 |
| Nuclear Envelope Breakdown | 50 | 8.52e-01 | -1.52e-02 | 9.49e-01 |
| Dopamine Neurotransmitter Release Cycle | 21 | 8.54e-01 | -2.32e-02 | 9.49e-01 |
| VxPx cargo-targeting to cilium | 20 | 8.56e-01 | 2.34e-02 | 9.49e-01 |
| PIP3 activates AKT signaling | 252 | 8.56e-01 | 6.64e-03 | 9.49e-01 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | 33 | 8.56e-01 | -1.82e-02 | 9.49e-01 |
| Diseases of mitotic cell cycle | 33 | 8.56e-01 | -1.82e-02 | 9.49e-01 |
| Synthesis of IP3 and IP4 in the cytosol | 26 | 8.56e-01 | 2.05e-02 | 9.49e-01 |
| GRB2 events in EGFR signaling | 12 | 8.61e-01 | -2.91e-02 | 9.49e-01 |
| Estrogen-dependent gene expression | 90 | 8.61e-01 | 1.07e-02 | 9.49e-01 |
| mRNA decay by 5’ to 3’ exoribonuclease | 14 | 8.62e-01 | -2.69e-02 | 9.49e-01 |
| Activation of ATR in response to replication stress | 36 | 8.62e-01 | 1.67e-02 | 9.49e-01 |
| Signaling by Erythropoietin | 23 | 8.63e-01 | -2.08e-02 | 9.49e-01 |
| Constitutive Signaling by Aberrant PI3K in Cancer | 70 | 8.64e-01 | 1.19e-02 | 9.49e-01 |
| KSRP (KHSRP) binds and destabilizes mRNA | 16 | 8.64e-01 | 2.48e-02 | 9.49e-01 |
| Tight junction interactions | 24 | 8.64e-01 | 2.03e-02 | 9.49e-01 |
| Macroautophagy | 103 | 8.64e-01 | -9.78e-03 | 9.49e-01 |
| Negative regulators of DDX58/IFIH1 signaling | 28 | 8.64e-01 | 1.87e-02 | 9.49e-01 |
| Downstream signal transduction | 27 | 8.66e-01 | 1.88e-02 | 9.49e-01 |
| Spry regulation of FGF signaling | 12 | 8.66e-01 | 2.82e-02 | 9.49e-01 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | 52 | 8.67e-01 | -1.34e-02 | 9.49e-01 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | 52 | 8.67e-01 | -1.34e-02 | 9.49e-01 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | 52 | 8.67e-01 | -1.34e-02 | 9.49e-01 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | 52 | 8.67e-01 | -1.34e-02 | 9.49e-01 |
| Signaling by NOTCH1 in Cancer | 52 | 8.67e-01 | -1.34e-02 | 9.49e-01 |
| O-linked glycosylation of mucins | 43 | 8.68e-01 | 1.47e-02 | 9.49e-01 |
| NOTCH2 intracellular domain regulates transcription | 10 | 8.68e-01 | -3.03e-02 | 9.49e-01 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | 13 | 8.70e-01 | 2.63e-02 | 9.50e-01 |
| PINK1-PRKN Mediated Mitophagy | 17 | 8.71e-01 | 2.28e-02 | 9.50e-01 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | 30 | 8.71e-01 | -1.71e-02 | 9.50e-01 |
| Deadenylation-dependent mRNA decay | 49 | 8.73e-01 | -1.32e-02 | 9.51e-01 |
| TNF signaling | 39 | 8.74e-01 | -1.46e-02 | 9.52e-01 |
| SUMOylation of chromatin organization proteins | 53 | 8.76e-01 | -1.24e-02 | 9.52e-01 |
| Diseases associated with N-glycosylation of proteins | 16 | 8.78e-01 | -2.22e-02 | 9.52e-01 |
| GAB1 signalosome | 17 | 8.79e-01 | 2.14e-02 | 9.52e-01 |
| Hyaluronan metabolism | 14 | 8.79e-01 | 2.35e-02 | 9.52e-01 |
| G0 and Early G1 | 27 | 8.79e-01 | -1.69e-02 | 9.52e-01 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | 36 | 8.80e-01 | -1.45e-02 | 9.52e-01 |
| Interferon gamma signaling | 74 | 8.81e-01 | -1.01e-02 | 9.52e-01 |
| Transport of Mature mRNA Derived from an Intronless Transcript | 40 | 8.82e-01 | 1.35e-02 | 9.52e-01 |
| RNA Pol II CTD phosphorylation and interaction with CE | 25 | 8.83e-01 | -1.70e-02 | 9.52e-01 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | 25 | 8.83e-01 | -1.70e-02 | 9.52e-01 |
| TNFR1-induced proapoptotic signaling | 11 | 8.83e-01 | 2.55e-02 | 9.52e-01 |
| Signaling by NTRKs | 126 | 8.84e-01 | 7.53e-03 | 9.52e-01 |
| Kinesins | 39 | 8.84e-01 | 1.35e-02 | 9.52e-01 |
| Signaling by TGF-beta Receptor Complex | 65 | 8.85e-01 | 1.04e-02 | 9.52e-01 |
| Inactivation, recovery and regulation of the phototransduction cascade | 29 | 8.85e-01 | 1.55e-02 | 9.52e-01 |
| Neutrophil degranulation | 429 | 8.86e-01 | 4.03e-03 | 9.52e-01 |
| Pre-NOTCH Expression and Processing | 55 | 8.87e-01 | -1.11e-02 | 9.52e-01 |
| Resolution of D-Loop Structures | 31 | 8.87e-01 | 1.47e-02 | 9.52e-01 |
| Attenuation phase | 21 | 8.89e-01 | 1.76e-02 | 9.53e-01 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | 48 | 8.92e-01 | -1.14e-02 | 9.55e-01 |
| Regulation of MECP2 expression and activity | 30 | 8.92e-01 | 1.44e-02 | 9.55e-01 |
| Signaling by PDGFR in disease | 16 | 8.94e-01 | 1.92e-02 | 9.56e-01 |
| RNA Polymerase III Transcription Termination | 19 | 8.94e-01 | 1.76e-02 | 9.56e-01 |
| G1/S-Specific Transcription | 29 | 8.96e-01 | -1.41e-02 | 9.56e-01 |
| Extension of Telomeres | 49 | 8.96e-01 | -1.08e-02 | 9.56e-01 |
| Methylation | 13 | 8.97e-01 | -2.08e-02 | 9.56e-01 |
| tRNA processing | 113 | 8.97e-01 | -7.06e-03 | 9.56e-01 |
| Constitutive Signaling by AKT1 E17K in Cancer | 24 | 8.97e-01 | 1.52e-02 | 9.56e-01 |
| PKA-mediated phosphorylation of CREB | 18 | 9.00e-01 | 1.70e-02 | 9.58e-01 |
| Cellular Senescence | 123 | 9.03e-01 | -6.37e-03 | 9.60e-01 |
| Signaling by ERBB2 | 44 | 9.05e-01 | 1.05e-02 | 9.61e-01 |
| SUMOylation of ubiquitinylation proteins | 38 | 9.06e-01 | -1.10e-02 | 9.63e-01 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | 13 | 9.08e-01 | 1.86e-02 | 9.63e-01 |
| Beta defensins | 14 | 9.09e-01 | 1.76e-02 | 9.64e-01 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | 20 | 9.10e-01 | -1.46e-02 | 9.64e-01 |
| Synthesis of glycosylphosphatidylinositol (GPI) | 15 | 9.10e-01 | -1.69e-02 | 9.64e-01 |
| FLT3 Signaling | 264 | 9.14e-01 | 3.87e-03 | 9.67e-01 |
| Notch-HLH transcription pathway | 26 | 9.18e-01 | -1.17e-02 | 9.68e-01 |
| Intracellular signaling by second messengers | 289 | 9.18e-01 | 3.55e-03 | 9.68e-01 |
| Cargo trafficking to the periciliary membrane | 47 | 9.18e-01 | -8.72e-03 | 9.68e-01 |
| Export of Viral Ribonucleoproteins from Nucleus | 31 | 9.19e-01 | 1.06e-02 | 9.68e-01 |
| MAPK targets/ Nuclear events mediated by MAP kinases | 29 | 9.20e-01 | -1.08e-02 | 9.68e-01 |
| Cyclin A/B1/B2 associated events during G2/M transition | 23 | 9.20e-01 | 1.21e-02 | 9.68e-01 |
| Phase 0 - rapid depolarisation | 27 | 9.21e-01 | -1.11e-02 | 9.68e-01 |
| FOXO-mediated transcription of cell death genes | 14 | 9.21e-01 | -1.54e-02 | 9.68e-01 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | 12 | 9.22e-01 | 1.64e-02 | 9.68e-01 |
| SHC1 events in ERBB4 signaling | 12 | 9.23e-01 | 1.62e-02 | 9.68e-01 |
| Intraflagellar transport | 39 | 9.23e-01 | -8.90e-03 | 9.68e-01 |
| Signaling by Activin | 13 | 9.25e-01 | -1.50e-02 | 9.68e-01 |
| ADORA2B mediated anti-inflammatory cytokines production | 105 | 9.26e-01 | 5.25e-03 | 9.68e-01 |
| HDR through MMEJ (alt-NHEJ) | 10 | 9.27e-01 | 1.68e-02 | 9.68e-01 |
| Cleavage of the damaged purine | 13 | 9.27e-01 | -1.47e-02 | 9.68e-01 |
| Depurination | 13 | 9.27e-01 | -1.47e-02 | 9.68e-01 |
| Recognition and association of DNA glycosylase with site containing an affected purine | 13 | 9.27e-01 | -1.47e-02 | 9.68e-01 |
| IL-6-type cytokine receptor ligand interactions | 17 | 9.28e-01 | 1.27e-02 | 9.68e-01 |
| G-protein mediated events | 51 | 9.28e-01 | 7.32e-03 | 9.68e-01 |
| The phototransduction cascade | 30 | 9.31e-01 | 9.20e-03 | 9.69e-01 |
| Interleukin-2 signaling | 10 | 9.31e-01 | 1.59e-02 | 9.69e-01 |
| Endosomal/Vacuolar pathway | 10 | 9.33e-01 | 1.53e-02 | 9.70e-01 |
| MET activates PTK2 signaling | 18 | 9.34e-01 | -1.13e-02 | 9.70e-01 |
| NOTCH4 Intracellular Domain Regulates Transcription | 17 | 9.34e-01 | 1.16e-02 | 9.70e-01 |
| SUMOylation | 161 | 9.34e-01 | 3.77e-03 | 9.70e-01 |
| Polo-like kinase mediated events | 15 | 9.36e-01 | 1.21e-02 | 9.70e-01 |
| TCF dependent signaling in response to WNT | 155 | 9.36e-01 | -3.75e-03 | 9.70e-01 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | 12 | 9.36e-01 | 1.33e-02 | 9.70e-01 |
| Glucagon-type ligand receptors | 28 | 9.38e-01 | -8.51e-03 | 9.71e-01 |
| Homologous DNA Pairing and Strand Exchange | 39 | 9.41e-01 | -6.85e-03 | 9.74e-01 |
| HSF1-dependent transactivation | 30 | 9.43e-01 | -7.57e-03 | 9.75e-01 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | 41 | 9.44e-01 | -6.37e-03 | 9.75e-01 |
| Keratan sulfate/keratin metabolism | 30 | 9.45e-01 | -7.30e-03 | 9.75e-01 |
| Disease | 1337 | 9.46e-01 | 1.13e-03 | 9.75e-01 |
| PKA activation | 16 | 9.46e-01 | -9.77e-03 | 9.75e-01 |
| Interleukin-37 signaling | 20 | 9.46e-01 | 8.74e-03 | 9.75e-01 |
| Interleukin receptor SHC signaling | 23 | 9.51e-01 | -7.47e-03 | 9.78e-01 |
| Synthesis of PIPs at the Golgi membrane | 17 | 9.51e-01 | -8.56e-03 | 9.78e-01 |
| Processing of Intronless Pre-mRNAs | 17 | 9.53e-01 | -8.32e-03 | 9.79e-01 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | 10 | 9.57e-01 | 9.86e-03 | 9.82e-01 |
| Diseases of metabolism | 215 | 9.58e-01 | 2.11e-03 | 9.82e-01 |
| Toll Like Receptor 3 (TLR3) Cascade | 81 | 9.58e-01 | 3.40e-03 | 9.82e-01 |
| DNA Double Strand Break Response | 38 | 9.58e-01 | 4.96e-03 | 9.82e-01 |
| Interleukin-12 signaling | 39 | 9.59e-01 | 4.76e-03 | 9.82e-01 |
| MAPK1/MAPK3 signaling | 256 | 9.61e-01 | 1.79e-03 | 9.83e-01 |
| Fcgamma receptor (FCGR) dependent phagocytosis | 93 | 9.61e-01 | 2.92e-03 | 9.83e-01 |
| Signaling by NTRK2 (TRKB) | 23 | 9.66e-01 | 5.12e-03 | 9.87e-01 |
| Glycolysis | 68 | 9.67e-01 | -2.92e-03 | 9.87e-01 |
| Olfactory Signaling Pathway | 79 | 9.67e-01 | -2.65e-03 | 9.87e-01 |
| Transcriptional Regulation by MECP2 | 56 | 9.71e-01 | -2.84e-03 | 9.88e-01 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | 17 | 9.71e-01 | 5.09e-03 | 9.88e-01 |
| Transport of Ribonucleoproteins into the Host Nucleus | 31 | 9.72e-01 | -3.61e-03 | 9.88e-01 |
| Interactions of Vpr with host cellular proteins | 34 | 9.73e-01 | 3.42e-03 | 9.88e-01 |
| p75NTR signals via NF-kB | 13 | 9.73e-01 | 5.49e-03 | 9.88e-01 |
| PKA activation in glucagon signalling | 16 | 9.73e-01 | -4.81e-03 | 9.88e-01 |
| RORA activates gene expression | 18 | 9.73e-01 | 4.53e-03 | 9.88e-01 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | 44 | 9.74e-01 | -2.83e-03 | 9.88e-01 |
| SUMOylation of RNA binding proteins | 43 | 9.75e-01 | -2.76e-03 | 9.88e-01 |
| BMAL1:CLOCK,NPAS2 activates circadian gene expression | 27 | 9.76e-01 | 3.39e-03 | 9.88e-01 |
| Collagen degradation | 36 | 9.76e-01 | 2.94e-03 | 9.88e-01 |
| Defects in cobalamin (B12) metabolism | 13 | 9.78e-01 | 4.39e-03 | 9.89e-01 |
| PCNA-Dependent Long Patch Base Excision Repair | 20 | 9.79e-01 | -3.38e-03 | 9.90e-01 |
| Post-chaperonin tubulin folding pathway | 17 | 9.82e-01 | -3.15e-03 | 9.92e-01 |
| TRAF6 mediated IRF7 activation | 14 | 9.82e-01 | -3.40e-03 | 9.92e-01 |
| SUMOylation of transcription factors | 16 | 9.86e-01 | 2.61e-03 | 9.94e-01 |
| Metabolism of carbohydrates | 261 | 9.86e-01 | -6.36e-04 | 9.94e-01 |
| Phenylalanine and tyrosine metabolism | 10 | 9.88e-01 | -2.82e-03 | 9.94e-01 |
| Scavenging of heme from plasma | 24 | 9.88e-01 | -1.77e-03 | 9.94e-01 |
| SUMOylation of DNA damage response and repair proteins | 71 | 9.89e-01 | 9.35e-04 | 9.95e-01 |
| Amino acids regulate mTORC1 | 46 | 9.90e-01 | 1.10e-03 | 9.95e-01 |
| NEP/NS2 Interacts with the Cellular Export Machinery | 30 | 9.92e-01 | 1.11e-03 | 9.96e-01 |
| Gluconeogenesis | 30 | 9.95e-01 | 6.22e-04 | 9.98e-01 |
| Circadian Clock | 66 | 9.96e-01 | -3.89e-04 | 9.98e-01 |
| Opioid Signalling | 83 | 9.96e-01 | 3.37e-04 | 9.98e-01 |
| Transcriptional Regulation by E2F6 | 32 | 9.99e-01 | -1.01e-04 | 1.00e+00 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | 11 | 9.99e-01 | -1.21e-04 | 1.00e+00 |
| RHO GTPase Effectors | 236 | 1.00e+00 | 1.98e-05 | 1.00e+00 |
Major pathway of rRNA processing in the nucleolus and cytosol
| 648 | |
|---|---|
| set | Major pathway of rRNA processing in the nucleolus and cytosol |
| setSize | 148 |
| pANOVA | 7.55e-15 |
| s.dist | -0.37 |
| p.adjustANOVA | 1.06e-11 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282 |
| RPS16 | -8246 |
| TSR1 | -8237 |
| RPS17 | -8231 |
| LAS1L | -8220 |
| HEATR1 | -8214 |
| EXOSC1 | -8073 |
| RPP40 | -7990 |
| RPS3A | -7929 |
| RPS28 | -7809 |
| WDR75 | -7780 |
| RPL29 | -7770 |
| RPS21 | -7764 |
| RPS5 | -7648 |
| RPS27A | -7640 |
| RPS15 | -7548 |
| RPS11 | -7379 |
| RPS14 | -7325 |
| RPL38 | -7298 |
| BMS1 | -7297 |
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| RPS16 | -8246.0 |
| TSR1 | -8237.0 |
| RPS17 | -8231.0 |
| LAS1L | -8220.0 |
| HEATR1 | -8214.0 |
| EXOSC1 | -8073.0 |
| RPP40 | -7990.0 |
| RPS3A | -7929.0 |
| RPS28 | -7809.0 |
| WDR75 | -7780.0 |
| RPL29 | -7770.0 |
| RPS21 | -7764.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| RPS15 | -7548.0 |
| RPS11 | -7379.0 |
| RPS14 | -7325.0 |
| RPL38 | -7298.0 |
| BMS1 | -7297.0 |
| RPL13A | -7282.0 |
| RCL1 | -7096.0 |
| RPL24 | -7065.0 |
| RPL32 | -7023.0 |
| MPHOSPH6 | -6988.0 |
| RPL6 | -6916.0 |
| RPS10 | -6822.5 |
| RIOK3 | -6733.0 |
| RPS26 | -6692.0 |
| RPL18 | -6689.0 |
| RPL18A | -6679.0 |
| RPLP1 | -6661.0 |
| RPS8 | -6597.0 |
| EXOSC9 | -6555.0 |
| EMG1 | -6502.0 |
| EBNA1BP2 | -6480.0 |
| RPL36 | -6366.0 |
| RPLP2 | -6273.0 |
| RPL23 | -6194.0 |
| RPL30 | -6152.0 |
| RPL15 | -6030.0 |
| RPS4X | -6019.0 |
| NOP14 | -5999.0 |
| LTV1 | -5990.5 |
| RPL28 | -5981.0 |
| RPL35 | -5900.0 |
| RPS23 | -5865.0 |
| PNO1 | -5857.0 |
| WDR12 | -5752.0 |
| RPL5 | -5749.0 |
| TEX10 | -5719.0 |
| IMP4 | -5693.0 |
| PWP2 | -5683.5 |
| NOC4L | -5659.0 |
| RPS19 | -5609.0 |
| DDX52 | -5552.0 |
| NOL12 | -5510.5 |
| RPL37A | -5473.0 |
| NOP58 | -5436.0 |
| DDX21 | -5435.0 |
| DHX37 | -5426.0 |
| IMP3 | -5333.0 |
| NOL9 | -5210.0 |
| UTP6 | -5198.0 |
| NIP7 | -5163.0 |
| RPL19 | -5108.0 |
| UTP15 | -4961.0 |
| RPP30 | -4931.0 |
| WDR36 | -4849.0 |
| FAU | -4829.0 |
| RPP25 | -4689.0 |
| BOP1 | -4674.0 |
| FTSJ3 | -4563.0 |
| WDR3 | -4529.0 |
| RPL35A | -4460.0 |
| C1D | -4432.0 |
| RPL13 | -4424.0 |
| UTP18 | -4374.0 |
| RPS6 | -4373.0 |
| RPSA | -4027.0 |
| RPL3 | -3968.0 |
| RPL10A | -3822.0 |
| RPS13 | -3718.0 |
| RRP9 | -3702.0 |
| DDX49 | -3628.0 |
| NOP56 | -3482.0 |
| EXOSC4 | -3421.0 |
| EXOSC5 | -3356.0 |
| WDR43 | -3348.0 |
| NCL | -3329.0 |
| GNL3 | -3174.0 |
| UTP20 | -3157.0 |
| FCF1 | -2809.0 |
| MTREX | -2791.0 |
| RPL7 | -2750.0 |
| DCAF13 | -2707.0 |
| PELP1 | -2654.0 |
| RPL8 | -2587.0 |
| RPS18 | -2478.0 |
| EXOSC3 | -2219.0 |
| NOL11 | -1943.0 |
| DDX47 | -1644.0 |
| DIS3 | -1452.0 |
| RPL23A | -1088.0 |
| RIOK1 | -1046.0 |
| BYSL | -877.0 |
| RIOK2 | -834.0 |
| UTP14A | -381.5 |
| UTP14C | -381.5 |
| ERI1 | -324.0 |
| RPL31 | -303.0 |
| RPS2 | -219.0 |
| SNU13 | 188.0 |
| UTP11 | 411.0 |
| RPS27L | 522.0 |
| RPL27 | 706.0 |
| UTP3 | 843.0 |
| MPHOSPH10 | 991.0 |
| NOB1 | 1300.0 |
| TBL3 | 1340.0 |
| RPL7A | 1400.0 |
| UTP4 | 1419.0 |
| RRP7A | 1528.0 |
| EXOSC10 | 1617.0 |
| PDCD11 | 1804.0 |
| EXOSC7 | 2356.0 |
| RRP36 | 2367.0 |
| RPL37 | 2677.0 |
| SENP3 | 2732.5 |
| KRR1 | 2965.0 |
| EXOSC6 | 3010.0 |
| RBM28 | 3020.0 |
| RPS9 | 3031.0 |
| RPS3 | 3136.0 |
| PES1 | 3220.0 |
| ISG20L2 | 3698.0 |
| FBL | 3970.0 |
| EXOSC8 | 4292.0 |
| RPL3L | 4494.0 |
| XRN2 | 4993.0 |
| RPL22 | 5158.0 |
| WDR46 | 5939.0 |
| CSNK1D | 6028.0 |
| RRP1 | 6389.0 |
| NOL6 | 7692.0 |
| CSNK1E | 7737.5 |
| EXOSC2 | 7761.0 |
| WDR18 | 7833.0 |
SRP-dependent cotranslational protein targeting to membrane
| 1073 | |
|---|---|
| set | SRP-dependent cotranslational protein targeting to membrane |
| setSize | 83 |
| pANOVA | 2.52e-14 |
| s.dist | -0.484 |
| p.adjustANOVA | 1.24e-11 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282 |
| RPS16 | -8246 |
| RPS17 | -8231 |
| SEC61A2 | -7949 |
| RPS3A | -7929 |
| RPS28 | -7809 |
| RPL29 | -7770 |
| RPS21 | -7764 |
| RPS5 | -7648 |
| RPS27A | -7640 |
| RPS15 | -7548 |
| SSR2 | -7472 |
| RPS11 | -7379 |
| SPCS3 | -7363 |
| RPS14 | -7325 |
| RPN2 | -7299 |
| RPL38 | -7298 |
| RPL13A | -7282 |
| SRP72 | -7203 |
| RPL24 | -7065 |
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| RPS16 | -8246.0 |
| RPS17 | -8231.0 |
| SEC61A2 | -7949.0 |
| RPS3A | -7929.0 |
| RPS28 | -7809.0 |
| RPL29 | -7770.0 |
| RPS21 | -7764.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| RPS15 | -7548.0 |
| SSR2 | -7472.0 |
| RPS11 | -7379.0 |
| SPCS3 | -7363.0 |
| RPS14 | -7325.0 |
| RPN2 | -7299.0 |
| RPL38 | -7298.0 |
| RPL13A | -7282.0 |
| SRP72 | -7203.0 |
| RPL24 | -7065.0 |
| RPL32 | -7023.0 |
| SSR4 | -6987.0 |
| RPL6 | -6916.0 |
| RPS10 | -6822.5 |
| RPS26 | -6692.0 |
| RPL18 | -6689.0 |
| RPL18A | -6679.0 |
| RPLP1 | -6661.0 |
| RPS8 | -6597.0 |
| SRP14 | -6394.0 |
| RPL36 | -6366.0 |
| RPLP2 | -6273.0 |
| RPL23 | -6194.0 |
| RPL30 | -6152.0 |
| RPL15 | -6030.0 |
| RPS4X | -6019.0 |
| RPL28 | -5981.0 |
| RPL35 | -5900.0 |
| RPS23 | -5865.0 |
| SEC61G | -5830.0 |
| RPL5 | -5749.0 |
| RPS19 | -5609.0 |
| SRP9 | -5584.0 |
| RPL37A | -5473.0 |
| RPL19 | -5108.0 |
| FAU | -4829.0 |
| SEC61B | -4808.0 |
| SEC11A | -4525.0 |
| RPL35A | -4460.0 |
| RPL13 | -4424.0 |
| RPS6 | -4373.0 |
| RPSA | -4027.0 |
| SPCS1 | -4020.0 |
| RPL3 | -3968.0 |
| RPL10A | -3822.0 |
| RPS13 | -3718.0 |
| SRP19 | -3584.0 |
| SSR1 | -3579.0 |
| SSR3 | -2883.0 |
| SRP54 | -2836.0 |
| SEC11C | -2812.0 |
| RPL7 | -2750.0 |
| SRPRA | -2690.0 |
| RPL8 | -2587.0 |
| RPS18 | -2478.0 |
| RPL23A | -1088.0 |
| RPN1 | -1071.0 |
| RPL31 | -303.0 |
| RPS2 | -219.0 |
| RPS27L | 522.0 |
| RPL27 | 706.0 |
| SPCS2 | 959.0 |
| RPL7A | 1400.0 |
| SEC61A1 | 2087.0 |
| RPL37 | 2677.0 |
| RPS9 | 3031.0 |
| RPS3 | 3136.0 |
| RPL3L | 4494.0 |
| RPL22 | 5158.0 |
| TRAM1 | 5163.0 |
| DDOST | 6465.0 |
| SRPRB | 6995.0 |
| SRP68 | 7282.0 |
rRNA processing in the nucleus and cytosol
| 1396 | |
|---|---|
| set | rRNA processing in the nucleus and cytosol |
| setSize | 155 |
| pANOVA | 2.66e-14 |
| s.dist | -0.354 |
| p.adjustANOVA | 1.24e-11 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282 |
| RPS16 | -8246 |
| TSR1 | -8237 |
| RPS17 | -8231 |
| LAS1L | -8220 |
| HEATR1 | -8214 |
| EXOSC1 | -8073 |
| RPP40 | -7990 |
| RPS3A | -7929 |
| RPS28 | -7809 |
| WDR75 | -7780 |
| RPL29 | -7770 |
| RPS21 | -7764 |
| NAT10 | -7652 |
| RPS5 | -7648 |
| RPS27A | -7640 |
| RPS15 | -7548 |
| RPS11 | -7379 |
| RPS14 | -7325 |
| RPL38 | -7298 |
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| RPS16 | -8246.0 |
| TSR1 | -8237.0 |
| RPS17 | -8231.0 |
| LAS1L | -8220.0 |
| HEATR1 | -8214.0 |
| EXOSC1 | -8073.0 |
| RPP40 | -7990.0 |
| RPS3A | -7929.0 |
| RPS28 | -7809.0 |
| WDR75 | -7780.0 |
| RPL29 | -7770.0 |
| RPS21 | -7764.0 |
| NAT10 | -7652.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| RPS15 | -7548.0 |
| RPS11 | -7379.0 |
| RPS14 | -7325.0 |
| RPL38 | -7298.0 |
| BMS1 | -7297.0 |
| RPL13A | -7282.0 |
| RCL1 | -7096.0 |
| RPL24 | -7065.0 |
| RPL32 | -7023.0 |
| MPHOSPH6 | -6988.0 |
| RPL6 | -6916.0 |
| RPS10 | -6822.5 |
| RIOK3 | -6733.0 |
| RPS26 | -6692.0 |
| RPL18 | -6689.0 |
| RPL18A | -6679.0 |
| RPLP1 | -6661.0 |
| RPS8 | -6597.0 |
| EXOSC9 | -6555.0 |
| EMG1 | -6502.0 |
| EBNA1BP2 | -6480.0 |
| RPL36 | -6366.0 |
| RPLP2 | -6273.0 |
| RPL23 | -6194.0 |
| RPL30 | -6152.0 |
| RPL15 | -6030.0 |
| RPS4X | -6019.0 |
| NOP14 | -5999.0 |
| LTV1 | -5990.5 |
| RPL28 | -5981.0 |
| RPL35 | -5900.0 |
| RPS23 | -5865.0 |
| PNO1 | -5857.0 |
| WDR12 | -5752.0 |
| RPL5 | -5749.0 |
| TEX10 | -5719.0 |
| IMP4 | -5693.0 |
| PWP2 | -5683.5 |
| NOC4L | -5659.0 |
| RPS19 | -5609.0 |
| DDX52 | -5552.0 |
| NOL12 | -5510.5 |
| RPL37A | -5473.0 |
| NOP58 | -5436.0 |
| DDX21 | -5435.0 |
| DHX37 | -5426.0 |
| NOP10 | -5374.0 |
| IMP3 | -5333.0 |
| NOL9 | -5210.0 |
| UTP6 | -5198.0 |
| NIP7 | -5163.0 |
| RPL19 | -5108.0 |
| UTP15 | -4961.0 |
| RPP30 | -4931.0 |
| WDR36 | -4849.0 |
| FAU | -4829.0 |
| RPP25 | -4689.0 |
| BOP1 | -4674.0 |
| FTSJ3 | -4563.0 |
| WDR3 | -4529.0 |
| RPL35A | -4460.0 |
| C1D | -4432.0 |
| RPL13 | -4424.0 |
| UTP18 | -4374.0 |
| RPS6 | -4373.0 |
| RPSA | -4027.0 |
| RPL3 | -3968.0 |
| RPL10A | -3822.0 |
| RPS13 | -3718.0 |
| RRP9 | -3702.0 |
| DDX49 | -3628.0 |
| NOP56 | -3482.0 |
| EXOSC4 | -3421.0 |
| EXOSC5 | -3356.0 |
| WDR43 | -3348.0 |
| NCL | -3329.0 |
| GNL3 | -3174.0 |
| UTP20 | -3157.0 |
| FCF1 | -2809.0 |
| MTREX | -2791.0 |
| RPL7 | -2750.0 |
| DCAF13 | -2707.0 |
| PELP1 | -2654.0 |
| RPL8 | -2587.0 |
| RPS18 | -2478.0 |
| DIMT1 | -2344.0 |
| EXOSC3 | -2219.0 |
| NOL11 | -1943.0 |
| DDX47 | -1644.0 |
| DIS3 | -1452.0 |
| RPL23A | -1088.0 |
| THUMPD1 | -1054.0 |
| RIOK1 | -1046.0 |
| BYSL | -877.0 |
| RIOK2 | -834.0 |
| UTP14A | -381.5 |
| UTP14C | -381.5 |
| ERI1 | -324.0 |
| RPL31 | -303.0 |
| RPS2 | -219.0 |
| SNU13 | 188.0 |
| TSR3 | 320.0 |
| UTP11 | 411.0 |
| RPS27L | 522.0 |
| RPL27 | 706.0 |
| UTP3 | 843.0 |
| MPHOSPH10 | 991.0 |
| NOB1 | 1300.0 |
| TBL3 | 1340.0 |
| RPL7A | 1400.0 |
| UTP4 | 1419.0 |
| RRP7A | 1528.0 |
| EXOSC10 | 1617.0 |
| PDCD11 | 1804.0 |
| EXOSC7 | 2356.0 |
| RRP36 | 2367.0 |
| RPL37 | 2677.0 |
| SENP3 | 2732.5 |
| KRR1 | 2965.0 |
| EXOSC6 | 3010.0 |
| RBM28 | 3020.0 |
| RPS9 | 3031.0 |
| RPS3 | 3136.0 |
| PES1 | 3220.0 |
| ISG20L2 | 3698.0 |
| FBL | 3970.0 |
| EXOSC8 | 4292.0 |
| RPL3L | 4494.0 |
| XRN2 | 4993.0 |
| RPL22 | 5158.0 |
| WDR46 | 5939.0 |
| CSNK1D | 6028.0 |
| RRP1 | 6389.0 |
| DKC1 | 7024.0 |
| NOL6 | 7692.0 |
| CSNK1E | 7737.5 |
| EXOSC2 | 7761.0 |
| GAR1 | 7789.0 |
| WDR18 | 7833.0 |
Response of EIF2AK4 (GCN2) to amino acid deficiency
| 1040 | |
|---|---|
| set | Response of EIF2AK4 (GCN2) to amino acid deficiency |
| setSize | 72 |
| pANOVA | 1.15e-12 |
| s.dist | -0.485 |
| p.adjustANOVA | 3.56e-10 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282 |
| RPS16 | -8246 |
| RPS17 | -8231 |
| RPS3A | -7929 |
| RPS28 | -7809 |
| RPL29 | -7770 |
| RPS21 | -7764 |
| RPS5 | -7648 |
| RPS27A | -7640 |
| RPS15 | -7548 |
| ATF4 | -7426 |
| RPS11 | -7379 |
| RPS14 | -7325 |
| RPL38 | -7298 |
| RPL13A | -7282 |
| RPL24 | -7065 |
| RPL32 | -7023 |
| EIF2S1 | -7018 |
| ATF3 | -7015 |
| RPL6 | -6916 |
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| RPS16 | -8246.0 |
| RPS17 | -8231.0 |
| RPS3A | -7929.0 |
| RPS28 | -7809.0 |
| RPL29 | -7770.0 |
| RPS21 | -7764.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| RPS15 | -7548.0 |
| ATF4 | -7426.0 |
| RPS11 | -7379.0 |
| RPS14 | -7325.0 |
| RPL38 | -7298.0 |
| RPL13A | -7282.0 |
| RPL24 | -7065.0 |
| RPL32 | -7023.0 |
| EIF2S1 | -7018.0 |
| ATF3 | -7015.0 |
| RPL6 | -6916.0 |
| IMPACT | -6882.0 |
| RPS10 | -6822.5 |
| RPS26 | -6692.0 |
| RPL18 | -6689.0 |
| RPL18A | -6679.0 |
| RPLP1 | -6661.0 |
| RPS8 | -6597.0 |
| EIF2S2 | -6402.0 |
| RPL36 | -6366.0 |
| RPLP2 | -6273.0 |
| RPL23 | -6194.0 |
| RPL30 | -6152.0 |
| RPL15 | -6030.0 |
| RPS4X | -6019.0 |
| RPL28 | -5981.0 |
| RPL35 | -5900.0 |
| RPS23 | -5865.0 |
| EIF2S3 | -5766.5 |
| RPL5 | -5749.0 |
| RPS19 | -5609.0 |
| RPL37A | -5473.0 |
| RPL19 | -5108.0 |
| EIF2AK4 | -4948.0 |
| FAU | -4829.0 |
| RPL35A | -4460.0 |
| RPL13 | -4424.0 |
| RPS6 | -4373.0 |
| RPSA | -4027.0 |
| RPL3 | -3968.0 |
| RPL10A | -3822.0 |
| RPS13 | -3718.0 |
| RPL7 | -2750.0 |
| RPL8 | -2587.0 |
| RPS18 | -2478.0 |
| ASNS | -2006.0 |
| RPL23A | -1088.0 |
| RPL31 | -303.0 |
| RPS2 | -219.0 |
| RPS27L | 522.0 |
| RPL27 | 706.0 |
| CEBPB | 1323.0 |
| RPL7A | 1400.0 |
| CEBPG | 2139.0 |
| RPL37 | 2677.0 |
| RPS9 | 3031.0 |
| RPS3 | 3136.0 |
| GCN1 | 3486.0 |
| RPL3L | 4494.0 |
| RPL22 | 5158.0 |
| TRIB3 | 5887.0 |
| ATF2 | 5957.0 |
| DDIT3 | 6317.0 |
Peptide chain elongation
| 833 | |
|---|---|
| set | Peptide chain elongation |
| setSize | 60 |
| pANOVA | 1.66e-12 |
| s.dist | -0.527 |
| p.adjustANOVA | 3.56e-10 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| RPS16 | -8246.0 |
| RPS17 | -8231.0 |
| RPS3A | -7929.0 |
| RPS28 | -7809.0 |
| RPL29 | -7770.0 |
| RPS21 | -7764.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| RPS15 | -7548.0 |
| RPS11 | -7379.0 |
| RPS14 | -7325.0 |
| RPL38 | -7298.0 |
| RPL13A | -7282.0 |
| RPL24 | -7065.0 |
| RPL32 | -7023.0 |
| RPL6 | -6916.0 |
| RPS10 | -6822.5 |
| RPS26 | -6692.0 |
| RPL18 | -6689.0 |
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| RPS16 | -8246.0 |
| RPS17 | -8231.0 |
| RPS3A | -7929.0 |
| RPS28 | -7809.0 |
| RPL29 | -7770.0 |
| RPS21 | -7764.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| RPS15 | -7548.0 |
| RPS11 | -7379.0 |
| RPS14 | -7325.0 |
| RPL38 | -7298.0 |
| RPL13A | -7282.0 |
| RPL24 | -7065.0 |
| RPL32 | -7023.0 |
| RPL6 | -6916.0 |
| RPS10 | -6822.5 |
| RPS26 | -6692.0 |
| RPL18 | -6689.0 |
| RPL18A | -6679.0 |
| RPLP1 | -6661.0 |
| RPS8 | -6597.0 |
| RPL36 | -6366.0 |
| RPLP2 | -6273.0 |
| RPL23 | -6194.0 |
| RPL30 | -6152.0 |
| RPL15 | -6030.0 |
| RPS4X | -6019.0 |
| RPL28 | -5981.0 |
| RPL35 | -5900.0 |
| RPS23 | -5865.0 |
| RPL5 | -5749.0 |
| RPS19 | -5609.0 |
| RPL37A | -5473.0 |
| RPL19 | -5108.0 |
| FAU | -4829.0 |
| RPL35A | -4460.0 |
| RPL13 | -4424.0 |
| RPS6 | -4373.0 |
| RPSA | -4027.0 |
| RPL3 | -3968.0 |
| RPL10A | -3822.0 |
| RPS13 | -3718.0 |
| RPL7 | -2750.0 |
| RPL8 | -2587.0 |
| RPS18 | -2478.0 |
| EEF1A1 | -1278.0 |
| RPL23A | -1088.0 |
| RPL31 | -303.0 |
| RPS2 | -219.0 |
| RPS27L | 522.0 |
| RPL27 | 706.0 |
| RPL7A | 1400.0 |
| RPL37 | 2677.0 |
| RPS9 | 3031.0 |
| RPS3 | 3136.0 |
| RPL3L | 4494.0 |
| RPL22 | 5158.0 |
| EEF2 | 6302.0 |
Eukaryotic Translation Termination
| 365 | |
|---|---|
| set | Eukaryotic Translation Termination |
| setSize | 63 |
| pANOVA | 1.73e-12 |
| s.dist | -0.514 |
| p.adjustANOVA | 3.56e-10 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| RPS16 | -8246.0 |
| RPS17 | -8231.0 |
| RPS3A | -7929.0 |
| RPS28 | -7809.0 |
| RPL29 | -7770.0 |
| RPS21 | -7764.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| RPS15 | -7548.0 |
| RPS11 | -7379.0 |
| RPS14 | -7325.0 |
| RPL38 | -7298.0 |
| RPL13A | -7282.0 |
| RPL24 | -7065.0 |
| RPL32 | -7023.0 |
| RPL6 | -6916.0 |
| RPS10 | -6822.5 |
| RPS26 | -6692.0 |
| RPL18 | -6689.0 |
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| RPS16 | -8246.0 |
| RPS17 | -8231.0 |
| RPS3A | -7929.0 |
| RPS28 | -7809.0 |
| RPL29 | -7770.0 |
| RPS21 | -7764.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| RPS15 | -7548.0 |
| RPS11 | -7379.0 |
| RPS14 | -7325.0 |
| RPL38 | -7298.0 |
| RPL13A | -7282.0 |
| RPL24 | -7065.0 |
| RPL32 | -7023.0 |
| RPL6 | -6916.0 |
| RPS10 | -6822.5 |
| RPS26 | -6692.0 |
| RPL18 | -6689.0 |
| RPL18A | -6679.0 |
| RPLP1 | -6661.0 |
| RPS8 | -6597.0 |
| RPL36 | -6366.0 |
| RPLP2 | -6273.0 |
| RPL23 | -6194.0 |
| RPL30 | -6152.0 |
| RPL15 | -6030.0 |
| RPS4X | -6019.0 |
| RPL28 | -5981.0 |
| RPL35 | -5900.0 |
| RPS23 | -5865.0 |
| RPL5 | -5749.0 |
| RPS19 | -5609.0 |
| RPL37A | -5473.0 |
| RPL19 | -5108.0 |
| FAU | -4829.0 |
| GSPT2 | -4504.0 |
| RPL35A | -4460.0 |
| N6AMT1 | -4431.0 |
| RPL13 | -4424.0 |
| RPS6 | -4373.0 |
| ETF1 | -4323.0 |
| RPSA | -4027.0 |
| RPL3 | -3968.0 |
| RPL10A | -3822.0 |
| RPS13 | -3718.0 |
| RPL7 | -2750.0 |
| RPL8 | -2587.0 |
| RPS18 | -2478.0 |
| RPL23A | -1088.0 |
| RPL31 | -303.0 |
| RPS2 | -219.0 |
| RPS27L | 522.0 |
| RPL27 | 706.0 |
| RPL7A | 1400.0 |
| RPL37 | 2677.0 |
| RPS9 | 3031.0 |
| RPS3 | 3136.0 |
| RPL3L | 4494.0 |
| RPL22 | 5158.0 |
| APEH | 5520.0 |
| GSPT1 | 6438.0 |
Viral mRNA Translation
| 1353 | |
|---|---|
| set | Viral mRNA Translation |
| setSize | 60 |
| pANOVA | 1.88e-12 |
| s.dist | -0.526 |
| p.adjustANOVA | 3.56e-10 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| RPS16 | -8246.0 |
| RPS17 | -8231.0 |
| RPS3A | -7929.0 |
| RPS28 | -7809.0 |
| RPL29 | -7770.0 |
| RPS21 | -7764.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| RPS15 | -7548.0 |
| RPS11 | -7379.0 |
| RPS14 | -7325.0 |
| RPL38 | -7298.0 |
| RPL13A | -7282.0 |
| RPL24 | -7065.0 |
| RPL32 | -7023.0 |
| RPL6 | -6916.0 |
| RPS10 | -6822.5 |
| RPS26 | -6692.0 |
| RPL18 | -6689.0 |
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| RPS16 | -8246.0 |
| RPS17 | -8231.0 |
| RPS3A | -7929.0 |
| RPS28 | -7809.0 |
| RPL29 | -7770.0 |
| RPS21 | -7764.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| RPS15 | -7548.0 |
| RPS11 | -7379.0 |
| RPS14 | -7325.0 |
| RPL38 | -7298.0 |
| RPL13A | -7282.0 |
| RPL24 | -7065.0 |
| RPL32 | -7023.0 |
| RPL6 | -6916.0 |
| RPS10 | -6822.5 |
| RPS26 | -6692.0 |
| RPL18 | -6689.0 |
| RPL18A | -6679.0 |
| RPLP1 | -6661.0 |
| RPS8 | -6597.0 |
| RPL36 | -6366.0 |
| RPLP2 | -6273.0 |
| RPL23 | -6194.0 |
| RPL30 | -6152.0 |
| RPL15 | -6030.0 |
| RPS4X | -6019.0 |
| RPL28 | -5981.0 |
| RPL35 | -5900.0 |
| RPS23 | -5865.0 |
| RPL5 | -5749.0 |
| RPS19 | -5609.0 |
| RPL37A | -5473.0 |
| RPL19 | -5108.0 |
| FAU | -4829.0 |
| RPL35A | -4460.0 |
| RPL13 | -4424.0 |
| RPS6 | -4373.0 |
| RPSA | -4027.0 |
| RPL3 | -3968.0 |
| RPL10A | -3822.0 |
| RPS13 | -3718.0 |
| RPL7 | -2750.0 |
| RPL8 | -2587.0 |
| RPS18 | -2478.0 |
| DNAJC3 | -2019.0 |
| RPL23A | -1088.0 |
| RPL31 | -303.0 |
| RPS2 | -219.0 |
| RPS27L | 522.0 |
| RPL27 | 706.0 |
| RPL7A | 1400.0 |
| RPL37 | 2677.0 |
| RPS9 | 3031.0 |
| RPS3 | 3136.0 |
| RPL3L | 4494.0 |
| RPL22 | 5158.0 |
| GRSF1 | 7696.0 |
Selenocysteine synthesis
| 1093 | |
|---|---|
| set | Selenocysteine synthesis |
| setSize | 63 |
| pANOVA | 2.03e-12 |
| s.dist | -0.512 |
| p.adjustANOVA | 3.56e-10 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| RPS16 | -8246.0 |
| RPS17 | -8231.0 |
| RPS3A | -7929.0 |
| RPS28 | -7809.0 |
| RPL29 | -7770.0 |
| RPS21 | -7764.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| RPS15 | -7548.0 |
| RPS11 | -7379.0 |
| RPS14 | -7325.0 |
| RPL38 | -7298.0 |
| RPL13A | -7282.0 |
| RPL24 | -7065.0 |
| RPL32 | -7023.0 |
| RPL6 | -6916.0 |
| RPS10 | -6822.5 |
| RPS26 | -6692.0 |
| RPL18 | -6689.0 |
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| RPS16 | -8246.0 |
| RPS17 | -8231.0 |
| RPS3A | -7929.0 |
| RPS28 | -7809.0 |
| RPL29 | -7770.0 |
| RPS21 | -7764.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| RPS15 | -7548.0 |
| RPS11 | -7379.0 |
| RPS14 | -7325.0 |
| RPL38 | -7298.0 |
| RPL13A | -7282.0 |
| RPL24 | -7065.0 |
| RPL32 | -7023.0 |
| RPL6 | -6916.0 |
| RPS10 | -6822.5 |
| RPS26 | -6692.0 |
| RPL18 | -6689.0 |
| RPL18A | -6679.0 |
| RPLP1 | -6661.0 |
| RPS8 | -6597.0 |
| SEPSECS | -6470.0 |
| RPL36 | -6366.0 |
| RPLP2 | -6273.0 |
| RPL23 | -6194.0 |
| RPL30 | -6152.0 |
| RPL15 | -6030.0 |
| RPS4X | -6019.0 |
| RPL28 | -5981.0 |
| RPL35 | -5900.0 |
| RPS23 | -5865.0 |
| RPL5 | -5749.0 |
| RPS19 | -5609.0 |
| RPL37A | -5473.0 |
| RPL19 | -5108.0 |
| FAU | -4829.0 |
| EEFSEC | -4655.0 |
| RPL35A | -4460.0 |
| RPL13 | -4424.0 |
| RPS6 | -4373.0 |
| SECISBP2 | -4050.0 |
| RPSA | -4027.0 |
| RPL3 | -3968.0 |
| RPL10A | -3822.0 |
| RPS13 | -3718.0 |
| RPL7 | -2750.0 |
| RPL8 | -2587.0 |
| RPS18 | -2478.0 |
| RPL23A | -1088.0 |
| RPL31 | -303.0 |
| RPS2 | -219.0 |
| RPS27L | 522.0 |
| RPL27 | 706.0 |
| RPL7A | 1400.0 |
| RPL37 | 2677.0 |
| RPS9 | 3031.0 |
| RPS3 | 3136.0 |
| RPL3L | 4494.0 |
| RPL22 | 5158.0 |
| PSTK | 7348.0 |
| SARS1 | 7350.0 |
Metabolism
| 655 | |
|---|---|
| set | Metabolism |
| setSize | 1845 |
| pANOVA | 2.7e-12 |
| s.dist | 0.0997 |
| p.adjustANOVA | 3.92e-10 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NEU1 | 8176.0 |
| PPIP5K1 | 8159.0 |
| OPLAH | 8158.0 |
| SLC19A2 | 8155.0 |
| RXRB | 8151.0 |
| SLC37A2 | 8145.0 |
| ABCB4 | 8143.0 |
| GK | 8138.5 |
| GK3P | 8138.5 |
| PPT2 | 8132.5 |
| PAPSS1 | 8121.0 |
| IMPA2 | 8120.0 |
| PITPNM2 | 8100.0 |
| ASS1 | 8096.0 |
| CYP2A13 | 8073.0 |
| CYP2A6 | 8073.0 |
| CYP2A7 | 8073.0 |
| ACACB | 8064.0 |
| NUDT7 | 8063.0 |
| SULT2A1 | 8062.0 |
| GeneID | Gene Rank |
|---|---|
| NEU1 | 8176.0 |
| PPIP5K1 | 8159.0 |
| OPLAH | 8158.0 |
| SLC19A2 | 8155.0 |
| RXRB | 8151.0 |
| SLC37A2 | 8145.0 |
| ABCB4 | 8143.0 |
| GK | 8138.5 |
| GK3P | 8138.5 |
| PPT2 | 8132.5 |
| PAPSS1 | 8121.0 |
| IMPA2 | 8120.0 |
| PITPNM2 | 8100.0 |
| ASS1 | 8096.0 |
| CYP2A13 | 8073.0 |
| CYP2A6 | 8073.0 |
| CYP2A7 | 8073.0 |
| ACACB | 8064.0 |
| NUDT7 | 8063.0 |
| SULT2A1 | 8062.0 |
| PPM1K | 8055.0 |
| SGMS1 | 8040.0 |
| ALAS1 | 8037.0 |
| ALAD | 8036.0 |
| PLA2G6 | 8032.0 |
| HMOX2 | 8031.0 |
| MGLL | 8020.0 |
| SLC2A1 | 8017.0 |
| OGDH | 8010.0 |
| PPARA | 7997.0 |
| GMPS | 7992.0 |
| PRKD1 | 7988.0 |
| AZIN2 | 7979.0 |
| GPAM | 7972.0 |
| BPNT1 | 7970.0 |
| GBE1 | 7961.0 |
| ACOT7 | 7952.0 |
| SLCO1A2 | 7943.0 |
| ACSM1 | 7940.0 |
| AHCYL1 | 7929.0 |
| AKR1D1 | 7924.0 |
| STXBP1 | 7922.0 |
| TXNRD1 | 7917.0 |
| ACSL6 | 7907.5 |
| PHKG2 | 7896.0 |
| COQ7 | 7888.0 |
| SELENOI | 7885.0 |
| EPHX1 | 7880.0 |
| GSTO1 | 7872.0 |
| ADCY4 | 7870.0 |
| GGT5 | 7852.0 |
| DGAT2 | 7843.0 |
| CHST15 | 7804.0 |
| GSR | 7801.0 |
| SLC5A6 | 7796.0 |
| GOT1 | 7788.0 |
| SLC27A2 | 7786.0 |
| ACSL1 | 7784.0 |
| HSD17B8 | 7780.0 |
| SCAP | 7769.0 |
| TPMT | 7768.0 |
| SIN3A | 7728.0 |
| AGRN | 7727.0 |
| CYP1B1 | 7721.0 |
| NAMPT | 7697.0 |
| RAPGEF4 | 7690.0 |
| GYS1 | 7689.0 |
| NEU3 | 7685.0 |
| MTMR3 | 7682.0 |
| CDIPT | 7681.0 |
| GNB3 | 7673.0 |
| HAO2 | 7672.0 |
| ACAA2 | 7671.0 |
| DPYD | 7658.0 |
| PAPSS2 | 7656.0 |
| OSBPL1A | 7651.0 |
| ACOX2 | 7644.0 |
| GDPD1 | 7639.0 |
| OSBPL9 | 7624.0 |
| PPP1CC | 7613.0 |
| LDHC | 7609.0 |
| CD36 | 7608.0 |
| ABCB7 | 7604.0 |
| PCCA | 7601.0 |
| ALDH1L1 | 7595.0 |
| FAM120B | 7582.0 |
| SRR | 7575.0 |
| GUSB | 7571.0 |
| BSG | 7570.0 |
| GOT2 | 7568.0 |
| PFKL | 7566.0 |
| SLC2A2 | 7562.0 |
| PPIP5K2 | 7553.0 |
| PSMB8 | 7523.0 |
| ACOT1 | 7508.5 |
| ACOT2 | 7508.5 |
| SLC44A1 | 7506.0 |
| GBA2 | 7505.0 |
| CA2 | 7502.0 |
| HSD17B4 | 7497.0 |
| MIGA1 | 7495.0 |
| ESRRA | 7493.0 |
| SYNJ1 | 7489.0 |
| NDUFA10 | 7483.0 |
| PHYKPL | 7482.0 |
| LIPE | 7475.0 |
| CACNA1D | 7472.0 |
| PDHX | 7471.0 |
| ADCY8 | 7470.0 |
| ACO2 | 7469.0 |
| PDHB | 7468.0 |
| AKR7L | 7460.0 |
| PIK3R1 | 7450.0 |
| DMGDH | 7433.0 |
| SLC22A1 | 7430.0 |
| PIP5K1C | 7429.0 |
| ADCY6 | 7405.0 |
| COX10 | 7392.0 |
| OSBPL6 | 7390.0 |
| FMO1 | 7389.0 |
| PLPP3 | 7387.5 |
| PTPN13 | 7381.0 |
| OAZ3 | 7380.0 |
| DEGS1 | 7375.0 |
| CRAT | 7368.0 |
| UGCG | 7366.0 |
| PKLR | 7362.0 |
| CS | 7355.0 |
| SARS1 | 7350.0 |
| PSTK | 7348.0 |
| SLC35B2 | 7343.0 |
| MTHFD1L | 7328.0 |
| AIMP2 | 7324.0 |
| DLAT | 7320.0 |
| CKMT1A | 7304.5 |
| HIBCH | 7300.0 |
| GNAI2 | 7291.0 |
| HADHB | 7290.0 |
| RGL1 | 7289.0 |
| HGD | 7287.0 |
| PPARGC1A | 7286.0 |
| NUDT5 | 7278.0 |
| PLA2G12A | 7271.0 |
| PPARD | 7270.0 |
| SLC25A28 | 7261.0 |
| ACOX1 | 7255.0 |
| RDH11 | 7225.5 |
| TM7SF2 | 7221.0 |
| NCOA1 | 7218.0 |
| PTGES2 | 7214.0 |
| MECR | 7210.0 |
| PPA2 | 7187.0 |
| SYNJ2 | 7186.0 |
| CYP4A11 | 7182.5 |
| CYP4A22 | 7182.5 |
| CYP4F11 | 7182.5 |
| CYP4F12 | 7182.5 |
| HK1 | 7172.0 |
| HPD | 7170.0 |
| CACNB2 | 7168.0 |
| G6PC3 | 7163.0 |
| MAT2B | 7160.0 |
| CYP3A4 | 7151.0 |
| CYP3A43 | 7151.0 |
| CYP3A5 | 7151.0 |
| CYP3A7 | 7151.0 |
| GLUD1 | 7147.5 |
| GLUD2 | 7147.5 |
| FDFT1 | 7140.0 |
| ITPR3 | 7138.0 |
| HK2 | 7136.0 |
| KYAT3 | 7134.0 |
| SMPD1 | 7133.0 |
| SLC52A3 | 7132.0 |
| NDUFA8 | 7131.0 |
| NDUFA12 | 7130.0 |
| KDSR | 7127.0 |
| SLCO1B1 | 7114.0 |
| SLCO1B3 | 7114.0 |
| ME3 | 7099.0 |
| MVK | 7089.0 |
| RAB14 | 7078.0 |
| RAPGEF3 | 7075.0 |
| DLST | 7073.0 |
| CA4 | 7059.0 |
| ACSF3 | 7053.0 |
| ACOT13 | 7051.0 |
| PTGR2 | 7049.5 |
| PHYH | 7045.0 |
| SLC27A5 | 7037.0 |
| MIGA2 | 7028.0 |
| CTH | 7025.0 |
| SPR | 7022.0 |
| MT-CYB | 7011.0 |
| ACADVL | 7006.0 |
| NDST2 | 7004.5 |
| NDUFAB1 | 6996.0 |
| CSPG4 | 6993.0 |
| ALDH3A2 | 6988.0 |
| MVD | 6987.0 |
| GCK | 6985.0 |
| LRAT | 6979.0 |
| ECSIT | 6963.0 |
| UQCRC1 | 6960.0 |
| ACER2 | 6955.0 |
| ITPR1 | 6954.0 |
| OXCT1 | 6953.0 |
| HAGH | 6949.0 |
| MCCC2 | 6930.0 |
| ELOVL1 | 6929.0 |
| NUDT11 | 6928.0 |
| SERINC3 | 6922.0 |
| THEM4 | 6916.0 |
| PISD | 6915.0 |
| DDHD1 | 6907.0 |
| CIAO3 | 6903.0 |
| FAHD1 | 6902.0 |
| HEXB | 6896.0 |
| PCYT2 | 6881.0 |
| THTPA | 6880.0 |
| NMRAL1 | 6858.0 |
| ADRA2C | 6852.0 |
| ALAS2 | 6834.0 |
| L2HGDH | 6828.0 |
| DGAT1 | 6818.0 |
| PLBD1 | 6813.0 |
| ECI1 | 6811.0 |
| HMGCS2 | 6810.0 |
| SLC25A27 | 6807.0 |
| ST3GAL6 | 6802.0 |
| AUH | 6798.0 |
| SLC27A1 | 6792.0 |
| NNT | 6791.0 |
| APOC2 | 6777.5 |
| ARSB | 6768.0 |
| AMACR | 6750.0 |
| NUP155 | 6749.0 |
| PLCD3 | 6748.0 |
| MCEE | 6734.0 |
| SMPD2 | 6732.0 |
| ABHD14B | 6728.0 |
| DHTKD1 | 6727.0 |
| PRPS1 | 6718.0 |
| CYP4F2 | 6710.0 |
| LIPH | 6703.0 |
| MMAB | 6701.0 |
| PANK1 | 6687.0 |
| NDST1 | 6686.0 |
| D2HGDH | 6672.0 |
| RETSAT | 6670.0 |
| MCCC1 | 6666.0 |
| NAPRT | 6662.0 |
| AK4 | 6653.0 |
| ADK | 6650.0 |
| ADCY9 | 6648.0 |
| STARD7 | 6643.0 |
| BDH1 | 6632.0 |
| CBS | 6623.5 |
| CBSL | 6623.5 |
| MTMR14 | 6619.0 |
| PTDSS2 | 6618.0 |
| PSME1 | 6608.0 |
| NAALAD2 | 6593.0 |
| CIDEA | 6565.0 |
| CKMT2 | 6560.0 |
| BCKDK | 6559.0 |
| PAH | 6547.0 |
| ACSS3 | 6546.0 |
| ADH7 | 6545.0 |
| GPC3 | 6542.0 |
| ACOT11 | 6541.0 |
| UROC1 | 6538.0 |
| SLC26A1 | 6532.0 |
| KCNC2 | 6530.0 |
| PFKP | 6516.0 |
| NDUFV1 | 6489.0 |
| LRP12 | 6488.0 |
| ATP5F1B | 6480.0 |
| GPD1L | 6475.0 |
| PLCD1 | 6467.0 |
| B3GALT6 | 6461.0 |
| ACAD9 | 6453.0 |
| CPT1B | 6451.0 |
| SLC25A20 | 6449.0 |
| ITPKB | 6447.0 |
| COX5B | 6442.0 |
| SDC3 | 6440.0 |
| ABCD1 | 6427.0 |
| MMAA | 6426.0 |
| CHPT1 | 6423.0 |
| PNPO | 6410.0 |
| FTCD | 6406.0 |
| VAMP2 | 6400.5 |
| BCKDHB | 6380.0 |
| HADHA | 6375.0 |
| PLCE1 | 6370.0 |
| KARS1 | 6365.0 |
| B4GAT1 | 6339.0 |
| KYNU | 6336.0 |
| PRKG2 | 6322.0 |
| CAV1 | 6314.0 |
| MTM1 | 6305.0 |
| FUT11 | 6301.0 |
| IDH3G | 6298.0 |
| DCTD | 6296.0 |
| ALOX12 | 6295.0 |
| MARS1 | 6293.0 |
| ABCB11 | 6290.0 |
| FIG4 | 6289.0 |
| GNPAT | 6274.0 |
| MGST3 | 6268.0 |
| LPCAT1 | 6266.0 |
| SLC25A37 | 6264.0 |
| ACAT1 | 6251.0 |
| PNPLA6 | 6241.0 |
| TAZ | 6238.0 |
| NOS3 | 6235.0 |
| INPP5E | 6233.0 |
| SLC35D1 | 6230.0 |
| GNA11 | 6218.0 |
| CIAPIN1 | 6211.0 |
| NDUFA9 | 6209.0 |
| PFKFB1 | 6194.0 |
| NUP50 | 6188.0 |
| PSMF1 | 6184.0 |
| CHP1 | 6183.0 |
| TK1 | 6181.0 |
| HYAL2 | 6167.0 |
| ATP5F1D | 6163.0 |
| MT-CO1 | 6162.0 |
| LDHB | 6149.5 |
| SLC25A12 | 6148.0 |
| GSTM2 | 6146.0 |
| SLC9A1 | 6140.0 |
| MAPKAPK2 | 6139.0 |
| TRAP1 | 6126.0 |
| ACAA1 | 6125.0 |
| DPYS | 6124.0 |
| SDHC | 6123.0 |
| NDUFB10 | 6086.0 |
| SCD | 6085.0 |
| HELZ2 | 6066.0 |
| SLC52A1 | 6063.5 |
| SLC52A2 | 6063.5 |
| ESYT1 | 6061.0 |
| RIMKLA | 6059.0 |
| STARD3 | 6047.0 |
| B3GALT2 | 6029.0 |
| GLYAT | 6027.0 |
| COX5A | 6026.0 |
| EHHADH | 6024.0 |
| IDH2 | 6021.0 |
| CD38 | 6012.0 |
| COX4I1 | 6009.0 |
| POLD1 | 6006.0 |
| ARSL | 5997.0 |
| NAGLU | 5992.0 |
| ACADM | 5984.0 |
| PLA2G3 | 5983.0 |
| SHMT2 | 5982.0 |
| SLC25A15 | 5980.0 |
| ACADL | 5978.0 |
| ADSL | 5973.0 |
| MTMR4 | 5959.0 |
| SPHK2 | 5954.0 |
| MTARC2 | 5951.0 |
| PIAS4 | 5949.0 |
| ST3GAL2 | 5935.0 |
| CYP2S1 | 5928.0 |
| IMPDH1 | 5924.0 |
| MBOAT7 | 5900.0 |
| COX18 | 5890.0 |
| TRIB3 | 5887.0 |
| NR1H4 | 5883.0 |
| GNG8 | 5873.0 |
| PPCDC | 5868.0 |
| ABHD3 | 5864.0 |
| FABP3 | 5858.0 |
| SPTLC3 | 5843.0 |
| ADA | 5832.0 |
| NDC1 | 5827.0 |
| HADH | 5813.0 |
| APOA5 | 5800.0 |
| NUP58 | 5787.0 |
| BAAT | 5784.0 |
| CYP26B1 | 5783.0 |
| PYCR2 | 5775.5 |
| SLC25A19 | 5771.0 |
| MDH1 | 5761.0 |
| ETFB | 5756.0 |
| GART | 5752.0 |
| UPB1 | 5745.0 |
| PANK4 | 5739.0 |
| PLA2G15 | 5737.0 |
| SPNS2 | 5733.0 |
| HSD17B3 | 5727.0 |
| PPP2R5D | 5723.0 |
| OSBPL2 | 5717.0 |
| ACSS2 | 5711.0 |
| ELOVL5 | 5710.0 |
| NUP133 | 5700.0 |
| NAT8L | 5686.0 |
| NADK2 | 5681.0 |
| ABCD4 | 5673.0 |
| SRD5A3 | 5664.0 |
| PRKD2 | 5653.0 |
| SDHB | 5629.0 |
| EPHX2 | 5626.0 |
| CPT2 | 5615.0 |
| NDUFS5 | 5612.0 |
| PTPMT1 | 5611.0 |
| PI4KA | 5609.0 |
| GNA14 | 5590.0 |
| ATP5MC3 | 5582.0 |
| MT-ND1 | 5579.0 |
| IDO2 | 5575.0 |
| NDUFB7 | 5573.0 |
| SLC35D2 | 5569.5 |
| PITPNM1 | 5555.0 |
| CPNE7 | 5543.0 |
| GLTP | 5539.0 |
| CHKB | 5535.0 |
| NDUFV3 | 5524.0 |
| PLEKHA5 | 5521.0 |
| TSPO | 5508.0 |
| ENTPD4 | 5505.0 |
| MT-ATP8 | 5500.0 |
| SPHK1 | 5497.0 |
| GDPD3 | 5492.0 |
| MTHFD1 | 5481.0 |
| NDUFAF7 | 5479.0 |
| IQGAP1 | 5465.0 |
| NUDT19 | 5464.0 |
| DPEP3 | 5463.0 |
| LHPP | 5454.0 |
| FUT4 | 5450.0 |
| POR | 5441.0 |
| NCOA3 | 5428.0 |
| TTPA | 5425.0 |
| CPOX | 5413.0 |
| GLRX5 | 5404.0 |
| HDAC3 | 5383.0 |
| TKFC | 5376.0 |
| ETFDH | 5372.0 |
| SULT2B1 | 5346.0 |
| COQ10A | 5345.0 |
| APOA2 | 5339.0 |
| LPIN2 | 5328.0 |
| LPL | 5325.0 |
| NCOA2 | 5324.0 |
| GNG12 | 5320.0 |
| MDH2 | 5314.0 |
| FLAD1 | 5296.0 |
| HSD17B11 | 5290.0 |
| B4GALT7 | 5289.0 |
| MED20 | 5287.0 |
| MED11 | 5275.0 |
| FABP1 | 5273.0 |
| PCK2 | 5270.0 |
| ETFA | 5269.0 |
| ABCC1 | 5260.0 |
| LRP8 | 5255.0 |
| CPT1A | 5252.0 |
| CA14 | 5251.0 |
| KPNB1 | 5247.0 |
| NQO2 | 5239.0 |
| AHR | 5235.5 |
| AGPAT3 | 5234.0 |
| ISCU | 5231.0 |
| RBP1 | 5230.0 |
| SULT1E1 | 5228.5 |
| NUDT12 | 5225.0 |
| CPTP | 5212.0 |
| GUK1 | 5202.0 |
| BPHL | 5199.0 |
| LPIN3 | 5191.0 |
| APRT | 5190.0 |
| VDR | 5181.0 |
| PON2 | 5161.0 |
| RPL22 | 5158.0 |
| CERS5 | 5142.0 |
| AGPAT2 | 5125.0 |
| RAB5A | 5118.0 |
| GCH1 | 5114.0 |
| AGMAT | 5096.0 |
| PARP14 | 5095.0 |
| CSNK2B | 5077.0 |
| ITPR2 | 5073.0 |
| MTHFD2L | 5050.0 |
| AK2 | 5044.0 |
| NCOR2 | 5040.0 |
| ALDH7A1 | 5036.0 |
| PDPR | 5035.0 |
| GCKR | 5033.0 |
| PPP1CA | 5029.0 |
| PSMB9 | 5019.0 |
| OSBPL3 | 4992.0 |
| LTA4H | 4990.0 |
| B3GNT7 | 4989.0 |
| NDUFB6 | 4983.0 |
| OTC | 4960.0 |
| FITM2 | 4958.0 |
| IDH3A | 4957.0 |
| CYP7A1 | 4954.0 |
| ST3GAL3 | 4940.0 |
| MT-ND5 | 4937.0 |
| CA7 | 4924.0 |
| IPMK | 4921.0 |
| INPP4B | 4919.0 |
| IDH3B | 4913.0 |
| INPPL1 | 4912.0 |
| GNAI1 | 4905.0 |
| AHCY | 4901.0 |
| NT5C3A | 4888.0 |
| CYC1 | 4883.0 |
| MT-ND2 | 4879.0 |
| TIMMDC1 | 4862.0 |
| ARSG | 4846.0 |
| ESYT3 | 4844.0 |
| ANKRD1 | 4842.0 |
| INPP5A | 4841.0 |
| HMGCS1 | 4840.0 |
| SERPINA6 | 4838.0 |
| NUDT13 | 4824.0 |
| ACOT6 | 4818.0 |
| GLP1R | 4816.0 |
| NADK | 4808.0 |
| SPTLC1 | 4801.0 |
| MTMR2 | 4800.0 |
| PSAP | 4789.0 |
| SLC10A1 | 4785.0 |
| GAA | 4773.0 |
| MT-ND6 | 4767.0 |
| TDO2 | 4761.0 |
| CA12 | 4759.0 |
| PRKAR1A | 4751.0 |
| MLYCD | 4748.0 |
| PARP9 | 4747.0 |
| PON1 | 4745.0 |
| MMACHC | 4740.0 |
| ALDH3B1 | 4733.0 |
| ACADS | 4701.0 |
| CYP21A2 | 4683.0 |
| PRODH | 4680.5 |
| APOA4 | 4672.0 |
| FBP1 | 4657.0 |
| HPSE | 4653.0 |
| HSD17B1 | 4651.0 |
| ACY1 | 4649.5 |
| LPGAT1 | 4643.0 |
| BGN | 4642.0 |
| FH | 4639.0 |
| SDC4 | 4637.0 |
| HIBADH | 4633.0 |
| MT-ATP6 | 4629.0 |
| SBF1 | 4623.0 |
| ITPA | 4619.0 |
| IARS1 | 4606.0 |
| NHLRC1 | 4600.0 |
| ACSF2 | 4566.0 |
| CHPF2 | 4563.0 |
| PLA2G4C | 4558.0 |
| ETNK1 | 4555.0 |
| PIK3R3 | 4535.5 |
| QDPR | 4524.0 |
| NUP98 | 4522.0 |
| PCCB | 4518.0 |
| COQ9 | 4517.0 |
| PRKACA | 4516.0 |
| NUP93 | 4512.0 |
| ENPP1 | 4507.0 |
| NCAN | 4501.0 |
| PSMD13 | 4498.0 |
| RPL3L | 4494.0 |
| MCAT | 4486.0 |
| PLAAT3 | 4482.0 |
| PARP16 | 4481.0 |
| LPCAT4 | 4480.0 |
| COASY | 4460.0 |
| MBOAT2 | 4446.0 |
| BTD | 4442.0 |
| MPC2 | 4435.0 |
| SIN3B | 4433.0 |
| PLA2G4F | 4411.0 |
| BMX | 4404.0 |
| ENTPD5 | 4385.0 |
| MT-ND4 | 4382.0 |
| NDUFS3 | 4380.0 |
| NDOR1 | 4367.0 |
| ADCY5 | 4361.0 |
| CYP27A1 | 4354.0 |
| SLC5A5 | 4347.0 |
| PIK3R4 | 4339.0 |
| PDHA1 | 4337.0 |
| CYP2C18 | 4328.5 |
| ELOVL2 | 4317.0 |
| IP6K3 | 4313.0 |
| PPCS | 4307.0 |
| NR1D1 | 4304.0 |
| COX11 | 4280.0 |
| GSS | 4276.0 |
| CAD | 4271.0 |
| TCN2 | 4268.0 |
| CHST7 | 4266.0 |
| FABP12 | 4262.0 |
| FA2H | 4252.0 |
| DNPH1 | 4246.0 |
| CYGB | 4243.0 |
| CRYL1 | 4217.0 |
| CHDH | 4204.0 |
| AIP | 4203.0 |
| SAMHD1 | 4197.0 |
| PAOX | 4192.5 |
| CERK | 4167.0 |
| ORMDL2 | 4164.0 |
| MORC2 | 4155.0 |
| ACBD5 | 4146.0 |
| GBA3 | 4143.0 |
| HK3 | 4114.0 |
| PSMD12 | 4108.0 |
| ABHD4 | 4098.0 |
| TACO1 | 4096.0 |
| PDK4 | 4094.0 |
| AASS | 4076.0 |
| MED30 | 4073.0 |
| NDUFB11 | 4068.0 |
| ELOVL3 | 4059.0 |
| CPS1 | 4058.0 |
| HAL | 4053.0 |
| FMO2 | 4047.0 |
| DMAC2L | 4044.0 |
| GYG1 | 4039.0 |
| SLC46A1 | 4034.0 |
| GCAT | 4033.0 |
| NFYC | 4019.0 |
| GNS | 4017.0 |
| THRAP3 | 4012.0 |
| SLC25A10 | 4009.5 |
| DNM2 | 3996.0 |
| MT-CO2 | 3989.0 |
| ATP5ME | 3979.0 |
| NDUFAF3 | 3956.0 |
| SLC6A12 | 3944.0 |
| PTGR1 | 3940.0 |
| BCKDHA | 3938.5 |
| SLC25A11 | 3937.0 |
| ACLY | 3933.0 |
| INPP5F | 3921.0 |
| PRODH2 | 3914.0 |
| MRI1 | 3905.0 |
| BLVRB | 3893.0 |
| SLC44A4 | 3892.0 |
| ENTPD1 | 3885.0 |
| RFK | 3881.0 |
| MT-CO3 | 3879.0 |
| SRD5A1 | 3839.0 |
| LYPLA1 | 3830.0 |
| NDUFS1 | 3819.0 |
| GCSH | 3817.0 |
| ALB | 3808.0 |
| PPP2R1A | 3805.0 |
| ENOPH1 | 3801.0 |
| HSPG2 | 3786.0 |
| IVD | 3772.0 |
| AMT | 3769.5 |
| UCP2 | 3761.0 |
| PLD6 | 3759.0 |
| CNDP2 | 3758.0 |
| BHMT | 3748.0 |
| SLC3A2 | 3743.0 |
| NMNAT1 | 3733.0 |
| LIPT2 | 3725.0 |
| STK11 | 3719.0 |
| B4GALT1 | 3685.0 |
| SLC25A14 | 3669.0 |
| LIAS | 3668.0 |
| CYP2U1 | 3661.0 |
| VDAC1 | 3653.0 |
| GLB1 | 3652.0 |
| GGT1 | 3624.0 |
| CDK19 | 3619.0 |
| LRP10 | 3616.0 |
| PI4K2A | 3614.0 |
| PLCB3 | 3610.0 |
| PDSS2 | 3586.0 |
| SUCLG1 | 3584.0 |
| GPAT3 | 3583.0 |
| SLC44A5 | 3580.0 |
| COQ5 | 3578.0 |
| ALOXE3 | 3570.0 |
| CERS4 | 3565.0 |
| NOSTRIN | 3557.0 |
| DEGS2 | 3556.0 |
| COX6B1 | 3551.0 |
| NAXD | 3541.0 |
| PNP | 3539.0 |
| BST1 | 3532.0 |
| AKT1 | 3530.0 |
| POM121 | 3523.5 |
| POM121C | 3523.5 |
| DCK | 3522.0 |
| VAPB | 3515.0 |
| ARG2 | 3514.0 |
| UPP1 | 3510.0 |
| NDUFS8 | 3493.0 |
| COX7A2L | 3473.0 |
| ACER3 | 3467.0 |
| INPP5J | 3451.0 |
| UROS | 3436.0 |
| SLC25A44 | 3433.0 |
| ADPGK | 3429.0 |
| GMPR | 3427.0 |
| AS3MT | 3419.0 |
| CDA | 3407.0 |
| CIAO1 | 3399.0 |
| IDO1 | 3376.0 |
| PLCH2 | 3374.0 |
| PDK2 | 3361.0 |
| ATP5PD | 3350.0 |
| ANGPTL4 | 3332.0 |
| CDS2 | 3330.0 |
| COQ6 | 3306.0 |
| ALDOC | 3305.0 |
| ELOVL7 | 3264.0 |
| PLCG1 | 3263.0 |
| HSD11B2 | 3260.0 |
| GPC4 | 3253.0 |
| AGPAT1 | 3237.0 |
| SLC44A2 | 3226.0 |
| DBT | 3223.0 |
| XYLT2 | 3222.0 |
| B3GALT1 | 3217.0 |
| ACOT8 | 3216.0 |
| UGT8 | 3214.0 |
| UQCRC2 | 3202.0 |
| CHST2 | 3199.0 |
| GPX2 | 3181.0 |
| HEXA | 3177.5 |
| CYB5R3 | 3176.0 |
| GPC2 | 3173.0 |
| AAAS | 3172.0 |
| ACP6 | 3169.0 |
| MED13 | 3167.0 |
| MED16 | 3165.0 |
| GALT | 3160.0 |
| CRYM | 3157.0 |
| PXMP2 | 3147.0 |
| RPS3 | 3136.0 |
| ASAH1 | 3132.0 |
| PFKFB3 | 3131.0 |
| CSPG5 | 3130.0 |
| NQO1 | 3127.0 |
| SDHA | 3123.5 |
| ALDOB | 3122.0 |
| PNPLA7 | 3113.0 |
| MED25 | 3110.0 |
| NAXE | 3109.0 |
| AKR7A3 | 3107.0 |
| DLD | 3101.0 |
| SLC16A1 | 3094.0 |
| MTMR9 | 3093.0 |
| NDUFS7 | 3090.0 |
| SULT1B1 | 3083.0 |
| HAO1 | 3075.0 |
| UQCRFS1 | 3065.0 |
| GSTP1 | 3048.0 |
| TPST2 | 3036.0 |
| RPS9 | 3031.0 |
| TYMS | 3027.0 |
| BHMT2 | 3019.0 |
| CYP4B1 | 3008.0 |
| PLEKHA1 | 2999.0 |
| MOGAT2 | 2998.0 |
| ITPK1 | 2994.0 |
| MTMR1 | 2992.0 |
| CYP46A1 | 2984.0 |
| ATP5PO | 2966.5 |
| PDP2 | 2951.0 |
| PTGS1 | 2945.0 |
| CA5B | 2939.0 |
| ELOVL6 | 2936.0 |
| SDS | 2931.0 |
| NUBP2 | 2930.0 |
| FABP5 | 2903.0 |
| NDUFB4 | 2890.0 |
| FHL2 | 2888.0 |
| PFKFB2 | 2887.0 |
| NDUFAF6 | 2862.0 |
| MMUT | 2827.0 |
| EPRS1 | 2820.0 |
| HS6ST1 | 2818.0 |
| CACNA2D2 | 2816.0 |
| PYGB | 2807.0 |
| AKAP5 | 2803.0 |
| B4GALT6 | 2792.0 |
| GPC1 | 2787.0 |
| B4GALT2 | 2782.0 |
| B4GALT4 | 2769.0 |
| RHCE | 2752.5 |
| RHD | 2752.5 |
| DIO1 | 2734.0 |
| SLC25A13 | 2731.0 |
| PIK3C2G | 2726.0 |
| NUP85 | 2708.0 |
| TBL1X | 2701.5 |
| LALBA | 2697.0 |
| PCYT1A | 2694.0 |
| LSS | 2690.0 |
| UBIAD1 | 2682.0 |
| RPL37 | 2677.0 |
| HMOX1 | 2671.0 |
| PTGIS | 2632.0 |
| ERCC2 | 2618.0 |
| UPP2 | 2616.0 |
| OSBP | 2607.0 |
| SLC7A5 | 2601.0 |
| GNB2 | 2595.0 |
| GNB1 | 2583.0 |
| DHCR24 | 2582.0 |
| ENO2 | 2577.0 |
| HACL1 | 2573.0 |
| EBP | 2569.5 |
| AMPD3 | 2560.0 |
| FABP9 | 2555.0 |
| MTAP | 2547.5 |
| CYP8B1 | 2544.0 |
| ISCA1 | 2527.0 |
| ACSL5 | 2484.0 |
| ACOX3 | 2479.0 |
| APOM | 2476.0 |
| MFSD2A | 2468.0 |
| ADAL | 2466.0 |
| CRLS1 | 2459.0 |
| COX6A1 | 2441.0 |
| CHRM3 | 2433.0 |
| PLEKHA4 | 2428.0 |
| NDUFA4 | 2427.0 |
| STAB2 | 2402.0 |
| SLC22A2 | 2395.0 |
| NUP153 | 2394.0 |
| GLS2 | 2379.0 |
| SLCO2B1 | 2372.0 |
| SORD | 2363.0 |
| FMO3 | 2351.0 |
| ENTPD3 | 2340.0 |
| GC | 2339.0 |
| GCDH | 2330.0 |
| UMPS | 2328.0 |
| NEU4 | 2309.0 |
| SGPP1 | 2300.0 |
| CPNE6 | 2292.0 |
| NT5E | 2278.0 |
| PIP5K1B | 2275.0 |
| PSMC3 | 2256.0 |
| PSME2 | 2230.0 |
| NDUFA6 | 2222.0 |
| NT5C2 | 2210.0 |
| GPAT4 | 2166.0 |
| RBP4 | 2158.0 |
| ENTPD8 | 2150.0 |
| ADH5 | 2145.0 |
| NDUFS4 | 2132.0 |
| GNG7 | 2130.0 |
| GNB5 | 2123.0 |
| ACOXL | 2122.0 |
| PITPNM3 | 2118.0 |
| TXN2 | 2111.0 |
| ARV1 | 2104.0 |
| HSD17B14 | 2069.0 |
| PLB1 | 2066.0 |
| SUMF1 | 2058.0 |
| COMT | 2047.0 |
| SACM1L | 2044.0 |
| GDA | 2042.0 |
| PDK1 | 2031.0 |
| NT5M | 2013.0 |
| CDS1 | 1993.0 |
| CYP1A2 | 1984.0 |
| TIAM2 | 1970.0 |
| BPNT2 | 1965.0 |
| DHFR | 1944.5 |
| DHFR2 | 1944.5 |
| GPT | 1940.0 |
| TPR | 1935.0 |
| PLCG2 | 1922.0 |
| PLA2G2A | 1916.0 |
| FXN | 1911.0 |
| ACER1 | 1906.0 |
| NT5C | 1896.0 |
| UCKL1 | 1893.0 |
| DERA | 1883.0 |
| PPP2CB | 1876.0 |
| HMGCL | 1875.0 |
| NUDT18 | 1867.0 |
| GSTM4 | 1859.0 |
| CYP4V2 | 1840.0 |
| SUCLG2 | 1833.0 |
| DECR1 | 1813.0 |
| PIP4K2C | 1803.0 |
| PIP5K1A | 1793.0 |
| GNG2 | 1781.0 |
| HMGCR | 1772.0 |
| HS3ST3A1 | 1761.0 |
| NUDT4 | 1756.5 |
| HSD17B10 | 1753.0 |
| CHAT | 1738.0 |
| MTMR12 | 1733.0 |
| SLC45A2 | 1727.0 |
| FDX1 | 1690.0 |
| SULT4A1 | 1685.0 |
| PDXK | 1638.0 |
| GLDC | 1630.0 |
| AMDHD1 | 1625.0 |
| PPARG | 1599.0 |
| HSP90AB1 | 1597.0 |
| TSPOAP1 | 1582.0 |
| ACSS1 | 1581.0 |
| DDAH1 | 1571.0 |
| PECR | 1557.0 |
| MED19 | 1555.0 |
| SRD5A2 | 1549.0 |
| PSMB2 | 1548.0 |
| KCNG2 | 1519.0 |
| INPP1 | 1515.0 |
| PSME4 | 1510.0 |
| PRKAR1B | 1495.0 |
| BDH2 | 1484.0 |
| SCO1 | 1481.0 |
| PLPP6 | 1469.0 |
| FITM1 | 1457.0 |
| ETNPPL | 1441.0 |
| GNB4 | 1440.0 |
| NUP62 | 1422.0 |
| ACSM4 | 1420.0 |
| AOC3 | 1403.0 |
| COQ3 | 1402.0 |
| RPL7A | 1400.0 |
| UCP1 | 1390.0 |
| BCHE | 1382.0 |
| PTGDS | 1364.5 |
| TNFAIP8L3 | 1336.0 |
| CYP4F22 | 1324.0 |
| AMN | 1309.0 |
| NDUFAF4 | 1307.0 |
| NUDT9 | 1283.0 |
| MAOB | 1278.0 |
| HYKK | 1271.0 |
| CA3 | 1268.0 |
| TECR | 1244.0 |
| PODXL2 | 1242.0 |
| ETHE1 | 1214.0 |
| INS | 1207.5 |
| HS6ST2 | 1202.0 |
| NDUFAF1 | 1191.0 |
| CYP11A1 | 1187.0 |
| BCO1 | 1128.0 |
| ADI1 | 1124.0 |
| PSMC1 | 1107.0 |
| CYP19A1 | 1077.0 |
| FFAR1 | 1077.0 |
| TYR | 1077.0 |
| AANAT | 1063.5 |
| KCNB1 | 1044.0 |
| NDUFB8 | 1015.5 |
| UBC | 1013.0 |
| ABCC2 | 1006.0 |
| SLC36A4 | 997.0 |
| PLIN2 | 985.0 |
| GNPDA1 | 966.0 |
| NUP188 | 957.0 |
| HAAO | 944.0 |
| STAR | 921.0 |
| PNLIP | 915.0 |
| ABO | 914.0 |
| B3GAT2 | 894.0 |
| HACD3 | 849.0 |
| CIAO2B | 845.0 |
| AOC1 | 786.0 |
| PLAAT1 | 782.0 |
| THEM5 | 765.0 |
| TALDO1 | 753.0 |
| COQ2 | 749.0 |
| XDH | 745.0 |
| CBR1 | 743.0 |
| RPL27 | 706.0 |
| ALOX12B | 627.0 |
| SHPK | 615.5 |
| HMBS | 610.0 |
| SUCLA2 | 608.0 |
| STARD5 | 594.0 |
| SUOX | 589.0 |
| GNMT | 585.0 |
| CHST3 | 565.0 |
| NDUFA13 | 544.0 |
| CSNK1G2 | 527.0 |
| RPS27L | 522.0 |
| NCOR1 | 513.0 |
| SGMS2 | 511.0 |
| SP1 | 506.0 |
| DGAT2L6 | 503.0 |
| ARSA | 498.0 |
| PPP2CA | 497.0 |
| SNAP25 | 491.0 |
| ELOVL4 | 485.0 |
| AGPS | 484.0 |
| CSGALNACT2 | 479.0 |
| ADRA2A | 478.0 |
| SULT1C2 | 473.0 |
| CEMIP | 447.0 |
| AKR1B1 | 438.0 |
| POMC | 432.0 |
| NUP37 | 424.0 |
| MPC1 | 407.0 |
| FABP6 | 393.5 |
| ST3GAL4 | 357.0 |
| PLA2G4D | 356.0 |
| MID1IP1 | 349.0 |
| PSMD7 | 321.0 |
| PANK3 | 310.0 |
| SLC5A8 | 302.0 |
| NDST4 | 263.0 |
| NCOA6 | 255.0 |
| GLYATL3 | 246.0 |
| GCG | 188.0 |
| RIMKLB | 188.0 |
| ACAT2 | 54.0 |
| IPPK | 27.0 |
| HACD4 | 7.0 |
| CHST14 | 5.0 |
| PTEN | 0.0 |
| PPOX | -1.0 |
| PGP | -4.0 |
| MED15 | -8.0 |
| MAN2B1 | -33.5 |
| MMS19 | -48.0 |
| CSAD | -92.0 |
| TPTE | -98.5 |
| TPTE2 | -98.5 |
| PLCB4 | -100.0 |
| GGCT | -116.5 |
| MED13L | -127.0 |
| MOGAT1 | -129.0 |
| APOE | -136.0 |
| GALC | -145.0 |
| PC | -150.0 |
| PRKAA2 | -151.0 |
| PSMB5 | -153.0 |
| RRM1 | -157.0 |
| SEC24B | -161.0 |
| MED7 | -167.0 |
| SLC6A11 | -176.0 |
| AADAC | -188.0 |
| ENO1 | -219.0 |
| GNG10 | -219.0 |
| RPS2 | -219.0 |
| TAT | -219.0 |
| PFKM | -255.0 |
| PHGDH | -257.0 |
| RAE1 | -259.0 |
| CGA | -264.0 |
| ACBD4 | -269.0 |
| RPL31 | -303.0 |
| TPH1 | -304.0 |
| MOCS3 | -315.0 |
| INPP5B | -319.0 |
| SERINC5 | -323.0 |
| AGK | -326.0 |
| NAGS | -332.0 |
| PIK3C3 | -335.0 |
| RBP2 | -340.0 |
| INSIG2 | -349.0 |
| SDHD | -389.5 |
| GDE1 | -397.0 |
| KCNS3 | -398.0 |
| ADPRM | -403.0 |
| FOLH1 | -423.0 |
| ISYNA1 | -469.0 |
| ACAD10 | -476.0 |
| SERINC4 | -479.0 |
| GSTK1 | -481.0 |
| UGT2A3 | -484.0 |
| AIMP1 | -487.0 |
| TECRL | -489.0 |
| PLCZ1 | -491.0 |
| FAAH | -494.0 |
| ACBD6 | -500.0 |
| B3GALT5 | -504.0 |
| GGPS1 | -505.0 |
| PNPLA4 | -507.0 |
| KCNJ11 | -540.0 |
| HS3ST3B1 | -547.0 |
| PDK3 | -549.0 |
| ALDH1B1 | -557.0 |
| AFMID | -564.0 |
| NUP210 | -565.0 |
| PLA2G4E | -576.0 |
| CA1 | -581.0 |
| PSMA5 | -604.0 |
| GALE | -606.0 |
| SLC37A1 | -608.0 |
| PLA2G1B | -633.0 |
| PNPLA5 | -633.0 |
| TH | -720.5 |
| TPO | -720.5 |
| UGT3A2 | -720.5 |
| CA13 | -800.0 |
| SLC19A1 | -820.0 |
| INPP4A | -824.0 |
| MBTPS2 | -837.0 |
| TYRP1 | -874.0 |
| CHD9 | -885.0 |
| ACMSD | -901.0 |
| RUFY1 | -910.0 |
| CYP2W1 | -912.0 |
| CERS3 | -915.0 |
| AGPAT4 | -928.0 |
| DBH | -942.0 |
| NDUFA3 | -953.0 |
| ABHD10 | -956.0 |
| PARP6 | -973.0 |
| GPX1 | -981.0 |
| SLC23A2 | -991.0 |
| PLEKHA3 | -993.0 |
| CHSY1 | -998.0 |
| MGST2 | -1004.0 |
| INMT | -1055.5 |
| IYD | -1079.0 |
| RPL23A | -1088.0 |
| B3GAT1 | -1126.0 |
| TSHB | -1126.0 |
| PSMD3 | -1168.0 |
| PSMD11 | -1181.0 |
| PAICS | -1184.0 |
| NR1H3 | -1186.0 |
| OLAH | -1201.0 |
| ATP5PF | -1203.0 |
| PLCB1 | -1249.0 |
| PSPH | -1263.0 |
| GALK1 | -1270.0 |
| CA5A | -1322.0 |
| GK2 | -1329.0 |
| GLCE | -1342.0 |
| EPM2A | -1357.0 |
| NR1H2 | -1366.0 |
| ABHD5 | -1376.0 |
| MAN2B2 | -1433.0 |
| B4GALT3 | -1440.0 |
| PIP4K2A | -1448.0 |
| SULT1A1 | -1455.0 |
| SULT1A2 | -1455.0 |
| AGXT2 | -1462.0 |
| SMS | -1473.0 |
| SLC22A3 | -1492.0 |
| ATIC | -1526.0 |
| DDC | -1527.0 |
| FUT2 | -1539.0 |
| PSMC6 | -1541.0 |
| PLA2G2F | -1548.0 |
| SYT5 | -1557.0 |
| AGPAT5 | -1570.0 |
| ACOT12 | -1585.0 |
| CES2 | -1591.0 |
| IDUA | -1594.0 |
| IDH1 | -1627.0 |
| CREBBP | -1636.0 |
| PANK2 | -1640.0 |
| GATM | -1643.0 |
| SAMD8 | -1654.0 |
| MGST1 | -1655.0 |
| GGT7 | -1675.0 |
| PSMA8 | -1679.0 |
| CYP17A1 | -1685.0 |
| HS3ST6 | -1686.0 |
| CTSA | -1693.0 |
| ARG1 | -1696.0 |
| RAB4A | -1698.0 |
| APOB | -1729.0 |
| FABP7 | -1750.0 |
| TNFAIP8 | -1764.0 |
| UCP3 | -1769.0 |
| NUDT1 | -1771.0 |
| CHST9 | -1774.0 |
| CHST1 | -1780.0 |
| GLA | -1815.0 |
| UBE2I | -1820.0 |
| CARM1 | -1862.0 |
| B3GALNT1 | -1886.0 |
| ATP5MF | -1892.0 |
| PARP10 | -1918.0 |
| NDUFB5 | -1930.0 |
| DUOX2 | -1935.0 |
| GNG11 | -1937.0 |
| CHAC1 | -1970.0 |
| RXRA | -1980.0 |
| STARD3NL | -1991.0 |
| MED1 | -2004.0 |
| ASNS | -2006.0 |
| DBI | -2008.0 |
| PIK3R2 | -2014.5 |
| NDST3 | -2026.0 |
| LCLAT1 | -2037.0 |
| DPEP1 | -2058.0 |
| APOC3 | -2065.5 |
| NFS1 | -2085.0 |
| ACSBG2 | -2092.0 |
| CYP51A1 | -2093.0 |
| ALDH3A1 | -2094.0 |
| PSMD1 | -2102.0 |
| PMVK | -2107.0 |
| EP300 | -2111.0 |
| KHK | -2119.0 |
| SERINC1 | -2128.0 |
| CYP1A1 | -2131.0 |
| PGM2 | -2150.0 |
| PLCB2 | -2167.0 |
| MED17 | -2171.5 |
| NDUFV2 | -2183.0 |
| PHKA2 | -2203.0 |
| STX1A | -2228.0 |
| FUT1 | -2236.0 |
| COX7B | -2241.0 |
| SRM | -2260.0 |
| LARS1 | -2263.0 |
| ADCY3 | -2277.0 |
| PPP1CB | -2278.0 |
| CHST12 | -2284.0 |
| ODC1 | -2302.0 |
| ASPG | -2305.0 |
| PSMD2 | -2319.0 |
| NME2 | -2324.0 |
| ENTPD6 | -2327.0 |
| ISCA2 | -2335.0 |
| GPS2 | -2353.0 |
| SLC19A3 | -2361.0 |
| WASL | -2377.0 |
| HSD3B7 | -2383.0 |
| PFKFB4 | -2384.0 |
| PSMA1 | -2388.0 |
| ALOX15B | -2390.0 |
| RARS1 | -2400.0 |
| FDX2 | -2403.5 |
| RRM2B | -2406.0 |
| FADS2 | -2411.0 |
| CERT1 | -2435.0 |
| LGMN | -2445.0 |
| CERS2 | -2467.0 |
| RPS18 | -2478.0 |
| SPTLC2 | -2485.0 |
| CKB | -2496.0 |
| GLUL | -2505.0 |
| XYLB | -2515.0 |
| MTMR10 | -2519.0 |
| B3GNT3 | -2523.0 |
| HSD17B2 | -2550.0 |
| B4GALT5 | -2557.0 |
| PLEKHA8 | -2559.0 |
| MAN2C1 | -2560.0 |
| PSMA7 | -2576.0 |
| RPL8 | -2587.0 |
| STARD6 | -2592.0 |
| PLD2 | -2600.0 |
| ACOT4 | -2617.0 |
| GPC6 | -2630.0 |
| ME2 | -2641.0 |
| NMNAT2 | -2651.0 |
| PLA2G5 | -2658.0 |
| GPAT2 | -2660.0 |
| SMPD3 | -2703.0 |
| CYP24A1 | -2704.0 |
| PIK3CA | -2711.0 |
| UGDH | -2712.0 |
| FAR2 | -2715.0 |
| MINPP1 | -2737.0 |
| RPL7 | -2750.0 |
| CEPT1 | -2753.0 |
| LRP2 | -2756.0 |
| PIK3C2A | -2762.0 |
| TBL1XR1 | -2764.0 |
| BCAN | -2767.0 |
| CYP2R1 | -2805.0 |
| SLC26A2 | -2832.0 |
| CYP2F1 | -2838.0 |
| MMADHC | -2847.0 |
| SREBF2 | -2861.0 |
| RAP1A | -2869.0 |
| HSD17B13 | -2870.0 |
| NUP88 | -2879.0 |
| CTRB1 | -2885.5 |
| CTRB2 | -2885.5 |
| AHRR | -2888.0 |
| LIPT1 | -2889.0 |
| ACAD11 | -2890.0 |
| BRIP1 | -2904.0 |
| CPNE3 | -2918.0 |
| PIP4K2B | -2963.0 |
| CHST11 | -2967.0 |
| GNG5 | -2972.0 |
| ACSM3 | -2985.0 |
| ENTPD2 | -2996.0 |
| HSCB | -3003.0 |
| PLA2G4B | -3004.5 |
| PSMC4 | -3007.0 |
| UROD | -3027.0 |
| NDUFC2 | -3052.5 |
| SMPD4 | -3098.0 |
| SLC6A8 | -3103.5 |
| MT-ND3 | -3112.0 |
| PSMD4 | -3118.0 |
| NUDT3 | -3135.0 |
| ORMDL3 | -3146.0 |
| VAC14 | -3150.0 |
| ALDH6A1 | -3168.0 |
| CSNK2A2 | -3177.0 |
| CHST13 | -3208.0 |
| UQCR11 | -3215.5 |
| PGLS | -3223.0 |
| ACADSB | -3225.0 |
| AGMO | -3234.0 |
| IMPA1 | -3238.0 |
| TKT | -3243.0 |
| BBOX1 | -3284.0 |
| OSBPL10 | -3302.0 |
| UCK1 | -3319.0 |
| NDUFA11 | -3345.5 |
| PSMD6 | -3353.0 |
| NUBPL | -3355.0 |
| PIPOX | -3372.0 |
| NDUFA2 | -3380.0 |
| PEMT | -3381.0 |
| INPP5K | -3389.0 |
| CD320 | -3394.0 |
| NDUFS2 | -3401.0 |
| PTGS2 | -3418.0 |
| PSMC2 | -3419.0 |
| PLD3 | -3441.0 |
| SLC23A1 | -3445.0 |
| MED23 | -3449.0 |
| INPP5D | -3469.0 |
| BCAT2 | -3476.0 |
| DHODH | -3496.0 |
| PI4K2B | -3521.0 |
| RIDA | -3529.0 |
| CACNB3 | -3530.0 |
| TGS1 | -3538.0 |
| MED10 | -3546.0 |
| OCA2 | -3562.0 |
| TTR | -3574.0 |
| HLCS | -3583.0 |
| G6PD | -3588.0 |
| CACNA1A | -3590.0 |
| ASRGL1 | -3599.0 |
| COX7C | -3618.0 |
| AK8 | -3635.0 |
| TNFRSF21 | -3652.0 |
| PSMB3 | -3665.0 |
| SMOX | -3678.0 |
| PIK3R6 | -3686.0 |
| MPST | -3696.0 |
| FAH | -3704.0 |
| GMPR2 | -3708.0 |
| RPS13 | -3718.0 |
| ENPP3 | -3728.0 |
| PPT1 | -3753.0 |
| NME1 | -3770.0 |
| OSBPL5 | -3773.0 |
| SQLE | -3782.0 |
| SULT1A3 | -3792.5 |
| SULT1A4 | -3792.5 |
| PON3 | -3794.0 |
| SDC1 | -3814.0 |
| SERINC2 | -3821.0 |
| RPL10A | -3822.0 |
| AGT | -3831.0 |
| MED29 | -3833.0 |
| SARDH | -3844.0 |
| KMO | -3849.0 |
| PSMD8 | -3851.0 |
| PNMT | -3860.0 |
| PIK3R5 | -3873.0 |
| KYAT1 | -3903.5 |
| RPIA | -3910.0 |
| FUT10 | -3918.0 |
| AWAT2 | -3928.0 |
| TK2 | -3952.0 |
| CARNMT1 | -3953.0 |
| ENTPD7 | -3961.0 |
| ADIPOR2 | -3965.0 |
| RPL3 | -3968.0 |
| NAT1 | -3974.5 |
| NAT2 | -3974.5 |
| GLYCTK | -3989.0 |
| MED22 | -3992.0 |
| ACAD8 | -3994.0 |
| UQCR10 | -3998.0 |
| XYLT1 | -4000.0 |
| FADS1 | -4018.0 |
| RPSA | -4027.0 |
| CMBL | -4036.0 |
| SECISBP2 | -4050.0 |
| PSMD14 | -4055.0 |
| NRF1 | -4104.0 |
| ARF1 | -4106.0 |
| SPTSSA | -4118.0 |
| HS3ST5 | -4128.0 |
| CSNK2A1 | -4141.5 |
| CCNC | -4162.0 |
| PRPS2 | -4167.0 |
| ALPI | -4177.0 |
| PDSS1 | -4194.0 |
| ALOX15 | -4198.0 |
| SCLY | -4215.0 |
| ASL | -4221.5 |
| SLC25A21 | -4239.0 |
| GLB1L | -4268.0 |
| COQ10B | -4282.0 |
| PHOSPHO1 | -4283.0 |
| PLA2G4A | -4306.0 |
| STS | -4310.0 |
| ADHFE1 | -4312.0 |
| CARNS1 | -4324.0 |
| HAS1 | -4328.0 |
| VKORC1 | -4349.0 |
| HMGCLL1 | -4359.0 |
| SMARCD3 | -4369.0 |
| RPS6 | -4373.0 |
| DARS1 | -4385.0 |
| PLAAT5 | -4389.0 |
| RPL13 | -4424.0 |
| CYP39A1 | -4425.0 |
| N6AMT1 | -4431.0 |
| SDC2 | -4440.0 |
| HACD2 | -4442.0 |
| LMBRD1 | -4449.0 |
| RPL35A | -4460.0 |
| RRM2 | -4468.0 |
| PHKG1 | -4479.0 |
| SEC24D | -4488.0 |
| GNA15 | -4495.0 |
| GNG3 | -4499.0 |
| NADSYN1 | -4517.0 |
| GCLC | -4521.0 |
| OAZ1 | -4538.0 |
| MAT1A | -4559.0 |
| HMMR | -4596.0 |
| FECH | -4603.0 |
| NSDHL | -4612.0 |
| NUP35 | -4632.0 |
| NUP107 | -4634.0 |
| EEFSEC | -4655.0 |
| AK9 | -4676.0 |
| MTF1 | -4679.0 |
| PLPP2 | -4680.0 |
| DSEL | -4682.0 |
| NMRK1 | -4705.0 |
| MTHFR | -4706.0 |
| ABCC8 | -4720.0 |
| MED4 | -4721.0 |
| ACSL4 | -4736.0 |
| DAO | -4749.0 |
| ADCY2 | -4754.0 |
| PLPP1 | -4758.0 |
| GYS2 | -4766.0 |
| ITPKC | -4772.0 |
| GLIPR1 | -4774.0 |
| ESYT2 | -4775.0 |
| APOA1 | -4811.0 |
| ST6GALNAC6 | -4815.5 |
| B4GALNT1 | -4824.0 |
| NDUFAF5 | -4827.0 |
| FAU | -4829.0 |
| PGM1 | -4856.0 |
| MTHFS | -4859.5 |
| CYP26A1 | -4873.0 |
| GPI | -4891.0 |
| CHPF | -4909.0 |
| NUP54 | -4913.0 |
| CYP27B1 | -4916.0 |
| ARSK | -4920.0 |
| PIK3CG | -4924.0 |
| MTHFD2 | -4932.0 |
| MED24 | -4941.0 |
| DDO | -4966.0 |
| LPCAT2 | -4982.0 |
| MARCKS | -5000.0 |
| ACOT9 | -5006.0 |
| UQCRB | -5007.0 |
| ADCY1 | -5008.0 |
| CBR4 | -5009.0 |
| CHSY3 | -5014.0 |
| NUDT15 | -5027.0 |
| MBOAT1 | -5042.0 |
| HSD17B7 | -5043.0 |
| LRP1 | -5044.0 |
| SLC16A8 | -5046.0 |
| SGPL1 | -5047.0 |
| PSMA2 | -5050.5 |
| PCK1 | -5060.0 |
| ENO3 | -5070.0 |
| PSMA3 | -5078.0 |
| GRHL1 | -5079.0 |
| SLC22A13 | -5093.0 |
| RPL19 | -5108.0 |
| SLC35B3 | -5115.0 |
| CA6 | -5117.0 |
| FASN | -5133.0 |
| NOSIP | -5142.0 |
| MED6 | -5143.0 |
| UQCRH | -5150.5 |
| NUP42 | -5168.0 |
| PTDSS1 | -5228.0 |
| ACP5 | -5237.0 |
| CKM | -5253.0 |
| AGL | -5258.0 |
| SLC44A3 | -5267.0 |
| CYP2E1 | -5268.0 |
| MED28 | -5278.0 |
| VNN1 | -5284.0 |
| GNPDA2 | -5305.0 |
| PARP8 | -5316.0 |
| TMEM126B | -5318.0 |
| PYGM | -5322.0 |
| PRKD3 | -5324.0 |
| ITPKA | -5325.0 |
| MSMO1 | -5327.0 |
| DHCR7 | -5329.0 |
| AASDHPPT | -5346.0 |
| DCN | -5361.0 |
| CHKA | -5389.0 |
| RBKS | -5394.0 |
| PLA1A | -5396.0 |
| GSTM3 | -5409.0 |
| PSMD5 | -5412.0 |
| MED21 | -5422.0 |
| OGN | -5441.0 |
| PGS1 | -5459.0 |
| MTMR7 | -5471.0 |
| RPL37A | -5473.0 |
| CTPS2 | -5477.0 |
| TXN | -5519.0 |
| CSGALNACT1 | -5528.0 |
| SEC13 | -5544.0 |
| DPEP2 | -5556.0 |
| B3GNT2 | -5587.0 |
| LPCAT3 | -5589.0 |
| QPRT | -5597.0 |
| PSMB4 | -5607.0 |
| RPS19 | -5609.0 |
| NUP160 | -5641.0 |
| SLC25A17 | -5644.0 |
| SLC27A3 | -5657.0 |
| PIKFYVE | -5658.0 |
| PLA2G2D | -5665.0 |
| RNLS | -5667.0 |
| TPK1 | -5669.0 |
| KERA | -5674.0 |
| UST | -5678.0 |
| NMNAT3 | -5680.0 |
| ATP5MG | -5696.5 |
| PCTP | -5715.0 |
| HS2ST1 | -5747.5 |
| RPL5 | -5749.0 |
| PI4KB | -5750.0 |
| PLD1 | -5751.0 |
| ARNT2 | -5773.0 |
| AADAT | -5792.0 |
| AMD1 | -5826.0 |
| CYP26C1 | -5829.0 |
| AMPD1 | -5835.0 |
| FABP4 | -5849.0 |
| GPCPD1 | -5855.0 |
| RPS23 | -5865.0 |
| TNFAIP8L2 | -5866.0 |
| RPL35 | -5900.0 |
| FMOD | -5918.0 |
| G0S2 | -5922.0 |
| PSMB1 | -5931.0 |
| PDP1 | -5939.0 |
| RPL28 | -5981.0 |
| RPS4X | -6019.0 |
| GNAS | -6021.0 |
| PGAM2 | -6024.0 |
| RPL15 | -6030.0 |
| B3GALT4 | -6036.0 |
| ALDH1A1 | -6037.0 |
| IDS | -6043.5 |
| MED27 | -6062.0 |
| THRSP | -6068.0 |
| DGUOK | -6071.0 |
| PPP1R3C | -6072.0 |
| DUT | -6073.0 |
| RORA | -6076.0 |
| CMPK1 | -6086.0 |
| PCYT1B | -6101.0 |
| OAZ2 | -6139.0 |
| PIK3CD | -6147.0 |
| RPL30 | -6152.0 |
| NMRK2 | -6159.0 |
| FBP2 | -6162.0 |
| FOLR2 | -6185.0 |
| DDHD2 | -6193.0 |
| RPL23 | -6194.0 |
| ZDHHC21 | -6207.0 |
| EXT1 | -6236.0 |
| PSMB7 | -6252.0 |
| EXT2 | -6253.0 |
| CA9 | -6259.0 |
| PGM2L1 | -6262.0 |
| AGXT | -6265.0 |
| AACS | -6268.0 |
| ASMT | -6271.0 |
| RPLP2 | -6273.0 |
| LDLR | -6289.0 |
| LTC4S | -6307.0 |
| INSIG1 | -6310.0 |
| PRKACB | -6340.0 |
| ABCA1 | -6344.0 |
| RPL36 | -6366.0 |
| ENPP6 | -6377.0 |
| PEX11A | -6415.0 |
| PLA2R1 | -6447.0 |
| SEPSECS | -6470.0 |
| PLD4 | -6472.0 |
| ECI2 | -6476.0 |
| ADCY7 | -6487.0 |
| OAT | -6490.0 |
| MED31 | -6496.0 |
| MTMR6 | -6513.0 |
| HPGD | -6516.0 |
| SDSL | -6518.0 |
| SLC25A1 | -6520.0 |
| COX16 | -6527.0 |
| SAR1B | -6531.0 |
| MOCS1 | -6532.0 |
| HACD1 | -6539.0 |
| STARD4 | -6556.0 |
| MLX | -6572.0 |
| PSMC5 | -6575.0 |
| ADIPOR1 | -6590.0 |
| PTS | -6591.0 |
| TBXAS1 | -6596.0 |
| RPS8 | -6597.0 |
| GCLM | -6619.0 |
| CUBN | -6631.0 |
| GM2A | -6634.0 |
| IP6K2 | -6646.0 |
| RPLP1 | -6661.0 |
| CALM1 | -6675.0 |
| GBA | -6677.0 |
| RPL18A | -6679.0 |
| GPD1 | -6680.0 |
| RPL18 | -6689.0 |
| RPS26 | -6692.0 |
| GLS | -6702.0 |
| AOX1 | -6706.0 |
| SLC16A3 | -6714.0 |
| PTGES3 | -6729.0 |
| TMLHE | -6738.0 |
| GAPDHS | -6739.0 |
| NUP43 | -6740.0 |
| GPD2 | -6755.0 |
| ACSL3 | -6761.0 |
| PYGL | -6766.0 |
| CDO1 | -6767.0 |
| PRELP | -6795.0 |
| CD44 | -6801.0 |
| SBF2 | -6804.0 |
| ALDOA | -6806.0 |
| GGT6 | -6808.0 |
| RPS10 | -6822.5 |
| ST3GAL1 | -6845.0 |
| LUM | -6863.0 |
| AKR1A1 | -6866.0 |
| ABCC5 | -6870.0 |
| GDPD5 | -6872.0 |
| PFAS | -6896.0 |
| RPL6 | -6916.0 |
| PRKAG2 | -6923.0 |
| DCTPP1 | -6925.0 |
| HPGDS | -6927.0 |
| NDUFB3 | -6948.0 |
| NNMT | -6950.0 |
| FPGS | -6953.0 |
| ESD | -6972.0 |
| PPP2R1B | -6978.0 |
| PSMB6 | -6996.0 |
| DTYMK | -6999.0 |
| PRKAR2A | -7003.0 |
| TPST1 | -7010.0 |
| RPL32 | -7023.0 |
| CH25H | -7050.0 |
| RPL24 | -7065.0 |
| PIK3C2B | -7081.0 |
| AK1 | -7082.0 |
| GLO1 | -7083.0 |
| PRKCA | -7092.0 |
| CERS6 | -7111.0 |
| HPRT1 | -7123.0 |
| ALDH1L2 | -7133.0 |
| HAS2 | -7148.0 |
| GSTA5 | -7174.0 |
| NFYA | -7197.0 |
| CTPS1 | -7200.0 |
| NUP205 | -7210.0 |
| BLVRA | -7225.0 |
| GSTM1 | -7232.0 |
| HDC | -7234.0 |
| NUP214 | -7243.0 |
| AK5 | -7249.0 |
| PSMA6 | -7250.0 |
| MBTPS1 | -7280.0 |
| RPL13A | -7282.0 |
| MAT2A | -7283.0 |
| GSTZ1 | -7293.0 |
| RPL38 | -7298.0 |
| CYP4F8 | -7313.0 |
| RPS14 | -7325.0 |
| HAS3 | -7330.0 |
| ARSI | -7339.0 |
| FUT7 | -7349.0 |
| GLRX | -7364.0 |
| MTRR | -7367.0 |
| CIDEC | -7371.0 |
| RPS11 | -7379.0 |
| PYCR1 | -7391.0 |
| PSMA4 | -7394.0 |
| LDHA | -7395.0 |
| VAPA | -7396.0 |
| LPIN1 | -7406.0 |
| RANBP2 | -7410.0 |
| MED26 | -7415.5 |
| SAT1 | -7423.0 |
| APIP | -7433.0 |
| MAOA | -7453.0 |
| PNPLA3 | -7463.0 |
| PPARGC1B | -7464.0 |
| PKM | -7469.0 |
| ARNT | -7477.0 |
| OSBPL7 | -7479.0 |
| SHMT1 | -7480.0 |
| GAMT | -7485.0 |
| IDI1 | -7502.0 |
| ACSBG1 | -7512.0 |
| ARNTL | -7523.0 |
| ASAH2 | -7526.0 |
| MTR | -7527.0 |
| OCRL | -7541.0 |
| DDAH2 | -7547.0 |
| RPS15 | -7548.0 |
| SLC37A4 | -7558.0 |
| UGP2 | -7573.0 |
| COX19 | -7585.0 |
| NFYB | -7587.0 |
| TPI1 | -7603.0 |
| ALOX5AP | -7609.0 |
| IL4I1 | -7612.0 |
| BCO2 | -7616.0 |
| STARD10 | -7620.0 |
| PGK1 | -7636.0 |
| RPS27A | -7640.0 |
| CACNA1E | -7644.0 |
| RPS5 | -7648.0 |
| OMD | -7649.0 |
| PRKAB2 | -7660.0 |
| AZIN1 | -7688.0 |
| HOGA1 | -7689.0 |
| PM20D1 | -7706.0 |
| SEC23A | -7718.0 |
| AMPD2 | -7721.0 |
| MANBA | -7725.0 |
| CACNA1C | -7730.0 |
| CYP2J2 | -7731.0 |
| PITPNB | -7740.0 |
| CYP2D6 | -7746.5 |
| CYP4F3 | -7751.0 |
| RPS21 | -7764.0 |
| PLCD4 | -7765.0 |
| SLC25A32 | -7766.5 |
| RPL29 | -7770.0 |
| MOCOS | -7784.0 |
| BCAT1 | -7785.0 |
| PLCH1 | -7799.0 |
| RPS28 | -7809.0 |
| GSTT2 | -7816.5 |
| GSTT2B | -7816.5 |
| MED12 | -7822.0 |
| ABCC3 | -7823.0 |
| PNPLA8 | -7824.0 |
| ETNK2 | -7825.0 |
| NEU2 | -7830.0 |
| CYP7B1 | -7839.0 |
| PSAT1 | -7845.0 |
| TST | -7850.0 |
| PPAT | -7851.0 |
| DUOX1 | -7858.0 |
| NPAS2 | -7864.0 |
| GPT2 | -7865.0 |
| HSD17B12 | -7912.0 |
| RPS3A | -7929.0 |
| BPGM | -7934.0 |
| ADIPOQ | -7940.0 |
| UCK2 | -7942.0 |
| CTRC | -7943.0 |
| SREBF1 | -7944.0 |
| ACACA | -7955.0 |
| CYB5B | -7964.0 |
| ACHE | -7966.0 |
| MED9 | -7970.0 |
| ME1 | -7972.0 |
| AK6 | -7987.0 |
| AK7 | -7999.0 |
| ACSM5 | -8005.0 |
| GAPDH | -8006.0 |
| OSBPL8 | -8008.0 |
| DHRS7B | -8015.0 |
| PHKB | -8035.0 |
| RTEL1 | -8038.5 |
| PPA1 | -8054.0 |
| FLVCR1 | -8055.0 |
| MOCS2 | -8058.0 |
| DSE | -8059.5 |
| AKR1B10 | -8061.0 |
| ACAN | -8071.0 |
| ALOX5 | -8075.0 |
| GRHPR | -8084.0 |
| ATP5F1E | -8086.0 |
| ASPA | -8103.0 |
| ENPP2 | -8119.0 |
| CLOCK | -8141.0 |
| PLIN1 | -8142.0 |
| SEC24A | -8147.0 |
| SLC6A7 | -8151.0 |
| VCAN | -8165.0 |
| PRKAR2B | -8171.0 |
| PHKA1 | -8179.0 |
| CROT | -8187.0 |
| FAR1 | -8198.0 |
| GPX4 | -8221.0 |
| RPS17 | -8231.0 |
| RPS16 | -8246.0 |
| RPE | -8252.5 |
| RPEL1 | -8252.5 |
| MED14 | -8255.0 |
| UGT1A1 | -8268.0 |
| CES1 | -8279.0 |
| RPS15A | -8282.0 |
Eukaryotic Translation Elongation
| 363 | |
|---|---|
| set | Eukaryotic Translation Elongation |
| setSize | 63 |
| pANOVA | 2.79e-12 |
| s.dist | -0.509 |
| p.adjustANOVA | 3.92e-10 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| RPS16 | -8246.0 |
| RPS17 | -8231.0 |
| RPS3A | -7929.0 |
| RPS28 | -7809.0 |
| RPL29 | -7770.0 |
| RPS21 | -7764.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| EEF1B2 | -7570.0 |
| RPS15 | -7548.0 |
| RPS11 | -7379.0 |
| RPS14 | -7325.0 |
| RPL38 | -7298.0 |
| RPL13A | -7282.0 |
| RPL24 | -7065.0 |
| RPL32 | -7023.0 |
| RPL6 | -6916.0 |
| RPS10 | -6822.5 |
| RPS26 | -6692.0 |
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| RPS16 | -8246.0 |
| RPS17 | -8231.0 |
| RPS3A | -7929.0 |
| RPS28 | -7809.0 |
| RPL29 | -7770.0 |
| RPS21 | -7764.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| EEF1B2 | -7570.0 |
| RPS15 | -7548.0 |
| RPS11 | -7379.0 |
| RPS14 | -7325.0 |
| RPL38 | -7298.0 |
| RPL13A | -7282.0 |
| RPL24 | -7065.0 |
| RPL32 | -7023.0 |
| RPL6 | -6916.0 |
| RPS10 | -6822.5 |
| RPS26 | -6692.0 |
| RPL18 | -6689.0 |
| RPL18A | -6679.0 |
| RPLP1 | -6661.0 |
| RPS8 | -6597.0 |
| RPL36 | -6366.0 |
| RPLP2 | -6273.0 |
| RPL23 | -6194.0 |
| RPL30 | -6152.0 |
| RPL15 | -6030.0 |
| RPS4X | -6019.0 |
| RPL28 | -5981.0 |
| RPL35 | -5900.0 |
| RPS23 | -5865.0 |
| RPL5 | -5749.0 |
| RPS19 | -5609.0 |
| RPL37A | -5473.0 |
| RPL19 | -5108.0 |
| FAU | -4829.0 |
| RPL35A | -4460.0 |
| RPL13 | -4424.0 |
| RPS6 | -4373.0 |
| RPSA | -4027.0 |
| RPL3 | -3968.0 |
| RPL10A | -3822.0 |
| RPS13 | -3718.0 |
| RPL7 | -2750.0 |
| RPL8 | -2587.0 |
| RPS18 | -2478.0 |
| EEF1A1 | -1278.0 |
| RPL23A | -1088.0 |
| RPL31 | -303.0 |
| RPS2 | -219.0 |
| RPS27L | 522.0 |
| RPL27 | 706.0 |
| EEF1D | 748.0 |
| RPL7A | 1400.0 |
| RPL37 | 2677.0 |
| EEF1G | 3002.0 |
| RPS9 | 3031.0 |
| RPS3 | 3136.0 |
| RPL3L | 4494.0 |
| RPL22 | 5158.0 |
| EEF2 | 6302.0 |
Cap-dependent Translation Initiation
| 149 | |
|---|---|
| set | Cap-dependent Translation Initiation |
| setSize | 87 |
| pANOVA | 9.53e-12 |
| s.dist | -0.423 |
| p.adjustANOVA | 1.12e-09 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| RPS16 | -8246.0 |
| RPS17 | -8231.0 |
| EIF2B1 | -8218.0 |
| RPS3A | -7929.0 |
| RPS28 | -7809.0 |
| RPL29 | -7770.0 |
| RPS21 | -7764.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| RPS15 | -7548.0 |
| RPS11 | -7379.0 |
| RPS14 | -7325.0 |
| RPL38 | -7298.0 |
| RPL13A | -7282.0 |
| RPL24 | -7065.0 |
| RPL32 | -7023.0 |
| EIF2S1 | -7018.0 |
| RPL6 | -6916.0 |
| RPS10 | -6822.5 |
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| RPS16 | -8246.0 |
| RPS17 | -8231.0 |
| EIF2B1 | -8218.0 |
| RPS3A | -7929.0 |
| RPS28 | -7809.0 |
| RPL29 | -7770.0 |
| RPS21 | -7764.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| RPS15 | -7548.0 |
| RPS11 | -7379.0 |
| RPS14 | -7325.0 |
| RPL38 | -7298.0 |
| RPL13A | -7282.0 |
| RPL24 | -7065.0 |
| RPL32 | -7023.0 |
| EIF2S1 | -7018.0 |
| RPL6 | -6916.0 |
| RPS10 | -6822.5 |
| RPS26 | -6692.0 |
| RPL18 | -6689.0 |
| RPL18A | -6679.0 |
| RPLP1 | -6661.0 |
| RPS8 | -6597.0 |
| EIF4EBP1 | -6482.0 |
| EIF2S2 | -6402.0 |
| RPL36 | -6366.0 |
| RPLP2 | -6273.0 |
| RPL23 | -6194.0 |
| RPL30 | -6152.0 |
| RPL15 | -6030.0 |
| RPS4X | -6019.0 |
| RPL28 | -5981.0 |
| EIF4A2 | -5979.0 |
| RPL35 | -5900.0 |
| EIF3M | -5875.0 |
| RPS23 | -5865.0 |
| EIF2S3 | -5766.5 |
| RPL5 | -5749.0 |
| RPS19 | -5609.0 |
| RPL37A | -5473.0 |
| EIF3K | -5288.0 |
| RPL19 | -5108.0 |
| EIF5 | -4910.0 |
| FAU | -4829.0 |
| EIF2B5 | -4627.0 |
| RPL35A | -4460.0 |
| RPL13 | -4424.0 |
| RPS6 | -4373.0 |
| RPSA | -4027.0 |
| RPL3 | -3968.0 |
| RPL10A | -3822.0 |
| RPS13 | -3718.0 |
| EIF2B2 | -2977.0 |
| RPL7 | -2750.0 |
| EIF3H | -2613.0 |
| RPL8 | -2587.0 |
| RPS18 | -2478.0 |
| EIF5B | -2410.0 |
| EIF3E | -1890.0 |
| EIF3G | -1499.0 |
| RPL23A | -1088.0 |
| EIF3J | -866.0 |
| RPL31 | -303.0 |
| RPS2 | -219.0 |
| EIF4A1 | -181.0 |
| EIF3B | -78.0 |
| EIF4E | -29.0 |
| EIF3A | -12.0 |
| RPS27L | 522.0 |
| RPL27 | 706.0 |
| RPL7A | 1400.0 |
| EIF3C | 1656.5 |
| EIF3D | 2550.0 |
| RPL37 | 2677.0 |
| EIF3L | 2985.0 |
| RPS9 | 3031.0 |
| RPS3 | 3136.0 |
| EIF2B3 | 3266.0 |
| EIF1AX | 3460.0 |
| EIF2B4 | 3594.0 |
| EIF4G1 | 4151.0 |
| RPL3L | 4494.0 |
| RPL22 | 5158.0 |
| EIF3F | 5628.0 |
| EIF4H | 7514.0 |
Eukaryotic Translation Initiation
| 364 | |
|---|---|
| set | Eukaryotic Translation Initiation |
| setSize | 87 |
| pANOVA | 9.53e-12 |
| s.dist | -0.423 |
| p.adjustANOVA | 1.12e-09 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| RPS16 | -8246.0 |
| RPS17 | -8231.0 |
| EIF2B1 | -8218.0 |
| RPS3A | -7929.0 |
| RPS28 | -7809.0 |
| RPL29 | -7770.0 |
| RPS21 | -7764.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| RPS15 | -7548.0 |
| RPS11 | -7379.0 |
| RPS14 | -7325.0 |
| RPL38 | -7298.0 |
| RPL13A | -7282.0 |
| RPL24 | -7065.0 |
| RPL32 | -7023.0 |
| EIF2S1 | -7018.0 |
| RPL6 | -6916.0 |
| RPS10 | -6822.5 |
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| RPS16 | -8246.0 |
| RPS17 | -8231.0 |
| EIF2B1 | -8218.0 |
| RPS3A | -7929.0 |
| RPS28 | -7809.0 |
| RPL29 | -7770.0 |
| RPS21 | -7764.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| RPS15 | -7548.0 |
| RPS11 | -7379.0 |
| RPS14 | -7325.0 |
| RPL38 | -7298.0 |
| RPL13A | -7282.0 |
| RPL24 | -7065.0 |
| RPL32 | -7023.0 |
| EIF2S1 | -7018.0 |
| RPL6 | -6916.0 |
| RPS10 | -6822.5 |
| RPS26 | -6692.0 |
| RPL18 | -6689.0 |
| RPL18A | -6679.0 |
| RPLP1 | -6661.0 |
| RPS8 | -6597.0 |
| EIF4EBP1 | -6482.0 |
| EIF2S2 | -6402.0 |
| RPL36 | -6366.0 |
| RPLP2 | -6273.0 |
| RPL23 | -6194.0 |
| RPL30 | -6152.0 |
| RPL15 | -6030.0 |
| RPS4X | -6019.0 |
| RPL28 | -5981.0 |
| EIF4A2 | -5979.0 |
| RPL35 | -5900.0 |
| EIF3M | -5875.0 |
| RPS23 | -5865.0 |
| EIF2S3 | -5766.5 |
| RPL5 | -5749.0 |
| RPS19 | -5609.0 |
| RPL37A | -5473.0 |
| EIF3K | -5288.0 |
| RPL19 | -5108.0 |
| EIF5 | -4910.0 |
| FAU | -4829.0 |
| EIF2B5 | -4627.0 |
| RPL35A | -4460.0 |
| RPL13 | -4424.0 |
| RPS6 | -4373.0 |
| RPSA | -4027.0 |
| RPL3 | -3968.0 |
| RPL10A | -3822.0 |
| RPS13 | -3718.0 |
| EIF2B2 | -2977.0 |
| RPL7 | -2750.0 |
| EIF3H | -2613.0 |
| RPL8 | -2587.0 |
| RPS18 | -2478.0 |
| EIF5B | -2410.0 |
| EIF3E | -1890.0 |
| EIF3G | -1499.0 |
| RPL23A | -1088.0 |
| EIF3J | -866.0 |
| RPL31 | -303.0 |
| RPS2 | -219.0 |
| EIF4A1 | -181.0 |
| EIF3B | -78.0 |
| EIF4E | -29.0 |
| EIF3A | -12.0 |
| RPS27L | 522.0 |
| RPL27 | 706.0 |
| RPL7A | 1400.0 |
| EIF3C | 1656.5 |
| EIF3D | 2550.0 |
| RPL37 | 2677.0 |
| EIF3L | 2985.0 |
| RPS9 | 3031.0 |
| RPS3 | 3136.0 |
| EIF2B3 | 3266.0 |
| EIF1AX | 3460.0 |
| EIF2B4 | 3594.0 |
| EIF4G1 | 4151.0 |
| RPL3L | 4494.0 |
| RPL22 | 5158.0 |
| EIF3F | 5628.0 |
| EIF4H | 7514.0 |
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
| 765 | |
|---|---|
| set | Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) |
| setSize | 65 |
| pANOVA | 1.98e-11 |
| s.dist | -0.481 |
| p.adjustANOVA | 2.01e-09 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| RPS16 | -8246.0 |
| RPS17 | -8231.0 |
| RPS3A | -7929.0 |
| RPS28 | -7809.0 |
| RPL29 | -7770.0 |
| RPS21 | -7764.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| RPS15 | -7548.0 |
| RPS11 | -7379.0 |
| RPS14 | -7325.0 |
| RPL38 | -7298.0 |
| RPL13A | -7282.0 |
| RPL24 | -7065.0 |
| RPL32 | -7023.0 |
| RPL6 | -6916.0 |
| RPS10 | -6822.5 |
| RPS26 | -6692.0 |
| RPL18 | -6689.0 |
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| RPS16 | -8246.0 |
| RPS17 | -8231.0 |
| RPS3A | -7929.0 |
| RPS28 | -7809.0 |
| RPL29 | -7770.0 |
| RPS21 | -7764.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| RPS15 | -7548.0 |
| RPS11 | -7379.0 |
| RPS14 | -7325.0 |
| RPL38 | -7298.0 |
| RPL13A | -7282.0 |
| RPL24 | -7065.0 |
| RPL32 | -7023.0 |
| RPL6 | -6916.0 |
| RPS10 | -6822.5 |
| RPS26 | -6692.0 |
| RPL18 | -6689.0 |
| RPL18A | -6679.0 |
| RPLP1 | -6661.0 |
| RPS8 | -6597.0 |
| RPL36 | -6366.0 |
| RPLP2 | -6273.0 |
| RPL23 | -6194.0 |
| RPL30 | -6152.0 |
| RPL15 | -6030.0 |
| RPS4X | -6019.0 |
| RPL28 | -5981.0 |
| RPL35 | -5900.0 |
| RPS23 | -5865.0 |
| RPL5 | -5749.0 |
| RPS19 | -5609.0 |
| RPL37A | -5473.0 |
| RPL19 | -5108.0 |
| FAU | -4829.0 |
| GSPT2 | -4504.0 |
| RPL35A | -4460.0 |
| RPL13 | -4424.0 |
| RPS6 | -4373.0 |
| ETF1 | -4323.0 |
| RPSA | -4027.0 |
| RPL3 | -3968.0 |
| RPL10A | -3822.0 |
| RPS13 | -3718.0 |
| NCBP1 | -3144.0 |
| RPL7 | -2750.0 |
| RPL8 | -2587.0 |
| RPS18 | -2478.0 |
| RPL23A | -1088.0 |
| RPL31 | -303.0 |
| RPS2 | -219.0 |
| RPS27L | 522.0 |
| RPL27 | 706.0 |
| NCBP2 | 898.0 |
| RPL7A | 1400.0 |
| RPL37 | 2677.0 |
| RPS9 | 3031.0 |
| RPS3 | 3136.0 |
| EIF4G1 | 4151.0 |
| RPL3L | 4494.0 |
| RPL22 | 5158.0 |
| GSPT1 | 6438.0 |
| UPF1 | 8167.0 |
GTP hydrolysis and joining of the 60S ribosomal subunit
| 456 | |
|---|---|
| set | GTP hydrolysis and joining of the 60S ribosomal subunit |
| setSize | 81 |
| pANOVA | 2e-11 |
| s.dist | -0.431 |
| p.adjustANOVA | 2.01e-09 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| RPS16 | -8246.0 |
| RPS17 | -8231.0 |
| RPS3A | -7929.0 |
| RPS28 | -7809.0 |
| RPL29 | -7770.0 |
| RPS21 | -7764.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| RPS15 | -7548.0 |
| RPS11 | -7379.0 |
| RPS14 | -7325.0 |
| RPL38 | -7298.0 |
| RPL13A | -7282.0 |
| RPL24 | -7065.0 |
| RPL32 | -7023.0 |
| EIF2S1 | -7018.0 |
| RPL6 | -6916.0 |
| RPS10 | -6822.5 |
| RPS26 | -6692.0 |
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| RPS16 | -8246.0 |
| RPS17 | -8231.0 |
| RPS3A | -7929.0 |
| RPS28 | -7809.0 |
| RPL29 | -7770.0 |
| RPS21 | -7764.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| RPS15 | -7548.0 |
| RPS11 | -7379.0 |
| RPS14 | -7325.0 |
| RPL38 | -7298.0 |
| RPL13A | -7282.0 |
| RPL24 | -7065.0 |
| RPL32 | -7023.0 |
| EIF2S1 | -7018.0 |
| RPL6 | -6916.0 |
| RPS10 | -6822.5 |
| RPS26 | -6692.0 |
| RPL18 | -6689.0 |
| RPL18A | -6679.0 |
| RPLP1 | -6661.0 |
| RPS8 | -6597.0 |
| EIF2S2 | -6402.0 |
| RPL36 | -6366.0 |
| RPLP2 | -6273.0 |
| RPL23 | -6194.0 |
| RPL30 | -6152.0 |
| RPL15 | -6030.0 |
| RPS4X | -6019.0 |
| RPL28 | -5981.0 |
| EIF4A2 | -5979.0 |
| RPL35 | -5900.0 |
| EIF3M | -5875.0 |
| RPS23 | -5865.0 |
| EIF2S3 | -5766.5 |
| RPL5 | -5749.0 |
| RPS19 | -5609.0 |
| RPL37A | -5473.0 |
| EIF3K | -5288.0 |
| RPL19 | -5108.0 |
| EIF5 | -4910.0 |
| FAU | -4829.0 |
| RPL35A | -4460.0 |
| RPL13 | -4424.0 |
| RPS6 | -4373.0 |
| RPSA | -4027.0 |
| RPL3 | -3968.0 |
| RPL10A | -3822.0 |
| RPS13 | -3718.0 |
| RPL7 | -2750.0 |
| EIF3H | -2613.0 |
| RPL8 | -2587.0 |
| RPS18 | -2478.0 |
| EIF5B | -2410.0 |
| EIF3E | -1890.0 |
| EIF3G | -1499.0 |
| RPL23A | -1088.0 |
| EIF3J | -866.0 |
| RPL31 | -303.0 |
| RPS2 | -219.0 |
| EIF4A1 | -181.0 |
| EIF3B | -78.0 |
| EIF4E | -29.0 |
| EIF3A | -12.0 |
| RPS27L | 522.0 |
| RPL27 | 706.0 |
| RPL7A | 1400.0 |
| EIF3C | 1656.5 |
| EIF3D | 2550.0 |
| RPL37 | 2677.0 |
| EIF3L | 2985.0 |
| RPS9 | 3031.0 |
| RPS3 | 3136.0 |
| EIF1AX | 3460.0 |
| EIF4G1 | 4151.0 |
| RPL3L | 4494.0 |
| RPL22 | 5158.0 |
| EIF3F | 5628.0 |
| EIF4H | 7514.0 |
Formation of a pool of free 40S subunits
| 415 | |
|---|---|
| set | Formation of a pool of free 40S subunits |
| setSize | 71 |
| pANOVA | 2.96e-11 |
| s.dist | -0.456 |
| p.adjustANOVA | 2.77e-09 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| RPS16 | -8246.0 |
| RPS17 | -8231.0 |
| RPS3A | -7929.0 |
| RPS28 | -7809.0 |
| RPL29 | -7770.0 |
| RPS21 | -7764.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| RPS15 | -7548.0 |
| RPS11 | -7379.0 |
| RPS14 | -7325.0 |
| RPL38 | -7298.0 |
| RPL13A | -7282.0 |
| RPL24 | -7065.0 |
| RPL32 | -7023.0 |
| RPL6 | -6916.0 |
| RPS10 | -6822.5 |
| RPS26 | -6692.0 |
| RPL18 | -6689.0 |
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| RPS16 | -8246.0 |
| RPS17 | -8231.0 |
| RPS3A | -7929.0 |
| RPS28 | -7809.0 |
| RPL29 | -7770.0 |
| RPS21 | -7764.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| RPS15 | -7548.0 |
| RPS11 | -7379.0 |
| RPS14 | -7325.0 |
| RPL38 | -7298.0 |
| RPL13A | -7282.0 |
| RPL24 | -7065.0 |
| RPL32 | -7023.0 |
| RPL6 | -6916.0 |
| RPS10 | -6822.5 |
| RPS26 | -6692.0 |
| RPL18 | -6689.0 |
| RPL18A | -6679.0 |
| RPLP1 | -6661.0 |
| RPS8 | -6597.0 |
| RPL36 | -6366.0 |
| RPLP2 | -6273.0 |
| RPL23 | -6194.0 |
| RPL30 | -6152.0 |
| RPL15 | -6030.0 |
| RPS4X | -6019.0 |
| RPL28 | -5981.0 |
| RPL35 | -5900.0 |
| EIF3M | -5875.0 |
| RPS23 | -5865.0 |
| RPL5 | -5749.0 |
| RPS19 | -5609.0 |
| RPL37A | -5473.0 |
| EIF3K | -5288.0 |
| RPL19 | -5108.0 |
| FAU | -4829.0 |
| RPL35A | -4460.0 |
| RPL13 | -4424.0 |
| RPS6 | -4373.0 |
| RPSA | -4027.0 |
| RPL3 | -3968.0 |
| RPL10A | -3822.0 |
| RPS13 | -3718.0 |
| RPL7 | -2750.0 |
| EIF3H | -2613.0 |
| RPL8 | -2587.0 |
| RPS18 | -2478.0 |
| EIF3E | -1890.0 |
| EIF3G | -1499.0 |
| RPL23A | -1088.0 |
| EIF3J | -866.0 |
| RPL31 | -303.0 |
| RPS2 | -219.0 |
| EIF3B | -78.0 |
| EIF3A | -12.0 |
| RPS27L | 522.0 |
| RPL27 | 706.0 |
| RPL7A | 1400.0 |
| EIF3C | 1656.5 |
| EIF3D | 2550.0 |
| RPL37 | 2677.0 |
| EIF3L | 2985.0 |
| RPS9 | 3031.0 |
| RPS3 | 3136.0 |
| EIF1AX | 3460.0 |
| RPL3L | 4494.0 |
| RPL22 | 5158.0 |
| EIF3F | 5628.0 |
L13a-mediated translational silencing of Ceruloplasmin expression
| 610 | |
|---|---|
| set | L13a-mediated translational silencing of Ceruloplasmin expression |
| setSize | 79 |
| pANOVA | 3.62e-11 |
| s.dist | -0.431 |
| p.adjustANOVA | 3.18e-09 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| RPS16 | -8246.0 |
| RPS17 | -8231.0 |
| RPS3A | -7929.0 |
| RPS28 | -7809.0 |
| RPL29 | -7770.0 |
| RPS21 | -7764.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| RPS15 | -7548.0 |
| RPS11 | -7379.0 |
| RPS14 | -7325.0 |
| RPL38 | -7298.0 |
| RPL13A | -7282.0 |
| RPL24 | -7065.0 |
| RPL32 | -7023.0 |
| EIF2S1 | -7018.0 |
| RPL6 | -6916.0 |
| RPS10 | -6822.5 |
| RPS26 | -6692.0 |
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| RPS16 | -8246.0 |
| RPS17 | -8231.0 |
| RPS3A | -7929.0 |
| RPS28 | -7809.0 |
| RPL29 | -7770.0 |
| RPS21 | -7764.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| RPS15 | -7548.0 |
| RPS11 | -7379.0 |
| RPS14 | -7325.0 |
| RPL38 | -7298.0 |
| RPL13A | -7282.0 |
| RPL24 | -7065.0 |
| RPL32 | -7023.0 |
| EIF2S1 | -7018.0 |
| RPL6 | -6916.0 |
| RPS10 | -6822.5 |
| RPS26 | -6692.0 |
| RPL18 | -6689.0 |
| RPL18A | -6679.0 |
| RPLP1 | -6661.0 |
| RPS8 | -6597.0 |
| EIF2S2 | -6402.0 |
| RPL36 | -6366.0 |
| RPLP2 | -6273.0 |
| RPL23 | -6194.0 |
| RPL30 | -6152.0 |
| RPL15 | -6030.0 |
| RPS4X | -6019.0 |
| RPL28 | -5981.0 |
| EIF4A2 | -5979.0 |
| RPL35 | -5900.0 |
| EIF3M | -5875.0 |
| RPS23 | -5865.0 |
| EIF2S3 | -5766.5 |
| RPL5 | -5749.0 |
| RPS19 | -5609.0 |
| RPL37A | -5473.0 |
| EIF3K | -5288.0 |
| RPL19 | -5108.0 |
| FAU | -4829.0 |
| RPL35A | -4460.0 |
| RPL13 | -4424.0 |
| RPS6 | -4373.0 |
| RPSA | -4027.0 |
| RPL3 | -3968.0 |
| RPL10A | -3822.0 |
| RPS13 | -3718.0 |
| RPL7 | -2750.0 |
| EIF3H | -2613.0 |
| RPL8 | -2587.0 |
| RPS18 | -2478.0 |
| EIF3E | -1890.0 |
| EIF3G | -1499.0 |
| RPL23A | -1088.0 |
| EIF3J | -866.0 |
| RPL31 | -303.0 |
| RPS2 | -219.0 |
| EIF4A1 | -181.0 |
| EIF3B | -78.0 |
| EIF4E | -29.0 |
| EIF3A | -12.0 |
| RPS27L | 522.0 |
| RPL27 | 706.0 |
| RPL7A | 1400.0 |
| EIF3C | 1656.5 |
| EIF3D | 2550.0 |
| RPL37 | 2677.0 |
| EIF3L | 2985.0 |
| RPS9 | 3031.0 |
| RPS3 | 3136.0 |
| EIF1AX | 3460.0 |
| EIF4G1 | 4151.0 |
| RPL3L | 4494.0 |
| RPL22 | 5158.0 |
| EIF3F | 5628.0 |
| EIF4H | 7514.0 |
The citric acid (TCA) cycle and respiratory electron transport
| 1265 | |
|---|---|
| set | The citric acid (TCA) cycle and respiratory electron transport |
| setSize | 150 |
| pANOVA | 6.21e-11 |
| s.dist | 0.309 |
| p.adjustANOVA | 5.13e-09 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| OGDH | 8010 |
| LDHC | 7609 |
| BSG | 7570 |
| NDUFA10 | 7483 |
| PDHX | 7471 |
| ACO2 | 7469 |
| PDHB | 7468 |
| CS | 7355 |
| DLAT | 7320 |
| PPARD | 7270 |
| NDUFA8 | 7131 |
| NDUFA12 | 7130 |
| ME3 | 7099 |
| DLST | 7073 |
| MT-CYB | 7011 |
| NDUFAB1 | 6996 |
| ECSIT | 6963 |
| UQCRC1 | 6960 |
| HAGH | 6949 |
| FAHD1 | 6902 |
| GeneID | Gene Rank |
|---|---|
| OGDH | 8010.0 |
| LDHC | 7609.0 |
| BSG | 7570.0 |
| NDUFA10 | 7483.0 |
| PDHX | 7471.0 |
| ACO2 | 7469.0 |
| PDHB | 7468.0 |
| CS | 7355.0 |
| DLAT | 7320.0 |
| PPARD | 7270.0 |
| NDUFA8 | 7131.0 |
| NDUFA12 | 7130.0 |
| ME3 | 7099.0 |
| DLST | 7073.0 |
| MT-CYB | 7011.0 |
| NDUFAB1 | 6996.0 |
| ECSIT | 6963.0 |
| UQCRC1 | 6960.0 |
| HAGH | 6949.0 |
| FAHD1 | 6902.0 |
| L2HGDH | 6828.0 |
| SLC25A27 | 6807.0 |
| NNT | 6791.0 |
| D2HGDH | 6672.0 |
| NDUFV1 | 6489.0 |
| ATP5F1B | 6480.0 |
| ACAD9 | 6453.0 |
| COX5B | 6442.0 |
| IDH3G | 6298.0 |
| NDUFA9 | 6209.0 |
| ATP5F1D | 6163.0 |
| MT-CO1 | 6162.0 |
| LDHB | 6149.5 |
| TRAP1 | 6126.0 |
| SDHC | 6123.0 |
| NDUFB10 | 6086.0 |
| COX5A | 6026.0 |
| IDH2 | 6021.0 |
| COX4I1 | 6009.0 |
| COX18 | 5890.0 |
| ETFB | 5756.0 |
| SDHB | 5629.0 |
| NDUFS5 | 5612.0 |
| ATP5MC3 | 5582.0 |
| MT-ND1 | 5579.0 |
| NDUFB7 | 5573.0 |
| NDUFV3 | 5524.0 |
| MT-ATP8 | 5500.0 |
| NDUFAF7 | 5479.0 |
| ETFDH | 5372.0 |
| COQ10A | 5345.0 |
| MDH2 | 5314.0 |
| ETFA | 5269.0 |
| PDPR | 5035.0 |
| NDUFB6 | 4983.0 |
| IDH3A | 4957.0 |
| MT-ND5 | 4937.0 |
| IDH3B | 4913.0 |
| CYC1 | 4883.0 |
| MT-ND2 | 4879.0 |
| TIMMDC1 | 4862.0 |
| MT-ND6 | 4767.0 |
| FH | 4639.0 |
| MT-ATP6 | 4629.0 |
| MPC2 | 4435.0 |
| MT-ND4 | 4382.0 |
| NDUFS3 | 4380.0 |
| PDHA1 | 4337.0 |
| COX11 | 4280.0 |
| TACO1 | 4096.0 |
| PDK4 | 4094.0 |
| NDUFB11 | 4068.0 |
| DMAC2L | 4044.0 |
| MT-CO2 | 3989.0 |
| ATP5ME | 3979.0 |
| NDUFAF3 | 3956.0 |
| MT-CO3 | 3879.0 |
| NDUFS1 | 3819.0 |
| UCP2 | 3761.0 |
| SLC25A14 | 3669.0 |
| VDAC1 | 3653.0 |
| SUCLG1 | 3584.0 |
| COX6B1 | 3551.0 |
| NDUFS8 | 3493.0 |
| COX7A2L | 3473.0 |
| PDK2 | 3361.0 |
| ATP5PD | 3350.0 |
| UQCRC2 | 3202.0 |
| SDHA | 3123.5 |
| DLD | 3101.0 |
| SLC16A1 | 3094.0 |
| NDUFS7 | 3090.0 |
| UQCRFS1 | 3065.0 |
| ATP5PO | 2966.5 |
| PDP2 | 2951.0 |
| NDUFB4 | 2890.0 |
| NDUFAF6 | 2862.0 |
| COX6A1 | 2441.0 |
| NDUFA4 | 2427.0 |
| NDUFA6 | 2222.0 |
| NDUFS4 | 2132.0 |
| PDK1 | 2031.0 |
| SUCLG2 | 1833.0 |
| SCO1 | 1481.0 |
| UCP1 | 1390.0 |
| NDUFAF4 | 1307.0 |
| NDUFAF1 | 1191.0 |
| NDUFB8 | 1015.5 |
| SUCLA2 | 608.0 |
| NDUFA13 | 544.0 |
| MPC1 | 407.0 |
| SDHD | -389.5 |
| PDK3 | -549.0 |
| NDUFA3 | -953.0 |
| ATP5PF | -1203.0 |
| UCP3 | -1769.0 |
| ATP5MF | -1892.0 |
| NDUFB5 | -1930.0 |
| RXRA | -1980.0 |
| NDUFV2 | -2183.0 |
| COX7B | -2241.0 |
| ME2 | -2641.0 |
| NDUFC2 | -3052.5 |
| MT-ND3 | -3112.0 |
| UQCR11 | -3215.5 |
| NDUFA11 | -3345.5 |
| NUBPL | -3355.0 |
| NDUFA2 | -3380.0 |
| NDUFS2 | -3401.0 |
| COX7C | -3618.0 |
| UQCR10 | -3998.0 |
| COQ10B | -4282.0 |
| ADHFE1 | -4312.0 |
| NDUFAF5 | -4827.0 |
| UQCRB | -5007.0 |
| SLC16A8 | -5046.0 |
| UQCRH | -5150.5 |
| TMEM126B | -5318.0 |
| ATP5MG | -5696.5 |
| PDP1 | -5939.0 |
| COX16 | -6527.0 |
| SLC16A3 | -6714.0 |
| NDUFB3 | -6948.0 |
| GLO1 | -7083.0 |
| GSTZ1 | -7293.0 |
| LDHA | -7395.0 |
| COX19 | -7585.0 |
| PM20D1 | -7706.0 |
| ME1 | -7972.0 |
| ATP5F1E | -8086.0 |
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
| 764 | |
|---|---|
| set | Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) |
| setSize | 83 |
| pANOVA | 1.19e-10 |
| s.dist | -0.409 |
| p.adjustANOVA | 8.76e-09 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282 |
| RPS16 | -8246 |
| RPS17 | -8231 |
| UPF2 | -8156 |
| RPS3A | -7929 |
| SMG7 | -7916 |
| RPS28 | -7809 |
| RPL29 | -7770 |
| RPS21 | -7764 |
| SMG6 | -7760 |
| RPS5 | -7648 |
| RPS27A | -7640 |
| RPS15 | -7548 |
| RPS11 | -7379 |
| RPS14 | -7325 |
| RPL38 | -7298 |
| RPL13A | -7282 |
| RPL24 | -7065 |
| RPL32 | -7023 |
| RPL6 | -6916 |
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| RPS16 | -8246.0 |
| RPS17 | -8231.0 |
| UPF2 | -8156.0 |
| RPS3A | -7929.0 |
| SMG7 | -7916.0 |
| RPS28 | -7809.0 |
| RPL29 | -7770.0 |
| RPS21 | -7764.0 |
| SMG6 | -7760.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| RPS15 | -7548.0 |
| RPS11 | -7379.0 |
| RPS14 | -7325.0 |
| RPL38 | -7298.0 |
| RPL13A | -7282.0 |
| RPL24 | -7065.0 |
| RPL32 | -7023.0 |
| RPL6 | -6916.0 |
| RPS10 | -6822.5 |
| RPS26 | -6692.0 |
| RPL18 | -6689.0 |
| RPL18A | -6679.0 |
| RPLP1 | -6661.0 |
| RPS8 | -6597.0 |
| RPL36 | -6366.0 |
| SMG5 | -6279.0 |
| RPLP2 | -6273.0 |
| RPL23 | -6194.0 |
| RPL30 | -6152.0 |
| RPL15 | -6030.0 |
| RPS4X | -6019.0 |
| RPL28 | -5981.0 |
| RPL35 | -5900.0 |
| RPS23 | -5865.0 |
| RPL5 | -5749.0 |
| RPS19 | -5609.0 |
| RPL37A | -5473.0 |
| RPL19 | -5108.0 |
| FAU | -4829.0 |
| GSPT2 | -4504.0 |
| RPL35A | -4460.0 |
| RPL13 | -4424.0 |
| UPF3A | -4384.0 |
| RPS6 | -4373.0 |
| ETF1 | -4323.0 |
| MAGOH | -4309.0 |
| RPSA | -4027.0 |
| RPL3 | -3968.0 |
| RPL10A | -3822.0 |
| RPS13 | -3718.0 |
| NCBP1 | -3144.0 |
| RPL7 | -2750.0 |
| RPL8 | -2587.0 |
| RBM8A | -2564.0 |
| RPS18 | -2478.0 |
| RPL23A | -1088.0 |
| DCP1A | -1050.0 |
| RPL31 | -303.0 |
| RPS2 | -219.0 |
| PPP2CA | 497.0 |
| RPS27L | 522.0 |
| SMG9 | 582.0 |
| RPL27 | 706.0 |
| RNPS1 | 803.0 |
| NCBP2 | 898.0 |
| EIF4A3 | 950.0 |
| RPL7A | 1400.0 |
| MAGOHB | 1608.0 |
| UPF3B | 2124.0 |
| CASC3 | 2399.0 |
| RPL37 | 2677.0 |
| PPP2R2A | 2684.0 |
| RPS9 | 3031.0 |
| RPS3 | 3136.0 |
| PPP2R1A | 3805.0 |
| EIF4G1 | 4151.0 |
| SMG8 | 4226.0 |
| RPL3L | 4494.0 |
| RPL22 | 5158.0 |
| GSPT1 | 6438.0 |
| UPF1 | 8167.0 |
Nonsense-Mediated Decay (NMD)
| 766 | |
|---|---|
| set | Nonsense-Mediated Decay (NMD) |
| setSize | 83 |
| pANOVA | 1.19e-10 |
| s.dist | -0.409 |
| p.adjustANOVA | 8.76e-09 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282 |
| RPS16 | -8246 |
| RPS17 | -8231 |
| UPF2 | -8156 |
| RPS3A | -7929 |
| SMG7 | -7916 |
| RPS28 | -7809 |
| RPL29 | -7770 |
| RPS21 | -7764 |
| SMG6 | -7760 |
| RPS5 | -7648 |
| RPS27A | -7640 |
| RPS15 | -7548 |
| RPS11 | -7379 |
| RPS14 | -7325 |
| RPL38 | -7298 |
| RPL13A | -7282 |
| RPL24 | -7065 |
| RPL32 | -7023 |
| RPL6 | -6916 |
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| RPS16 | -8246.0 |
| RPS17 | -8231.0 |
| UPF2 | -8156.0 |
| RPS3A | -7929.0 |
| SMG7 | -7916.0 |
| RPS28 | -7809.0 |
| RPL29 | -7770.0 |
| RPS21 | -7764.0 |
| SMG6 | -7760.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| RPS15 | -7548.0 |
| RPS11 | -7379.0 |
| RPS14 | -7325.0 |
| RPL38 | -7298.0 |
| RPL13A | -7282.0 |
| RPL24 | -7065.0 |
| RPL32 | -7023.0 |
| RPL6 | -6916.0 |
| RPS10 | -6822.5 |
| RPS26 | -6692.0 |
| RPL18 | -6689.0 |
| RPL18A | -6679.0 |
| RPLP1 | -6661.0 |
| RPS8 | -6597.0 |
| RPL36 | -6366.0 |
| SMG5 | -6279.0 |
| RPLP2 | -6273.0 |
| RPL23 | -6194.0 |
| RPL30 | -6152.0 |
| RPL15 | -6030.0 |
| RPS4X | -6019.0 |
| RPL28 | -5981.0 |
| RPL35 | -5900.0 |
| RPS23 | -5865.0 |
| RPL5 | -5749.0 |
| RPS19 | -5609.0 |
| RPL37A | -5473.0 |
| RPL19 | -5108.0 |
| FAU | -4829.0 |
| GSPT2 | -4504.0 |
| RPL35A | -4460.0 |
| RPL13 | -4424.0 |
| UPF3A | -4384.0 |
| RPS6 | -4373.0 |
| ETF1 | -4323.0 |
| MAGOH | -4309.0 |
| RPSA | -4027.0 |
| RPL3 | -3968.0 |
| RPL10A | -3822.0 |
| RPS13 | -3718.0 |
| NCBP1 | -3144.0 |
| RPL7 | -2750.0 |
| RPL8 | -2587.0 |
| RBM8A | -2564.0 |
| RPS18 | -2478.0 |
| RPL23A | -1088.0 |
| DCP1A | -1050.0 |
| RPL31 | -303.0 |
| RPS2 | -219.0 |
| PPP2CA | 497.0 |
| RPS27L | 522.0 |
| SMG9 | 582.0 |
| RPL27 | 706.0 |
| RNPS1 | 803.0 |
| NCBP2 | 898.0 |
| EIF4A3 | 950.0 |
| RPL7A | 1400.0 |
| MAGOHB | 1608.0 |
| UPF3B | 2124.0 |
| CASC3 | 2399.0 |
| RPL37 | 2677.0 |
| PPP2R2A | 2684.0 |
| RPS9 | 3031.0 |
| RPS3 | 3136.0 |
| PPP2R1A | 3805.0 |
| EIF4G1 | 4151.0 |
| SMG8 | 4226.0 |
| RPL3L | 4494.0 |
| RPL22 | 5158.0 |
| GSPT1 | 6438.0 |
| UPF1 | 8167.0 |
rRNA processing
| 1394 | |
|---|---|
| set | rRNA processing |
| setSize | 176 |
| pANOVA | 1.45e-09 |
| s.dist | -0.265 |
| p.adjustANOVA | 1.01e-07 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282 |
| RPS16 | -8246 |
| TSR1 | -8237 |
| RPS17 | -8231 |
| LAS1L | -8220 |
| HEATR1 | -8214 |
| EXOSC1 | -8073 |
| RPP40 | -7990 |
| RPS3A | -7929 |
| RPS28 | -7809 |
| WDR75 | -7780 |
| RPL29 | -7770 |
| RPS21 | -7764 |
| NAT10 | -7652 |
| RPS5 | -7648 |
| RPS27A | -7640 |
| RPS15 | -7548 |
| RPS11 | -7379 |
| RPS14 | -7325 |
| RPL38 | -7298 |
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| RPS16 | -8246.0 |
| TSR1 | -8237.0 |
| RPS17 | -8231.0 |
| LAS1L | -8220.0 |
| HEATR1 | -8214.0 |
| EXOSC1 | -8073.0 |
| RPP40 | -7990.0 |
| RPS3A | -7929.0 |
| RPS28 | -7809.0 |
| WDR75 | -7780.0 |
| RPL29 | -7770.0 |
| RPS21 | -7764.0 |
| NAT10 | -7652.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| RPS15 | -7548.0 |
| RPS11 | -7379.0 |
| RPS14 | -7325.0 |
| RPL38 | -7298.0 |
| BMS1 | -7297.0 |
| RPL13A | -7282.0 |
| RCL1 | -7096.0 |
| RPL24 | -7065.0 |
| RPL32 | -7023.0 |
| MPHOSPH6 | -6988.0 |
| RPL6 | -6916.0 |
| RPS10 | -6822.5 |
| RIOK3 | -6733.0 |
| RPS26 | -6692.0 |
| RPL18 | -6689.0 |
| RPL18A | -6679.0 |
| RPLP1 | -6661.0 |
| RPS8 | -6597.0 |
| EXOSC9 | -6555.0 |
| EMG1 | -6502.0 |
| EBNA1BP2 | -6480.0 |
| RPL36 | -6366.0 |
| RPLP2 | -6273.0 |
| RPL23 | -6194.0 |
| RPL30 | -6152.0 |
| RPL15 | -6030.0 |
| RPS4X | -6019.0 |
| NOP14 | -5999.0 |
| LTV1 | -5990.5 |
| RPL28 | -5981.0 |
| RPL35 | -5900.0 |
| RPS23 | -5865.0 |
| PNO1 | -5857.0 |
| WDR12 | -5752.0 |
| RPL5 | -5749.0 |
| TEX10 | -5719.0 |
| IMP4 | -5693.0 |
| PWP2 | -5683.5 |
| NOC4L | -5659.0 |
| RPS19 | -5609.0 |
| DDX52 | -5552.0 |
| NOL12 | -5510.5 |
| RPL37A | -5473.0 |
| NOP58 | -5436.0 |
| DDX21 | -5435.0 |
| DHX37 | -5426.0 |
| NOP10 | -5374.0 |
| IMP3 | -5333.0 |
| NOL9 | -5210.0 |
| UTP6 | -5198.0 |
| NIP7 | -5163.0 |
| RPL19 | -5108.0 |
| UTP15 | -4961.0 |
| RPP30 | -4931.0 |
| WDR36 | -4849.0 |
| FAU | -4829.0 |
| RPP25 | -4689.0 |
| BOP1 | -4674.0 |
| FTSJ3 | -4563.0 |
| WDR3 | -4529.0 |
| RPL35A | -4460.0 |
| C1D | -4432.0 |
| RPL13 | -4424.0 |
| UTP18 | -4374.0 |
| RPS6 | -4373.0 |
| RPSA | -4027.0 |
| RPL3 | -3968.0 |
| RPL10A | -3822.0 |
| RPS13 | -3718.0 |
| RRP9 | -3702.0 |
| DDX49 | -3628.0 |
| NOP56 | -3482.0 |
| EXOSC4 | -3421.0 |
| EXOSC5 | -3356.0 |
| WDR43 | -3348.0 |
| NCL | -3329.0 |
| GNL3 | -3174.0 |
| UTP20 | -3157.0 |
| TRMT10C | -3148.0 |
| MT-ND3 | -3112.0 |
| FCF1 | -2809.0 |
| MTREX | -2791.0 |
| RPL7 | -2750.0 |
| DCAF13 | -2707.0 |
| PELP1 | -2654.0 |
| RPL8 | -2587.0 |
| RPS18 | -2478.0 |
| DIMT1 | -2344.0 |
| EXOSC3 | -2219.0 |
| NOL11 | -1943.0 |
| DDX47 | -1644.0 |
| DIS3 | -1452.0 |
| MRM1 | -1343.0 |
| RPL23A | -1088.0 |
| THUMPD1 | -1054.0 |
| RIOK1 | -1046.0 |
| BYSL | -877.0 |
| RIOK2 | -834.0 |
| UTP14A | -381.5 |
| UTP14C | -381.5 |
| ERI1 | -324.0 |
| RPL31 | -303.0 |
| RPS2 | -219.0 |
| SNU13 | 188.0 |
| TSR3 | 320.0 |
| UTP11 | 411.0 |
| RPS27L | 522.0 |
| RPL27 | 706.0 |
| TFB1M | 788.0 |
| UTP3 | 843.0 |
| MRM2 | 930.5 |
| MPHOSPH10 | 991.0 |
| PRORP | 1105.5 |
| NOB1 | 1300.0 |
| TBL3 | 1340.0 |
| RPL7A | 1400.0 |
| UTP4 | 1419.0 |
| RRP7A | 1528.0 |
| EXOSC10 | 1617.0 |
| HSD17B10 | 1753.0 |
| PDCD11 | 1804.0 |
| EXOSC7 | 2356.0 |
| RRP36 | 2367.0 |
| RPL37 | 2677.0 |
| SENP3 | 2732.5 |
| KRR1 | 2965.0 |
| EXOSC6 | 3010.0 |
| RBM28 | 3020.0 |
| RPS9 | 3031.0 |
| RPS3 | 3136.0 |
| PES1 | 3220.0 |
| MT-ND4L | 3569.0 |
| ISG20L2 | 3698.0 |
| MT-CO3 | 3879.0 |
| FBL | 3970.0 |
| MT-CO2 | 3989.0 |
| EXOSC8 | 4292.0 |
| MT-ND4 | 4382.0 |
| RPL3L | 4494.0 |
| MT-ATP6 | 4629.0 |
| MRM3 | 4729.0 |
| MT-ND2 | 4879.0 |
| MT-ND5 | 4937.0 |
| XRN2 | 4993.0 |
| RPL22 | 5158.0 |
| MTERF4 | 5363.0 |
| MT-ATP8 | 5500.0 |
| MT-ND1 | 5579.0 |
| WDR46 | 5939.0 |
| CSNK1D | 6028.0 |
| ELAC2 | 6048.0 |
| MT-CO1 | 6162.0 |
| RRP1 | 6389.0 |
| MT-CYB | 7011.0 |
| DKC1 | 7024.0 |
| NOL6 | 7692.0 |
| CSNK1E | 7737.5 |
| EXOSC2 | 7761.0 |
| GAR1 | 7789.0 |
| WDR18 | 7833.0 |
Metabolism of lipids
| 664 | |
|---|---|
| set | Metabolism of lipids |
| setSize | 669 |
| pANOVA | 2.49e-09 |
| s.dist | 0.136 |
| p.adjustANOVA | 1.67e-07 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NEU1 | 8176.0 |
| RXRB | 8151.0 |
| ABCB4 | 8143.0 |
| GK | 8138.5 |
| GK3P | 8138.5 |
| PPT2 | 8132.5 |
| PITPNM2 | 8100.0 |
| ACACB | 8064.0 |
| NUDT7 | 8063.0 |
| SULT2A1 | 8062.0 |
| SGMS1 | 8040.0 |
| ALAS1 | 8037.0 |
| PLA2G6 | 8032.0 |
| MGLL | 8020.0 |
| PPARA | 7997.0 |
| PRKD1 | 7988.0 |
| GPAM | 7972.0 |
| ACOT7 | 7952.0 |
| SLCO1A2 | 7943.0 |
| AKR1D1 | 7924.0 |
| GeneID | Gene Rank |
|---|---|
| NEU1 | 8176.0 |
| RXRB | 8151.0 |
| ABCB4 | 8143.0 |
| GK | 8138.5 |
| GK3P | 8138.5 |
| PPT2 | 8132.5 |
| PITPNM2 | 8100.0 |
| ACACB | 8064.0 |
| NUDT7 | 8063.0 |
| SULT2A1 | 8062.0 |
| SGMS1 | 8040.0 |
| ALAS1 | 8037.0 |
| PLA2G6 | 8032.0 |
| MGLL | 8020.0 |
| PPARA | 7997.0 |
| PRKD1 | 7988.0 |
| GPAM | 7972.0 |
| ACOT7 | 7952.0 |
| SLCO1A2 | 7943.0 |
| AKR1D1 | 7924.0 |
| TXNRD1 | 7917.0 |
| ACSL6 | 7907.5 |
| SELENOI | 7885.0 |
| GGT5 | 7852.0 |
| DGAT2 | 7843.0 |
| SLC27A2 | 7786.0 |
| ACSL1 | 7784.0 |
| HSD17B8 | 7780.0 |
| SCAP | 7769.0 |
| SIN3A | 7728.0 |
| CYP1B1 | 7721.0 |
| NEU3 | 7685.0 |
| MTMR3 | 7682.0 |
| CDIPT | 7681.0 |
| HAO2 | 7672.0 |
| ACAA2 | 7671.0 |
| OSBPL1A | 7651.0 |
| ACOX2 | 7644.0 |
| GDPD1 | 7639.0 |
| OSBPL9 | 7624.0 |
| PPP1CC | 7613.0 |
| CD36 | 7608.0 |
| PCCA | 7601.0 |
| FAM120B | 7582.0 |
| ACOT1 | 7508.5 |
| ACOT2 | 7508.5 |
| SLC44A1 | 7506.0 |
| GBA2 | 7505.0 |
| HSD17B4 | 7497.0 |
| MIGA1 | 7495.0 |
| ESRRA | 7493.0 |
| SYNJ1 | 7489.0 |
| LIPE | 7475.0 |
| PIK3R1 | 7450.0 |
| PIP5K1C | 7429.0 |
| OSBPL6 | 7390.0 |
| PLPP3 | 7387.5 |
| PTPN13 | 7381.0 |
| DEGS1 | 7375.0 |
| CRAT | 7368.0 |
| UGCG | 7366.0 |
| HADHB | 7290.0 |
| RGL1 | 7289.0 |
| PPARGC1A | 7286.0 |
| PLA2G12A | 7271.0 |
| PPARD | 7270.0 |
| ACOX1 | 7255.0 |
| TM7SF2 | 7221.0 |
| NCOA1 | 7218.0 |
| PTGES2 | 7214.0 |
| MECR | 7210.0 |
| SYNJ2 | 7186.0 |
| CYP4A11 | 7182.5 |
| CYP4A22 | 7182.5 |
| CYP4F11 | 7182.5 |
| CYP3A4 | 7151.0 |
| FDFT1 | 7140.0 |
| SMPD1 | 7133.0 |
| KDSR | 7127.0 |
| SLCO1B1 | 7114.0 |
| SLCO1B3 | 7114.0 |
| MVK | 7089.0 |
| RAB14 | 7078.0 |
| ACSF3 | 7053.0 |
| ACOT13 | 7051.0 |
| PTGR2 | 7049.5 |
| PHYH | 7045.0 |
| SLC27A5 | 7037.0 |
| MIGA2 | 7028.0 |
| ACADVL | 7006.0 |
| NDUFAB1 | 6996.0 |
| ALDH3A2 | 6988.0 |
| MVD | 6987.0 |
| ACER2 | 6955.0 |
| OXCT1 | 6953.0 |
| ELOVL1 | 6929.0 |
| THEM4 | 6916.0 |
| PISD | 6915.0 |
| DDHD1 | 6907.0 |
| HEXB | 6896.0 |
| PCYT2 | 6881.0 |
| DGAT1 | 6818.0 |
| PLBD1 | 6813.0 |
| ECI1 | 6811.0 |
| HMGCS2 | 6810.0 |
| SLC27A1 | 6792.0 |
| ARSB | 6768.0 |
| AMACR | 6750.0 |
| MCEE | 6734.0 |
| SMPD2 | 6732.0 |
| CYP4F2 | 6710.0 |
| LIPH | 6703.0 |
| STARD7 | 6643.0 |
| BDH1 | 6632.0 |
| MTMR14 | 6619.0 |
| PTDSS2 | 6618.0 |
| CIDEA | 6565.0 |
| ACSS3 | 6546.0 |
| ACOT11 | 6541.0 |
| GPD1L | 6475.0 |
| CPT1B | 6451.0 |
| SLC25A20 | 6449.0 |
| ABCD1 | 6427.0 |
| MMAA | 6426.0 |
| CHPT1 | 6423.0 |
| HADHA | 6375.0 |
| CAV1 | 6314.0 |
| MTM1 | 6305.0 |
| ALOX12 | 6295.0 |
| ABCB11 | 6290.0 |
| FIG4 | 6289.0 |
| GNPAT | 6274.0 |
| LPCAT1 | 6266.0 |
| ACAT1 | 6251.0 |
| PNPLA6 | 6241.0 |
| TAZ | 6238.0 |
| INPP5E | 6233.0 |
| MAPKAPK2 | 6139.0 |
| ACAA1 | 6125.0 |
| SCD | 6085.0 |
| HELZ2 | 6066.0 |
| ESYT1 | 6061.0 |
| STARD3 | 6047.0 |
| EHHADH | 6024.0 |
| ARSL | 5997.0 |
| ACADM | 5984.0 |
| PLA2G3 | 5983.0 |
| ACADL | 5978.0 |
| MTMR4 | 5959.0 |
| SPHK2 | 5954.0 |
| PIAS4 | 5949.0 |
| MBOAT7 | 5900.0 |
| TRIB3 | 5887.0 |
| NR1H4 | 5883.0 |
| ABHD3 | 5864.0 |
| FABP3 | 5858.0 |
| SPTLC3 | 5843.0 |
| HADH | 5813.0 |
| APOA5 | 5800.0 |
| BAAT | 5784.0 |
| PLA2G15 | 5737.0 |
| SPNS2 | 5733.0 |
| HSD17B3 | 5727.0 |
| OSBPL2 | 5717.0 |
| ELOVL5 | 5710.0 |
| SRD5A3 | 5664.0 |
| PRKD2 | 5653.0 |
| EPHX2 | 5626.0 |
| CPT2 | 5615.0 |
| PTPMT1 | 5611.0 |
| PI4KA | 5609.0 |
| PITPNM1 | 5555.0 |
| CPNE7 | 5543.0 |
| GLTP | 5539.0 |
| CHKB | 5535.0 |
| PLEKHA5 | 5521.0 |
| TSPO | 5508.0 |
| SPHK1 | 5497.0 |
| GDPD3 | 5492.0 |
| NUDT19 | 5464.0 |
| DPEP3 | 5463.0 |
| NCOA3 | 5428.0 |
| HDAC3 | 5383.0 |
| APOA2 | 5339.0 |
| LPIN2 | 5328.0 |
| NCOA2 | 5324.0 |
| HSD17B11 | 5290.0 |
| MED20 | 5287.0 |
| MED11 | 5275.0 |
| FABP1 | 5273.0 |
| ABCC1 | 5260.0 |
| CPT1A | 5252.0 |
| KPNB1 | 5247.0 |
| AHR | 5235.5 |
| AGPAT3 | 5234.0 |
| CPTP | 5212.0 |
| LPIN3 | 5191.0 |
| VDR | 5181.0 |
| PON2 | 5161.0 |
| CERS5 | 5142.0 |
| AGPAT2 | 5125.0 |
| RAB5A | 5118.0 |
| CSNK2B | 5077.0 |
| NCOR2 | 5040.0 |
| PPP1CA | 5029.0 |
| OSBPL3 | 4992.0 |
| LTA4H | 4990.0 |
| FITM2 | 4958.0 |
| CYP7A1 | 4954.0 |
| INPP4B | 4919.0 |
| INPPL1 | 4912.0 |
| ARSG | 4846.0 |
| ESYT3 | 4844.0 |
| ANKRD1 | 4842.0 |
| HMGCS1 | 4840.0 |
| SERPINA6 | 4838.0 |
| ACOT6 | 4818.0 |
| SPTLC1 | 4801.0 |
| MTMR2 | 4800.0 |
| PSAP | 4789.0 |
| SLC10A1 | 4785.0 |
| MLYCD | 4748.0 |
| PON1 | 4745.0 |
| ALDH3B1 | 4733.0 |
| ACADS | 4701.0 |
| CYP21A2 | 4683.0 |
| HSD17B1 | 4651.0 |
| LPGAT1 | 4643.0 |
| SBF1 | 4623.0 |
| ACSF2 | 4566.0 |
| PLA2G4C | 4558.0 |
| ETNK1 | 4555.0 |
| PIK3R3 | 4535.5 |
| PCCB | 4518.0 |
| PRKACA | 4516.0 |
| MCAT | 4486.0 |
| PLAAT3 | 4482.0 |
| LPCAT4 | 4480.0 |
| MBOAT2 | 4446.0 |
| SIN3B | 4433.0 |
| PLA2G4F | 4411.0 |
| BMX | 4404.0 |
| CYP27A1 | 4354.0 |
| PIK3R4 | 4339.0 |
| ELOVL2 | 4317.0 |
| NR1D1 | 4304.0 |
| FABP12 | 4262.0 |
| FA2H | 4252.0 |
| CERK | 4167.0 |
| ORMDL2 | 4164.0 |
| MORC2 | 4155.0 |
| ACBD5 | 4146.0 |
| GBA3 | 4143.0 |
| ABHD4 | 4098.0 |
| MED30 | 4073.0 |
| ELOVL3 | 4059.0 |
| NFYC | 4019.0 |
| THRAP3 | 4012.0 |
| PTGR1 | 3940.0 |
| ACLY | 3933.0 |
| INPP5F | 3921.0 |
| SLC44A4 | 3892.0 |
| SRD5A1 | 3839.0 |
| ALB | 3808.0 |
| PLD6 | 3759.0 |
| CYP2U1 | 3661.0 |
| GLB1 | 3652.0 |
| GGT1 | 3624.0 |
| CDK19 | 3619.0 |
| PI4K2A | 3614.0 |
| GPAT3 | 3583.0 |
| SLC44A5 | 3580.0 |
| ALOXE3 | 3570.0 |
| CERS4 | 3565.0 |
| DEGS2 | 3556.0 |
| VAPB | 3515.0 |
| ACER3 | 3467.0 |
| INPP5J | 3451.0 |
| ANGPTL4 | 3332.0 |
| CDS2 | 3330.0 |
| ELOVL7 | 3264.0 |
| HSD11B2 | 3260.0 |
| AGPAT1 | 3237.0 |
| SLC44A2 | 3226.0 |
| ACOT8 | 3216.0 |
| UGT8 | 3214.0 |
| GPX2 | 3181.0 |
| HEXA | 3177.5 |
| ACP6 | 3169.0 |
| MED13 | 3167.0 |
| MED16 | 3165.0 |
| ASAH1 | 3132.0 |
| PNPLA7 | 3113.0 |
| MED25 | 3110.0 |
| MTMR9 | 3093.0 |
| CYP4B1 | 3008.0 |
| PLEKHA1 | 2999.0 |
| MOGAT2 | 2998.0 |
| MTMR1 | 2992.0 |
| CYP46A1 | 2984.0 |
| PTGS1 | 2945.0 |
| ELOVL6 | 2936.0 |
| FABP5 | 2903.0 |
| FHL2 | 2888.0 |
| MMUT | 2827.0 |
| PIK3C2G | 2726.0 |
| TBL1X | 2701.5 |
| PCYT1A | 2694.0 |
| LSS | 2690.0 |
| PTGIS | 2632.0 |
| OSBP | 2607.0 |
| DHCR24 | 2582.0 |
| HACL1 | 2573.0 |
| EBP | 2569.5 |
| FABP9 | 2555.0 |
| CYP8B1 | 2544.0 |
| ACSL5 | 2484.0 |
| ACOX3 | 2479.0 |
| MFSD2A | 2468.0 |
| CRLS1 | 2459.0 |
| PLEKHA4 | 2428.0 |
| GC | 2339.0 |
| NEU4 | 2309.0 |
| SGPP1 | 2300.0 |
| CPNE6 | 2292.0 |
| PIP5K1B | 2275.0 |
| GPAT4 | 2166.0 |
| ACOXL | 2122.0 |
| PITPNM3 | 2118.0 |
| ARV1 | 2104.0 |
| HSD17B14 | 2069.0 |
| PLB1 | 2066.0 |
| SUMF1 | 2058.0 |
| SACM1L | 2044.0 |
| CDS1 | 1993.0 |
| CYP1A2 | 1984.0 |
| TIAM2 | 1970.0 |
| PLA2G2A | 1916.0 |
| ACER1 | 1906.0 |
| HMGCL | 1875.0 |
| GSTM4 | 1859.0 |
| DECR1 | 1813.0 |
| PIP4K2C | 1803.0 |
| PIP5K1A | 1793.0 |
| HMGCR | 1772.0 |
| CHAT | 1738.0 |
| MTMR12 | 1733.0 |
| FDX1 | 1690.0 |
| PPARG | 1599.0 |
| TSPOAP1 | 1582.0 |
| PECR | 1557.0 |
| MED19 | 1555.0 |
| SRD5A2 | 1549.0 |
| BDH2 | 1484.0 |
| PLPP6 | 1469.0 |
| FITM1 | 1457.0 |
| ETNPPL | 1441.0 |
| BCHE | 1382.0 |
| PTGDS | 1364.5 |
| TNFAIP8L3 | 1336.0 |
| CYP4F22 | 1324.0 |
| TECR | 1244.0 |
| CYP11A1 | 1187.0 |
| CYP19A1 | 1077.0 |
| PLIN2 | 985.0 |
| STAR | 921.0 |
| HACD3 | 849.0 |
| PLAAT1 | 782.0 |
| THEM5 | 765.0 |
| CBR1 | 743.0 |
| ALOX12B | 627.0 |
| STARD5 | 594.0 |
| CSNK1G2 | 527.0 |
| NCOR1 | 513.0 |
| SGMS2 | 511.0 |
| SP1 | 506.0 |
| DGAT2L6 | 503.0 |
| ARSA | 498.0 |
| ELOVL4 | 485.0 |
| AGPS | 484.0 |
| AKR1B1 | 438.0 |
| POMC | 432.0 |
| FABP6 | 393.5 |
| PLA2G4D | 356.0 |
| MID1IP1 | 349.0 |
| NCOA6 | 255.0 |
| ACAT2 | 54.0 |
| HACD4 | 7.0 |
| PTEN | 0.0 |
| MED15 | -8.0 |
| TPTE | -98.5 |
| TPTE2 | -98.5 |
| MED13L | -127.0 |
| MOGAT1 | -129.0 |
| GALC | -145.0 |
| PRKAA2 | -151.0 |
| SEC24B | -161.0 |
| MED7 | -167.0 |
| CGA | -264.0 |
| ACBD4 | -269.0 |
| AGK | -326.0 |
| PIK3C3 | -335.0 |
| INSIG2 | -349.0 |
| GDE1 | -397.0 |
| ACAD10 | -476.0 |
| TECRL | -489.0 |
| FAAH | -494.0 |
| ACBD6 | -500.0 |
| GGPS1 | -505.0 |
| PNPLA4 | -507.0 |
| PLA2G4E | -576.0 |
| PLA2G1B | -633.0 |
| PNPLA5 | -633.0 |
| INPP4A | -824.0 |
| MBTPS2 | -837.0 |
| CHD9 | -885.0 |
| RUFY1 | -910.0 |
| CERS3 | -915.0 |
| AGPAT4 | -928.0 |
| GPX1 | -981.0 |
| PLEKHA3 | -993.0 |
| NR1H3 | -1186.0 |
| OLAH | -1201.0 |
| GK2 | -1329.0 |
| NR1H2 | -1366.0 |
| ABHD5 | -1376.0 |
| PIP4K2A | -1448.0 |
| PLA2G2F | -1548.0 |
| AGPAT5 | -1570.0 |
| ACOT12 | -1585.0 |
| CREBBP | -1636.0 |
| SAMD8 | -1654.0 |
| CYP17A1 | -1685.0 |
| CTSA | -1693.0 |
| RAB4A | -1698.0 |
| FABP7 | -1750.0 |
| TNFAIP8 | -1764.0 |
| GLA | -1815.0 |
| UBE2I | -1820.0 |
| CARM1 | -1862.0 |
| B3GALNT1 | -1886.0 |
| RXRA | -1980.0 |
| STARD3NL | -1991.0 |
| MED1 | -2004.0 |
| DBI | -2008.0 |
| PIK3R2 | -2014.5 |
| LCLAT1 | -2037.0 |
| DPEP1 | -2058.0 |
| ACSBG2 | -2092.0 |
| CYP51A1 | -2093.0 |
| PMVK | -2107.0 |
| EP300 | -2111.0 |
| CYP1A1 | -2131.0 |
| MED17 | -2171.5 |
| PPP1CB | -2278.0 |
| GPS2 | -2353.0 |
| HSD3B7 | -2383.0 |
| ALOX15B | -2390.0 |
| FDX2 | -2403.5 |
| FADS2 | -2411.0 |
| CERT1 | -2435.0 |
| LGMN | -2445.0 |
| CERS2 | -2467.0 |
| SPTLC2 | -2485.0 |
| MTMR10 | -2519.0 |
| HSD17B2 | -2550.0 |
| PLEKHA8 | -2559.0 |
| STARD6 | -2592.0 |
| PLD2 | -2600.0 |
| ACOT4 | -2617.0 |
| PLA2G5 | -2658.0 |
| GPAT2 | -2660.0 |
| SMPD3 | -2703.0 |
| CYP24A1 | -2704.0 |
| PIK3CA | -2711.0 |
| FAR2 | -2715.0 |
| CEPT1 | -2753.0 |
| LRP2 | -2756.0 |
| PIK3C2A | -2762.0 |
| TBL1XR1 | -2764.0 |
| CYP2R1 | -2805.0 |
| SREBF2 | -2861.0 |
| HSD17B13 | -2870.0 |
| AHRR | -2888.0 |
| ACAD11 | -2890.0 |
| CPNE3 | -2918.0 |
| PIP4K2B | -2963.0 |
| ACSM3 | -2985.0 |
| PLA2G4B | -3004.5 |
| SMPD4 | -3098.0 |
| ORMDL3 | -3146.0 |
| VAC14 | -3150.0 |
| CSNK2A2 | -3177.0 |
| AGMO | -3234.0 |
| OSBPL10 | -3302.0 |
| PEMT | -3381.0 |
| INPP5K | -3389.0 |
| PTGS2 | -3418.0 |
| PLD3 | -3441.0 |
| MED23 | -3449.0 |
| INPP5D | -3469.0 |
| PI4K2B | -3521.0 |
| TGS1 | -3538.0 |
| MED10 | -3546.0 |
| TNFRSF21 | -3652.0 |
| PIK3R6 | -3686.0 |
| PPT1 | -3753.0 |
| OSBPL5 | -3773.0 |
| SQLE | -3782.0 |
| PON3 | -3794.0 |
| AGT | -3831.0 |
| MED29 | -3833.0 |
| PIK3R5 | -3873.0 |
| AWAT2 | -3928.0 |
| MED22 | -3992.0 |
| FADS1 | -4018.0 |
| NRF1 | -4104.0 |
| ARF1 | -4106.0 |
| SPTSSA | -4118.0 |
| CSNK2A1 | -4141.5 |
| CCNC | -4162.0 |
| ALPI | -4177.0 |
| ALOX15 | -4198.0 |
| GLB1L | -4268.0 |
| PHOSPHO1 | -4283.0 |
| PLA2G4A | -4306.0 |
| STS | -4310.0 |
| HMGCLL1 | -4359.0 |
| SMARCD3 | -4369.0 |
| PLAAT5 | -4389.0 |
| CYP39A1 | -4425.0 |
| HACD2 | -4442.0 |
| SEC24D | -4488.0 |
| NSDHL | -4612.0 |
| MTF1 | -4679.0 |
| PLPP2 | -4680.0 |
| MED4 | -4721.0 |
| ACSL4 | -4736.0 |
| PLPP1 | -4758.0 |
| GLIPR1 | -4774.0 |
| ESYT2 | -4775.0 |
| APOA1 | -4811.0 |
| B4GALNT1 | -4824.0 |
| CYP27B1 | -4916.0 |
| ARSK | -4920.0 |
| PIK3CG | -4924.0 |
| MED24 | -4941.0 |
| LPCAT2 | -4982.0 |
| ACOT9 | -5006.0 |
| CBR4 | -5009.0 |
| MBOAT1 | -5042.0 |
| HSD17B7 | -5043.0 |
| SGPL1 | -5047.0 |
| GRHL1 | -5079.0 |
| FASN | -5133.0 |
| MED6 | -5143.0 |
| PTDSS1 | -5228.0 |
| SLC44A3 | -5267.0 |
| CYP2E1 | -5268.0 |
| MED28 | -5278.0 |
| PRKD3 | -5324.0 |
| MSMO1 | -5327.0 |
| DHCR7 | -5329.0 |
| CHKA | -5389.0 |
| PLA1A | -5396.0 |
| MED21 | -5422.0 |
| PGS1 | -5459.0 |
| MTMR7 | -5471.0 |
| DPEP2 | -5556.0 |
| LPCAT3 | -5589.0 |
| SLC25A17 | -5644.0 |
| SLC27A3 | -5657.0 |
| PIKFYVE | -5658.0 |
| PLA2G2D | -5665.0 |
| PCTP | -5715.0 |
| PI4KB | -5750.0 |
| PLD1 | -5751.0 |
| ARNT2 | -5773.0 |
| FABP4 | -5849.0 |
| GPCPD1 | -5855.0 |
| TNFAIP8L2 | -5866.0 |
| G0S2 | -5922.0 |
| MED27 | -6062.0 |
| THRSP | -6068.0 |
| RORA | -6076.0 |
| PCYT1B | -6101.0 |
| PIK3CD | -6147.0 |
| DDHD2 | -6193.0 |
| AACS | -6268.0 |
| LTC4S | -6307.0 |
| INSIG1 | -6310.0 |
| PRKACB | -6340.0 |
| ABCA1 | -6344.0 |
| ENPP6 | -6377.0 |
| PEX11A | -6415.0 |
| PLA2R1 | -6447.0 |
| PLD4 | -6472.0 |
| ECI2 | -6476.0 |
| MED31 | -6496.0 |
| MTMR6 | -6513.0 |
| HPGD | -6516.0 |
| SLC25A1 | -6520.0 |
| SAR1B | -6531.0 |
| HACD1 | -6539.0 |
| STARD4 | -6556.0 |
| TBXAS1 | -6596.0 |
| CUBN | -6631.0 |
| GM2A | -6634.0 |
| GBA | -6677.0 |
| GPD1 | -6680.0 |
| PTGES3 | -6729.0 |
| GPD2 | -6755.0 |
| ACSL3 | -6761.0 |
| SBF2 | -6804.0 |
| GDPD5 | -6872.0 |
| PRKAG2 | -6923.0 |
| HPGDS | -6927.0 |
| CH25H | -7050.0 |
| PIK3C2B | -7081.0 |
| CERS6 | -7111.0 |
| NFYA | -7197.0 |
| MBTPS1 | -7280.0 |
| CYP4F8 | -7313.0 |
| ARSI | -7339.0 |
| CIDEC | -7371.0 |
| VAPA | -7396.0 |
| LPIN1 | -7406.0 |
| MED26 | -7415.5 |
| PNPLA3 | -7463.0 |
| PPARGC1B | -7464.0 |
| ARNT | -7477.0 |
| OSBPL7 | -7479.0 |
| IDI1 | -7502.0 |
| ACSBG1 | -7512.0 |
| ARNTL | -7523.0 |
| ASAH2 | -7526.0 |
| OCRL | -7541.0 |
| NFYB | -7587.0 |
| ALOX5AP | -7609.0 |
| STARD10 | -7620.0 |
| PRKAB2 | -7660.0 |
| SEC23A | -7718.0 |
| CYP2J2 | -7731.0 |
| PITPNB | -7740.0 |
| CYP2D6 | -7746.5 |
| CYP4F3 | -7751.0 |
| MED12 | -7822.0 |
| ABCC3 | -7823.0 |
| PNPLA8 | -7824.0 |
| ETNK2 | -7825.0 |
| NEU2 | -7830.0 |
| CYP7B1 | -7839.0 |
| NPAS2 | -7864.0 |
| HSD17B12 | -7912.0 |
| SREBF1 | -7944.0 |
| ACACA | -7955.0 |
| ACHE | -7966.0 |
| MED9 | -7970.0 |
| ME1 | -7972.0 |
| OSBPL8 | -8008.0 |
| DHRS7B | -8015.0 |
| ALOX5 | -8075.0 |
| CLOCK | -8141.0 |
| PLIN1 | -8142.0 |
| SEC24A | -8147.0 |
| CROT | -8187.0 |
| FAR1 | -8198.0 |
| GPX4 | -8221.0 |
| MED14 | -8255.0 |
Regulation of expression of SLITs and ROBOs
| 1010 | |
|---|---|
| set | Regulation of expression of SLITs and ROBOs |
| setSize | 133 |
| pANOVA | 2.86e-09 |
| s.dist | -0.298 |
| p.adjustANOVA | 1.82e-07 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282 |
| RPS16 | -8246 |
| RPS17 | -8231 |
| ELOC | -8174 |
| ROBO2 | -8163 |
| UPF2 | -8156 |
| RPS3A | -7929 |
| RPS28 | -7809 |
| RPL29 | -7770 |
| RPS21 | -7764 |
| RPS5 | -7648 |
| RPS27A | -7640 |
| RPS15 | -7548 |
| PSMA4 | -7394 |
| RPS11 | -7379 |
| RPS14 | -7325 |
| RPL38 | -7298 |
| RPL13A | -7282 |
| PSMA6 | -7250 |
| RPL24 | -7065 |
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| RPS16 | -8246.0 |
| RPS17 | -8231.0 |
| ELOC | -8174.0 |
| ROBO2 | -8163.0 |
| UPF2 | -8156.0 |
| RPS3A | -7929.0 |
| RPS28 | -7809.0 |
| RPL29 | -7770.0 |
| RPS21 | -7764.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| RPS15 | -7548.0 |
| PSMA4 | -7394.0 |
| RPS11 | -7379.0 |
| RPS14 | -7325.0 |
| RPL38 | -7298.0 |
| RPL13A | -7282.0 |
| PSMA6 | -7250.0 |
| RPL24 | -7065.0 |
| RPL32 | -7023.0 |
| PSMB6 | -6996.0 |
| RPL6 | -6916.0 |
| RPS10 | -6822.5 |
| RPS26 | -6692.0 |
| RPL18 | -6689.0 |
| RPL18A | -6679.0 |
| RPLP1 | -6661.0 |
| RPS8 | -6597.0 |
| PSMC5 | -6575.0 |
| RPL36 | -6366.0 |
| RPLP2 | -6273.0 |
| PSMB7 | -6252.0 |
| RPL23 | -6194.0 |
| RPL30 | -6152.0 |
| RPL15 | -6030.0 |
| RPS4X | -6019.0 |
| RPL28 | -5981.0 |
| PSMB1 | -5931.0 |
| RPL35 | -5900.0 |
| RPS23 | -5865.0 |
| RPL5 | -5749.0 |
| RPS19 | -5609.0 |
| PSMB4 | -5607.0 |
| RPL37A | -5473.0 |
| PSMD5 | -5412.0 |
| RPL19 | -5108.0 |
| PSMA3 | -5078.0 |
| PSMA2 | -5050.5 |
| FAU | -4829.0 |
| GSPT2 | -4504.0 |
| RPL35A | -4460.0 |
| RPL13 | -4424.0 |
| UPF3A | -4384.0 |
| RPS6 | -4373.0 |
| COL4A5 | -4372.0 |
| ETF1 | -4323.0 |
| MAGOH | -4309.0 |
| PSMD14 | -4055.0 |
| RPSA | -4027.0 |
| RPL3 | -3968.0 |
| ISL1 | -3924.0 |
| PSMD8 | -3851.0 |
| RPL10A | -3822.0 |
| RPS13 | -3718.0 |
| PSMB3 | -3665.0 |
| LHX2 | -3561.0 |
| PSMC2 | -3419.0 |
| PSMD6 | -3353.0 |
| RBX1 | -3219.0 |
| NCBP1 | -3144.0 |
| PSMD4 | -3118.0 |
| PSMC4 | -3007.0 |
| RPL7 | -2750.0 |
| RPL8 | -2587.0 |
| PSMA7 | -2576.0 |
| RBM8A | -2564.0 |
| RPS18 | -2478.0 |
| PSMA1 | -2388.0 |
| PSMD2 | -2319.0 |
| PSMD1 | -2102.0 |
| ROBO1 | -1904.0 |
| PSMA8 | -1679.0 |
| PSMC6 | -1541.0 |
| LHX4 | -1469.0 |
| PSMD11 | -1181.0 |
| PSMD3 | -1168.0 |
| RPL23A | -1088.0 |
| PSMA5 | -604.0 |
| CUL2 | -316.0 |
| RPL31 | -303.0 |
| ZSWIM8 | -287.0 |
| RPS2 | -219.0 |
| PSMB5 | -153.0 |
| PSMD7 | 321.0 |
| ROBO3 | 480.0 |
| RPS27L | 522.0 |
| LHX3 | 607.0 |
| RPL27 | 706.0 |
| RNPS1 | 803.0 |
| NCBP2 | 898.0 |
| EIF4A3 | 950.0 |
| UBC | 1013.0 |
| PSMC1 | 1107.0 |
| RPL7A | 1400.0 |
| PSME4 | 1510.0 |
| PSMB2 | 1548.0 |
| MAGOHB | 1608.0 |
| UPF3B | 2124.0 |
| PSME2 | 2230.0 |
| PSMC3 | 2256.0 |
| CASC3 | 2399.0 |
| RPL37 | 2677.0 |
| DAG1 | 2723.0 |
| RPS9 | 3031.0 |
| RPS3 | 3136.0 |
| HOXA2 | 3282.0 |
| USP33 | 3752.0 |
| PSMD12 | 4108.0 |
| EIF4G1 | 4151.0 |
| LHX9 | 4232.0 |
| RPL3L | 4494.0 |
| PSMD13 | 4498.0 |
| PSMB9 | 5019.0 |
| RPL22 | 5158.0 |
| SLIT1 | 5988.0 |
| LDB1 | 5989.0 |
| PSMF1 | 6184.0 |
| GSPT1 | 6438.0 |
| MSI1 | 6507.0 |
| PSME1 | 6608.0 |
| PSMB8 | 7523.0 |
| SLIT2 | 7657.0 |
Metabolism of RNA
| 657 | |
|---|---|
| set | Metabolism of RNA |
| setSize | 604 |
| pANOVA | 2.49e-08 |
| s.dist | -0.133 |
| p.adjustANOVA | 1.52e-06 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282 |
| BUD31 | -8277 |
| RPS16 | -8246 |
| TSR1 | -8237 |
| RPS17 | -8231 |
| MYC | -8227 |
| LAS1L | -8220 |
| HEATR1 | -8214 |
| SF3A3 | -8199 |
| UPF2 | -8156 |
| ENPP2 | -8119 |
| QTRT2 | -8113 |
| EXOSC1 | -8073 |
| HNRNPH1 | -8040 |
| RPP40 | -7990 |
| PPIH | -7952 |
| RPS3A | -7929 |
| CSTF3 | -7917 |
| SMG7 | -7916 |
| GTF2H1 | -7913 |
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| BUD31 | -8277.0 |
| RPS16 | -8246.0 |
| TSR1 | -8237.0 |
| RPS17 | -8231.0 |
| MYC | -8227.0 |
| LAS1L | -8220.0 |
| HEATR1 | -8214.0 |
| SF3A3 | -8199.0 |
| UPF2 | -8156.0 |
| ENPP2 | -8119.0 |
| QTRT2 | -8113.0 |
| EXOSC1 | -8073.0 |
| HNRNPH1 | -8040.0 |
| RPP40 | -7990.0 |
| PPIH | -7952.0 |
| RPS3A | -7929.0 |
| CSTF3 | -7917.0 |
| SMG7 | -7916.0 |
| GTF2H1 | -7913.0 |
| CDKAL1 | -7811.0 |
| RPS28 | -7809.0 |
| WDR75 | -7780.0 |
| RPL29 | -7770.0 |
| RPS21 | -7764.0 |
| SMG6 | -7760.0 |
| RTRAF | -7745.0 |
| HNRNPF | -7672.0 |
| TPRKB | -7658.0 |
| NAT10 | -7652.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| SNRPD3 | -7627.5 |
| APOBEC1 | -7613.0 |
| WDR77 | -7592.0 |
| TRMT61A | -7560.0 |
| APOBEC2 | -7555.0 |
| RPS15 | -7548.0 |
| PPIL1 | -7506.0 |
| ZFP36 | -7486.0 |
| POLR2D | -7461.0 |
| GTF2H5 | -7457.0 |
| RANBP2 | -7410.0 |
| PSMA4 | -7394.0 |
| RPS11 | -7379.0 |
| RPS14 | -7325.0 |
| PPIE | -7317.0 |
| SRSF5 | -7315.0 |
| SMNDC1 | -7314.0 |
| PAIP1 | -7306.0 |
| RPL38 | -7298.0 |
| BMS1 | -7297.0 |
| RPL13A | -7282.0 |
| PSMA6 | -7250.0 |
| NUP214 | -7243.0 |
| NUP205 | -7210.0 |
| SLU7 | -7196.0 |
| SNRNP25 | -7143.0 |
| RCL1 | -7096.0 |
| PRKCA | -7092.0 |
| RPL24 | -7065.0 |
| RPL32 | -7023.0 |
| CWC15 | -7021.0 |
| THOC6 | -7012.0 |
| PSMB6 | -6996.0 |
| MPHOSPH6 | -6988.0 |
| TRMT5 | -6970.0 |
| RPL6 | -6916.0 |
| TRMT13 | -6888.0 |
| PPIL3 | -6875.0 |
| PRPF40A | -6829.0 |
| RPS10 | -6822.5 |
| THG1L | -6817.0 |
| CD44 | -6801.0 |
| MAPK11 | -6774.0 |
| NUP43 | -6740.0 |
| ZMAT5 | -6736.0 |
| RIOK3 | -6733.0 |
| RPS26 | -6692.0 |
| RPL18 | -6689.0 |
| RPL18A | -6679.0 |
| CNOT10 | -6663.0 |
| RPLP1 | -6661.0 |
| SLBP | -6655.0 |
| POP5 | -6654.0 |
| RPS8 | -6597.0 |
| PSMC5 | -6575.0 |
| EXOSC9 | -6555.0 |
| THOC1 | -6514.0 |
| EMG1 | -6502.0 |
| ALKBH8 | -6484.0 |
| EBNA1BP2 | -6480.0 |
| TTC37 | -6455.0 |
| NXT1 | -6449.0 |
| DDX23 | -6407.0 |
| RPL36 | -6366.0 |
| SMG5 | -6279.0 |
| RPLP2 | -6273.0 |
| XRN1 | -6263.0 |
| PSMB7 | -6252.0 |
| IGF2BP3 | -6248.0 |
| RPL23 | -6194.0 |
| RPL30 | -6152.0 |
| HBS1L | -6113.0 |
| PUS3 | -6107.0 |
| SRSF3 | -6066.0 |
| RPL15 | -6030.0 |
| RPS4X | -6019.0 |
| NOP14 | -5999.0 |
| LTV1 | -5990.5 |
| RPL28 | -5981.0 |
| EIF4A2 | -5979.0 |
| ZC3H11A | -5961.5 |
| PSMB1 | -5931.0 |
| LSM5 | -5924.0 |
| APOBEC3H | -5912.0 |
| RPL35 | -5900.0 |
| RPS23 | -5865.0 |
| FTSJ1 | -5861.0 |
| PNO1 | -5857.0 |
| DDX6 | -5851.0 |
| WDR61 | -5781.0 |
| POP7 | -5763.0 |
| WDR12 | -5752.0 |
| RPL5 | -5749.0 |
| SNRNP48 | -5745.0 |
| TEX10 | -5719.0 |
| IMP4 | -5693.0 |
| PWP2 | -5683.5 |
| GEMIN2 | -5661.0 |
| NOC4L | -5659.0 |
| TRMT6 | -5651.0 |
| NUP160 | -5641.0 |
| RPS19 | -5609.0 |
| PRPF4 | -5608.0 |
| PSMB4 | -5607.0 |
| MAPK14 | -5555.0 |
| DDX52 | -5552.0 |
| SRSF11 | -5549.0 |
| SEC13 | -5544.0 |
| NOL12 | -5510.5 |
| RPL37A | -5473.0 |
| PQBP1 | -5466.0 |
| NOP58 | -5436.0 |
| DDX21 | -5435.0 |
| DHX37 | -5426.0 |
| PSMD5 | -5412.0 |
| LSM4 | -5405.0 |
| TP53RK | -5386.0 |
| NOP10 | -5374.0 |
| SF3B1 | -5370.0 |
| DDX39A | -5351.0 |
| IMP3 | -5333.0 |
| DDX20 | -5321.0 |
| NOL9 | -5210.0 |
| GEMIN7 | -5204.0 |
| UTP6 | -5198.0 |
| NUP42 | -5168.0 |
| NIP7 | -5163.0 |
| RPL19 | -5108.0 |
| PSMA3 | -5078.0 |
| PSMA2 | -5050.5 |
| CLNS1A | -5049.0 |
| HNRNPA3 | -5022.0 |
| UTP15 | -4961.0 |
| BCAS2 | -4951.0 |
| RPP30 | -4931.0 |
| NUP54 | -4913.0 |
| CWC27 | -4911.0 |
| LAGE3 | -4890.0 |
| PAN2 | -4866.0 |
| WDR36 | -4849.0 |
| FAU | -4829.0 |
| NXF1 | -4803.0 |
| PHAX | -4752.0 |
| TRMT12 | -4731.0 |
| LSM7 | -4729.0 |
| TNFSF13 | -4724.0 |
| RPP25 | -4689.0 |
| POLR2C | -4681.0 |
| BOP1 | -4674.0 |
| PPIL6 | -4667.0 |
| NUP107 | -4634.0 |
| NUP35 | -4632.0 |
| GEMIN8 | -4630.0 |
| SRSF6 | -4629.0 |
| PPIL4 | -4622.0 |
| FTSJ3 | -4563.0 |
| CNOT4 | -4531.0 |
| WDR3 | -4529.0 |
| GTF2H2 | -4507.5 |
| GSPT2 | -4504.0 |
| RPL35A | -4460.0 |
| SNRPD1 | -4459.0 |
| C1D | -4432.0 |
| RPL13 | -4424.0 |
| WDR33 | -4408.0 |
| RNPC3 | -4388.0 |
| UPF3A | -4384.0 |
| UTP18 | -4374.0 |
| RPS6 | -4373.0 |
| PCF11 | -4346.0 |
| ETF1 | -4323.0 |
| MAGOH | -4309.0 |
| TRA2B | -4288.0 |
| GEMIN6 | -4286.0 |
| DUS2 | -4285.0 |
| PRKCD | -4252.0 |
| POLR2G | -4208.0 |
| TSEN15 | -4205.0 |
| PCBP2 | -4190.0 |
| PSMD14 | -4055.0 |
| METTL14 | -4046.0 |
| RPSA | -4027.0 |
| SNRPG | -4015.0 |
| HSPA8 | -3970.0 |
| RPL3 | -3968.0 |
| DDX46 | -3929.0 |
| SRRT | -3902.0 |
| PSMD8 | -3851.0 |
| RPL10A | -3822.0 |
| RPS13 | -3718.0 |
| ZBTB8OS | -3706.0 |
| RRP9 | -3702.0 |
| PSMB3 | -3665.0 |
| METTL1 | -3645.0 |
| DDX49 | -3628.0 |
| PUS7 | -3589.0 |
| LSM3 | -3545.0 |
| TGS1 | -3538.0 |
| THADA | -3532.0 |
| PRMT5 | -3512.0 |
| NOP56 | -3482.0 |
| EXOSC4 | -3421.0 |
| THOC7 | -3420.0 |
| PSMC2 | -3419.0 |
| GLE1 | -3391.0 |
| EXOSC5 | -3356.0 |
| PSMD6 | -3353.0 |
| WDR43 | -3348.0 |
| NCL | -3329.0 |
| ISY1 | -3295.5 |
| PAPOLA | -3280.0 |
| SNRNP200 | -3275.0 |
| GNL3 | -3174.0 |
| UTP20 | -3157.0 |
| DDX42 | -3155.0 |
| TRMT10C | -3148.0 |
| NCBP1 | -3144.0 |
| PSMD4 | -3118.0 |
| MT-ND3 | -3112.0 |
| GTF2F2 | -3055.0 |
| CWC22 | -3035.0 |
| WTAP | -3021.0 |
| PSMC4 | -3007.0 |
| PRPF3 | -2927.0 |
| ZNF473 | -2914.0 |
| NUP88 | -2879.0 |
| PRPF19 | -2878.0 |
| IGF2BP2 | -2814.0 |
| DDX5 | -2813.0 |
| FCF1 | -2809.0 |
| MTREX | -2791.0 |
| THOC2 | -2790.0 |
| RPL7 | -2750.0 |
| SRSF1 | -2734.0 |
| DCAF13 | -2707.0 |
| PRPF38A | -2657.0 |
| PELP1 | -2654.0 |
| SRSF2 | -2590.0 |
| RPL8 | -2587.0 |
| PSMA7 | -2576.0 |
| RBM8A | -2564.0 |
| SNRPD2 | -2490.0 |
| PLRG1 | -2479.0 |
| RPS18 | -2478.0 |
| POLR2L | -2471.0 |
| CPSF4 | -2453.0 |
| SNRPA | -2408.0 |
| PSMA1 | -2388.0 |
| CCNH | -2363.0 |
| DIMT1 | -2344.0 |
| CPSF7 | -2334.0 |
| SRRM2 | -2320.0 |
| PSMD2 | -2319.0 |
| CTU2 | -2309.0 |
| POLR2I | -2271.0 |
| HNRNPK | -2251.0 |
| C2orf49 | -2232.0 |
| EXOSC3 | -2219.0 |
| SNRNP40 | -2214.0 |
| SRSF7 | -2197.0 |
| PSMD1 | -2102.0 |
| NOL11 | -1943.0 |
| SF3B6 | -1936.0 |
| PRPF6 | -1876.0 |
| THOC5 | -1866.0 |
| SNRNP35 | -1825.0 |
| CSTF2 | -1811.0 |
| SNRPB2 | -1742.0 |
| TSEN2 | -1709.0 |
| PSMA8 | -1679.0 |
| CWC25 | -1677.0 |
| ADAT1 | -1673.0 |
| DDX47 | -1644.0 |
| CNOT2 | -1622.0 |
| DDX1 | -1572.0 |
| MNAT1 | -1564.0 |
| PSMC6 | -1541.0 |
| HSPB1 | -1531.0 |
| PHF5A | -1498.0 |
| DIS3 | -1452.0 |
| DNAJC8 | -1356.0 |
| LCMT2 | -1353.0 |
| MRM1 | -1343.0 |
| SUGP1 | -1338.0 |
| ZRSR2 | -1321.0 |
| CCAR1 | -1243.0 |
| PSMD11 | -1181.0 |
| PSMD3 | -1168.0 |
| IGF2BP1 | -1126.0 |
| RPL23A | -1088.0 |
| U2SURP | -1070.0 |
| POLR2H | -1058.0 |
| THUMPD1 | -1054.0 |
| DCP1A | -1050.0 |
| RIOK1 | -1046.0 |
| SNRPC | -1045.0 |
| ELAVL1 | -955.0 |
| POLR2F | -932.0 |
| BYSL | -877.0 |
| RIOK2 | -834.0 |
| PSMA5 | -604.0 |
| POP4 | -571.0 |
| U2AF1 | -569.5 |
| NUP210 | -565.0 |
| CNOT11 | -455.0 |
| UTP14A | -381.5 |
| UTP14C | -381.5 |
| ERI1 | -324.0 |
| RBM22 | -320.0 |
| RPL31 | -303.0 |
| DHX38 | -274.0 |
| CLP1 | -273.0 |
| RAE1 | -259.0 |
| RPS2 | -219.0 |
| SNRPE | -219.0 |
| URM1 | -219.0 |
| EIF4A1 | -181.0 |
| RNMT | -179.0 |
| RBM17 | -160.0 |
| PSMB5 | -153.0 |
| NSUN6 | -71.0 |
| EIF4E | -29.0 |
| PAN3 | -13.0 |
| POLDIP3 | -9.0 |
| HNRNPM | -5.0 |
| SNU13 | 188.0 |
| AQR | 242.0 |
| TSR3 | 320.0 |
| PSMD7 | 321.0 |
| UTP11 | 411.0 |
| NUP37 | 424.0 |
| PPWD1 | 426.0 |
| TYW5 | 430.0 |
| PPP2CA | 497.0 |
| RPS27L | 522.0 |
| GTF2H3 | 553.0 |
| SMG9 | 582.0 |
| RPL27 | 706.0 |
| SF3B5 | 715.0 |
| SYMPK | 735.0 |
| TFB1M | 788.0 |
| RNPS1 | 803.0 |
| UTP3 | 843.0 |
| NCBP2 | 898.0 |
| MRM2 | 930.5 |
| PRPF31 | 934.0 |
| CTU1 | 935.0 |
| EIF4A3 | 950.0 |
| NUP188 | 957.0 |
| OSGEP | 990.0 |
| MPHOSPH10 | 991.0 |
| UBC | 1013.0 |
| TRMT44 | 1039.0 |
| PRORP | 1105.5 |
| PSMC1 | 1107.0 |
| RBM5 | 1159.0 |
| SF3B3 | 1273.0 |
| ZCRB1 | 1290.0 |
| NOB1 | 1300.0 |
| TBL3 | 1340.0 |
| RPL7A | 1400.0 |
| UTP4 | 1419.0 |
| NUP62 | 1422.0 |
| CTNNBL1 | 1424.0 |
| PABPN1 | 1437.5 |
| SNRPA1 | 1460.0 |
| U2AF2 | 1467.0 |
| PSME4 | 1510.0 |
| RRP7A | 1528.0 |
| USP39 | 1547.0 |
| PSMB2 | 1548.0 |
| TRIT1 | 1588.0 |
| MAGOHB | 1608.0 |
| EXOSC10 | 1617.0 |
| CHERP | 1618.0 |
| CDC40 | 1669.0 |
| ACTB | 1684.0 |
| TNPO1 | 1708.0 |
| TRNT1 | 1725.0 |
| HSD17B10 | 1753.0 |
| PDCD7 | 1768.0 |
| PDCD11 | 1804.0 |
| LSM6 | 1811.0 |
| GTF2H4 | 1930.0 |
| TPR | 1935.0 |
| EDC4 | 2001.0 |
| XPO1 | 2059.0 |
| TSEN54 | 2074.0 |
| UPF3B | 2124.0 |
| TSEN34 | 2164.0 |
| XPOT | 2214.0 |
| PSME2 | 2230.0 |
| TRDMT1 | 2232.0 |
| PSMC3 | 2256.0 |
| PUF60 | 2268.0 |
| EXOSC7 | 2356.0 |
| RRP36 | 2367.0 |
| HSPA1A | 2373.5 |
| METTL3 | 2390.0 |
| NUP153 | 2394.0 |
| CASC3 | 2399.0 |
| U2AF1L4 | 2416.5 |
| TRMT1 | 2430.0 |
| HNRNPA0 | 2449.0 |
| POLR2B | 2513.0 |
| GPKOW | 2516.0 |
| QTRT1 | 2520.0 |
| SRSF10 | 2596.0 |
| ERCC2 | 2618.0 |
| RTCB | 2647.0 |
| RPL37 | 2677.0 |
| PPP2R2A | 2684.0 |
| NUP85 | 2708.0 |
| GTF2F1 | 2709.0 |
| SENP3 | 2732.5 |
| ALYREF | 2748.0 |
| SYF2 | 2768.0 |
| EPRS1 | 2820.0 |
| SRRM1 | 2836.0 |
| TRMU | 2928.0 |
| TRMT10A | 2938.0 |
| FUS | 2948.0 |
| KRR1 | 2965.0 |
| DCP1B | 2978.0 |
| EXOSC6 | 3010.0 |
| SRSF4 | 3011.0 |
| RBM28 | 3020.0 |
| RPS9 | 3031.0 |
| TNKS1BP1 | 3073.0 |
| TFIP11 | 3096.0 |
| RPS3 | 3136.0 |
| AAAS | 3172.0 |
| PES1 | 3220.0 |
| SKIV2L | 3278.0 |
| SNUPN | 3347.0 |
| ZFP36L1 | 3380.0 |
| SNRPB | 3448.0 |
| SARNP | 3479.0 |
| POM121 | 3523.5 |
| POM121C | 3523.5 |
| AKT1 | 3530.0 |
| EDC3 | 3543.0 |
| CNOT8 | 3544.0 |
| GTPBP3 | 3564.0 |
| MT-ND4L | 3569.0 |
| CPSF2 | 3593.0 |
| NUDT21 | 3672.0 |
| DHX16 | 3676.0 |
| ISG20L2 | 3698.0 |
| DHX15 | 3789.0 |
| PPP2R1A | 3805.0 |
| MT-CO3 | 3879.0 |
| PUS1 | 3916.0 |
| FYTTD1 | 3957.0 |
| FBL | 3970.0 |
| DHX9 | 3976.0 |
| MT-CO2 | 3989.0 |
| SNW1 | 4003.0 |
| PSMD12 | 4108.0 |
| EIF4G1 | 4151.0 |
| GPRC5A | 4169.0 |
| SRSF9 | 4225.0 |
| SMG8 | 4226.0 |
| TYW1 | 4287.5 |
| EXOSC8 | 4292.0 |
| HNRNPR | 4294.0 |
| HNRNPA2B1 | 4375.0 |
| MT-ND4 | 4382.0 |
| CD2BP2 | 4387.0 |
| SMN1 | 4395.5 |
| ADAR | 4425.0 |
| MTO1 | 4449.0 |
| NXF2 | 4458.0 |
| RPL3L | 4494.0 |
| PSMD13 | 4498.0 |
| NUP93 | 4512.0 |
| ERCC3 | 4515.0 |
| NUP98 | 4522.0 |
| CNOT1 | 4545.0 |
| POP1 | 4612.0 |
| MT-ATP6 | 4629.0 |
| FAM98B | 4656.0 |
| YWHAB | 4694.0 |
| NT5C3B | 4710.0 |
| SF3B2 | 4713.0 |
| MRM3 | 4729.0 |
| MT-ND6 | 4767.0 |
| NSUN2 | 4779.0 |
| ANP32A | 4822.5 |
| TYW3 | 4832.0 |
| HNRNPU | 4859.0 |
| CNOT7 | 4870.0 |
| MT-ND2 | 4879.0 |
| MT-ND5 | 4937.0 |
| CDK7 | 4949.0 |
| CSTF1 | 4970.0 |
| TRMT9B | 4973.0 |
| GEMIN4 | 4978.0 |
| CNOT6L | 4982.0 |
| XRN2 | 4993.0 |
| PSMB9 | 5019.0 |
| CPSF3 | 5037.0 |
| SART1 | 5045.0 |
| ELAVL2 | 5064.0 |
| LSM11 | 5145.0 |
| RPL22 | 5158.0 |
| LSM1 | 5165.0 |
| WDR4 | 5261.0 |
| GEMIN5 | 5282.0 |
| MTERF4 | 5363.0 |
| SF3B4 | 5375.0 |
| ADAT2 | 5399.0 |
| SUPT5H | 5401.0 |
| XAB2 | 5426.0 |
| PATL1 | 5473.0 |
| CRNKL1 | 5484.0 |
| MT-ATP8 | 5500.0 |
| RNGTT | 5571.0 |
| MT-ND1 | 5579.0 |
| NUP133 | 5700.0 |
| KHSRP | 5715.0 |
| CNOT3 | 5744.0 |
| NUP58 | 5787.0 |
| NDC1 | 5827.0 |
| HNRNPH2 | 5828.0 |
| A1CF | 5886.0 |
| IGF2 | 5925.0 |
| WDR46 | 5939.0 |
| SF3A2 | 5950.0 |
| CSNK1D | 6028.0 |
| ELAC2 | 6048.0 |
| MAPKAPK2 | 6139.0 |
| MT-CO1 | 6162.0 |
| PSMF1 | 6184.0 |
| NUP50 | 6188.0 |
| PARN | 6220.0 |
| CDC5L | 6282.0 |
| POLR2A | 6384.0 |
| RRP1 | 6389.0 |
| GSPT1 | 6438.0 |
| THOC3 | 6469.0 |
| ADARB1 | 6485.0 |
| HNRNPUL1 | 6548.0 |
| RBMX | 6602.5 |
| TRMT11 | 6607.0 |
| PSME1 | 6608.0 |
| PRCC | 6678.0 |
| NUP155 | 6749.0 |
| SF1 | 6765.0 |
| YWHAZ | 6876.0 |
| MT-CYB | 7011.0 |
| DKC1 | 7024.0 |
| WBP4 | 7252.0 |
| SF3A1 | 7281.0 |
| CNOT6 | 7360.0 |
| GCFC2 | 7411.0 |
| PRPF8 | 7446.0 |
| CPSF1 | 7491.0 |
| PSMB8 | 7523.0 |
| CHTOP | 7574.0 |
| NOL6 | 7692.0 |
| CSNK1E | 7737.5 |
| EXOSC2 | 7761.0 |
| GAR1 | 7789.0 |
| WDR18 | 7833.0 |
| LSM2 | 7903.0 |
| HNRNPL | 7955.5 |
| POLR2E | 8049.0 |
| HNRNPD | 8054.0 |
| DDX39B | 8068.0 |
| UPF1 | 8167.0 |
| EFTUD2 | 8177.0 |
Influenza Viral RNA Transcription and Replication
| 547 | |
|---|---|
| set | Influenza Viral RNA Transcription and Replication |
| setSize | 103 |
| pANOVA | 4.97e-08 |
| s.dist | -0.311 |
| p.adjustANOVA | 2.91e-06 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282 |
| RPS16 | -8246 |
| RPS17 | -8231 |
| RPS3A | -7929 |
| RPS28 | -7809 |
| RPL29 | -7770 |
| RPS21 | -7764 |
| RPS5 | -7648 |
| RPS27A | -7640 |
| RPS15 | -7548 |
| POLR2D | -7461 |
| RANBP2 | -7410 |
| RPS11 | -7379 |
| RPS14 | -7325 |
| RPL38 | -7298 |
| RPL13A | -7282 |
| NUP214 | -7243 |
| NUP205 | -7210 |
| RPL24 | -7065 |
| RPL32 | -7023 |
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| RPS16 | -8246.0 |
| RPS17 | -8231.0 |
| RPS3A | -7929.0 |
| RPS28 | -7809.0 |
| RPL29 | -7770.0 |
| RPS21 | -7764.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| RPS15 | -7548.0 |
| POLR2D | -7461.0 |
| RANBP2 | -7410.0 |
| RPS11 | -7379.0 |
| RPS14 | -7325.0 |
| RPL38 | -7298.0 |
| RPL13A | -7282.0 |
| NUP214 | -7243.0 |
| NUP205 | -7210.0 |
| RPL24 | -7065.0 |
| RPL32 | -7023.0 |
| RPL6 | -6916.0 |
| RPS10 | -6822.5 |
| NUP43 | -6740.0 |
| RPS26 | -6692.0 |
| RPL18 | -6689.0 |
| RPL18A | -6679.0 |
| RPLP1 | -6661.0 |
| RPS8 | -6597.0 |
| RPL36 | -6366.0 |
| RPLP2 | -6273.0 |
| RPL23 | -6194.0 |
| RPL30 | -6152.0 |
| RPL15 | -6030.0 |
| RPS4X | -6019.0 |
| RPL28 | -5981.0 |
| RPL35 | -5900.0 |
| RPS23 | -5865.0 |
| RPL5 | -5749.0 |
| NUP160 | -5641.0 |
| RPS19 | -5609.0 |
| SEC13 | -5544.0 |
| RPL37A | -5473.0 |
| NUP42 | -5168.0 |
| RPL19 | -5108.0 |
| NUP54 | -4913.0 |
| FAU | -4829.0 |
| POLR2C | -4681.0 |
| NUP107 | -4634.0 |
| NUP35 | -4632.0 |
| RPL35A | -4460.0 |
| RPL13 | -4424.0 |
| RPS6 | -4373.0 |
| POLR2G | -4208.0 |
| RPSA | -4027.0 |
| RPL3 | -3968.0 |
| RPL10A | -3822.0 |
| RPS13 | -3718.0 |
| GTF2F2 | -3055.0 |
| NUP88 | -2879.0 |
| RPL7 | -2750.0 |
| RPL8 | -2587.0 |
| RPS18 | -2478.0 |
| POLR2L | -2471.0 |
| POLR2I | -2271.0 |
| DNAJC3 | -2019.0 |
| PARP1 | -1776.0 |
| RPL23A | -1088.0 |
| POLR2H | -1058.0 |
| POLR2F | -932.0 |
| NUP210 | -565.0 |
| RPL31 | -303.0 |
| RAE1 | -259.0 |
| RPS2 | -219.0 |
| NUP37 | 424.0 |
| RPS27L | 522.0 |
| RPL27 | 706.0 |
| NUP188 | 957.0 |
| RPL7A | 1400.0 |
| NUP62 | 1422.0 |
| TPR | 1935.0 |
| NUP153 | 2394.0 |
| POLR2B | 2513.0 |
| RPL37 | 2677.0 |
| NUP85 | 2708.0 |
| GTF2F1 | 2709.0 |
| RPS9 | 3031.0 |
| RPS3 | 3136.0 |
| AAAS | 3172.0 |
| POM121 | 3523.5 |
| POM121C | 3523.5 |
| RPL3L | 4494.0 |
| NUP93 | 4512.0 |
| NUP98 | 4522.0 |
| RPL22 | 5158.0 |
| NUP133 | 5700.0 |
| NUP58 | 5787.0 |
| NDC1 | 5827.0 |
| IPO5 | 5863.0 |
| NUP50 | 6188.0 |
| POLR2A | 6384.0 |
| NUP155 | 6749.0 |
| GRSF1 | 7696.0 |
| POLR2E | 8049.0 |
Formation of the ternary complex, and subsequently, the 43S complex
| 420 | |
|---|---|
| set | Formation of the ternary complex, and subsequently, the 43S complex |
| setSize | 42 |
| pANOVA | 4.75e-07 |
| s.dist | -0.449 |
| p.adjustANOVA | 2.67e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| RPS16 | -8246.0 |
| RPS17 | -8231.0 |
| RPS3A | -7929.0 |
| RPS28 | -7809.0 |
| RPS21 | -7764.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| RPS15 | -7548.0 |
| RPS11 | -7379.0 |
| RPS14 | -7325.0 |
| EIF2S1 | -7018.0 |
| RPS10 | -6822.5 |
| RPS26 | -6692.0 |
| RPS8 | -6597.0 |
| EIF2S2 | -6402.0 |
| RPS4X | -6019.0 |
| EIF3M | -5875.0 |
| RPS23 | -5865.0 |
| EIF2S3 | -5766.5 |
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| RPS16 | -8246.0 |
| RPS17 | -8231.0 |
| RPS3A | -7929.0 |
| RPS28 | -7809.0 |
| RPS21 | -7764.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| RPS15 | -7548.0 |
| RPS11 | -7379.0 |
| RPS14 | -7325.0 |
| EIF2S1 | -7018.0 |
| RPS10 | -6822.5 |
| RPS26 | -6692.0 |
| RPS8 | -6597.0 |
| EIF2S2 | -6402.0 |
| RPS4X | -6019.0 |
| EIF3M | -5875.0 |
| RPS23 | -5865.0 |
| EIF2S3 | -5766.5 |
| RPS19 | -5609.0 |
| EIF3K | -5288.0 |
| FAU | -4829.0 |
| RPS6 | -4373.0 |
| RPSA | -4027.0 |
| RPS13 | -3718.0 |
| EIF3H | -2613.0 |
| RPS18 | -2478.0 |
| EIF3E | -1890.0 |
| EIF3G | -1499.0 |
| EIF3J | -866.0 |
| RPS2 | -219.0 |
| EIF3B | -78.0 |
| EIF3A | -12.0 |
| RPS27L | 522.0 |
| EIF3C | 1656.5 |
| EIF3D | 2550.0 |
| EIF3L | 2985.0 |
| RPS9 | 3031.0 |
| RPS3 | 3136.0 |
| EIF1AX | 3460.0 |
| EIF3F | 5628.0 |
Influenza Infection
| 546 | |
|---|---|
| set | Influenza Infection |
| setSize | 120 |
| pANOVA | 6.95e-07 |
| s.dist | -0.262 |
| p.adjustANOVA | 3.75e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282 |
| RPS16 | -8246 |
| RPS17 | -8231 |
| RPS3A | -7929 |
| RPS28 | -7809 |
| RPL29 | -7770 |
| RPS21 | -7764 |
| RPS5 | -7648 |
| RPS27A | -7640 |
| RPS15 | -7548 |
| POLR2D | -7461 |
| RANBP2 | -7410 |
| RPS11 | -7379 |
| RPS14 | -7325 |
| RPL38 | -7298 |
| RPL13A | -7282 |
| NUP214 | -7243 |
| NUP205 | -7210 |
| RPL24 | -7065 |
| RPL32 | -7023 |
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| RPS16 | -8246.0 |
| RPS17 | -8231.0 |
| RPS3A | -7929.0 |
| RPS28 | -7809.0 |
| RPL29 | -7770.0 |
| RPS21 | -7764.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| RPS15 | -7548.0 |
| POLR2D | -7461.0 |
| RANBP2 | -7410.0 |
| RPS11 | -7379.0 |
| RPS14 | -7325.0 |
| RPL38 | -7298.0 |
| RPL13A | -7282.0 |
| NUP214 | -7243.0 |
| NUP205 | -7210.0 |
| RPL24 | -7065.0 |
| RPL32 | -7023.0 |
| RPL6 | -6916.0 |
| RPS10 | -6822.5 |
| NUP43 | -6740.0 |
| RPS26 | -6692.0 |
| RPL18 | -6689.0 |
| RPL18A | -6679.0 |
| RPLP1 | -6661.0 |
| RPS8 | -6597.0 |
| RPL36 | -6366.0 |
| RPLP2 | -6273.0 |
| RPL23 | -6194.0 |
| RPL30 | -6152.0 |
| RPL15 | -6030.0 |
| RPS4X | -6019.0 |
| RPL28 | -5981.0 |
| RPL35 | -5900.0 |
| RPS23 | -5865.0 |
| RPL5 | -5749.0 |
| NUP160 | -5641.0 |
| RPS19 | -5609.0 |
| SEC13 | -5544.0 |
| RPL37A | -5473.0 |
| KPNA3 | -5380.0 |
| NUP42 | -5168.0 |
| RPL19 | -5108.0 |
| NUP54 | -4913.0 |
| FAU | -4829.0 |
| POLR2C | -4681.0 |
| NUP107 | -4634.0 |
| NUP35 | -4632.0 |
| RPL35A | -4460.0 |
| KPNA1 | -4441.0 |
| RPL13 | -4424.0 |
| RPS6 | -4373.0 |
| POLR2G | -4208.0 |
| RPSA | -4027.0 |
| KPNA2 | -3986.0 |
| RPL3 | -3968.0 |
| RPL10A | -3822.0 |
| KPNA5 | -3761.0 |
| RPS13 | -3718.0 |
| GTF2F2 | -3055.0 |
| NUP88 | -2879.0 |
| RPL7 | -2750.0 |
| RPL8 | -2587.0 |
| RPS18 | -2478.0 |
| POLR2L | -2471.0 |
| CPSF4 | -2453.0 |
| KPNA4 | -2276.0 |
| POLR2I | -2271.0 |
| DNAJC3 | -2019.0 |
| CLTC | -1818.0 |
| PARP1 | -1776.0 |
| RPL23A | -1088.0 |
| POLR2H | -1058.0 |
| CANX | -1011.0 |
| POLR2F | -932.0 |
| NUP210 | -565.0 |
| RPL31 | -303.0 |
| RAE1 | -259.0 |
| RPS2 | -219.0 |
| NUP37 | 424.0 |
| RPS27L | 522.0 |
| RPL27 | 706.0 |
| NUP188 | 957.0 |
| RPL7A | 1400.0 |
| NUP62 | 1422.0 |
| PABPN1 | 1437.5 |
| CALR | 1483.0 |
| KPNA7 | 1735.5 |
| TPR | 1935.0 |
| XPO1 | 2059.0 |
| HSPA1A | 2373.5 |
| NUP153 | 2394.0 |
| POLR2B | 2513.0 |
| RPL37 | 2677.0 |
| NUP85 | 2708.0 |
| GTF2F1 | 2709.0 |
| RPS9 | 3031.0 |
| RPS3 | 3136.0 |
| AAAS | 3172.0 |
| EIF2AK2 | 3497.0 |
| POM121 | 3523.5 |
| POM121C | 3523.5 |
| TGFB1 | 3695.0 |
| RPL3L | 4494.0 |
| NUP93 | 4512.0 |
| NUP98 | 4522.0 |
| RPL22 | 5158.0 |
| KPNB1 | 5247.0 |
| NUP133 | 5700.0 |
| NUP58 | 5787.0 |
| NDC1 | 5827.0 |
| IPO5 | 5863.0 |
| NUP50 | 6188.0 |
| POLR2A | 6384.0 |
| NUP155 | 6749.0 |
| CLTA | 7341.0 |
| GRSF1 | 7696.0 |
| POLR2E | 8049.0 |
Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.
| 1038 | |
|---|---|
| set | Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
| setSize | 102 |
| pANOVA | 7.85e-07 |
| s.dist | 0.283 |
| p.adjustANOVA | 4.08e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NDUFA10 | 7483 |
| NDUFA8 | 7131 |
| NDUFA12 | 7130 |
| MT-CYB | 7011 |
| NDUFAB1 | 6996 |
| ECSIT | 6963 |
| UQCRC1 | 6960 |
| SLC25A27 | 6807 |
| NDUFV1 | 6489 |
| ATP5F1B | 6480 |
| ACAD9 | 6453 |
| COX5B | 6442 |
| NDUFA9 | 6209 |
| ATP5F1D | 6163 |
| MT-CO1 | 6162 |
| TRAP1 | 6126 |
| SDHC | 6123 |
| NDUFB10 | 6086 |
| COX5A | 6026 |
| COX4I1 | 6009 |
| GeneID | Gene Rank |
|---|---|
| NDUFA10 | 7483.0 |
| NDUFA8 | 7131.0 |
| NDUFA12 | 7130.0 |
| MT-CYB | 7011.0 |
| NDUFAB1 | 6996.0 |
| ECSIT | 6963.0 |
| UQCRC1 | 6960.0 |
| SLC25A27 | 6807.0 |
| NDUFV1 | 6489.0 |
| ATP5F1B | 6480.0 |
| ACAD9 | 6453.0 |
| COX5B | 6442.0 |
| NDUFA9 | 6209.0 |
| ATP5F1D | 6163.0 |
| MT-CO1 | 6162.0 |
| TRAP1 | 6126.0 |
| SDHC | 6123.0 |
| NDUFB10 | 6086.0 |
| COX5A | 6026.0 |
| COX4I1 | 6009.0 |
| COX18 | 5890.0 |
| ETFB | 5756.0 |
| SDHB | 5629.0 |
| NDUFS5 | 5612.0 |
| ATP5MC3 | 5582.0 |
| MT-ND1 | 5579.0 |
| NDUFB7 | 5573.0 |
| NDUFV3 | 5524.0 |
| MT-ATP8 | 5500.0 |
| NDUFAF7 | 5479.0 |
| ETFDH | 5372.0 |
| COQ10A | 5345.0 |
| ETFA | 5269.0 |
| NDUFB6 | 4983.0 |
| MT-ND5 | 4937.0 |
| CYC1 | 4883.0 |
| MT-ND2 | 4879.0 |
| TIMMDC1 | 4862.0 |
| MT-ND6 | 4767.0 |
| MT-ATP6 | 4629.0 |
| MT-ND4 | 4382.0 |
| NDUFS3 | 4380.0 |
| COX11 | 4280.0 |
| TACO1 | 4096.0 |
| NDUFB11 | 4068.0 |
| DMAC2L | 4044.0 |
| MT-CO2 | 3989.0 |
| ATP5ME | 3979.0 |
| NDUFAF3 | 3956.0 |
| MT-CO3 | 3879.0 |
| NDUFS1 | 3819.0 |
| UCP2 | 3761.0 |
| SLC25A14 | 3669.0 |
| COX6B1 | 3551.0 |
| NDUFS8 | 3493.0 |
| COX7A2L | 3473.0 |
| ATP5PD | 3350.0 |
| UQCRC2 | 3202.0 |
| SDHA | 3123.5 |
| NDUFS7 | 3090.0 |
| UQCRFS1 | 3065.0 |
| ATP5PO | 2966.5 |
| NDUFB4 | 2890.0 |
| NDUFAF6 | 2862.0 |
| COX6A1 | 2441.0 |
| NDUFA4 | 2427.0 |
| NDUFA6 | 2222.0 |
| NDUFS4 | 2132.0 |
| SCO1 | 1481.0 |
| UCP1 | 1390.0 |
| NDUFAF4 | 1307.0 |
| NDUFAF1 | 1191.0 |
| NDUFB8 | 1015.5 |
| NDUFA13 | 544.0 |
| SDHD | -389.5 |
| NDUFA3 | -953.0 |
| ATP5PF | -1203.0 |
| UCP3 | -1769.0 |
| ATP5MF | -1892.0 |
| NDUFB5 | -1930.0 |
| NDUFV2 | -2183.0 |
| COX7B | -2241.0 |
| NDUFC2 | -3052.5 |
| MT-ND3 | -3112.0 |
| UQCR11 | -3215.5 |
| NDUFA11 | -3345.5 |
| NUBPL | -3355.0 |
| NDUFA2 | -3380.0 |
| NDUFS2 | -3401.0 |
| COX7C | -3618.0 |
| UQCR10 | -3998.0 |
| COQ10B | -4282.0 |
| NDUFAF5 | -4827.0 |
| UQCRB | -5007.0 |
| UQCRH | -5150.5 |
| TMEM126B | -5318.0 |
| ATP5MG | -5696.5 |
| COX16 | -6527.0 |
| NDUFB3 | -6948.0 |
| COX19 | -7585.0 |
| PM20D1 | -7706.0 |
| ATP5F1E | -8086.0 |
Mitochondrial Fatty Acid Beta-Oxidation
| 685 | |
|---|---|
| set | Mitochondrial Fatty Acid Beta-Oxidation |
| setSize | 34 |
| pANOVA | 9.41e-07 |
| s.dist | 0.486 |
| p.adjustANOVA | 4.72e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ACOT7 | 7952.0 |
| ACAA2 | 7671.0 |
| PCCA | 7601.0 |
| ACOT1 | 7508.5 |
| ACOT2 | 7508.5 |
| HADHB | 7290.0 |
| MECR | 7210.0 |
| ACOT13 | 7051.0 |
| ACADVL | 7006.0 |
| NDUFAB1 | 6996.0 |
| THEM4 | 6916.0 |
| ECI1 | 6811.0 |
| MCEE | 6734.0 |
| ACOT11 | 6541.0 |
| MMAA | 6426.0 |
| HADHA | 6375.0 |
| ACADM | 5984.0 |
| ACADL | 5978.0 |
| HADH | 5813.0 |
| ACADS | 4701.0 |
| GeneID | Gene Rank |
|---|---|
| ACOT7 | 7952.0 |
| ACAA2 | 7671.0 |
| PCCA | 7601.0 |
| ACOT1 | 7508.5 |
| ACOT2 | 7508.5 |
| HADHB | 7290.0 |
| MECR | 7210.0 |
| ACOT13 | 7051.0 |
| ACADVL | 7006.0 |
| NDUFAB1 | 6996.0 |
| THEM4 | 6916.0 |
| ECI1 | 6811.0 |
| MCEE | 6734.0 |
| ACOT11 | 6541.0 |
| MMAA | 6426.0 |
| HADHA | 6375.0 |
| ACADM | 5984.0 |
| ACADL | 5978.0 |
| HADH | 5813.0 |
| ACADS | 4701.0 |
| ACSF2 | 4566.0 |
| PCCB | 4518.0 |
| MCAT | 4486.0 |
| MMUT | 2827.0 |
| DECR1 | 1813.0 |
| THEM5 | 765.0 |
| ACAD10 | -476.0 |
| ACBD6 | -500.0 |
| ACOT12 | -1585.0 |
| DBI | -2008.0 |
| ACAD11 | -2890.0 |
| ACSM3 | -2985.0 |
| ACOT9 | -5006.0 |
| PCTP | -5715.0 |
Selenoamino acid metabolism
| 1092 | |
|---|---|
| set | Selenoamino acid metabolism |
| setSize | 84 |
| pANOVA | 1.09e-06 |
| s.dist | -0.308 |
| p.adjustANOVA | 5.17e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| RPS16 | -8246.0 |
| RPS17 | -8231.0 |
| RPS3A | -7929.0 |
| RPS28 | -7809.0 |
| RPL29 | -7770.0 |
| RPS21 | -7764.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| RPS15 | -7548.0 |
| RPS11 | -7379.0 |
| RPS14 | -7325.0 |
| RPL38 | -7298.0 |
| RPL13A | -7282.0 |
| RPL24 | -7065.0 |
| RPL32 | -7023.0 |
| NNMT | -6950.0 |
| RPL6 | -6916.0 |
| RPS10 | -6822.5 |
| RPS26 | -6692.0 |
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| RPS16 | -8246.0 |
| RPS17 | -8231.0 |
| RPS3A | -7929.0 |
| RPS28 | -7809.0 |
| RPL29 | -7770.0 |
| RPS21 | -7764.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| RPS15 | -7548.0 |
| RPS11 | -7379.0 |
| RPS14 | -7325.0 |
| RPL38 | -7298.0 |
| RPL13A | -7282.0 |
| RPL24 | -7065.0 |
| RPL32 | -7023.0 |
| NNMT | -6950.0 |
| RPL6 | -6916.0 |
| RPS10 | -6822.5 |
| RPS26 | -6692.0 |
| RPL18 | -6689.0 |
| RPL18A | -6679.0 |
| RPLP1 | -6661.0 |
| RPS8 | -6597.0 |
| SEPSECS | -6470.0 |
| RPL36 | -6366.0 |
| RPLP2 | -6273.0 |
| RPL23 | -6194.0 |
| RPL30 | -6152.0 |
| RPL15 | -6030.0 |
| RPS4X | -6019.0 |
| RPL28 | -5981.0 |
| RPL35 | -5900.0 |
| RPS23 | -5865.0 |
| RPL5 | -5749.0 |
| RPS19 | -5609.0 |
| RPL37A | -5473.0 |
| RPL19 | -5108.0 |
| FAU | -4829.0 |
| EEFSEC | -4655.0 |
| MAT1A | -4559.0 |
| RPL35A | -4460.0 |
| RPL13 | -4424.0 |
| DARS1 | -4385.0 |
| RPS6 | -4373.0 |
| SCLY | -4215.0 |
| SECISBP2 | -4050.0 |
| RPSA | -4027.0 |
| RPL3 | -3968.0 |
| RPL10A | -3822.0 |
| RPS13 | -3718.0 |
| RPL7 | -2750.0 |
| RPL8 | -2587.0 |
| RPS18 | -2478.0 |
| RARS1 | -2400.0 |
| LARS1 | -2263.0 |
| RPL23A | -1088.0 |
| INMT | -1055.5 |
| AIMP1 | -487.0 |
| RPL31 | -303.0 |
| RPS2 | -219.0 |
| RPS27L | 522.0 |
| GNMT | 585.0 |
| RPL27 | 706.0 |
| RPL7A | 1400.0 |
| RPL37 | 2677.0 |
| EPRS1 | 2820.0 |
| RPS9 | 3031.0 |
| RPS3 | 3136.0 |
| RPL3L | 4494.0 |
| IARS1 | 4606.0 |
| AHCY | 4901.0 |
| RPL22 | 5158.0 |
| MARS1 | 6293.0 |
| KARS1 | 6365.0 |
| CBS | 6623.5 |
| CTH | 7025.0 |
| AIMP2 | 7324.0 |
| PSTK | 7348.0 |
| SARS1 | 7350.0 |
| PAPSS2 | 7656.0 |
| GSR | 7801.0 |
| TXNRD1 | 7917.0 |
| PAPSS1 | 8121.0 |
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
| 539 | |
|---|---|
| set | Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| setSize | 106 |
| pANOVA | 1.11e-06 |
| s.dist | -0.274 |
| p.adjustANOVA | 5.17e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| FCGR2B | -8284.0 |
| CD300C | -8175.0 |
| CD300LF | -8159.0 |
| CD22 | -8146.0 |
| LILRA1 | -8064.5 |
| LILRA2 | -8064.5 |
| LILRB1 | -8064.5 |
| LILRB2 | -8064.5 |
| CLEC2D | -8029.0 |
| SIGLEC1 | -7792.0 |
| CD200R1 | -7467.5 |
| CD300A | -7398.5 |
| CD300LD | -7398.5 |
| TREML2 | -7173.0 |
| FCGR1A | -7140.5 |
| PVR | -7125.0 |
| ITGA4 | -7054.0 |
| CD33 | -6719.5 |
| SIGLEC6 | -6719.5 |
| TRBC1 | -6620.5 |
| GeneID | Gene Rank |
|---|---|
| FCGR2B | -8284.0 |
| CD300C | -8175.0 |
| CD300LF | -8159.0 |
| CD22 | -8146.0 |
| LILRA1 | -8064.5 |
| LILRA2 | -8064.5 |
| LILRB1 | -8064.5 |
| LILRB2 | -8064.5 |
| CLEC2D | -8029.0 |
| SIGLEC1 | -7792.0 |
| CD200R1 | -7467.5 |
| CD300A | -7398.5 |
| CD300LD | -7398.5 |
| TREML2 | -7173.0 |
| FCGR1A | -7140.5 |
| PVR | -7125.0 |
| ITGA4 | -7054.0 |
| CD33 | -6719.5 |
| SIGLEC6 | -6719.5 |
| TRBC1 | -6620.5 |
| HCST | -6444.0 |
| TYROBP | -6404.0 |
| LAIR1 | -6386.0 |
| ITGB7 | -6367.0 |
| SIGLEC12 | -6057.5 |
| SIGLEC7 | -6057.5 |
| SIGLEC8 | -6057.5 |
| SIGLEC9 | -6057.5 |
| CRTAM | -5937.0 |
| CD247 | -5933.0 |
| ICAM5 | -5517.0 |
| COLEC12 | -5439.0 |
| TREM1 | -5414.0 |
| CD1D | -5308.0 |
| PIANP | -5292.0 |
| SLAMF7 | -5287.0 |
| TREM2 | -5197.0 |
| KLRC1 | -5053.5 |
| CD81 | -4889.0 |
| CD3E | -4862.0 |
| TREML4 | -3987.0 |
| RAET1E | -3907.5 |
| CD3D | -3905.0 |
| SIGLEC10 | -3863.5 |
| SIGLEC11 | -3863.5 |
| CD8A | -3675.0 |
| MADCAM1 | -3488.0 |
| KIR2DL1 | -3436.0 |
| KIR2DL3 | -3436.0 |
| KIR2DL4 | -3436.0 |
| KIR3DL1 | -3436.0 |
| KIR3DL2 | -3436.0 |
| CD3G | -3199.0 |
| CD8B | -3184.5 |
| KLRK1 | -3000.0 |
| CD34 | -2848.0 |
| SLAMF6 | -2843.0 |
| KLRB1 | -2512.0 |
| KLRD1 | -2105.0 |
| IGKV1-12 | -1796.5 |
| IGKV1-16 | -1796.5 |
| IGKV1-17 | -1796.5 |
| IGKV1-39 | -1796.5 |
| IGKV1-5 | -1796.5 |
| IGKV1D-12 | -1796.5 |
| IGKV1D-16 | -1796.5 |
| IGKV1D-39 | -1796.5 |
| IFITM1 | -1331.0 |
| IGLV6-57 | -1290.0 |
| ITGB2 | -1161.0 |
| SELL | -825.0 |
| ICAM4 | -501.0 |
| IGHV4-34 | -409.5 |
| IGHV4-39 | -409.5 |
| IGHV4-59 | -409.5 |
| CD300E | 245.0 |
| OSCAR | 529.0 |
| HLA-A | 538.5 |
| HLA-B | 538.5 |
| HLA-C | 538.5 |
| HLA-E | 538.5 |
| HLA-F | 538.5 |
| HLA-G | 538.5 |
| ICAM1 | 971.0 |
| TREML1 | 1797.0 |
| CD40LG | 1866.0 |
| B2M | 2072.0 |
| NECTIN2 | 2095.0 |
| ITGAL | 2183.0 |
| NCR3 | 2749.0 |
| IGKC | 2909.0 |
| CD226 | 3085.0 |
| CDH1 | 3439.0 |
| CXADR | 3737.0 |
| CD40 | 4249.0 |
| ITGB1 | 4674.0 |
| ICAM2 | 4707.0 |
| KLRG1 | 4769.0 |
| CLEC4G | 5542.0 |
| C3 | 6951.0 |
| CD19 | 7249.0 |
| CD300LG | 7303.0 |
| VCAM1 | 7321.0 |
| CD96 | 7332.0 |
| FCGR3A | 7385.5 |
| CD200 | 7711.0 |
Fatty acid metabolism
| 400 | |
|---|---|
| set | Fatty acid metabolism |
| setSize | 160 |
| pANOVA | 1.41e-06 |
| s.dist | 0.221 |
| p.adjustANOVA | 6.4e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PPT2 | 8132.5 |
| NUDT7 | 8063.0 |
| ACOT7 | 7952.0 |
| ACSL6 | 7907.5 |
| GGT5 | 7852.0 |
| SLC27A2 | 7786.0 |
| ACSL1 | 7784.0 |
| HSD17B8 | 7780.0 |
| CYP1B1 | 7721.0 |
| HAO2 | 7672.0 |
| ACAA2 | 7671.0 |
| ACOX2 | 7644.0 |
| PCCA | 7601.0 |
| ACOT1 | 7508.5 |
| ACOT2 | 7508.5 |
| HSD17B4 | 7497.0 |
| CRAT | 7368.0 |
| HADHB | 7290.0 |
| PPARD | 7270.0 |
| ACOX1 | 7255.0 |
| GeneID | Gene Rank |
|---|---|
| PPT2 | 8132.5 |
| NUDT7 | 8063.0 |
| ACOT7 | 7952.0 |
| ACSL6 | 7907.5 |
| GGT5 | 7852.0 |
| SLC27A2 | 7786.0 |
| ACSL1 | 7784.0 |
| HSD17B8 | 7780.0 |
| CYP1B1 | 7721.0 |
| HAO2 | 7672.0 |
| ACAA2 | 7671.0 |
| ACOX2 | 7644.0 |
| PCCA | 7601.0 |
| ACOT1 | 7508.5 |
| ACOT2 | 7508.5 |
| HSD17B4 | 7497.0 |
| CRAT | 7368.0 |
| HADHB | 7290.0 |
| PPARD | 7270.0 |
| ACOX1 | 7255.0 |
| PTGES2 | 7214.0 |
| MECR | 7210.0 |
| CYP4A11 | 7182.5 |
| CYP4A22 | 7182.5 |
| CYP4F11 | 7182.5 |
| ACSF3 | 7053.0 |
| ACOT13 | 7051.0 |
| PTGR2 | 7049.5 |
| PHYH | 7045.0 |
| ACADVL | 7006.0 |
| NDUFAB1 | 6996.0 |
| ALDH3A2 | 6988.0 |
| ELOVL1 | 6929.0 |
| THEM4 | 6916.0 |
| ECI1 | 6811.0 |
| AMACR | 6750.0 |
| MCEE | 6734.0 |
| CYP4F2 | 6710.0 |
| ACOT11 | 6541.0 |
| CPT1B | 6451.0 |
| SLC25A20 | 6449.0 |
| ABCD1 | 6427.0 |
| MMAA | 6426.0 |
| HADHA | 6375.0 |
| ALOX12 | 6295.0 |
| MAPKAPK2 | 6139.0 |
| ACAA1 | 6125.0 |
| SCD | 6085.0 |
| EHHADH | 6024.0 |
| ACADM | 5984.0 |
| ACADL | 5978.0 |
| HADH | 5813.0 |
| HSD17B3 | 5727.0 |
| ELOVL5 | 5710.0 |
| EPHX2 | 5626.0 |
| CPT2 | 5615.0 |
| NUDT19 | 5464.0 |
| DPEP3 | 5463.0 |
| ABCC1 | 5260.0 |
| CPT1A | 5252.0 |
| PON2 | 5161.0 |
| LTA4H | 4990.0 |
| ACOT6 | 4818.0 |
| MLYCD | 4748.0 |
| PON1 | 4745.0 |
| ACADS | 4701.0 |
| ACSF2 | 4566.0 |
| PCCB | 4518.0 |
| MCAT | 4486.0 |
| ELOVL2 | 4317.0 |
| MORC2 | 4155.0 |
| ACBD5 | 4146.0 |
| ELOVL3 | 4059.0 |
| PTGR1 | 3940.0 |
| ACLY | 3933.0 |
| CYP2U1 | 3661.0 |
| GGT1 | 3624.0 |
| ALOXE3 | 3570.0 |
| ELOVL7 | 3264.0 |
| ACOT8 | 3216.0 |
| GPX2 | 3181.0 |
| CYP4B1 | 3008.0 |
| PTGS1 | 2945.0 |
| ELOVL6 | 2936.0 |
| MMUT | 2827.0 |
| PTGIS | 2632.0 |
| HACL1 | 2573.0 |
| CYP8B1 | 2544.0 |
| ACSL5 | 2484.0 |
| ACOX3 | 2479.0 |
| ACOXL | 2122.0 |
| CYP1A2 | 1984.0 |
| DECR1 | 1813.0 |
| PECR | 1557.0 |
| PTGDS | 1364.5 |
| CYP4F22 | 1324.0 |
| TECR | 1244.0 |
| HACD3 | 849.0 |
| THEM5 | 765.0 |
| CBR1 | 743.0 |
| ALOX12B | 627.0 |
| ELOVL4 | 485.0 |
| MID1IP1 | 349.0 |
| HACD4 | 7.0 |
| PRKAA2 | -151.0 |
| ACBD4 | -269.0 |
| ACAD10 | -476.0 |
| TECRL | -489.0 |
| FAAH | -494.0 |
| ACBD6 | -500.0 |
| GPX1 | -981.0 |
| OLAH | -1201.0 |
| ACOT12 | -1585.0 |
| RXRA | -1980.0 |
| DBI | -2008.0 |
| DPEP1 | -2058.0 |
| ACSBG2 | -2092.0 |
| CYP1A1 | -2131.0 |
| ALOX15B | -2390.0 |
| FADS2 | -2411.0 |
| ACOT4 | -2617.0 |
| ACAD11 | -2890.0 |
| ACSM3 | -2985.0 |
| PTGS2 | -3418.0 |
| PPT1 | -3753.0 |
| PON3 | -3794.0 |
| FADS1 | -4018.0 |
| ALOX15 | -4198.0 |
| PLA2G4A | -4306.0 |
| HACD2 | -4442.0 |
| ACSL4 | -4736.0 |
| ACOT9 | -5006.0 |
| CBR4 | -5009.0 |
| FASN | -5133.0 |
| DPEP2 | -5556.0 |
| SLC25A17 | -5644.0 |
| SLC27A3 | -5657.0 |
| PCTP | -5715.0 |
| THRSP | -6068.0 |
| LTC4S | -6307.0 |
| ECI2 | -6476.0 |
| HPGD | -6516.0 |
| SLC25A1 | -6520.0 |
| HACD1 | -6539.0 |
| TBXAS1 | -6596.0 |
| PTGES3 | -6729.0 |
| ACSL3 | -6761.0 |
| PRKAG2 | -6923.0 |
| HPGDS | -6927.0 |
| CYP4F8 | -7313.0 |
| ACSBG1 | -7512.0 |
| ALOX5AP | -7609.0 |
| PRKAB2 | -7660.0 |
| CYP2J2 | -7731.0 |
| CYP4F3 | -7751.0 |
| HSD17B12 | -7912.0 |
| ACACA | -7955.0 |
| ALOX5 | -8075.0 |
| CROT | -8187.0 |
| GPX4 | -8221.0 |
Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S
| 52 | |
|---|---|
| set | Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
| setSize | 48 |
| pANOVA | 2.23e-06 |
| s.dist | -0.395 |
| p.adjustANOVA | 9.77e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| RPS16 | -8246.0 |
| RPS17 | -8231.0 |
| RPS3A | -7929.0 |
| RPS28 | -7809.0 |
| RPS21 | -7764.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| RPS15 | -7548.0 |
| RPS11 | -7379.0 |
| RPS14 | -7325.0 |
| EIF2S1 | -7018.0 |
| RPS10 | -6822.5 |
| RPS26 | -6692.0 |
| RPS8 | -6597.0 |
| EIF4EBP1 | -6482.0 |
| EIF2S2 | -6402.0 |
| RPS4X | -6019.0 |
| EIF4A2 | -5979.0 |
| EIF3M | -5875.0 |
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| RPS16 | -8246.0 |
| RPS17 | -8231.0 |
| RPS3A | -7929.0 |
| RPS28 | -7809.0 |
| RPS21 | -7764.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| RPS15 | -7548.0 |
| RPS11 | -7379.0 |
| RPS14 | -7325.0 |
| EIF2S1 | -7018.0 |
| RPS10 | -6822.5 |
| RPS26 | -6692.0 |
| RPS8 | -6597.0 |
| EIF4EBP1 | -6482.0 |
| EIF2S2 | -6402.0 |
| RPS4X | -6019.0 |
| EIF4A2 | -5979.0 |
| EIF3M | -5875.0 |
| RPS23 | -5865.0 |
| EIF2S3 | -5766.5 |
| RPS19 | -5609.0 |
| EIF3K | -5288.0 |
| FAU | -4829.0 |
| RPS6 | -4373.0 |
| RPSA | -4027.0 |
| RPS13 | -3718.0 |
| EIF3H | -2613.0 |
| RPS18 | -2478.0 |
| EIF3E | -1890.0 |
| EIF3G | -1499.0 |
| EIF3J | -866.0 |
| RPS2 | -219.0 |
| EIF4A1 | -181.0 |
| EIF3B | -78.0 |
| EIF4E | -29.0 |
| EIF3A | -12.0 |
| RPS27L | 522.0 |
| EIF3C | 1656.5 |
| EIF3D | 2550.0 |
| EIF3L | 2985.0 |
| RPS9 | 3031.0 |
| RPS3 | 3136.0 |
| EIF1AX | 3460.0 |
| EIF4G1 | 4151.0 |
| EIF3F | 5628.0 |
| EIF4H | 7514.0 |
Citric acid cycle (TCA cycle)
| 191 | |
|---|---|
| set | Citric acid cycle (TCA cycle) |
| setSize | 22 |
| pANOVA | 2.43e-06 |
| s.dist | 0.58 |
| p.adjustANOVA | 0.000103 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| OGDH | 8010.0 |
| ACO2 | 7469.0 |
| CS | 7355.0 |
| ME3 | 7099.0 |
| DLST | 7073.0 |
| FAHD1 | 6902.0 |
| NNT | 6791.0 |
| IDH3G | 6298.0 |
| SDHC | 6123.0 |
| IDH2 | 6021.0 |
| SDHB | 5629.0 |
| MDH2 | 5314.0 |
| IDH3A | 4957.0 |
| IDH3B | 4913.0 |
| FH | 4639.0 |
| SUCLG1 | 3584.0 |
| SDHA | 3123.5 |
| DLD | 3101.0 |
| SUCLG2 | 1833.0 |
| SUCLA2 | 608.0 |
| GeneID | Gene Rank |
|---|---|
| OGDH | 8010.0 |
| ACO2 | 7469.0 |
| CS | 7355.0 |
| ME3 | 7099.0 |
| DLST | 7073.0 |
| FAHD1 | 6902.0 |
| NNT | 6791.0 |
| IDH3G | 6298.0 |
| SDHC | 6123.0 |
| IDH2 | 6021.0 |
| SDHB | 5629.0 |
| MDH2 | 5314.0 |
| IDH3A | 4957.0 |
| IDH3B | 4913.0 |
| FH | 4639.0 |
| SUCLG1 | 3584.0 |
| SDHA | 3123.5 |
| DLD | 3101.0 |
| SUCLG2 | 1833.0 |
| SUCLA2 | 608.0 |
| SDHD | -389.5 |
| ME2 | -2641.0 |
Respiratory electron transport
| 1037 | |
|---|---|
| set | Respiratory electron transport |
| setSize | 83 |
| pANOVA | 2.51e-06 |
| s.dist | 0.299 |
| p.adjustANOVA | 0.000104 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NDUFA10 | 7483 |
| NDUFA8 | 7131 |
| NDUFA12 | 7130 |
| MT-CYB | 7011 |
| NDUFAB1 | 6996 |
| ECSIT | 6963 |
| UQCRC1 | 6960 |
| NDUFV1 | 6489 |
| ACAD9 | 6453 |
| COX5B | 6442 |
| NDUFA9 | 6209 |
| MT-CO1 | 6162 |
| TRAP1 | 6126 |
| SDHC | 6123 |
| NDUFB10 | 6086 |
| COX5A | 6026 |
| COX4I1 | 6009 |
| COX18 | 5890 |
| ETFB | 5756 |
| SDHB | 5629 |
| GeneID | Gene Rank |
|---|---|
| NDUFA10 | 7483.0 |
| NDUFA8 | 7131.0 |
| NDUFA12 | 7130.0 |
| MT-CYB | 7011.0 |
| NDUFAB1 | 6996.0 |
| ECSIT | 6963.0 |
| UQCRC1 | 6960.0 |
| NDUFV1 | 6489.0 |
| ACAD9 | 6453.0 |
| COX5B | 6442.0 |
| NDUFA9 | 6209.0 |
| MT-CO1 | 6162.0 |
| TRAP1 | 6126.0 |
| SDHC | 6123.0 |
| NDUFB10 | 6086.0 |
| COX5A | 6026.0 |
| COX4I1 | 6009.0 |
| COX18 | 5890.0 |
| ETFB | 5756.0 |
| SDHB | 5629.0 |
| NDUFS5 | 5612.0 |
| MT-ND1 | 5579.0 |
| NDUFB7 | 5573.0 |
| NDUFV3 | 5524.0 |
| NDUFAF7 | 5479.0 |
| ETFDH | 5372.0 |
| COQ10A | 5345.0 |
| ETFA | 5269.0 |
| NDUFB6 | 4983.0 |
| MT-ND5 | 4937.0 |
| CYC1 | 4883.0 |
| MT-ND2 | 4879.0 |
| TIMMDC1 | 4862.0 |
| MT-ND6 | 4767.0 |
| MT-ND4 | 4382.0 |
| NDUFS3 | 4380.0 |
| COX11 | 4280.0 |
| TACO1 | 4096.0 |
| NDUFB11 | 4068.0 |
| MT-CO2 | 3989.0 |
| NDUFAF3 | 3956.0 |
| MT-CO3 | 3879.0 |
| NDUFS1 | 3819.0 |
| COX6B1 | 3551.0 |
| NDUFS8 | 3493.0 |
| COX7A2L | 3473.0 |
| UQCRC2 | 3202.0 |
| SDHA | 3123.5 |
| NDUFS7 | 3090.0 |
| UQCRFS1 | 3065.0 |
| NDUFB4 | 2890.0 |
| NDUFAF6 | 2862.0 |
| COX6A1 | 2441.0 |
| NDUFA4 | 2427.0 |
| NDUFA6 | 2222.0 |
| NDUFS4 | 2132.0 |
| SCO1 | 1481.0 |
| NDUFAF4 | 1307.0 |
| NDUFAF1 | 1191.0 |
| NDUFB8 | 1015.5 |
| NDUFA13 | 544.0 |
| SDHD | -389.5 |
| NDUFA3 | -953.0 |
| NDUFB5 | -1930.0 |
| NDUFV2 | -2183.0 |
| COX7B | -2241.0 |
| NDUFC2 | -3052.5 |
| MT-ND3 | -3112.0 |
| UQCR11 | -3215.5 |
| NDUFA11 | -3345.5 |
| NUBPL | -3355.0 |
| NDUFA2 | -3380.0 |
| NDUFS2 | -3401.0 |
| COX7C | -3618.0 |
| UQCR10 | -3998.0 |
| COQ10B | -4282.0 |
| NDUFAF5 | -4827.0 |
| UQCRB | -5007.0 |
| UQCRH | -5150.5 |
| TMEM126B | -5318.0 |
| COX16 | -6527.0 |
| NDUFB3 | -6948.0 |
| COX19 | -7585.0 |
Signaling by ROBO receptors
| 1163 | |
|---|---|
| set | Signaling by ROBO receptors |
| setSize | 178 |
| pANOVA | 2.76e-06 |
| s.dist | -0.204 |
| p.adjustANOVA | 0.00011 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282 |
| RPS16 | -8246 |
| RPS17 | -8231 |
| ELOC | -8174 |
| ROBO2 | -8163 |
| UPF2 | -8156 |
| RPS3A | -7929 |
| RPS28 | -7809 |
| RPL29 | -7770 |
| RPS21 | -7764 |
| PAK3 | -7738 |
| RPS5 | -7648 |
| RPS27A | -7640 |
| PAK1 | -7605 |
| PAK4 | -7549 |
| RPS15 | -7548 |
| PSMA4 | -7394 |
| RPS11 | -7379 |
| VASP | -7374 |
| RPS14 | -7325 |
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| RPS16 | -8246.0 |
| RPS17 | -8231.0 |
| ELOC | -8174.0 |
| ROBO2 | -8163.0 |
| UPF2 | -8156.0 |
| RPS3A | -7929.0 |
| RPS28 | -7809.0 |
| RPL29 | -7770.0 |
| RPS21 | -7764.0 |
| PAK3 | -7738.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| PAK1 | -7605.0 |
| PAK4 | -7549.0 |
| RPS15 | -7548.0 |
| PSMA4 | -7394.0 |
| RPS11 | -7379.0 |
| VASP | -7374.0 |
| RPS14 | -7325.0 |
| RPL38 | -7298.0 |
| RPL13A | -7282.0 |
| PSMA6 | -7250.0 |
| SRC | -7166.0 |
| PRKCA | -7092.0 |
| RPL24 | -7065.0 |
| RPL32 | -7023.0 |
| PRKAR2A | -7003.0 |
| PSMB6 | -6996.0 |
| RPL6 | -6916.0 |
| RPS10 | -6822.5 |
| PPP3CB | -6779.0 |
| RPS26 | -6692.0 |
| RPL18 | -6689.0 |
| RPL18A | -6679.0 |
| RPLP1 | -6661.0 |
| RPS8 | -6597.0 |
| PSMC5 | -6575.0 |
| RPL36 | -6366.0 |
| PRKACB | -6340.0 |
| RPLP2 | -6273.0 |
| PSMB7 | -6252.0 |
| RPL23 | -6194.0 |
| CDC42 | -6175.0 |
| RPL30 | -6152.0 |
| PAK2 | -6088.0 |
| RPL15 | -6030.0 |
| RPS4X | -6019.0 |
| RPL28 | -5981.0 |
| PSMB1 | -5931.0 |
| RPL35 | -5900.0 |
| RPS23 | -5865.0 |
| SRGAP3 | -5850.0 |
| RPL5 | -5749.0 |
| RPS19 | -5609.0 |
| PSMB4 | -5607.0 |
| RPL37A | -5473.0 |
| PSMD5 | -5412.0 |
| RPL19 | -5108.0 |
| PSMA3 | -5078.0 |
| PSMA2 | -5050.5 |
| SRGAP2 | -4905.0 |
| FAU | -4829.0 |
| PAK5 | -4805.0 |
| FLRT3 | -4708.0 |
| GSPT2 | -4504.0 |
| RPL35A | -4460.0 |
| RPL13 | -4424.0 |
| NCK2 | -4387.0 |
| UPF3A | -4384.0 |
| RPS6 | -4373.0 |
| COL4A5 | -4372.0 |
| ETF1 | -4323.0 |
| MAGOH | -4309.0 |
| PSMD14 | -4055.0 |
| RPSA | -4027.0 |
| RPL3 | -3968.0 |
| ISL1 | -3924.0 |
| PSMD8 | -3851.0 |
| RPL10A | -3822.0 |
| RPS13 | -3718.0 |
| PSMB3 | -3665.0 |
| LHX2 | -3561.0 |
| PSMC2 | -3419.0 |
| PSMD6 | -3353.0 |
| RBX1 | -3219.0 |
| NCBP1 | -3144.0 |
| PSMD4 | -3118.0 |
| PSMC4 | -3007.0 |
| RPL7 | -2750.0 |
| RPL8 | -2587.0 |
| PSMA7 | -2576.0 |
| RBM8A | -2564.0 |
| RPS18 | -2478.0 |
| PSMA1 | -2388.0 |
| PSMD2 | -2319.0 |
| PSMD1 | -2102.0 |
| ROBO1 | -1904.0 |
| PSMA8 | -1679.0 |
| PSMC6 | -1541.0 |
| SOS1 | -1475.0 |
| LHX4 | -1469.0 |
| PSMD11 | -1181.0 |
| PSMD3 | -1168.0 |
| RPL23A | -1088.0 |
| PSMA5 | -604.0 |
| CUL2 | -316.0 |
| RPL31 | -303.0 |
| ZSWIM8 | -287.0 |
| RPS2 | -219.0 |
| PSMB5 | -153.0 |
| PSMD7 | 321.0 |
| ROBO3 | 480.0 |
| RPS27L | 522.0 |
| LHX3 | 607.0 |
| RPL27 | 706.0 |
| RNPS1 | 803.0 |
| NCBP2 | 898.0 |
| SOS2 | 945.0 |
| EIF4A3 | 950.0 |
| UBC | 1013.0 |
| PSMC1 | 1107.0 |
| RPL7A | 1400.0 |
| DCC | 1508.0 |
| PSME4 | 1510.0 |
| PSMB2 | 1548.0 |
| MAGOHB | 1608.0 |
| CAP2 | 1689.0 |
| UPF3B | 2124.0 |
| PSME2 | 2230.0 |
| PSMC3 | 2256.0 |
| CASC3 | 2399.0 |
| EVL | 2510.0 |
| RPL37 | 2677.0 |
| DAG1 | 2723.0 |
| GPC1 | 2787.0 |
| PFN1 | 2795.0 |
| AKAP5 | 2803.0 |
| PAK6 | 2950.0 |
| SRGAP1 | 3023.0 |
| RPS9 | 3031.0 |
| RPS3 | 3136.0 |
| HOXA2 | 3282.0 |
| MYO9B | 3440.0 |
| USP33 | 3752.0 |
| CAP1 | 3974.0 |
| ABL1 | 3993.0 |
| RHOA | 4069.0 |
| PSMD12 | 4108.0 |
| EIF4G1 | 4151.0 |
| NTN1 | 4195.0 |
| LHX9 | 4232.0 |
| ENAH | 4245.0 |
| RPL3L | 4494.0 |
| PSMD13 | 4498.0 |
| PRKACA | 4516.0 |
| ARHGAP39 | 4521.0 |
| SLIT3 | 4902.0 |
| NELL2 | 4955.0 |
| ABL2 | 5010.0 |
| PSMB9 | 5019.0 |
| RPL22 | 5158.0 |
| SLIT1 | 5988.0 |
| LDB1 | 5989.0 |
| PSMF1 | 6184.0 |
| GSPT1 | 6438.0 |
| MSI1 | 6507.0 |
| PSME1 | 6608.0 |
| CLASP2 | 6800.0 |
| CXCL12 | 6840.0 |
| NCK1 | 7272.0 |
| CXCR4 | 7462.0 |
| PSMB8 | 7523.0 |
| SLIT2 | 7657.0 |
| RAC1 | 7746.0 |
| NRP1 | 7939.0 |
| PFN2 | 7986.0 |
| CLASP1 | 8148.0 |
Ribosomal scanning and start codon recognition
| 1049 | |
|---|---|
| set | Ribosomal scanning and start codon recognition |
| setSize | 48 |
| pANOVA | 2.82e-06 |
| s.dist | -0.391 |
| p.adjustANOVA | 0.00011 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| RPS16 | -8246.0 |
| RPS17 | -8231.0 |
| RPS3A | -7929.0 |
| RPS28 | -7809.0 |
| RPS21 | -7764.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| RPS15 | -7548.0 |
| RPS11 | -7379.0 |
| RPS14 | -7325.0 |
| EIF2S1 | -7018.0 |
| RPS10 | -6822.5 |
| RPS26 | -6692.0 |
| RPS8 | -6597.0 |
| EIF2S2 | -6402.0 |
| RPS4X | -6019.0 |
| EIF4A2 | -5979.0 |
| EIF3M | -5875.0 |
| RPS23 | -5865.0 |
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| RPS16 | -8246.0 |
| RPS17 | -8231.0 |
| RPS3A | -7929.0 |
| RPS28 | -7809.0 |
| RPS21 | -7764.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| RPS15 | -7548.0 |
| RPS11 | -7379.0 |
| RPS14 | -7325.0 |
| EIF2S1 | -7018.0 |
| RPS10 | -6822.5 |
| RPS26 | -6692.0 |
| RPS8 | -6597.0 |
| EIF2S2 | -6402.0 |
| RPS4X | -6019.0 |
| EIF4A2 | -5979.0 |
| EIF3M | -5875.0 |
| RPS23 | -5865.0 |
| EIF2S3 | -5766.5 |
| RPS19 | -5609.0 |
| EIF3K | -5288.0 |
| EIF5 | -4910.0 |
| FAU | -4829.0 |
| RPS6 | -4373.0 |
| RPSA | -4027.0 |
| RPS13 | -3718.0 |
| EIF3H | -2613.0 |
| RPS18 | -2478.0 |
| EIF3E | -1890.0 |
| EIF3G | -1499.0 |
| EIF3J | -866.0 |
| RPS2 | -219.0 |
| EIF4A1 | -181.0 |
| EIF3B | -78.0 |
| EIF4E | -29.0 |
| EIF3A | -12.0 |
| RPS27L | 522.0 |
| EIF3C | 1656.5 |
| EIF3D | 2550.0 |
| EIF3L | 2985.0 |
| RPS9 | 3031.0 |
| RPS3 | 3136.0 |
| EIF1AX | 3460.0 |
| EIF4G1 | 4151.0 |
| EIF3F | 5628.0 |
| EIF4H | 7514.0 |
Pyruvate metabolism and Citric Acid (TCA) cycle
| 906 | |
|---|---|
| set | Pyruvate metabolism and Citric Acid (TCA) cycle |
| setSize | 52 |
| pANOVA | 4.4e-06 |
| s.dist | 0.368 |
| p.adjustANOVA | 0.000167 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| OGDH | 8010.0 |
| LDHC | 7609.0 |
| BSG | 7570.0 |
| PDHX | 7471.0 |
| ACO2 | 7469.0 |
| PDHB | 7468.0 |
| CS | 7355.0 |
| DLAT | 7320.0 |
| PPARD | 7270.0 |
| ME3 | 7099.0 |
| DLST | 7073.0 |
| HAGH | 6949.0 |
| FAHD1 | 6902.0 |
| L2HGDH | 6828.0 |
| NNT | 6791.0 |
| D2HGDH | 6672.0 |
| IDH3G | 6298.0 |
| LDHB | 6149.5 |
| SDHC | 6123.0 |
| IDH2 | 6021.0 |
| GeneID | Gene Rank |
|---|---|
| OGDH | 8010.0 |
| LDHC | 7609.0 |
| BSG | 7570.0 |
| PDHX | 7471.0 |
| ACO2 | 7469.0 |
| PDHB | 7468.0 |
| CS | 7355.0 |
| DLAT | 7320.0 |
| PPARD | 7270.0 |
| ME3 | 7099.0 |
| DLST | 7073.0 |
| HAGH | 6949.0 |
| FAHD1 | 6902.0 |
| L2HGDH | 6828.0 |
| NNT | 6791.0 |
| D2HGDH | 6672.0 |
| IDH3G | 6298.0 |
| LDHB | 6149.5 |
| SDHC | 6123.0 |
| IDH2 | 6021.0 |
| SDHB | 5629.0 |
| MDH2 | 5314.0 |
| PDPR | 5035.0 |
| IDH3A | 4957.0 |
| IDH3B | 4913.0 |
| FH | 4639.0 |
| MPC2 | 4435.0 |
| PDHA1 | 4337.0 |
| PDK4 | 4094.0 |
| VDAC1 | 3653.0 |
| SUCLG1 | 3584.0 |
| PDK2 | 3361.0 |
| SDHA | 3123.5 |
| DLD | 3101.0 |
| SLC16A1 | 3094.0 |
| PDP2 | 2951.0 |
| PDK1 | 2031.0 |
| SUCLG2 | 1833.0 |
| SUCLA2 | 608.0 |
| MPC1 | 407.0 |
| SDHD | -389.5 |
| PDK3 | -549.0 |
| RXRA | -1980.0 |
| ME2 | -2641.0 |
| ADHFE1 | -4312.0 |
| SLC16A8 | -5046.0 |
| PDP1 | -5939.0 |
| SLC16A3 | -6714.0 |
| GLO1 | -7083.0 |
| GSTZ1 | -7293.0 |
| LDHA | -7395.0 |
| ME1 | -7972.0 |
Translation initiation complex formation
| 1306 | |
|---|---|
| set | Translation initiation complex formation |
| setSize | 47 |
| pANOVA | 4.56e-06 |
| s.dist | -0.387 |
| p.adjustANOVA | 0.000168 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| RPS16 | -8246.0 |
| RPS17 | -8231.0 |
| RPS3A | -7929.0 |
| RPS28 | -7809.0 |
| RPS21 | -7764.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| RPS15 | -7548.0 |
| RPS11 | -7379.0 |
| RPS14 | -7325.0 |
| EIF2S1 | -7018.0 |
| RPS10 | -6822.5 |
| RPS26 | -6692.0 |
| RPS8 | -6597.0 |
| EIF2S2 | -6402.0 |
| RPS4X | -6019.0 |
| EIF4A2 | -5979.0 |
| EIF3M | -5875.0 |
| RPS23 | -5865.0 |
| GeneID | Gene Rank |
|---|---|
| RPS15A | -8282.0 |
| RPS16 | -8246.0 |
| RPS17 | -8231.0 |
| RPS3A | -7929.0 |
| RPS28 | -7809.0 |
| RPS21 | -7764.0 |
| RPS5 | -7648.0 |
| RPS27A | -7640.0 |
| RPS15 | -7548.0 |
| RPS11 | -7379.0 |
| RPS14 | -7325.0 |
| EIF2S1 | -7018.0 |
| RPS10 | -6822.5 |
| RPS26 | -6692.0 |
| RPS8 | -6597.0 |
| EIF2S2 | -6402.0 |
| RPS4X | -6019.0 |
| EIF4A2 | -5979.0 |
| EIF3M | -5875.0 |
| RPS23 | -5865.0 |
| EIF2S3 | -5766.5 |
| RPS19 | -5609.0 |
| EIF3K | -5288.0 |
| FAU | -4829.0 |
| RPS6 | -4373.0 |
| RPSA | -4027.0 |
| RPS13 | -3718.0 |
| EIF3H | -2613.0 |
| RPS18 | -2478.0 |
| EIF3E | -1890.0 |
| EIF3G | -1499.0 |
| EIF3J | -866.0 |
| RPS2 | -219.0 |
| EIF4A1 | -181.0 |
| EIF3B | -78.0 |
| EIF4E | -29.0 |
| EIF3A | -12.0 |
| RPS27L | 522.0 |
| EIF3C | 1656.5 |
| EIF3D | 2550.0 |
| EIF3L | 2985.0 |
| RPS9 | 3031.0 |
| RPS3 | 3136.0 |
| EIF1AX | 3460.0 |
| EIF4G1 | 4151.0 |
| EIF3F | 5628.0 |
| EIF4H | 7514.0 |
Bile acid and bile salt metabolism
| 113 | |
|---|---|
| set | Bile acid and bile salt metabolism |
| setSize | 37 |
| pANOVA | 1.16e-05 |
| s.dist | 0.417 |
| p.adjustANOVA | 0.000419 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SLCO1A2 | 7943 |
| AKR1D1 | 7924 |
| SLC27A2 | 7786 |
| OSBPL1A | 7651 |
| ACOX2 | 7644 |
| OSBPL9 | 7624 |
| HSD17B4 | 7497 |
| OSBPL6 | 7390 |
| NCOA1 | 7218 |
| SLCO1B1 | 7114 |
| SLCO1B3 | 7114 |
| SLC27A5 | 7037 |
| AMACR | 6750 |
| ABCB11 | 6290 |
| NR1H4 | 5883 |
| BAAT | 5784 |
| OSBPL2 | 5717 |
| NCOA2 | 5324 |
| OSBPL3 | 4992 |
| CYP7A1 | 4954 |
| GeneID | Gene Rank |
|---|---|
| SLCO1A2 | 7943.0 |
| AKR1D1 | 7924.0 |
| SLC27A2 | 7786.0 |
| OSBPL1A | 7651.0 |
| ACOX2 | 7644.0 |
| OSBPL9 | 7624.0 |
| HSD17B4 | 7497.0 |
| OSBPL6 | 7390.0 |
| NCOA1 | 7218.0 |
| SLCO1B1 | 7114.0 |
| SLCO1B3 | 7114.0 |
| SLC27A5 | 7037.0 |
| AMACR | 6750.0 |
| ABCB11 | 6290.0 |
| NR1H4 | 5883.0 |
| BAAT | 5784.0 |
| OSBPL2 | 5717.0 |
| NCOA2 | 5324.0 |
| OSBPL3 | 4992.0 |
| CYP7A1 | 4954.0 |
| SLC10A1 | 4785.0 |
| CYP27A1 | 4354.0 |
| ALB | 3808.0 |
| ACOT8 | 3216.0 |
| CYP46A1 | 2984.0 |
| PTGIS | 2632.0 |
| OSBP | 2607.0 |
| CYP8B1 | 2544.0 |
| STARD5 | 594.0 |
| FABP6 | 393.5 |
| RXRA | -1980.0 |
| HSD3B7 | -2383.0 |
| CYP39A1 | -4425.0 |
| CH25H | -7050.0 |
| OSBPL7 | -7479.0 |
| ABCC3 | -7823.0 |
| CYP7B1 | -7839.0 |
Adaptive Immune System
| 59 | |
|---|---|
| set | Adaptive Immune System |
| setSize | 643 |
| pANOVA | 2.24e-05 |
| s.dist | -0.0985 |
| p.adjustANOVA | 0.000785 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PTPRC | -8287.0 |
| FCGR2B | -8284.0 |
| TRIP12 | -8280.0 |
| HLA-DQB1 | -8259.5 |
| HLA-DQB2 | -8259.5 |
| PTPN6 | -8219.0 |
| IGHM | -8190.0 |
| CD300C | -8175.0 |
| ELOC | -8174.0 |
| KLHL20 | -8164.0 |
| CD300LF | -8159.0 |
| SEC24A | -8147.0 |
| CD22 | -8146.0 |
| HLA-DRA | -8140.0 |
| CD86 | -8127.0 |
| DYNC1LI2 | -8117.0 |
| LILRA1 | -8064.5 |
| LILRA2 | -8064.5 |
| LILRB1 | -8064.5 |
| LILRB2 | -8064.5 |
| GeneID | Gene Rank |
|---|---|
| PTPRC | -8287.0 |
| FCGR2B | -8284.0 |
| TRIP12 | -8280.0 |
| HLA-DQB1 | -8259.5 |
| HLA-DQB2 | -8259.5 |
| PTPN6 | -8219.0 |
| IGHM | -8190.0 |
| CD300C | -8175.0 |
| ELOC | -8174.0 |
| KLHL20 | -8164.0 |
| CD300LF | -8159.0 |
| SEC24A | -8147.0 |
| CD22 | -8146.0 |
| HLA-DRA | -8140.0 |
| CD86 | -8127.0 |
| DYNC1LI2 | -8117.0 |
| LILRA1 | -8064.5 |
| LILRA2 | -8064.5 |
| LILRB1 | -8064.5 |
| LILRB2 | -8064.5 |
| ASB12 | -8049.0 |
| CLEC2D | -8029.0 |
| PPIA | -8021.5 |
| UBE3C | -7971.0 |
| FBXW7 | -7963.0 |
| SEC61A2 | -7949.0 |
| KIF18A | -7894.0 |
| ASB9 | -7893.0 |
| CUL3 | -7874.0 |
| DCTN4 | -7862.0 |
| HECTD2 | -7859.0 |
| CD101 | -7849.0 |
| FBXL4 | -7829.0 |
| BTK | -7804.0 |
| SIGLEC1 | -7792.0 |
| PIK3AP1 | -7781.0 |
| HRAS | -7755.0 |
| PAK3 | -7738.0 |
| STX4 | -7729.0 |
| UBE2F | -7727.5 |
| SEC23A | -7718.0 |
| NEDD4 | -7710.0 |
| RASGRP3 | -7692.0 |
| YES1 | -7678.0 |
| WSB1 | -7676.0 |
| CD74 | -7670.0 |
| RPS27A | -7640.0 |
| PRKCB | -7632.0 |
| PAK1 | -7605.0 |
| LNX1 | -7568.0 |
| CD200R1 | -7467.5 |
| UBE2D3 | -7462.0 |
| RNF19B | -7429.0 |
| FBXW4 | -7425.0 |
| CUL1 | -7405.0 |
| CD300A | -7398.5 |
| CD300LD | -7398.5 |
| PSMA4 | -7394.0 |
| KLHL22 | -7386.5 |
| VASP | -7374.0 |
| RNF7 | -7356.0 |
| TIRAP | -7316.0 |
| DYNC1I2 | -7307.0 |
| RNF25 | -7281.0 |
| CUL7 | -7264.0 |
| PSMA6 | -7250.0 |
| TREML2 | -7173.0 |
| SRC | -7166.0 |
| FCGR1A | -7140.5 |
| FCGR1B | -7140.5 |
| PVR | -7125.0 |
| ANAPC10 | -7079.0 |
| ITGA4 | -7054.0 |
| PPP2R5A | -7024.0 |
| PSMB6 | -6996.0 |
| TAB2 | -6989.0 |
| CTSH | -6980.0 |
| PPP2R1B | -6978.0 |
| UBE2E2 | -6976.0 |
| TLR2 | -6961.0 |
| PJA1 | -6959.0 |
| WAS | -6934.0 |
| MRC1 | -6930.0 |
| DZIP3 | -6887.0 |
| FBXO4 | -6846.0 |
| SPSB1 | -6841.0 |
| MEX3C | -6814.0 |
| FBXO31 | -6782.0 |
| PPP3CB | -6779.0 |
| PPP2R5C | -6762.0 |
| UBE3A | -6726.0 |
| CD33 | -6719.5 |
| SIGLEC6 | -6719.5 |
| NFATC3 | -6716.0 |
| UBOX5 | -6711.0 |
| FBXO41 | -6697.0 |
| CTSK | -6682.0 |
| CALM1 | -6675.0 |
| HERC2 | -6623.0 |
| TRBC1 | -6620.5 |
| CAPZA2 | -6618.0 |
| RASGRP2 | -6609.0 |
| PSMC5 | -6575.0 |
| KIFAP3 | -6571.0 |
| SAR1B | -6531.0 |
| UBE2J1 | -6515.0 |
| PDCD1 | -6489.0 |
| PJA2 | -6466.0 |
| TRIM37 | -6450.0 |
| HCST | -6444.0 |
| PPP3R1 | -6429.5 |
| UBE3D | -6412.0 |
| ANAPC13 | -6410.0 |
| TYROBP | -6404.0 |
| MAP3K14 | -6387.0 |
| LAIR1 | -6386.0 |
| UBE2C | -6382.0 |
| ITGB7 | -6367.0 |
| UBAC1 | -6357.0 |
| ASB6 | -6352.0 |
| PRKACB | -6340.0 |
| BLMH | -6322.0 |
| PSMB7 | -6252.0 |
| KLHL3 | -6220.0 |
| KLHL42 | -6206.0 |
| CDC42 | -6175.0 |
| CBLB | -6160.0 |
| BTN2A2 | -6151.0 |
| PIK3CD | -6147.0 |
| UBE2E1 | -6131.0 |
| FYN | -6117.0 |
| NCF4 | -6094.0 |
| PAK2 | -6088.0 |
| SIGLEC12 | -6057.5 |
| SIGLEC7 | -6057.5 |
| SIGLEC8 | -6057.5 |
| SIGLEC9 | -6057.5 |
| TRAIP | -5968.0 |
| CRTAM | -5937.0 |
| CD247 | -5933.0 |
| PSMB1 | -5931.0 |
| RNF4 | -5915.0 |
| AKT2 | -5897.0 |
| FBXO40 | -5893.0 |
| KIF20A | -5872.0 |
| SEC61G | -5830.0 |
| HLA-DOA | -5812.0 |
| SYK | -5699.0 |
| FBXO15 | -5695.0 |
| RNF217 | -5691.0 |
| RBBP6 | -5612.0 |
| PSMB4 | -5607.0 |
| RICTOR | -5595.0 |
| SPTBN2 | -5593.0 |
| UBE2Q2 | -5545.0 |
| SEC13 | -5544.0 |
| ACTR10 | -5539.0 |
| ICAM5 | -5517.0 |
| SNAP23 | -5495.0 |
| UBE4A | -5481.0 |
| CDC20 | -5454.0 |
| COLEC12 | -5439.0 |
| TREM1 | -5414.0 |
| PSMD5 | -5412.0 |
| HLA-DOB | -5373.0 |
| ASB8 | -5356.0 |
| UBR1 | -5334.0 |
| CTSS | -5320.0 |
| CD1D | -5308.0 |
| MRC2 | -5303.0 |
| PIANP | -5292.0 |
| SLAMF7 | -5287.0 |
| WWP1 | -5285.0 |
| DET1 | -5265.5 |
| GRAP2 | -5255.0 |
| KIF2C | -5213.0 |
| TREM2 | -5197.0 |
| KIF11 | -5195.0 |
| MALT1 | -5170.0 |
| RASGRP1 | -5127.0 |
| PSMA3 | -5078.0 |
| KLRC1 | -5053.5 |
| PSMA2 | -5050.5 |
| IKBKB | -5045.0 |
| ANAPC1 | -4990.0 |
| TRIM69 | -4969.0 |
| MYD88 | -4944.0 |
| ASB5 | -4907.0 |
| KIF3B | -4901.0 |
| CD81 | -4889.0 |
| CD3E | -4862.0 |
| RNF138 | -4854.0 |
| SEC61B | -4808.0 |
| ORAI1 | -4788.0 |
| ASB14 | -4769.0 |
| VAV1 | -4760.0 |
| DAPP1 | -4730.0 |
| CDC34 | -4678.0 |
| NFKBIE | -4652.0 |
| ANAPC4 | -4616.0 |
| UBE2G1 | -4613.0 |
| HUWE1 | -4598.0 |
| ITK | -4571.0 |
| KIF2A | -4566.0 |
| SIAH2 | -4552.0 |
| SEC24D | -4488.0 |
| HECTD1 | -4471.0 |
| UBE2S | -4447.0 |
| FBXO22 | -4409.0 |
| KLHL13 | -4338.0 |
| KIF5B | -4217.0 |
| GLMN | -4209.0 |
| ATG7 | -4196.0 |
| ASB16 | -4168.0 |
| DCTN6 | -4150.0 |
| ARF1 | -4106.0 |
| PPP3CA | -4087.0 |
| PSMD14 | -4055.0 |
| PRKCQ | -3997.0 |
| TREML4 | -3987.0 |
| DNM1 | -3955.0 |
| CD80 | -3926.0 |
| RAET1E | -3907.5 |
| CD3D | -3905.0 |
| SIGLEC10 | -3863.5 |
| SIGLEC11 | -3863.5 |
| PSMD8 | -3851.0 |
| PDCD1LG2 | -3847.0 |
| AP2S1 | -3795.0 |
| PTPN11 | -3777.0 |
| HACE1 | -3725.0 |
| CD8A | -3675.0 |
| CD79B | -3668.0 |
| PSMB3 | -3665.0 |
| CUL5 | -3575.0 |
| MADCAM1 | -3488.0 |
| ITCH | -3484.0 |
| INPP5D | -3469.0 |
| DCTN5 | -3442.0 |
| KIR2DL1 | -3436.0 |
| KIR2DL3 | -3436.0 |
| KIR2DL4 | -3436.0 |
| KIR3DL1 | -3436.0 |
| KIR3DL2 | -3436.0 |
| PSMC2 | -3419.0 |
| UBE2D1 | -3359.0 |
| PSMD6 | -3353.0 |
| DCTN2 | -3343.0 |
| RBX1 | -3219.0 |
| CD3G | -3199.0 |
| CD8B | -3184.5 |
| HERC4 | -3166.0 |
| AP1S1 | -3138.0 |
| TLR4 | -3119.0 |
| PSMD4 | -3118.0 |
| DYNC1I1 | -3094.0 |
| CDC27 | -3085.0 |
| CTSC | -3056.0 |
| MAP3K7 | -3011.0 |
| PSMC4 | -3007.0 |
| KLRK1 | -3000.0 |
| SPSB2 | -2956.0 |
| UNKL | -2939.0 |
| CAPZB | -2925.0 |
| RAP1A | -2869.0 |
| CD34 | -2848.0 |
| SLAMF6 | -2843.0 |
| UBE2B | -2819.0 |
| UBE2A | -2808.0 |
| ARIH2 | -2782.0 |
| LCP2 | -2749.0 |
| LAT | -2726.0 |
| PIK3CA | -2711.0 |
| CTSV | -2661.0 |
| HERC1 | -2594.0 |
| PSMA7 | -2576.0 |
| ASB1 | -2539.0 |
| PDIA3 | -2534.0 |
| BTN1A1 | -2521.0 |
| KLRB1 | -2512.0 |
| PTPRJ | -2509.0 |
| UBA6 | -2493.0 |
| CYBB | -2489.0 |
| LGMN | -2445.0 |
| ANAPC5 | -2429.0 |
| PSMA1 | -2388.0 |
| DYNLL2 | -2370.0 |
| PSMD2 | -2319.0 |
| KIF23 | -2270.0 |
| AP1S3 | -2255.0 |
| SH3GL2 | -2205.0 |
| CHUK | -2181.0 |
| TRAT1 | -2158.0 |
| LRR1 | -2137.0 |
| KLRD1 | -2105.0 |
| PSMD1 | -2102.0 |
| CD14 | -2079.0 |
| AP1M2 | -2078.0 |
| TRIM63 | -2072.0 |
| PIK3R2 | -2014.5 |
| LRSAM1 | -1949.0 |
| RNF130 | -1887.0 |
| THOP1 | -1875.0 |
| KCTD7 | -1869.0 |
| ASB17 | -1856.0 |
| LRRC41 | -1846.0 |
| CLTC | -1818.0 |
| MYLIP | -1810.0 |
| CD209 | -1809.0 |
| IGKV1-12 | -1796.5 |
| IGKV1-16 | -1796.5 |
| IGKV1-17 | -1796.5 |
| IGKV1-39 | -1796.5 |
| IGKV1-5 | -1796.5 |
| IGKV1D-12 | -1796.5 |
| IGKV1D-16 | -1796.5 |
| IGKV1D-39 | -1796.5 |
| ICOSLG | -1745.5 |
| CTSE | -1724.0 |
| RNF14 | -1694.0 |
| CTSA | -1693.0 |
| BCL10 | -1692.0 |
| PSMA8 | -1679.0 |
| TRIM71 | -1667.0 |
| UBE2Q1 | -1598.0 |
| UBE3B | -1546.0 |
| PSMC6 | -1541.0 |
| SOS1 | -1475.0 |
| KLHL25 | -1463.0 |
| ZNRF2 | -1453.0 |
| IFITM1 | -1331.0 |
| IGLV6-57 | -1290.0 |
| LAG3 | -1255.0 |
| TRIM9 | -1241.0 |
| VAMP8 | -1223.0 |
| RAF1 | -1207.0 |
| CTLA4 | -1200.0 |
| PSMD11 | -1181.0 |
| DYNLL1 | -1170.0 |
| PSMD3 | -1168.0 |
| ITGB2 | -1161.0 |
| FBXW9 | -1016.0 |
| CANX | -1011.0 |
| NEDD4L | -1007.0 |
| ICOS | -1002.0 |
| DCTN3 | -958.0 |
| FBXW2 | -936.0 |
| FBXL13 | -911.0 |
| SELL | -825.0 |
| CYBA | -615.0 |
| ORAI2 | -614.0 |
| PSMA5 | -604.0 |
| ICAM4 | -501.0 |
| IGHV4-34 | -409.5 |
| IGHV4-39 | -409.5 |
| IGHV4-59 | -409.5 |
| RAP1B | -396.0 |
| RLIM | -359.0 |
| CUL2 | -316.0 |
| BTRC | -286.0 |
| SEC22B | -266.0 |
| DNM3 | -262.0 |
| KIF3A | -186.0 |
| UBE2N | -184.5 |
| SEC24B | -161.0 |
| AP2A2 | -158.0 |
| PSMB5 | -153.0 |
| FBXL20 | -149.0 |
| TLR1 | -140.0 |
| KLHL41 | -93.0 |
| SKP1 | -82.0 |
| UBE2L6 | -52.0 |
| PTEN | 0.0 |
| SOCS1 | 48.0 |
| CD300E | 245.0 |
| TPP2 | 306.0 |
| PSMD7 | 321.0 |
| UBE2V2 | 339.0 |
| RNF115 | 347.0 |
| VAMP3 | 439.0 |
| FBXO11 | 455.0 |
| LTN1 | 472.0 |
| PPP2CA | 497.0 |
| OSCAR | 529.0 |
| HLA-A | 538.5 |
| HLA-B | 538.5 |
| HLA-C | 538.5 |
| HLA-E | 538.5 |
| HLA-F | 538.5 |
| HLA-G | 538.5 |
| HSPA5 | 605.0 |
| RNF6 | 612.0 |
| RNF41 | 712.0 |
| XDH | 745.0 |
| RNF126 | 846.0 |
| LCK | 916.0 |
| CDC23 | 954.0 |
| ICAM1 | 971.0 |
| REL | 978.0 |
| TRIM41 | 981.0 |
| MLST8 | 1003.0 |
| UBC | 1013.0 |
| PSMC1 | 1107.0 |
| TNFRSF14 | 1133.0 |
| KIF22 | 1149.0 |
| IKBKG | 1225.0 |
| UBA5 | 1329.0 |
| FBXO2 | 1361.0 |
| FBXL5 | 1446.0 |
| MAPKAP1 | 1449.0 |
| CALR | 1483.0 |
| PSME4 | 1510.0 |
| PSMB2 | 1548.0 |
| PPP2R5B | 1592.0 |
| RNF213 | 1594.0 |
| RILP | 1602.0 |
| ASB4 | 1606.0 |
| PAG1 | 1610.0 |
| TRIM50 | 1674.0 |
| CD274 | 1677.0 |
| HECW2 | 1715.0 |
| FBXO9 | 1763.0 |
| TREML1 | 1797.0 |
| FBXL3 | 1810.0 |
| RIPK2 | 1837.0 |
| CD40LG | 1866.0 |
| BLNK | 1874.0 |
| PPP2CB | 1876.0 |
| MIB2 | 1900.0 |
| KIF15 | 1913.0 |
| PLCG2 | 1922.0 |
| PPL | 1950.0 |
| B2M | 2072.0 |
| SEC61A1 | 2087.0 |
| NECTIN2 | 2095.0 |
| KLHL21 | 2169.0 |
| KCTD6 | 2174.0 |
| ITGAL | 2183.0 |
| FBXO30 | 2192.0 |
| FBXL19 | 2218.0 |
| PSME2 | 2230.0 |
| PSMC3 | 2256.0 |
| NFKBIB | 2261.0 |
| SIPA1 | 2293.0 |
| PPP2R5E | 2334.0 |
| ZBTB16 | 2341.0 |
| FBXL22 | 2422.0 |
| UBE2G2 | 2507.0 |
| EVL | 2510.0 |
| ACTR1B | 2529.0 |
| KLC2 | 2543.0 |
| RNF114 | 2572.0 |
| UBR4 | 2668.0 |
| NCR3 | 2749.0 |
| BTNL2 | 2764.0 |
| PDPK1 | 2786.0 |
| UBA3 | 2804.0 |
| ASB2 | 2898.0 |
| DYNC1LI1 | 2899.0 |
| IGKC | 2909.0 |
| SKP2 | 2932.0 |
| CD226 | 3085.0 |
| GRB2 | 3145.0 |
| UFL1 | 3185.0 |
| PLCG1 | 3263.0 |
| UBR2 | 3270.0 |
| MAP3K8 | 3271.0 |
| CENPE | 3317.0 |
| RACGAP1 | 3339.0 |
| ASB18 | 3344.0 |
| LNPEP | 3368.0 |
| CDH1 | 3439.0 |
| AKT1 | 3530.0 |
| RNF34 | 3705.0 |
| RNF19A | 3706.0 |
| CXADR | 3737.0 |
| LYN | 3765.0 |
| SMURF2 | 3791.0 |
| PPP2R1A | 3805.0 |
| ANAPC2 | 3809.0 |
| KLHL11 | 3855.0 |
| NPEPPS | 3858.0 |
| FBXL7 | 3861.0 |
| FBXL18 | 3867.0 |
| CD28 | 3868.0 |
| BTLA | 3870.0 |
| MKRN1 | 3907.0 |
| GAN | 3943.0 |
| RELA | 3959.0 |
| DNM2 | 3996.0 |
| FBXL16 | 4011.0 |
| KIF5A | 4021.0 |
| LONRF1 | 4045.0 |
| DTX3L | 4070.0 |
| PSMD12 | 4108.0 |
| FBXO7 | 4174.0 |
| AREL1 | 4178.0 |
| ENAH | 4245.0 |
| CD40 | 4249.0 |
| UBE2Z | 4263.0 |
| CTSB | 4265.0 |
| TRAF6 | 4327.0 |
| SIAH1 | 4415.0 |
| NRAS | 4434.0 |
| RAB7A | 4453.0 |
| RNF220 | 4493.0 |
| PSMD13 | 4498.0 |
| PRKACA | 4516.0 |
| PIK3R3 | 4535.5 |
| TRIM32 | 4589.0 |
| FBXW10 | 4596.5 |
| AP1S2 | 4644.0 |
| ITGB1 | 4674.0 |
| YWHAB | 4694.0 |
| ICAM2 | 4707.0 |
| HERC6 | 4719.0 |
| NFATC2 | 4760.0 |
| KLRG1 | 4769.0 |
| PTPN22 | 4790.0 |
| FBXL15 | 4811.0 |
| CSK | 4821.0 |
| FBXL8 | 4827.5 |
| TAPBP | 4863.0 |
| RNF182 | 4884.0 |
| UBE2K | 4934.0 |
| KEAP1 | 4980.0 |
| PSMB9 | 5019.0 |
| ITPR2 | 5073.0 |
| VHL | 5081.0 |
| KIF4A | 5211.0 |
| BLK | 5218.0 |
| HECTD3 | 5245.0 |
| AP1M1 | 5259.0 |
| FBXW5 | 5268.0 |
| SPSB4 | 5357.0 |
| FBXO21 | 5361.0 |
| SH3RF1 | 5392.0 |
| UBE2W | 5409.5 |
| ASB13 | 5422.0 |
| TRIM11 | 5444.0 |
| MGRN1 | 5507.0 |
| KLC3 | 5514.0 |
| CLEC4G | 5542.0 |
| TAP2 | 5583.5 |
| FZR1 | 5603.0 |
| BTNL9 | 5608.0 |
| TRAF7 | 5613.0 |
| CTSF | 5650.0 |
| FBXO32 | 5712.0 |
| PPP2R5D | 5723.0 |
| UBA7 | 5741.0 |
| UBE2M | 5773.0 |
| ACTR1A | 5779.0 |
| CTSD | 5806.5 |
| DCTN1 | 5822.5 |
| AP2A1 | 5853.0 |
| KLC4 | 5877.0 |
| TRIB3 | 5887.0 |
| FBXW11 | 5901.0 |
| NFKB1 | 6004.0 |
| CCNF | 6074.0 |
| BTBD6 | 6075.0 |
| RNF111 | 6089.0 |
| TRIM36 | 6098.0 |
| PSMF1 | 6184.0 |
| TRIM21 | 6196.0 |
| FBXO27 | 6259.0 |
| BTBD1 | 6294.0 |
| RNF123 | 6354.0 |
| RAP1GAP | 6468.0 |
| FBXO17 | 6476.0 |
| FBXO6 | 6483.0 |
| KIF3C | 6498.0 |
| UBE2H | 6523.0 |
| CD79A | 6531.0 |
| IFI30 | 6556.0 |
| HERC3 | 6573.5 |
| ERAP1 | 6578.0 |
| SMURF1 | 6601.0 |
| PSME1 | 6608.0 |
| CDC16 | 6620.0 |
| KLHL5 | 6676.0 |
| FBXO10 | 6690.0 |
| UBE2J2 | 6724.0 |
| KBTBD8 | 6752.0 |
| AKT3 | 6761.0 |
| ASB10 | 6762.0 |
| KLHL2 | 6767.0 |
| KBTBD6 | 6824.5 |
| KBTBD7 | 6824.5 |
| UBE2R2 | 6861.0 |
| YWHAZ | 6876.0 |
| THEM4 | 6916.0 |
| ANAPC7 | 6926.0 |
| C3 | 6951.0 |
| ITPR1 | 6954.0 |
| UBE2O | 7003.0 |
| RAPGEF3 | 7075.0 |
| ASB7 | 7126.0 |
| ITPR3 | 7138.0 |
| STUB1 | 7195.0 |
| KIF5C | 7239.0 |
| CD19 | 7249.0 |
| ZNRF1 | 7259.0 |
| NCK1 | 7272.0 |
| UBA1 | 7293.0 |
| CD300LG | 7303.0 |
| RNF144B | 7313.0 |
| VCAM1 | 7321.0 |
| TLR6 | 7322.0 |
| CD96 | 7332.0 |
| CLTA | 7341.0 |
| AP1B1 | 7359.0 |
| SEC31A | 7378.0 |
| FCGR3A | 7385.5 |
| NFATC1 | 7397.0 |
| PIK3R1 | 7450.0 |
| TRPC1 | 7501.0 |
| PSMB8 | 7523.0 |
| CD36 | 7608.0 |
| LMO7 | 7618.0 |
| ASB15 | 7642.0 |
| HLA-DMB | 7645.5 |
| OSBPL1A | 7651.0 |
| RAPGEF4 | 7690.0 |
| CD200 | 7711.0 |
| RAC1 | 7746.0 |
| DYNC1H1 | 7820.0 |
| RAP1GAP2 | 7828.0 |
| ASB3 | 7830.0 |
| FBXW8 | 7847.0 |
| MTOR | 7871.0 |
| KIF26A | 7918.0 |
| AP2M1 | 7919.0 |
| AHCYL1 | 7929.0 |
| AP2B1 | 7931.0 |
| TAP1 | 7947.0 |
| RBCK1 | 7983.0 |
| NCF1 | 8002.0 |
| TRIM39 | 8048.0 |
| ITGAV | 8087.0 |
| SH3KBP1 | 8091.0 |
| STIM1 | 8152.0 |
Transport of small molecules
| 1326 | |
|---|---|
| set | Transport of small molecules |
| setSize | 656 |
| pANOVA | 3.34e-05 |
| s.dist | 0.0954 |
| p.adjustANOVA | 0.00114 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SLC12A7 | 8153 |
| SLC4A10 | 8147 |
| ABCB4 | 8143 |
| SLC8A1 | 8118 |
| ATP2B2 | 8113 |
| ANO2 | 8082 |
| ATP2A3 | 8057 |
| ABCB6 | 8047 |
| ALAD | 8036 |
| HMOX2 | 8031 |
| SLC2A1 | 8017 |
| SLC12A6 | 8015 |
| ATP6V1A | 8014 |
| ATP6V0A2 | 8004 |
| SPG7 | 7999 |
| TPCN1 | 7984 |
| ANO4 | 7982 |
| LIPA | 7953 |
| SLCO1A2 | 7943 |
| AP2B1 | 7931 |
| GeneID | Gene Rank |
|---|---|
| SLC12A7 | 8153.0 |
| SLC4A10 | 8147.0 |
| ABCB4 | 8143.0 |
| SLC8A1 | 8118.0 |
| ATP2B2 | 8113.0 |
| ANO2 | 8082.0 |
| ATP2A3 | 8057.0 |
| ABCB6 | 8047.0 |
| ALAD | 8036.0 |
| HMOX2 | 8031.0 |
| SLC2A1 | 8017.0 |
| SLC12A6 | 8015.0 |
| ATP6V1A | 8014.0 |
| ATP6V0A2 | 8004.0 |
| SPG7 | 7999.0 |
| TPCN1 | 7984.0 |
| ANO4 | 7982.0 |
| LIPA | 7953.0 |
| SLCO1A2 | 7943.0 |
| AP2B1 | 7931.0 |
| AP2M1 | 7919.0 |
| ATP6V0A1 | 7887.0 |
| ATP2B4 | 7877.0 |
| ADCY4 | 7870.0 |
| CTNS | 7866.0 |
| ATP1A2 | 7846.0 |
| ATP1B1 | 7826.0 |
| NCEH1 | 7823.0 |
| SLC5A6 | 7796.0 |
| ADD1 | 7776.0 |
| VDAC2 | 7762.0 |
| SLC11A2 | 7747.0 |
| SLC29A4 | 7735.0 |
| SLC26A7 | 7695.0 |
| SLC22A4 | 7678.0 |
| ABCF1 | 7674.0 |
| GNB3 | 7673.0 |
| NGB | 7665.0 |
| AKAP1 | 7638.0 |
| ABCB7 | 7604.0 |
| ABCA7 | 7600.0 |
| LRRC8A | 7593.0 |
| BSG | 7570.0 |
| TFRC | 7569.0 |
| SLC2A2 | 7562.0 |
| SLC25A29 | 7560.0 |
| NIPAL1 | 7559.0 |
| PSMB8 | 7523.0 |
| PHB2 | 7517.0 |
| SLC44A1 | 7506.0 |
| CA2 | 7502.0 |
| TRPC1 | 7501.0 |
| PEX19 | 7473.0 |
| ADCY8 | 7470.0 |
| SLC38A1 | 7441.0 |
| SLC41A1 | 7439.0 |
| LETM1 | 7437.0 |
| SLC22A1 | 7430.0 |
| SLC6A6 | 7423.0 |
| ADCY6 | 7405.0 |
| FXYD6 | 7395.0 |
| SLC35B2 | 7343.0 |
| CLTA | 7341.0 |
| SLC2A12 | 7317.0 |
| MCU | 7308.0 |
| SLC25A22 | 7276.0 |
| CYB5RL | 7268.5 |
| SLC4A7 | 7242.0 |
| ABCC6 | 7235.0 |
| SLC6A15 | 7201.0 |
| DMTN | 7200.0 |
| SLCO1B1 | 7114.0 |
| SLCO1B3 | 7114.0 |
| ARL2 | 7084.0 |
| RYR2 | 7076.0 |
| SLC17A3 | 7070.0 |
| CA4 | 7059.0 |
| SLC4A1 | 7043.0 |
| ABCG1 | 7040.0 |
| PMPCA | 7035.0 |
| SLC1A7 | 7013.0 |
| SOAT1 | 7010.0 |
| LDLRAP1 | 6882.0 |
| SLC2A4 | 6860.0 |
| SLC33A1 | 6857.0 |
| TTYH3 | 6854.0 |
| SLC20A2 | 6838.0 |
| SEL1L | 6795.0 |
| SLC27A1 | 6792.0 |
| APOC2 | 6777.5 |
| ABCD3 | 6773.0 |
| WNK4 | 6772.0 |
| ABCA6 | 6677.0 |
| ADCY9 | 6648.0 |
| PSME1 | 6608.0 |
| ATP6V0C | 6595.0 |
| SLC11A1 | 6568.0 |
| PARL | 6562.5 |
| ABCG4 | 6555.0 |
| SLC26A1 | 6532.0 |
| ABCB10 | 6463.0 |
| SLC25A26 | 6437.0 |
| ABCD1 | 6427.0 |
| SLC17A7 | 6408.0 |
| ATP2A2 | 6396.0 |
| SLC25A5 | 6360.0 |
| SLC43A2 | 6351.0 |
| ATP1A1 | 6348.0 |
| ATP13A2 | 6341.0 |
| WNK2 | 6340.0 |
| ANKH | 6248.0 |
| SLC7A1 | 6232.0 |
| SLC35D1 | 6230.0 |
| NIPAL3 | 6187.0 |
| PSMF1 | 6184.0 |
| SLC30A3 | 6165.0 |
| ABCB8 | 6147.0 |
| SLC9A1 | 6140.0 |
| MB | 6054.0 |
| AQP7 | 6016.5 |
| FKBP1B | 5990.0 |
| LMF1 | 5971.0 |
| SLC1A2 | 5955.0 |
| GNG8 | 5873.0 |
| AP2A1 | 5853.0 |
| APOA5 | 5800.0 |
| ATP7B | 5782.0 |
| SLC4A5 | 5706.0 |
| SLC6A1 | 5695.0 |
| SLCO3A1 | 5670.0 |
| ACO1 | 5632.0 |
| CREB3L3 | 5616.0 |
| STEAP3 | 5610.0 |
| OSTM1 | 5601.0 |
| AFG3L2 | 5585.0 |
| SLC35D2 | 5569.5 |
| MCOLN3 | 5557.0 |
| TUSC3 | 5549.0 |
| SLC2A7 | 5518.0 |
| PCSK9 | 5483.0 |
| ATP2C2 | 5482.0 |
| UNC80 | 5477.0 |
| SLC38A2 | 5432.0 |
| APOA2 | 5339.0 |
| SLC12A4 | 5332.0 |
| LPL | 5325.0 |
| GNG12 | 5320.0 |
| ERLIN2 | 5306.0 |
| LMF2 | 5276.0 |
| ABCC1 | 5260.0 |
| LRRC8E | 5213.0 |
| ATP6V0E2 | 5189.0 |
| SLC20A1 | 5121.0 |
| SLC30A1 | 5060.0 |
| LPA | 5058.0 |
| CYB5R1 | 5022.0 |
| PSMB9 | 5019.0 |
| SLC6A2 | 5016.0 |
| SLC9A3 | 4988.0 |
| SLC22A7 | 4974.0 |
| SRI | 4965.0 |
| ANGPTL3 | 4942.0 |
| MRS2 | 4909.0 |
| ATP12A | 4907.0 |
| ANO1 | 4876.0 |
| SLC9A7 | 4849.0 |
| SLC50A1 | 4796.0 |
| TRPM4 | 4784.0 |
| ABCA2 | 4783.0 |
| PRKAR1A | 4751.0 |
| APOD | 4746.0 |
| APOC4 | 4730.0 |
| LSR | 4727.0 |
| EMB | 4726.0 |
| ATP13A5 | 4724.0 |
| SLC2A8 | 4708.0 |
| APOA4 | 4672.0 |
| SLC4A2 | 4654.0 |
| SLC16A7 | 4632.0 |
| CP | 4601.0 |
| TRPV4 | 4551.0 |
| ATP4A | 4543.0 |
| PRKACA | 4516.0 |
| ATP8A2 | 4509.0 |
| PSMD13 | 4498.0 |
| SLC28A1 | 4479.0 |
| ABCG8 | 4478.0 |
| SLC17A8 | 4468.0 |
| AQP1 | 4436.0 |
| CLCN6 | 4423.0 |
| SLC2A6 | 4412.0 |
| SLC38A3 | 4403.0 |
| OS9 | 4393.0 |
| CLCN4 | 4369.0 |
| ADCY5 | 4361.0 |
| SLC5A5 | 4347.0 |
| ATP1A4 | 4344.0 |
| CYGB | 4243.0 |
| CLCA2 | 4231.0 |
| SLC25A4 | 4136.0 |
| PSMD12 | 4108.0 |
| ZDHHC8 | 4101.0 |
| SLC46A1 | 4034.0 |
| SLC25A10 | 4009.5 |
| ATP11B | 3977.0 |
| APOBR | 3948.0 |
| SLC6A12 | 3944.0 |
| SLC44A4 | 3892.0 |
| SLC36A2 | 3863.0 |
| SLC39A10 | 3838.0 |
| MCOLN1 | 3836.0 |
| CLCN3 | 3833.0 |
| SLC39A14 | 3829.0 |
| ALB | 3808.0 |
| ATP8B3 | 3775.0 |
| SLC3A2 | 3743.0 |
| SLC22A17 | 3730.0 |
| SLC15A4 | 3718.0 |
| STEAP2 | 3677.0 |
| LCN2 | 3656.0 |
| VDAC1 | 3653.0 |
| SLC4A4 | 3633.0 |
| LIPG | 3592.0 |
| ATP13A1 | 3582.0 |
| SLC44A5 | 3580.0 |
| STOM | 3571.0 |
| SLC8A2 | 3568.0 |
| AQP11 | 3545.0 |
| SLC24A5 | 3525.0 |
| RHBG | 3509.0 |
| MCUB | 3469.0 |
| LRRC8D | 3465.0 |
| SLC22A15 | 3434.0 |
| ATP6V1C2 | 3394.0 |
| ATP10B | 3351.0 |
| ANGPTL4 | 3332.0 |
| ADD2 | 3247.0 |
| ATP9A | 3244.0 |
| SOAT2 | 3238.0 |
| SLC44A2 | 3226.0 |
| ANO10 | 3213.0 |
| SLC9A6 | 3203.0 |
| TRPM5 | 3182.0 |
| SLC27A4 | 3117.0 |
| SLC13A4 | 3114.0 |
| SLC16A1 | 3094.0 |
| SLC12A1 | 3070.0 |
| SLC30A6 | 3026.0 |
| SLC7A6 | 3025.0 |
| MICU2 | 2979.0 |
| ASIC1 | 2969.0 |
| SLC35A2 | 2960.0 |
| NIPA1 | 2926.0 |
| ATP6V1C1 | 2920.0 |
| MICU1 | 2885.0 |
| BMP1 | 2815.0 |
| RAB11FIP2 | 2813.0 |
| SGK3 | 2720.5 |
| SLC24A2 | 2679.0 |
| SLC39A2 | 2676.0 |
| HMOX1 | 2671.0 |
| LRRC8B | 2666.0 |
| SLC12A5 | 2661.0 |
| NALCN | 2641.0 |
| SLC4A8 | 2612.0 |
| SLC7A5 | 2601.0 |
| GNB2 | 2595.0 |
| GNB1 | 2583.0 |
| SLC22A8 | 2502.0 |
| ARL2BP | 2500.0 |
| HBA1 | 2471.5 |
| SCNN1A | 2420.0 |
| SLC22A2 | 2395.0 |
| SLCO2B1 | 2372.0 |
| ANO9 | 2362.0 |
| SLC25A18 | 2352.0 |
| ATP6V1B2 | 2262.0 |
| PSMC3 | 2256.0 |
| SLC26A4 | 2239.0 |
| PSME2 | 2230.0 |
| GNG7 | 2130.0 |
| GNB5 | 2123.0 |
| SLC32A1 | 2101.0 |
| PMPCB | 2100.0 |
| SLC28A2 | 2079.0 |
| BSND | 2054.0 |
| VCP | 2037.0 |
| SLC47A1 | 2003.0 |
| SLCO2A1 | 2000.0 |
| NIPA2 | 1938.0 |
| ASIC2 | 1918.0 |
| SLC6A5 | 1917.0 |
| FGF21 | 1908.0 |
| DERL2 | 1865.0 |
| SLC6A3 | 1858.0 |
| ATP8A1 | 1828.0 |
| ABCD2 | 1806.0 |
| AQP8 | 1799.0 |
| GNG2 | 1781.0 |
| WNK3 | 1769.0 |
| SLC34A3 | 1735.5 |
| SLC17A6 | 1732.0 |
| CAND1 | 1711.0 |
| AZGP1 | 1695.0 |
| DERL1 | 1681.0 |
| SLC12A3 | 1675.0 |
| SLC36A1 | 1603.0 |
| PSMB2 | 1548.0 |
| SLC30A10 | 1546.0 |
| TRPA1 | 1536.0 |
| BEST4 | 1513.0 |
| PSME4 | 1510.0 |
| PRKAR1B | 1495.0 |
| SLC35B4 | 1486.0 |
| SLC5A1 | 1479.0 |
| ABCB9 | 1461.0 |
| FBXL5 | 1446.0 |
| GNB4 | 1440.0 |
| AQP2 | 1392.0 |
| ATP6V0D1 | 1316.0 |
| AMN | 1309.0 |
| AQP3 | 1301.0 |
| LCN9 | 1276.0 |
| SLC18A1 | 1266.0 |
| P4HB | 1245.0 |
| ANO6 | 1195.0 |
| LCN1 | 1182.0 |
| ATP1A3 | 1164.5 |
| SLC15A3 | 1113.0 |
| CLCN2 | 1112.0 |
| PSMC1 | 1107.0 |
| TSC22D3 | 1052.0 |
| RNF185 | 1043.0 |
| SLC22A6 | 1027.0 |
| RNF5 | 1020.0 |
| UBC | 1013.0 |
| ABCC2 | 1006.0 |
| SLC36A4 | 997.0 |
| ABCC10 | 973.0 |
| ABCG5 | 951.0 |
| MIP | 946.0 |
| ATP10D | 885.0 |
| SLC3A1 | 858.0 |
| AQP9 | 853.0 |
| BEST3 | 847.0 |
| CLCN7 | 720.0 |
| SLC34A1 | 663.5 |
| SLC5A4 | 622.0 |
| SLC15A1 | 604.0 |
| SLC5A10 | 592.0 |
| LIPC | 588.0 |
| SLC9A8 | 512.0 |
| TRPV5 | 481.0 |
| SLC26A6 | 422.0 |
| SLC24A3 | 417.0 |
| ABCB5 | 385.0 |
| CLCNKA | 369.5 |
| CLCNKB | 369.5 |
| NPC1 | 353.0 |
| SLC7A9 | 325.0 |
| PSMD7 | 321.0 |
| SLC5A8 | 302.0 |
| SLC1A6 | 247.0 |
| AQP5 | 225.0 |
| ATP6V1G3 | 225.0 |
| FURIN | 60.0 |
| SKP1 | -82.0 |
| AVP | -90.0 |
| APOE | -136.0 |
| PSMB5 | -153.0 |
| AP2A2 | -158.0 |
| SLC6A11 | -176.0 |
| BEST1 | -219.0 |
| GNG10 | -219.0 |
| RAB11A | -258.0 |
| STOML2 | -277.0 |
| RHAG | -305.0 |
| VDAC3 | -325.0 |
| SLC13A1 | -345.0 |
| CLCA1 | -361.0 |
| VLDLR | -387.0 |
| ANGPTL8 | -399.0 |
| TRPM3 | -437.0 |
| ATP6V1B1 | -443.0 |
| ATP6V0E1 | -470.0 |
| SLC6A19 | -503.0 |
| SLC6A18 | -520.0 |
| KCNJ11 | -540.0 |
| CA1 | -581.0 |
| SLC31A1 | -587.0 |
| SCNN1G | -594.0 |
| PSMA5 | -604.0 |
| SLCO1C1 | -633.0 |
| SLC24A4 | -810.0 |
| MBTPS2 | -837.0 |
| TRPV2 | -946.0 |
| SLC13A5 | -959.0 |
| YME1L1 | -990.0 |
| NEDD4L | -1007.0 |
| SLC9B2 | -1078.0 |
| FXYD4 | -1126.0 |
| SLC5A12 | -1126.0 |
| TRPV6 | -1126.0 |
| SLC26A3 | -1162.0 |
| PSMD3 | -1168.0 |
| PSMD11 | -1181.0 |
| NR1H3 | -1186.0 |
| RAF1 | -1207.0 |
| NIPAL2 | -1253.0 |
| MCOLN2 | -1350.0 |
| NR1H2 | -1366.0 |
| SLC26A9 | -1380.0 |
| SLC5A11 | -1410.0 |
| SLC5A9 | -1410.0 |
| MYO5B | -1444.5 |
| CYB5R4 | -1479.0 |
| SLC24A1 | -1486.0 |
| ATP6V0D2 | -1489.0 |
| SLC22A3 | -1492.0 |
| ASIC5 | -1495.0 |
| FTMT | -1532.0 |
| AHCYL2 | -1540.0 |
| PSMC6 | -1541.0 |
| ATP2B3 | -1554.0 |
| ABCA12 | -1617.0 |
| SLC38A5 | -1653.0 |
| SLC39A6 | -1676.0 |
| PSMA8 | -1679.0 |
| APOB | -1729.0 |
| SLC16A2 | -1761.0 |
| TRPC4AP | -1777.0 |
| ATP13A4 | -1806.0 |
| MYLIP | -1810.0 |
| CLTC | -1818.0 |
| A2M | -1891.0 |
| SLC5A2 | -1927.0 |
| TRPC3 | -1928.0 |
| ANO8 | -1929.0 |
| GNG11 | -1937.0 |
| ATP10A | -2027.0 |
| APOC3 | -2065.5 |
| SLC5A7 | -2065.5 |
| FXYD1 | -2086.0 |
| SLC13A2 | -2101.0 |
| PSMD1 | -2102.0 |
| UNC79 | -2185.0 |
| ATP6V1E1 | -2191.0 |
| SLC13A3 | -2200.0 |
| ATP6AP1 | -2220.0 |
| ATP4B | -2237.0 |
| ATP6V1E2 | -2246.0 |
| ANO3 | -2265.0 |
| TTYH1 | -2273.0 |
| ADCY3 | -2277.0 |
| SLC30A5 | -2293.0 |
| PSMD2 | -2319.0 |
| TRPM8 | -2333.0 |
| RYR3 | -2364.0 |
| PCSK5 | -2367.0 |
| PSMA1 | -2388.0 |
| SLC29A3 | -2395.0 |
| ABCC4 | -2420.0 |
| SLC17A1 | -2494.0 |
| GLRX3 | -2542.0 |
| SGK2 | -2566.0 |
| PSMA7 | -2576.0 |
| CFTR | -2632.0 |
| SLC2A13 | -2635.0 |
| SLC45A3 | -2735.0 |
| ATP1B2 | -2815.0 |
| SLC26A2 | -2832.0 |
| SLC26A11 | -2850.0 |
| ATP6V1D | -2852.0 |
| SLC9A5 | -2897.0 |
| MIR32 | -2910.0 |
| SLC43A1 | -2923.0 |
| TCIRG1 | -2929.0 |
| CUTC | -2950.0 |
| GNG5 | -2972.0 |
| NEDD8 | -2992.0 |
| PSMC4 | -3007.0 |
| SLC12A2 | -3024.0 |
| ATP2A1 | -3044.0 |
| PSMD4 | -3118.0 |
| ATP2B1 | -3182.0 |
| SLCO4C1 | -3230.0 |
| LCAT | -3245.0 |
| ATP1B3 | -3267.0 |
| TRPM2 | -3293.0 |
| TRPC5 | -3297.0 |
| CLCN1 | -3336.0 |
| SLC4A9 | -3342.0 |
| PSMD6 | -3353.0 |
| SLC4A3 | -3361.0 |
| TRPV3 | -3402.0 |
| PSMC2 | -3419.0 |
| CAMK2G | -3492.0 |
| SLC28A3 | -3523.0 |
| SLC22A18 | -3535.0 |
| IREB2 | -3556.0 |
| SLC7A3 | -3604.0 |
| ASIC4 | -3648.0 |
| TRPM6 | -3655.0 |
| PSMB3 | -3665.0 |
| ATP6V0B | -3671.0 |
| SLC8B1 | -3700.0 |
| ABCA3 | -3710.0 |
| SLC1A1 | -3714.0 |
| AP2S1 | -3795.0 |
| SLC7A2 | -3828.0 |
| SLC39A3 | -3841.0 |
| PSMD8 | -3851.0 |
| HFE | -3868.0 |
| SLC34A2 | -3898.0 |
| SLC6A13 | -3927.0 |
| SLC35A1 | -3954.0 |
| CLCA4 | -3977.0 |
| ABCC9 | -3996.0 |
| NPC2 | -4051.0 |
| PSMD14 | -4055.0 |
| SLC9A2 | -4068.0 |
| TRPM7 | -4095.0 |
| SLC6A9 | -4181.0 |
| ERLEC1 | -4213.0 |
| SLC22A12 | -4218.0 |
| NIPAL4 | -4251.0 |
| PEX3 | -4321.0 |
| BEST2 | -4325.0 |
| TRPV1 | -4342.0 |
| ABCA9 | -4400.0 |
| RHCG | -4437.0 |
| SLC41A2 | -4454.0 |
| SLC14A2 | -4481.0 |
| GNG3 | -4499.0 |
| SLC27A6 | -4582.0 |
| SLC7A10 | -4631.0 |
| SLC39A5 | -4658.0 |
| ATP11A | -4665.0 |
| SLC39A8 | -4683.0 |
| ADCY2 | -4754.0 |
| SLC9C1 | -4782.0 |
| APOA1 | -4811.0 |
| SLC18A2 | -4876.0 |
| ASIC3 | -4952.0 |
| ADCY1 | -5008.0 |
| SLC35C1 | -5036.0 |
| SLC16A8 | -5046.0 |
| PSMA2 | -5050.5 |
| PSMA3 | -5078.0 |
| SLC35B3 | -5115.0 |
| DERL3 | -5123.0 |
| SLC1A3 | -5153.0 |
| ATP8B1 | -5219.0 |
| SLC30A7 | -5261.0 |
| SLC44A3 | -5267.0 |
| WWP1 | -5285.0 |
| SLC9A4 | -5326.0 |
| ADD3 | -5398.0 |
| PSMD5 | -5412.0 |
| ABCA5 | -5428.0 |
| TPCN2 | -5457.5 |
| SLC29A2 | -5514.0 |
| PSMB4 | -5607.0 |
| ATP6V1H | -5756.0 |
| EIF2S3 | -5766.5 |
| SLC40A1 | -5771.0 |
| HEPH | -5816.0 |
| PSMB1 | -5931.0 |
| SLC39A1 | -6016.0 |
| GNAS | -6021.0 |
| CLCN5 | -6047.0 |
| PLTP | -6098.0 |
| SCARB1 | -6141.0 |
| SLC2A10 | -6156.0 |
| ABCA4 | -6183.0 |
| SLC1A4 | -6192.0 |
| PSMB7 | -6252.0 |
| SCNN1B | -6270.0 |
| RSC1A1 | -6272.0 |
| LDLR | -6289.0 |
| ABCA8 | -6320.0 |
| MTTP | -6324.0 |
| PRKACB | -6340.0 |
| ABCA1 | -6344.0 |
| ATP9B | -6355.0 |
| MICU3 | -6359.0 |
| ATP8B2 | -6360.0 |
| TRPM1 | -6401.0 |
| EIF2S2 | -6402.0 |
| SLC7A7 | -6426.0 |
| ANO7 | -6428.0 |
| APOC1 | -6439.0 |
| ADCY7 | -6487.0 |
| SAR1B | -6531.0 |
| PSMC5 | -6575.0 |
| SLC8A3 | -6593.0 |
| ATP11C | -6595.0 |
| CUBN | -6631.0 |
| SLC16A10 | -6644.0 |
| CYBRD1 | -6662.0 |
| TFR2 | -6666.0 |
| SLC30A2 | -6669.0 |
| CALM1 | -6675.0 |
| SLC16A3 | -6714.0 |
| SLC14A1 | -6788.0 |
| TTYH2 | -6797.0 |
| SLC9A9 | -6835.0 |
| ABCC5 | -6870.0 |
| ERLIN1 | -6880.0 |
| RYR1 | -6915.0 |
| PSMB6 | -6996.0 |
| TRPC6 | -7002.0 |
| PRKAR2A | -7003.0 |
| SLC7A11 | -7007.0 |
| SLC15A2 | -7011.0 |
| EIF2S1 | -7018.0 |
| SLC2A9 | -7074.0 |
| CLIC2 | -7084.0 |
| FXYD2 | -7136.5 |
| SLC29A1 | -7191.0 |
| RUNX1 | -7206.0 |
| PSMA6 | -7250.0 |
| MBTPS1 | -7280.0 |
| SLC66A1 | -7327.0 |
| ATP8B4 | -7331.0 |
| CAMK2A | -7362.0 |
| CIDEC | -7371.0 |
| PSMA4 | -7394.0 |
| CUL1 | -7405.0 |
| SLCO4A1 | -7409.0 |
| STOML3 | -7412.0 |
| CAMK2B | -7446.0 |
| SLC1A5 | -7484.0 |
| PCSK6 | -7514.0 |
| ANO5 | -7545.0 |
| SLC38A4 | -7551.0 |
| RPS27A | -7640.0 |
| SGK1 | -7659.0 |
| SLC10A6 | -7702.0 |
| TRPC4 | -7744.0 |
| ABCC3 | -7823.0 |
| MFSD4B | -7888.0 |
| CYB5R2 | -7891.0 |
| SLC39A4 | -7900.0 |
| WNK1 | -7918.0 |
| SLC7A8 | -7923.0 |
| HDLBP | -7956.0 |
| ATP2C1 | -7973.0 |
| FTL | -7977.0 |
| FLVCR1 | -8055.0 |
| MAGT1 | -8123.0 |
| TRDN | -8124.0 |
| SLC6A7 | -8151.0 |
| PRKAR2B | -8171.0 |
| ATP7A | -8245.0 |
| AQP4 | -8269.0 |
Peroxisomal lipid metabolism
| 836 | |
|---|---|
| set | Peroxisomal lipid metabolism |
| setSize | 27 |
| pANOVA | 3.54e-05 |
| s.dist | 0.46 |
| p.adjustANOVA | 0.00118 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NUDT7 | 8063 |
| SLC27A2 | 7786 |
| HAO2 | 7672 |
| ACOX2 | 7644 |
| HSD17B4 | 7497 |
| CRAT | 7368 |
| ACOX1 | 7255 |
| PHYH | 7045 |
| ALDH3A2 | 6988 |
| AMACR | 6750 |
| ABCD1 | 6427 |
| ACAA1 | 6125 |
| EHHADH | 6024 |
| NUDT19 | 5464 |
| ACOT6 | 4818 |
| MLYCD | 4748 |
| ACBD5 | 4146 |
| ACOT8 | 3216 |
| HACL1 | 2573 |
| ACOX3 | 2479 |
| GeneID | Gene Rank |
|---|---|
| NUDT7 | 8063 |
| SLC27A2 | 7786 |
| HAO2 | 7672 |
| ACOX2 | 7644 |
| HSD17B4 | 7497 |
| CRAT | 7368 |
| ACOX1 | 7255 |
| PHYH | 7045 |
| ALDH3A2 | 6988 |
| AMACR | 6750 |
| ABCD1 | 6427 |
| ACAA1 | 6125 |
| EHHADH | 6024 |
| NUDT19 | 5464 |
| ACOT6 | 4818 |
| MLYCD | 4748 |
| ACBD5 | 4146 |
| ACOT8 | 3216 |
| HACL1 | 2573 |
| ACOX3 | 2479 |
| ACOXL | 2122 |
| PECR | 1557 |
| ACBD4 | -269 |
| ACOT4 | -2617 |
| SLC25A17 | -5644 |
| ECI2 | -6476 |
| CROT | -8187 |
Synthesis of bile acids and bile salts
| 1212 | |
|---|---|
| set | Synthesis of bile acids and bile salts |
| setSize | 29 |
| pANOVA | 6.39e-05 |
| s.dist | 0.429 |
| p.adjustANOVA | 0.00209 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| AKR1D1 | 7924 |
| SLC27A2 | 7786 |
| OSBPL1A | 7651 |
| ACOX2 | 7644 |
| OSBPL9 | 7624 |
| HSD17B4 | 7497 |
| OSBPL6 | 7390 |
| NCOA1 | 7218 |
| SLC27A5 | 7037 |
| AMACR | 6750 |
| ABCB11 | 6290 |
| NR1H4 | 5883 |
| BAAT | 5784 |
| OSBPL2 | 5717 |
| NCOA2 | 5324 |
| OSBPL3 | 4992 |
| CYP7A1 | 4954 |
| CYP27A1 | 4354 |
| ACOT8 | 3216 |
| CYP46A1 | 2984 |
| GeneID | Gene Rank |
|---|---|
| AKR1D1 | 7924 |
| SLC27A2 | 7786 |
| OSBPL1A | 7651 |
| ACOX2 | 7644 |
| OSBPL9 | 7624 |
| HSD17B4 | 7497 |
| OSBPL6 | 7390 |
| NCOA1 | 7218 |
| SLC27A5 | 7037 |
| AMACR | 6750 |
| ABCB11 | 6290 |
| NR1H4 | 5883 |
| BAAT | 5784 |
| OSBPL2 | 5717 |
| NCOA2 | 5324 |
| OSBPL3 | 4992 |
| CYP7A1 | 4954 |
| CYP27A1 | 4354 |
| ACOT8 | 3216 |
| CYP46A1 | 2984 |
| PTGIS | 2632 |
| OSBP | 2607 |
| CYP8B1 | 2544 |
| RXRA | -1980 |
| HSD3B7 | -2383 |
| CYP39A1 | -4425 |
| CH25H | -7050 |
| OSBPL7 | -7479 |
| CYP7B1 | -7839 |
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol
| 1215 | |
|---|---|
| set | Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
| setSize | 19 |
| pANOVA | 8e-05 |
| s.dist | 0.523 |
| p.adjustANOVA | 0.00255 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| AKR1D1 | 7924 |
| SLC27A2 | 7786 |
| ACOX2 | 7644 |
| HSD17B4 | 7497 |
| NCOA1 | 7218 |
| SLC27A5 | 7037 |
| AMACR | 6750 |
| ABCB11 | 6290 |
| NR1H4 | 5883 |
| BAAT | 5784 |
| NCOA2 | 5324 |
| CYP7A1 | 4954 |
| CYP27A1 | 4354 |
| ACOT8 | 3216 |
| PTGIS | 2632 |
| CYP8B1 | 2544 |
| RXRA | -1980 |
| HSD3B7 | -2383 |
| CYP7B1 | -7839 |
| GeneID | Gene Rank |
|---|---|
| AKR1D1 | 7924 |
| SLC27A2 | 7786 |
| ACOX2 | 7644 |
| HSD17B4 | 7497 |
| NCOA1 | 7218 |
| SLC27A5 | 7037 |
| AMACR | 6750 |
| ABCB11 | 6290 |
| NR1H4 | 5883 |
| BAAT | 5784 |
| NCOA2 | 5324 |
| CYP7A1 | 4954 |
| CYP27A1 | 4354 |
| ACOT8 | 3216 |
| PTGIS | 2632 |
| CYP8B1 | 2544 |
| RXRA | -1980 |
| HSD3B7 | -2383 |
| CYP7B1 | -7839 |
Separation of Sister Chromatids
| 1099 | |
|---|---|
| set | Separation of Sister Chromatids |
| setSize | 157 |
| pANOVA | 0.000167 |
| s.dist | -0.174 |
| p.adjustANOVA | 0.0052 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| DYNC1LI2 | -8117 |
| KIF18A | -7894 |
| RPS27A | -7640 |
| MAPRE1 | -7594 |
| SGO2 | -7553 |
| NDC80 | -7482 |
| RANBP2 | -7410 |
| PSMA4 | -7394 |
| DYNC1I2 | -7307 |
| PSMA6 | -7250 |
| NSL1 | -7209 |
| PDS5B | -7204 |
| CENPK | -7198 |
| ZWILCH | -7171 |
| CENPM | -7089 |
| ANAPC10 | -7079 |
| PPP2R5A | -7024 |
| PSMB6 | -6996 |
| PPP2R1B | -6978 |
| PPP2R5C | -6762 |
| GeneID | Gene Rank |
|---|---|
| DYNC1LI2 | -8117.0 |
| KIF18A | -7894.0 |
| RPS27A | -7640.0 |
| MAPRE1 | -7594.0 |
| SGO2 | -7553.0 |
| NDC80 | -7482.0 |
| RANBP2 | -7410.0 |
| PSMA4 | -7394.0 |
| DYNC1I2 | -7307.0 |
| PSMA6 | -7250.0 |
| NSL1 | -7209.0 |
| PDS5B | -7204.0 |
| CENPK | -7198.0 |
| ZWILCH | -7171.0 |
| CENPM | -7089.0 |
| ANAPC10 | -7079.0 |
| PPP2R5A | -7024.0 |
| PSMB6 | -6996.0 |
| PPP2R1B | -6978.0 |
| PPP2R5C | -6762.0 |
| NUP43 | -6740.0 |
| ESPL1 | -6668.0 |
| PSMC5 | -6575.0 |
| ITGB3BP | -6486.0 |
| STAG1 | -6464.0 |
| BIRC5 | -6388.0 |
| UBE2C | -6382.0 |
| CENPL | -6358.0 |
| PSMB7 | -6252.0 |
| UBE2E1 | -6131.0 |
| PSMB1 | -5931.0 |
| NUF2 | -5692.0 |
| PDS5A | -5677.0 |
| NUP160 | -5641.0 |
| PSMB4 | -5607.0 |
| PTTG1 | -5560.5 |
| SEC13 | -5544.0 |
| CDC20 | -5454.0 |
| NDEL1 | -5451.0 |
| PSMD5 | -5412.0 |
| KNTC1 | -5312.0 |
| STAG2 | -5293.0 |
| KIF2C | -5213.0 |
| PSMA3 | -5078.0 |
| PSMA2 | -5050.5 |
| ZWINT | -5019.0 |
| ANAPC1 | -4990.0 |
| CENPA | -4978.0 |
| CENPF | -4787.0 |
| CENPU | -4727.0 |
| NUP107 | -4634.0 |
| ANAPC4 | -4616.0 |
| KIF2A | -4566.0 |
| SPDL1 | -4476.0 |
| UBE2S | -4447.0 |
| SPC25 | -4427.0 |
| WAPL | -4097.0 |
| PSMD14 | -4055.0 |
| PSMD8 | -3851.0 |
| ANAPC16 | -3705.0 |
| PSMB3 | -3665.0 |
| BUB1B | -3498.5 |
| PSMC2 | -3419.0 |
| UBE2D1 | -3359.0 |
| PSMD6 | -3353.0 |
| PSMD4 | -3118.0 |
| DYNC1I1 | -3094.0 |
| CDC27 | -3085.0 |
| BUB3 | -3061.0 |
| SPC24 | -3045.0 |
| PSMC4 | -3007.0 |
| ERCC6L | -2999.0 |
| PSMA7 | -2576.0 |
| CENPP | -2558.0 |
| CDCA8 | -2497.0 |
| KNL1 | -2495.0 |
| ANAPC5 | -2429.0 |
| PSMA1 | -2388.0 |
| DYNLL2 | -2370.0 |
| PLK1 | -2358.0 |
| PSMD2 | -2319.0 |
| CENPT | -2217.0 |
| CDCA5 | -2194.0 |
| PSMD1 | -2102.0 |
| NUDC | -1938.0 |
| ANAPC15 | -1852.0 |
| CKAP5 | -1758.0 |
| PSMA8 | -1679.0 |
| PSMC6 | -1541.0 |
| CENPH | -1458.0 |
| CENPI | -1365.0 |
| INCENP | -1351.0 |
| SKA1 | -1240.0 |
| PSMD11 | -1181.0 |
| DYNLL1 | -1170.0 |
| PSMD3 | -1168.0 |
| PSMA5 | -604.0 |
| CENPC | -183.0 |
| PSMB5 | -153.0 |
| HDAC8 | -113.5 |
| TAOK1 | -79.0 |
| PSMD7 | 321.0 |
| NUP37 | 424.0 |
| PPP2CA | 497.0 |
| PAFAH1B1 | 869.0 |
| CENPO | 895.0 |
| CDC23 | 954.0 |
| MAD1L1 | 988.0 |
| UBC | 1013.0 |
| PSMC1 | 1107.0 |
| MAD2L1 | 1260.0 |
| SMC1A | 1369.0 |
| DSN1 | 1476.0 |
| CENPQ | 1492.0 |
| PSME4 | 1510.0 |
| PSMB2 | 1548.0 |
| PPP2R5B | 1592.0 |
| PPP2CB | 1876.0 |
| XPO1 | 2059.0 |
| SKA2 | 2089.0 |
| PSME2 | 2230.0 |
| PSMC3 | 2256.0 |
| PPP2R5E | 2334.0 |
| B9D2 | 2398.0 |
| AURKB | 2419.0 |
| NUP85 | 2708.0 |
| SGO1 | 2870.0 |
| DYNC1LI1 | 2899.0 |
| ZW10 | 3246.0 |
| CENPE | 3317.0 |
| PPP2R1A | 3805.0 |
| ANAPC2 | 3809.0 |
| RCC2 | 3900.0 |
| PSMD12 | 4108.0 |
| PSMD13 | 4498.0 |
| NUP98 | 4522.0 |
| NDE1 | 4587.0 |
| BUB1 | 4819.0 |
| PSMB9 | 5019.0 |
| NUP133 | 5700.0 |
| PPP2R5D | 5723.0 |
| CENPN | 5911.0 |
| PSMF1 | 6184.0 |
| SMC3 | 6522.0 |
| PSME1 | 6608.0 |
| CDC16 | 6620.0 |
| CLASP2 | 6800.0 |
| PMF1 | 6871.0 |
| ANAPC7 | 6926.0 |
| AHCTF1 | 7008.0 |
| RAD21 | 7098.0 |
| PSMB8 | 7523.0 |
| PPP1CC | 7613.0 |
| RANGAP1 | 7699.0 |
| DYNC1H1 | 7820.0 |
| CLIP1 | 8035.0 |
| CLASP1 | 8148.0 |
Generation of second messenger molecules
| 469 | |
|---|---|
| set | Generation of second messenger molecules |
| setSize | 24 |
| pANOVA | 2e-04 |
| s.dist | -0.438 |
| p.adjustANOVA | 0.00612 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HLA-DQB1 | -8259.5 |
| HLA-DQB2 | -8259.5 |
| HLA-DRA | -8140.0 |
| CD101 | -7849.0 |
| PAK3 | -7738.0 |
| PAK1 | -7605.0 |
| VASP | -7374.0 |
| WAS | -6934.0 |
| TRBC1 | -6620.5 |
| PAK2 | -6088.0 |
| CD247 | -5933.0 |
| GRAP2 | -5255.0 |
| CD3E | -4862.0 |
| ITK | -4571.0 |
| CD3D | -3905.0 |
| CD3G | -3199.0 |
| LCP2 | -2749.0 |
| LAT | -2726.0 |
| LCK | 916.0 |
| PLCG2 | 1922.0 |
| GeneID | Gene Rank |
|---|---|
| HLA-DQB1 | -8259.5 |
| HLA-DQB2 | -8259.5 |
| HLA-DRA | -8140.0 |
| CD101 | -7849.0 |
| PAK3 | -7738.0 |
| PAK1 | -7605.0 |
| VASP | -7374.0 |
| WAS | -6934.0 |
| TRBC1 | -6620.5 |
| PAK2 | -6088.0 |
| CD247 | -5933.0 |
| GRAP2 | -5255.0 |
| CD3E | -4862.0 |
| ITK | -4571.0 |
| CD3D | -3905.0 |
| CD3G | -3199.0 |
| LCP2 | -2749.0 |
| LAT | -2726.0 |
| LCK | 916.0 |
| PLCG2 | 1922.0 |
| EVL | 2510.0 |
| PLCG1 | 3263.0 |
| ENAH | 4245.0 |
| NCK1 | 7272.0 |
TCR signaling
| 1226 | |
|---|---|
| set | TCR signaling |
| setSize | 96 |
| pANOVA | 0.000289 |
| s.dist | -0.214 |
| p.adjustANOVA | 0.00863 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PTPRC | -8287.0 |
| HLA-DQB1 | -8259.5 |
| HLA-DQB2 | -8259.5 |
| HLA-DRA | -8140.0 |
| CD101 | -7849.0 |
| PAK3 | -7738.0 |
| RPS27A | -7640.0 |
| PAK1 | -7605.0 |
| CUL1 | -7405.0 |
| PSMA4 | -7394.0 |
| VASP | -7374.0 |
| PSMA6 | -7250.0 |
| PSMB6 | -6996.0 |
| TAB2 | -6989.0 |
| WAS | -6934.0 |
| TRBC1 | -6620.5 |
| PSMC5 | -6575.0 |
| PSMB7 | -6252.0 |
| PAK2 | -6088.0 |
| CD247 | -5933.0 |
| GeneID | Gene Rank |
|---|---|
| PTPRC | -8287.0 |
| HLA-DQB1 | -8259.5 |
| HLA-DQB2 | -8259.5 |
| HLA-DRA | -8140.0 |
| CD101 | -7849.0 |
| PAK3 | -7738.0 |
| RPS27A | -7640.0 |
| PAK1 | -7605.0 |
| CUL1 | -7405.0 |
| PSMA4 | -7394.0 |
| VASP | -7374.0 |
| PSMA6 | -7250.0 |
| PSMB6 | -6996.0 |
| TAB2 | -6989.0 |
| WAS | -6934.0 |
| TRBC1 | -6620.5 |
| PSMC5 | -6575.0 |
| PSMB7 | -6252.0 |
| PAK2 | -6088.0 |
| CD247 | -5933.0 |
| PSMB1 | -5931.0 |
| PSMB4 | -5607.0 |
| PSMD5 | -5412.0 |
| GRAP2 | -5255.0 |
| MALT1 | -5170.0 |
| PSMA3 | -5078.0 |
| PSMA2 | -5050.5 |
| IKBKB | -5045.0 |
| CD3E | -4862.0 |
| CDC34 | -4678.0 |
| ITK | -4571.0 |
| PSMD14 | -4055.0 |
| PRKCQ | -3997.0 |
| CD3D | -3905.0 |
| PSMD8 | -3851.0 |
| PSMB3 | -3665.0 |
| INPP5D | -3469.0 |
| PSMC2 | -3419.0 |
| UBE2D1 | -3359.0 |
| PSMD6 | -3353.0 |
| CD3G | -3199.0 |
| PSMD4 | -3118.0 |
| MAP3K7 | -3011.0 |
| PSMC4 | -3007.0 |
| LCP2 | -2749.0 |
| LAT | -2726.0 |
| PIK3CA | -2711.0 |
| PSMA7 | -2576.0 |
| PTPRJ | -2509.0 |
| PSMA1 | -2388.0 |
| PSMD2 | -2319.0 |
| CHUK | -2181.0 |
| TRAT1 | -2158.0 |
| PSMD1 | -2102.0 |
| PIK3R2 | -2014.5 |
| BCL10 | -1692.0 |
| PSMA8 | -1679.0 |
| PSMC6 | -1541.0 |
| PSMD11 | -1181.0 |
| PSMD3 | -1168.0 |
| PSMA5 | -604.0 |
| BTRC | -286.0 |
| UBE2N | -184.5 |
| PSMB5 | -153.0 |
| SKP1 | -82.0 |
| PTEN | 0.0 |
| PSMD7 | 321.0 |
| LCK | 916.0 |
| UBC | 1013.0 |
| PSMC1 | 1107.0 |
| IKBKG | 1225.0 |
| PSME4 | 1510.0 |
| PSMB2 | 1548.0 |
| PAG1 | 1610.0 |
| RIPK2 | 1837.0 |
| PLCG2 | 1922.0 |
| PSME2 | 2230.0 |
| PSMC3 | 2256.0 |
| EVL | 2510.0 |
| PDPK1 | 2786.0 |
| PLCG1 | 3263.0 |
| RELA | 3959.0 |
| PSMD12 | 4108.0 |
| ENAH | 4245.0 |
| TRAF6 | 4327.0 |
| PSMD13 | 4498.0 |
| PTPN22 | 4790.0 |
| CSK | 4821.0 |
| PSMB9 | 5019.0 |
| FBXW11 | 5901.0 |
| NFKB1 | 6004.0 |
| PSMF1 | 6184.0 |
| PSME1 | 6608.0 |
| NCK1 | 7272.0 |
| PIK3R1 | 7450.0 |
| PSMB8 | 7523.0 |
Complex I biogenesis
| 210 | |
|---|---|
| set | Complex I biogenesis |
| setSize | 46 |
| pANOVA | 0.000344 |
| s.dist | 0.305 |
| p.adjustANOVA | 0.0101 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NDUFA10 | 7483 |
| NDUFA8 | 7131 |
| NDUFA12 | 7130 |
| NDUFAB1 | 6996 |
| ECSIT | 6963 |
| NDUFV1 | 6489 |
| ACAD9 | 6453 |
| NDUFA9 | 6209 |
| NDUFB10 | 6086 |
| NDUFS5 | 5612 |
| MT-ND1 | 5579 |
| NDUFB7 | 5573 |
| NDUFV3 | 5524 |
| NDUFAF7 | 5479 |
| NDUFB6 | 4983 |
| MT-ND5 | 4937 |
| MT-ND2 | 4879 |
| TIMMDC1 | 4862 |
| MT-ND6 | 4767 |
| MT-ND4 | 4382 |
| GeneID | Gene Rank |
|---|---|
| NDUFA10 | 7483.0 |
| NDUFA8 | 7131.0 |
| NDUFA12 | 7130.0 |
| NDUFAB1 | 6996.0 |
| ECSIT | 6963.0 |
| NDUFV1 | 6489.0 |
| ACAD9 | 6453.0 |
| NDUFA9 | 6209.0 |
| NDUFB10 | 6086.0 |
| NDUFS5 | 5612.0 |
| MT-ND1 | 5579.0 |
| NDUFB7 | 5573.0 |
| NDUFV3 | 5524.0 |
| NDUFAF7 | 5479.0 |
| NDUFB6 | 4983.0 |
| MT-ND5 | 4937.0 |
| MT-ND2 | 4879.0 |
| TIMMDC1 | 4862.0 |
| MT-ND6 | 4767.0 |
| MT-ND4 | 4382.0 |
| NDUFS3 | 4380.0 |
| NDUFB11 | 4068.0 |
| NDUFAF3 | 3956.0 |
| NDUFS1 | 3819.0 |
| NDUFS8 | 3493.0 |
| NDUFS7 | 3090.0 |
| NDUFB4 | 2890.0 |
| NDUFAF6 | 2862.0 |
| NDUFA6 | 2222.0 |
| NDUFS4 | 2132.0 |
| NDUFAF4 | 1307.0 |
| NDUFAF1 | 1191.0 |
| NDUFB8 | 1015.5 |
| NDUFA13 | 544.0 |
| NDUFA3 | -953.0 |
| NDUFB5 | -1930.0 |
| NDUFV2 | -2183.0 |
| NDUFC2 | -3052.5 |
| MT-ND3 | -3112.0 |
| NDUFA11 | -3345.5 |
| NUBPL | -3355.0 |
| NDUFA2 | -3380.0 |
| NDUFS2 | -3401.0 |
| NDUFAF5 | -4827.0 |
| TMEM126B | -5318.0 |
| NDUFB3 | -6948.0 |
PD-1 signaling
| 801 | |
|---|---|
| set | PD-1 signaling |
| setSize | 15 |
| pANOVA | 0.000593 |
| s.dist | -0.512 |
| p.adjustANOVA | 0.017 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HLA-DQB1 | -8259.5 |
| HLA-DQB2 | -8259.5 |
| PTPN6 | -8219.0 |
| HLA-DRA | -8140.0 |
| TRBC1 | -6620.5 |
| PDCD1 | -6489.0 |
| CD247 | -5933.0 |
| CD3E | -4862.0 |
| CD3D | -3905.0 |
| PDCD1LG2 | -3847.0 |
| PTPN11 | -3777.0 |
| CD3G | -3199.0 |
| LCK | 916.0 |
| CD274 | 1677.0 |
| CSK | 4821.0 |
| GeneID | Gene Rank |
|---|---|
| HLA-DQB1 | -8259.5 |
| HLA-DQB2 | -8259.5 |
| PTPN6 | -8219.0 |
| HLA-DRA | -8140.0 |
| TRBC1 | -6620.5 |
| PDCD1 | -6489.0 |
| CD247 | -5933.0 |
| CD3E | -4862.0 |
| CD3D | -3905.0 |
| PDCD1LG2 | -3847.0 |
| PTPN11 | -3777.0 |
| CD3G | -3199.0 |
| LCK | 916.0 |
| CD274 | 1677.0 |
| CSK | 4821.0 |
Protein localization
| 897 | |
|---|---|
| set | Protein localization |
| setSize | 144 |
| pANOVA | 0.000618 |
| s.dist | 0.165 |
| p.adjustANOVA | 0.0173 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NUDT7 | 8063.0 |
| TIMM50 | 7840.0 |
| SLC27A2 | 7786.0 |
| GRPEL1 | 7779.0 |
| MTX1 | 7773.0 |
| LONP2 | 7750.0 |
| LDHD | 7733.0 |
| HAO2 | 7672.0 |
| ACOX2 | 7644.0 |
| ACOT2 | 7508.5 |
| APP | 7507.0 |
| HSD17B4 | 7497.0 |
| PEX19 | 7473.0 |
| ACO2 | 7469.0 |
| TIMM44 | 7410.0 |
| CRAT | 7368.0 |
| CS | 7355.0 |
| ACOX1 | 7255.0 |
| PHYH | 7045.0 |
| PMPCA | 7035.0 |
| GeneID | Gene Rank |
|---|---|
| NUDT7 | 8063.0 |
| TIMM50 | 7840.0 |
| SLC27A2 | 7786.0 |
| GRPEL1 | 7779.0 |
| MTX1 | 7773.0 |
| LONP2 | 7750.0 |
| LDHD | 7733.0 |
| HAO2 | 7672.0 |
| ACOX2 | 7644.0 |
| ACOT2 | 7508.5 |
| APP | 7507.0 |
| HSD17B4 | 7497.0 |
| PEX19 | 7473.0 |
| ACO2 | 7469.0 |
| TIMM44 | 7410.0 |
| CRAT | 7368.0 |
| CS | 7355.0 |
| ACOX1 | 7255.0 |
| PHYH | 7045.0 |
| PMPCA | 7035.0 |
| ALDH3A2 | 6988.0 |
| ABCD3 | 6773.0 |
| AMACR | 6750.0 |
| UBE2J2 | 6724.0 |
| EMD | 6675.0 |
| SAMM50 | 6561.0 |
| ATP5F1B | 6480.0 |
| ECH1 | 6452.0 |
| ABCD1 | 6427.0 |
| TIMM22 | 6422.0 |
| VAMP2 | 6400.5 |
| PITRM1 | 6359.0 |
| IDH3G | 6298.0 |
| GNPAT | 6274.0 |
| TAZ | 6238.0 |
| PEX26 | 6222.0 |
| SLC25A12 | 6148.0 |
| ACAA1 | 6125.0 |
| PEX7 | 6090.0 |
| HSPA9 | 6038.0 |
| EHHADH | 6024.0 |
| BAAT | 5784.0 |
| EPHX2 | 5626.0 |
| NUDT19 | 5464.0 |
| TOMM40 | 5429.0 |
| CAT | 5335.0 |
| BAG6 | 5304.0 |
| OTC | 4960.0 |
| CYC1 | 4883.0 |
| MLYCD | 4748.0 |
| PXMP4 | 4429.0 |
| PAOX | 4192.5 |
| GET3 | 4148.0 |
| ACBD5 | 4146.0 |
| TIMM17A | 4145.0 |
| SLC25A4 | 4136.0 |
| DHRS4 | 4126.5 |
| VDAC1 | 3653.0 |
| MTX2 | 3387.0 |
| CHCHD3 | 3262.0 |
| ACOT8 | 3216.0 |
| PEX12 | 3158.0 |
| CHCHD10 | 3156.0 |
| PXMP2 | 3147.0 |
| HAO1 | 3075.0 |
| TIMM21 | 2922.0 |
| SLC25A13 | 2731.0 |
| HMOX1 | 2671.0 |
| CHCHD7 | 2631.0 |
| HACL1 | 2573.0 |
| HSPD1 | 2540.0 |
| PEX11B | 2503.0 |
| ACOX3 | 2479.0 |
| PEX5 | 2358.0 |
| PEX6 | 2282.0 |
| PMPCB | 2100.0 |
| FXN | 1911.0 |
| HMGCL | 1875.0 |
| ABCD2 | 1806.0 |
| PEX10 | 1682.0 |
| PECR | 1557.0 |
| BCS1L | 1252.0 |
| NDUFB8 | 1015.5 |
| UBC | 1013.0 |
| PEX14 | 982.0 |
| TOMM22 | 929.0 |
| SGTA | 760.0 |
| COQ2 | 749.0 |
| AGPS | 484.0 |
| TIMM13 | 265.0 |
| TOMM20 | -422.0 |
| GSTK1 | -481.0 |
| TIMM8A | -867.0 |
| GDAP1 | -1041.0 |
| OTOF | -1308.0 |
| CHCHD2 | -1467.0 |
| PEX1 | -1478.0 |
| IDH1 | -1627.0 |
| TOMM70 | -1868.0 |
| DNAJC19 | -2135.0 |
| STX1A | -2228.0 |
| TIMM10 | -2414.0 |
| ACOT4 | -2617.0 |
| PRNP | -2909.0 |
| HSCB | -3003.0 |
| CHCHD5 | -3068.0 |
| CHCHD4 | -3136.0 |
| GET1 | -3137.0 |
| UBE2D1 | -3359.0 |
| PIPOX | -3372.0 |
| GFER | -3386.0 |
| PAM16 | -3641.0 |
| MPV17 | -3835.0 |
| STX5 | -4049.0 |
| PEX3 | -4321.0 |
| CAMLG | -4503.0 |
| IDE | -4564.0 |
| PEX16 | -4578.0 |
| ZFAND6 | -4623.0 |
| DAO | -4749.0 |
| SEC61B | -4808.0 |
| DDO | -4966.0 |
| TIMM23 | -5484.0 |
| TYSND1 | -5636.0 |
| SLC25A17 | -5644.0 |
| NOS2 | -5755.0 |
| SEC61G | -5830.0 |
| AGXT | -6265.0 |
| CMC4 | -6302.0 |
| ECI2 | -6476.0 |
| GET4 | -6852.0 |
| TOMM7 | -7043.0 |
| TIMM8B | -7159.0 |
| PEX13 | -7177.0 |
| PEX2 | -7231.0 |
| VAPA | -7396.0 |
| UBE2D3 | -7462.0 |
| COX19 | -7585.0 |
| RPS27A | -7640.0 |
| TIMM9 | -7663.0 |
| SERP1 | -7703.0 |
| USP9X | -7812.0 |
| TIMM10B | -7813.5 |
| CROT | -8187.0 |
Here is the session info with all the versions of packages used.
sessionInfo()
## R version 4.2.0 (2022-04-22)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 20.04.4 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/openblas-pthread/libblas.so.3
## LAPACK: /usr/lib/x86_64-linux-gnu/openblas-pthread/liblapack.so.3
##
## locale:
## [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8
## [5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
## [7] LC_PAPER=en_US.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C
##
## attached base packages:
## [1] parallel stats4 stats graphics grDevices utils datasets
## [8] methods base
##
## other attached packages:
## [1] pkgload_1.2.4 GGally_2.1.2
## [3] ggplot2_3.3.5 beeswarm_0.4.0
## [5] gtools_3.9.2 tibble_3.1.6
## [7] dplyr_1.0.8 echarts4r_0.4.3
## [9] kableExtra_1.3.4 gplots_3.1.1
## [11] mitch_1.5.1 DESeq2_1.32.0
## [13] SummarizedExperiment_1.22.0 Biobase_2.52.0
## [15] MatrixGenerics_1.4.3 matrixStats_0.61.0
## [17] GenomicRanges_1.44.0 GenomeInfoDb_1.28.4
## [19] IRanges_2.26.0 S4Vectors_0.30.0
## [21] BiocGenerics_0.38.0 reshape2_1.4.4
##
## loaded via a namespace (and not attached):
## [1] colorspace_2.0-3 ellipsis_0.3.2 rprojroot_2.0.2
## [4] XVector_0.32.0 rstudioapi_0.13 bit64_4.0.5
## [7] AnnotationDbi_1.54.1 fansi_1.0.2 xml2_1.3.3
## [10] splines_4.2.0 cachem_1.0.6 geneplotter_1.70.0
## [13] knitr_1.37 jsonlite_1.7.3 annotate_1.70.0
## [16] png_0.1-7 shiny_1.7.1 compiler_4.2.0
## [19] httr_1.4.2 assertthat_0.2.1 Matrix_1.4-1
## [22] fastmap_1.1.0 cli_3.2.0 later_1.3.0
## [25] htmltools_0.5.2 tools_4.2.0 gtable_0.3.0
## [28] glue_1.6.1 GenomeInfoDbData_1.2.6 Rcpp_1.0.8
## [31] jquerylib_0.1.4 vctrs_0.3.8 Biostrings_2.60.2
## [34] svglite_2.1.0 xfun_0.29 stringr_1.4.0
## [37] brio_1.1.3 testthat_3.1.2 rvest_1.0.2
## [40] mime_0.12 lifecycle_1.0.1 XML_3.99-0.8
## [43] zlibbioc_1.38.0 MASS_7.3-57 scales_1.1.1
## [46] promises_1.2.0.1 RColorBrewer_1.1-2 yaml_2.3.5
## [49] memoise_2.0.1 gridExtra_2.3 sass_0.4.0
## [52] reshape_0.8.8 stringi_1.7.6 RSQLite_2.2.10
## [55] highr_0.9 genefilter_1.74.0 desc_1.4.0
## [58] caTools_1.18.2 BiocParallel_1.26.2 rlang_1.0.1
## [61] pkgconfig_2.0.3 systemfonts_1.0.4 bitops_1.0-7
## [64] evaluate_0.15 lattice_0.20-45 purrr_0.3.4
## [67] htmlwidgets_1.5.4 bit_4.0.4 tidyselect_1.1.2
## [70] plyr_1.8.6 magrittr_2.0.2 R6_2.5.1
## [73] generics_0.1.2 DelayedArray_0.18.0 DBI_1.1.2
## [76] pillar_1.7.0 withr_2.4.3 survival_3.2-13
## [79] KEGGREST_1.32.0 RCurl_1.98-1.6 crayon_1.5.0
## [82] KernSmooth_2.23-20 utf8_1.2.2 rmarkdown_2.11
## [85] locfit_1.5-9.4 grid_4.2.0 blob_1.2.2
## [88] digest_0.6.29 webshot_0.5.2 xtable_1.8-4
## [91] httpuv_1.6.5 munsell_0.5.0 viridisLite_0.4.0
## [94] bslib_0.3.1
END of report